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Abstract
Equity of utilisation of cardiovascular care and mental
health services in England: a cohort-based cross-sectional
study using small-area estimation
Sheena Asthana,1* Alex Gibson,1 Trevor Bailey,2 Graham Moon,3
Paul Hewson4 and Chris Dibben5
1School of Government, University of Plymouth, Plymouth, UK
2College of Mathematics and Physical Sciences, University of Exeter, Exeter, UK
3School of Geography and the Environment, University of Southampton, Southampton, UK
4School of Computing and Mathematics, University of Plymouth, Plymouth, UK
5School of Geosciences, University of Edinburgh, Edinburgh, UK
*Corresponding author sasthana@plymouth.ac.uk
Background: A strong policy emphasis on the need to reduce both health inequalities and unmet need in
deprived areas has resulted in the substantial redistribution of English NHS funding towards deprived areas.
This raises the question of whether or not socioeconomically disadvantaged people continue to be
disadvantaged in their access to and utilisation of health care.
Objectives: To generate estimates of the prevalence of cardiovascular disease (CVD) and common mental
health disorders (CMHDs) at a variety of scales, and to make these available for public use via Public Health
England (PHE). To compare these estimates with utilisation of NHS services in England to establish whether
inequalities of use relative to need at various stages on the health-care pathway are associated with
particular sociodemographic or other factors.
Design: Cross-sectional analysis of practice-, primary care trust- and Clinical Commissioning Group-level
variations in diagnosis, prescribing and specialist management of CVD and CMHDs relative to the
estimated prevalence of those conditions (calculated using small-area estimation).
Results: The utilisation of CVD care appears more equitable than the utilisation of care for CMHDs.
In contrast to the reviewed literature, we found little evidence of underutilisation of services by older
populations. Indeed, younger populations appear to be less likely to access care for some CVD conditions.
Nor did deprivation emerge as a consistent predictor of lower use relative to need for either CVD or
CMHDs. Ethnicity is a consistent predictor of variations in use relative to need. Rates of primary
management are lower than expected in areas with higher percentages of black populations for diabetes,
stroke and CMHDs. Areas with higher Asian populations have higher-than-expected rates of diabetes
presentation and prescribing and lower-than-expected rates of secondary care for diabetes. For both sets
of conditions, there are pronounced geographical variations in use relative to need. For instance, the North
East has relatively high levels of use of cardiac care services and rural (shire) areas have low levels of use
relative to need. For CMHDs, there appears to be a pronounced ‘London effect’, with the number of
people registered by general practitioners as having depression, or being prescribed antidepressants, being
much lower in London than expected. A total of 24 CVD and 41 CMHD prevalence estimates have been
provided to PHE and will be publicly available at a range of scales, from lower- and middle-layer super
output areas through to Clinical Commissioning Groups and local authorities.
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Conclusions: We found little evidence of socioeconomic inequality in use for CVD and CMHDs relative to
underlying need, which suggests that the strong targeting of NHS resources to deprived areas may well
have addressed longstanding concerns about unmet need. However, ethnicity has emerged as a significant
predictor of inequality, and there are large and unexplained geographical variations in use relative to need
for both conditions which undermine the principle of equal access to health care for equal needs. The
persistence of ethnic variations and the role of systematic factors (such as rurality) in shaping patterns of
utilisation deserve further investigation, as does the fact that the models were far better at explaining
variation in use of CVD than mental health services.
Funding: The National Institute for Health Research Health Services and Delivery Research programme.
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BOX 1 Standard LSI code frame 111
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Access The processes by which people gain entry to the health-care system (or from lower to higher levels
of the health-care system), which may be measured through service availability, service utilisation, service
quality and service outcomes.
Adjudication The process by which claims to candidacy (or expressed need) are judged and acted on by
health professionals. Again, systematic differences in adjudication at the population level are of interest
in this quantitative study. For example, are there differences in the primary or specialist management of
disease according to age, sex, socioeconomic status or ethnicity?
Candidacy The way(s) in which people recognise their eligibility for medical attention, leading them to
express their needs to health professionals. A key issue is whether or not and how demand-side factors
influence this process.
Deep end A term often applied to socioeconomically deprived areas with populations suffering complex
and interacting physical and mental health problems, financial difficulties, social and emotional problems,
substance abuse, chaotic lifestyles, etc. The expression aims to highlight the difficulties local general
practitioners face in such areas.
Demand-side factors Factors that influence a person’s decision to seek health care in the first place,
or to accept offers of care. In addition to clinical need, these may include knowledge, information,
psychological fears such as fear or stigma and practical issues such as difficulties in taking time off work.
Here, we are interested in systematic differences in the ways in which people express candidacy at a
population level. For example, are people of lower socioeconomic status less or more likely to seek health
care for the same symptoms?
Extra-welfarism An economic theory that departs from traditional welfare economics by prioritising
outcomes over utility, allowing gains in health to outweigh losses and promoting social over
individual values.
Health-care equity Equal availability or equal utilisation or health care for those in equal clinical need of
health care.
Health equity Equality in terms of health outcomes (i.e. no inequalities in health status).
Horizontal equity The equal treatment of equals (i.e. those who have equal levels of clinical need have
equal access to health care).
Illegitimate variation Variations in access which reflect unmet need or unjustified supply.
Inverse care law An observation first made by Julian Tudor Hart in 1971, whereby the availability of
good medical care varies inversely with the need for it in the population served. Tudor Hart was particularly
concerned with inverse care in the distribution of general practitioners. However, the term is now applied
beyond primary care and tends to be associated with the needs of socioeconomically deprived populations.
Legitimate variation Variations in utilisation which reflect variations in underlying need.
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Residualism Access to welfare is targeted at those who fall below a certain (e.g. income) threshold
(see also Selectivism). This approach is associated with means testing and social stigmatisation, although
targeted approaches to NHS provision have avoided this association because the NHS is still classed as a
universal service.
Rule of rescue Health care is provided in response to immediate clinical need.
Selectivism Access to welfare excludes those who are not considered sufficiently needy (see also
Residualism); that is, access is targeted.
Supply-side factors System/organisational factors that affect people’s ability to access care. Includes lack
of capacity (e.g. to provide specialist services or to ensure reasonable waiting times); variations in quality
(e.g. single-handed practice issues, specialist vs. generalist consultants); and differences in resource
allocation and features of service configuration (e.g. access to regional centres).
Universalism The unconditional and (other than responding to need) unfixed provision of social welfare
for all, financed by government on a non-discriminatory basis. It is the opposite of selective or
residual welfare.
Vertical equity The unequal treatment of equals (i.e. those who have equal levels of clinical need) in
order to achieve a greater equality in health outcomes (such as life expectancy).
Weighted capitation The approach by which per-capita needs for NHS funding are determined. In
England, this has been dominated by an econometric approach (where need for services over and above
that determined by age and sex and unavoidable differences in cost is established through the regression
modelling of use of services, attempting to control for supply).
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List of abbreviations
A&E accident and emergency
ACE angiotensin-converting-enzyme
ADS Attribution Data Set
APHO Association of Public Health
Observatories
APMS Adult Psychiatric Morbidity Survey
ARB angiotensin receptor blocker
AREA Allocation of Resources to
English Areas
BNF British National Formulary
CABG coronary artery bypass graft
CCG Clinical Commissioning Group
CHD coronary heart disease
CI confidence interval
CIS-R Clinical Interview Schedule –
Revised
CKD chronic kidney disease
CMHD common mental health disorder
COPD chronic obstructive pulmonary
disease
CRD Centre for Reviews and
Dissemination
CRHT crisis resolution and home
treatment
CVD cardiovascular disease
GHQ12 12-item General Health
Questionnaire
GHS General Household Survey
GOR Government Office Region
GP general practitioner
HSCIC Health and Social Care Information
Centre
HSfE Health Survey for England
IAPT Improving Access to Psychological
Therapies
IMD Index of Multiple Deprivation
LA local authority
LLTI limiting long-term illness
LSI long-standing illness
LSOA lower-layer super output area
MI myocardial infarction
MSOA middle-layer super output area
NEPHO North East Public Health
Observatory
NIC net ingredient cost
NICE National Institute for Health and
Care Excellence
ONS Office for National Statistics
PBC Programme Budget Category
PCI percutaneous coronary intervention
PCT primary care trust
PHE Public Health England
PSU primary sampling unit
QALY quality-adjusted life-year
QOF Quality and Outcomes Framework
RCGP Royal College of General
Practitioners
SHA Strategic Health Authority
SMR standardised mortality rate
TIA transient ischaemic attack
UKHLS UK Household Longitudinal Study
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The aim of this project was to explore whether or not the extent to which people use NHS services forcardiovascular disease (CVD) and common mental health disorders (CMHDs) varies according to their
personal characteristics and geographical location.
This was done by comparing the number of people in different populations diagnosed with, and treated
for, CVD and CMHDs with the estimated underlying number of people who have those conditions (based
on a technique called small-area estimation). Disease prevalence estimates for practices, primary care trusts
and Clinical Commissioning Groups were compared with (a) ‘presentation’ data on the number of adults
registered by general practitioners as having diabetes, high blood pressure, coronary heart disease, stroke
and depression; (b) expenditure on key drugs; (c) the number of people known to, or being treated by,
community services (such as Improving Access to Psychological Therapies); and (d) the number of people
receiving specialist interventions (such as elective and emergency admissions and surgical procedures).
With respect to CVD, the estimates of underlying need accounted for a significant proportion of
differential rates of use. Nevertheless, the analysis did yield evidence of some systematic inequalities in
utilisation of CVD health care, particularly with respect to ethnicity. Rural (shire) areas also have notably
low levels of cardiac care relative to need.
For CMHDs, the overall picture is one of unexplained variation, although ethnicity again emerges as an
important variable. There also appears to be a pronounced ‘London effect’, with rates of recorded disease
and, particularly, prescribing being much lower than expected.
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There is a general understanding that socioeconomically disadvantaged people are also disadvantaged with
respect to their access to NHS care. Insofar as considerable policy effort and NHS resources have been
targeted at deprived areas, it is important to better understand whether or not and why socioeconomic
variations in utilisation exist, not least so that policy-makers are informed about what they can further do
to address inequity.
This is the background to the project, which, reviewing the shifting policy context, proposes that any
inequalities in the utilisation of NHS care are today likely to be complex. First, we hypothesise that the
nature of inequality will vary according to clinical condition. For instance, given that the distribution of
mental health problems is profoundly different from that of degenerative disease [and general practitioners
(GPs) managing a high caseload of the former are likely to have a lower caseload of the latter], it is
unlikely that any variation in access to GP services will have a similar effect across all clinical conditions.
Second, we propose that inequalities in utilisation are likely to occur at different levels of the health-care
system, depending on how people identify and assert their claims for health care, and how those claims are
then acted on by health professionals. The relative mix of care can also influence patterns of use. For
example, the effective management of health problems by GPs may result in lower demand for hospital
care. Thus, it should not be presumed that inequalities characterise access and use uniformly. Third, there
are other dimensions of inequality than socioeconomic status, such as age, sex and ethnicity, which may
have been relatively neglected as a result of a prevailing concern with socioeconomic status. All of these
factors suggest the need for a more nuanced understanding of variations in access and in use.
Aims and objectives
Against this background, the overall aim of this project is to examine variations in the use of NHS care with
respect to two very different sets of conditions: cardiovascular disease (CVD) and common mental health
disorders (CMHDs). We seek to explore the extent to which variations in use (a) reflect underlying
health-care needs; (b) are characterised by systematic inequalities according to socioeconomic status, age,
sex, ethnicity and rurality; and (c) occur randomly. We also seek to investigate variations in use relative to
need at different points of the care pathway (i.e. presentation, primary management and secondary
management of disease).
To this end, our objectives are:
l to review existing evidence of variations in access to and use of cardiovascular care and mental
health services
l to build on existing techniques of small-area estimation in order to develop robust estimates of the
prevalence of CVD and CMHDs in populations served by general practices, primary care trusts (PCTs)
and Clinical Commissioning Groups (CCGs) in England
l to obtain, and apply to appropriate populations and population cohorts, health service utilisation data
relevant to the health-care needs for which estimates have been produced, and thereby generate
condition-specific use-to-need ratios
l to test the extent to which variations in the use of cardiovascular and mental health services (a) reflect
underlying differences in the health-care needs of general practices, PCTs and CCGs; (b) relate to the
sociodemographic, socioeconomic, ethnic and geographical characteristics of populations; and
(c) occur randomly.
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l to support service planning and delivery by disseminating, via Public Health England (PHE), estimates of
health-care need for a variety of geographic and organisational units, namely lower-layer super output
areas (LSOAs) and middle-layer super output areas (MSOAs), PCTs, CCGs, upper- and lower-tier local




To search relevant literature for quantitative and/or qualitative evidence of inequality, specifically relating to
variations in access to and utilisation of cardiovascular care or mental health services.
Inclusion criteria
Studies pertaining to the presentation, primary and specialist management of CVD and mental health;
studies of any design (even when methodologically flawed, although this has been flagged); studies
pertaining to the English NHS and published after 2004.
Exclusion criteria
Reviews of international studies where less than half of the reviewed evidence pertained to the English
NHS; expert opinion articles, letters and editorials.
Search strategy
The following databases were used in the search: Applied Social Sciences Index and Abstracts, MEDLINE,
PubMed, EMBASE, Social Sciences Citation Index (Web of Science). Cumulative Index to Nursing and Allied
Health Literature, PsycINFO, SOCindex, EThOS (national thesis service), and a range of websites consulted
for grey literature. Key phrase searching (with and without Boolean search functions), backwards and
forwards citation tracking and hand-searching of key journals were used with multiple combinations of key
phrases, terms relating to setting, access, type of service, type of disease and nature of inequality. The
searches were carried out from September 2014 to February 2015. Data published between 2004 and
2014 were accepted for inclusion.
Retrieved literature
Thousands of potentially relevant hits were retrieved, most eliminated through consulting the title and
abstract alone. A total of 123 studies were included that had investigated inequalities in access to CVD
services and 101 studies were included on mental health services. These were summarised according to
stage on care pathway (presentation, primary management, specialist management) and dimension
of inequality.
Development of prevalence estimates
The approach adopted involves a ‘bottom-up’ estimation of population-level disease prevalence through
the aggregation of modelled individual-level disease risk estimates. Thus, large-scale survey data sets are
interrogated to model the likelihood that different ‘person types’ will exhibit or develop particular diseases.
Person types are defined in terms of the level of deprivation of the area in which they live as well as with
respect to their sociodemographic characteristics, and the resulting disease likelihood risks are attached to
all such individuals in all populations for which prevalence estimates are required. Forging an appropriate
link between survey data and census data is crucial, with survey-based models being constructed using
only variables that are also available in the 2011 census. 2011 census multivariate tables provide evidence
on the sociodemographic composition of small areas (LSOAs and above), but not in sufficient detail.
A form of iterative microsimulation has thus been developed in order to derive a full description of the
composition of local populations. Individual disease risk estimates are then used to predict, mediated by a
Bernoulli trial, whether or not each individual in each area has or does not have a particular disease, and
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the number of people predicted to have the disease, divided by the denominator population, provides
the prevalence rate estimate. Estimate uncertainty is captured by taking bootstrap (‘with replacement’)
samples from the original survey data set and then replicating the entire process all the way to local area
estimation. Having generated multiple bootstrap-based estimates, summary data are extracted to describe
the nature (mean and 95% confidence interval) of the resulting estimate distributions. Summary data have
been produced for 12 age–sex defined cohorts, as well as for overall populations, across all English LSOAs,
MSOAs, upper- and lower-tier LAs, regions, general practices, PCTs, CCGs and SHAs. Many of these data
are to be disseminated via PHE’s ‘Local Health’ website.
Analysis of variations in use relative to need
Variations in use have been explored relative to modelled prevalence with respect to presentation [Quality
and Outcomes Framework (QOF)-recorded prevalence]; primary management [rates of prescribing by
British National Formulary code/category, Programme Budget Category (PBC) expenditure on prescribing
and, in the case of CMHDs, community management]; and specialist management (elective and
emergency admissions, specific procedures and PBC secondary expenditure). Using linear regression
modelling (in which stepwise parameter selection was used to identify significant predictors of per-capita
utilisation), the percentage variation in the utilisation of health-care services explained by (a) estimated
underlying need, (b) socioeconomic deprivation, (c) percentage of population Asian, (d) percentage of
population black, (e) percentage of adult population < 50 years old and (f) percentage of rural population
has been explored at CCG, PCT and practice levels.
Results
Literature review
A larger proportion (35%) of studies of variations in access to and use of CVD had explored inequalities by
socioeconomic status than by other social characteristics. In mental health studies, the largest proportion
(35%) of studies had explored inequalities by ethnicity. According to reviewed studies, older age and
female sex are the key dimensions of inequality with respect to CVD care; and older age and non-white
ethnicity are the key dimensions of inequality with respect to access to and use of mental health services.
For both CVD and mental health, very significant unexplained geographical variation exists in access and
use, which is strongly suggestive of a ‘postcode lottery’.
The reliability of the Plymouth needs estimates
Cardiovascular disease
A total of 24 prevalence estimates have been produced for CVD. Those for diabetes (a risk factor for CVD),
coronary heart disease (CHD), hypertension and stroke were compared against health service utilisation
data. These are better predictors of variations in QOF registration rates than existing equivalent PHE
estimates. Moreover, whereas the Plymouth prevalence estimates are invariably incorporated as
explanatory factors in linear models of variations of service use (and usually as the single most important
factor), the PHE estimates behave erratically.
Mental health
A total of 41 potential ‘markers of mental health needs’ were identified, resulting in a wide diversity of
prevalence rates. All perform poorly as predictors of the number of patients GPs identify as having
depression (and, therefore, the number they place on the QOF Depression Register). This may suggest that
the way in which people respond to questions about their mental health undermines the use of the resulting
data for predictive purposes. However, modelled prevalence rates were more effective at predicting
CCG-level variations in community mental health, Improving Access to Psychological Therapies and
secondary mental health services. This suggests that QOF registration may not provide useful information,
presumably because of variations in GP case finding. The Plymouth estimates explain a greater proportion of
variation in health service use than do existing North East Public Health Observatory estimates.
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All of the Plymouth needs estimates will be publicly available (via PHE) at a range of spatial scales (LSOAs,
MSOAs, LAs, general practices, PCTs and CCGs).
Analysis of variations in use relative to need
Cardiovascular disease
Underlying prevalence rates explain (% R2) between 62.1% (diabetes) and 87.4% (stroke) of the variation
in QOF registration rates at PCT level, and between 44.5% (diabetes) and 65.4% (CHD) of variation in
QOF registration rates at practice level. Incorporating additional factors (demography, ethnicity, deprivation
and rurality) into a linear regression model increases prediction to between 75.6% (diabetes) and 90.4%
(stroke) at PCT level, and between 57.6% (diabetes) and 70.5% (CHD) at practice level.
As one moves up the care pathway, the percentage of variance that can be explained by either estimated
prevalence or additional factors declines, although, at the PCT level, prediction (using the full model)
exceeds 50% for a number of use indicators, including drugs for diabetic use and PBC diabetic prescribing
(diabetes); angiotensin-converting-enzyme (ACE) inhibitor, beta-blocker, aspirin and bendroflumethiazide
prescribing (CHD) and admissions for main diagnosis angina/acute myocardial infarction (CHD); ACE
inhibitor, calcium channel, thiazide diuretic and PBC all circulatory/cerebrovascular prescribing
(hypertension); and oral anticoagulant, antiplatelet, warfarin and PBC cerebrovascular prescribing as well as
hospital admissions (stroke).
It is encouraging that variations in several indicators of use are largely explained by underlying need.
Nevertheless, the regression models yielded a number of significant (p< 0.05) standardised coefficients,
which suggest systematic sociodemographic inequalities in utilisation. In some cases, populations
make greater use of services than expected, while in other cases they make less use of services than expected.
Key findings
l Primary care trusts and practices with higher Asian populations have higher than expected rates of
diabetes presentation and prescribing and lower than expected rates of secondary care.
l Primary care trusts and practices with higher black populations have lower than expected rates of CHD
presentation and prescribing (for four of the six items considered) and higher than expected rates of
emergency admissions for coronary artery bypass graft (CABG) and any admission for percutaneous
coronary intervention (PCI). This may suggest that poor management of disease at lower levels of the
health-care system is resulting in higher demand for emergency and hospital care.
l There are pronounced geographical variations in use relative to need for CHD care. The North East has
relatively high levels of use of cardiac care, which contrasts with evidence of poor access to care in the
1990s. Relatively high rates of use, at least with respect to PBC secondary and total expenditure, are
also found in parts of the South East and South Central regions. Rural (shire) areas have low levels of
use relative to need.
l With the exception of lower than expected rates of prescribing among younger and rural practice
populations, evidence of inequality in the management of hypertension is mixed.
l Both black and Asian populations have lower QOF registrations of stroke and lower prescribing of oral
anticoagulants and warfarin than expected. Younger populations also have lower presentation and
prescribing rates. Secondary care use is also lower than expected among ethnic populations.
l Across the four categories, deprivation does not emerge as a consistent predictor of lower use relative
to need. Deprived practices make higher use than expected of many health-care services for diabetes,
hypertension and stroke. However, they have lower than expected rates of CABG and
PCI interventions.
l There is little evidence of age-related inequality, which conflicts with the key findings of the
literature review.
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Mental health
Variation in mental health service use is poorly explained by underlying need and the addition of potential
explanatory factors does not substantially improve matters. Thus, the overall picture is one of unexplained
variation. There are, however, some notable trends.
Key findings
l Rates of QOF registration and prescribing tend to be lower than expected in areas with large
black populations.
l Rates of QOF registration and prescribing tend to be higher than expected in areas serving more
deprived populations.
l Our findings of lower rates of mental health use among black populations and higher rates among
deprived populations correspond with existing literature. However, there is little evidence of age-related
inequality, which conflicts with a key finding of the literature review.
l There appears to be a pronounced ‘London effect’, with rates of QOF registration and prescribing
being much lower than expected.
l There is considerable practice-level variation in use relative to need, even in London and other
major cities.
Conclusions
This is an ambitious study, the largest of its kind with respect to national-level analysis of variations in
utilisation of CVD and CMHD health-care services. Great care has been taken to develop objective and
rigorous prevalence estimates, and the findings, which are nuanced and contrasting, support the
contention that, owing to different epidemiologies, patterns of utilisation relative to need are likely to vary
by clinical condition. Nevertheless, the fact that the models were far better at explaining variation in use of
CVD services than mental health services deserves further investigation. It is not known, for example,
whether this can be attributed to problems in the prevalence estimates or problems in mental health
service data sets or whether utilisation of mental health services in England is truly subject to the random
variation that is suggested by the modelling. More work thus needs to be done on modelling unexplained
variation. The project offers interesting insights (particularly with respect to CVD) regarding the importance
of relative mix of care (higher levels of presentation and primary management being associated with lower
levels of hospital admission); the persistence of ethnic variations after controlling for age and deprivation;
and the role of systematic factors (such as rurality) in shaping patterns of utilisation. These, it is proposed,
are fruitful areas for further investigation.
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Chapter 1 Background and overview
Understanding variations in the use of NHS care:
a shifting context?
Over 40 years since it was first proposed, the idea that access to NHS services remains subject to the
inverse care law, whereby the availability of good medical care varies inversely with the need for it in the
population served,1 has proved remarkably durable. Although Tudor Hart’s thesis was that working class
areas were underdoctored with respect to general practitioners (GPs), the term is now applied beyond
primary care. Indeed, as ‘access’ is understood to relate to the processes of gaining entry to the
health-care system (or to higher levels of the health-care system), most accounts of inverse care do not
focus solely on issues of service availability, but also focus on utilisation and, indeed, the quality and
outcomes of care. However, the implicit assumption is still that the major characteristic of inequality in
access and use is socioeconomic status.
Inverse care clearly threatens the core NHS principle of health-care equity (equal opportunity of access to
health care for people at equal risk). Insofar as differential use of preventative, screening, treatment and
rehabilitation services can influence rates of disease, cure and survival among different groups, inequities
in health care may compound the disadvantages conferred to health status by socioeconomic position.
This would undermine the second core principle of the NHS: that it should contribute to the reduction of
avoidable inequalities in health, or the promotion of health equity.
It is, therefore, important that inequalities in access to and use of health care are identified, understood
and acted on. However, this goal is complicated by the fact that, as a construct, health-care equity has
been understood through multiple, contested and competing perspectives. There is a lack of a robust
evidence base relating to health-care equity, with findings tending to be equivocal if not contradictory.
A range of methodological difficulties affect its practical investigation. Limited progress has been made in
conceptualising and understanding the complex array of factors that give rise to differential rates of access
and use. This is a field, moreover, that is characterised by powerful meta-narratives; deep debate with
respect to the moral claims of different definitions of equity; and a significant shift in the context within
which NHS services are accessed and used.
This chapter explores this shifting context in more detail to provide both a background to and a
justification of the aims and objectives of the study. It begins with the proposal that the inverse care law
has evolved into a ‘meta-narrative’, a taken-for-granted assumption that makes any attempt to critically
synthesise evidence on inequalities problematic (see the following section). At the same time, there has
been a pendulum shift away from an interest in equal access for equal needs and towards the argument
that unequal treatment so as to reduce health inequalities is the more ethical objective (see Health-care
equity: is it still a normative goal of the NHS?). Against this background, concerns about the continued
presence of inverse care may be based less on principles of universalism than on a more Rawlsian concern
with the least advantaged. The implications for health-care equity – and its investigation – are profound.
There are not only signs of growing public support for prioritising the goal of health equity. The
philosophical shift has had enormous policy influence, evidenced by both recent proposals by the UK’s
National Institute for Health and Care Excellence (NICE) to incorporate social value judgements in its
methods of appraising health technologies and the substantial redistribution of NHS resources towards
younger, more deprived populations (see A shifting policy context). This very positive targeting of policy
effort and funding does raise questions as to whether or not and why inverse care should continue to be a
defining feature of the NHS.
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In fact, the durability of inverse care may reflect shifting patterns of need for health-care services (which
would undermine the health-care equity principle). For example, there has been extensive discussion about
the challenges for GPs working in highly deprived areas (commonly described in the literature as working
at the ‘deep end’), where combined problems of financial difficulties, social and emotional problems,
mental health difficulties, physical health problems, substance abuse and chaotic lifestyles increase GPs’
workloads and give rise to a possible mismatch between need and supply (see Shifting patterns of
morbidity: implications for working at the ‘deep end’). Yet there are counterarguments to this picture of
inverse care, not least the fact that many high-profile accounts of lower provision, relative to need, in
deprived areas have been subject to statistical artefact.
There is, moreover, evidence that inequalities in access and use are considerably more complex than is
implied by the inverse care law. We do not know, for example, whether or not deprived populations have
poorer access to and make lower use of services for all clinical conditions and across the care pathway,
or if the difficulties facing the primary management of mental health are atypical of the NHS as a whole.
What, moreover, of other social groups (e.g. according to age, sex and ethnicity)? Has a concern to
demonstrate that socioeconomically disadvantaged people are disadvantaged in their access to health care
led us to overlook other dimensions of inequality (see Implications for research)?
This is the background to the research project, the overall aim of which is to examine variations in the use
of cardiovascular care and mental health services in England relative to underlying need. The specific aims
and objectives of the project are outlined in Aims and objectives, and the report structure is described in
This report.
Inverse care law and the NHS: a ‘prevailing paradigm’
Literature that yields insights into differential access to NHS services has been conceptualised and
empirically studied by researchers from a wide range of different disciplines, giving rise to a conflicting
body of research. Indeed, ‘access’ (which may refer to need, provision or utilisation of health services in
empirical research) is not always the primary outcome of relevant studies. As a result, systematic reviews
can overlook evidence, the existence of which is not immediately clear from the title or abstract.2
There is, moreover, evidence that researchers have made key assumptions (explicit and implicit) about
the nature of access to and use of NHS services, which, in turn, affect research design. According to
Dixon-Woods et al.,3 the inverse care law has come to operate as:
a meta-narrative: a distinct research tradition invoking specific sets of ‘normal science’ assumptions
that has developed as a storyline over time. Within this tradition, there has been ongoing concern to
demonstrate that socioeconomically disadvantaged people are disadvantaged in their access to health
care [our emphasis].
If inverse care has come to function as a ‘taken-for-granted’ assumption, it is important to recognise that this
may have shaped researchers’ choices about the most important questions to raise, the study designs and
methods best suited to answering those questions, and even the way in which they interpret their results.4
It is also important to accept that, where a set of assumptions guides commonplace views about a particular
topic, results that challenge those assumptions can be hard to publish. Against this background, the task of
interpreting previous evidence on variations in access to and use of NHS care is not straightforward. The
strategy we have used to review existing evidence is described in Chapter 2 (see Review strategy).
Health-care equity: is it still a normative goal of the NHS?
To further complicate matters, not everybody even agrees that the principle of ‘health-care equity’
(whereby health-care resources should be geographically distributed to ensure ‘equal opportunity of access
to health care for people at equal risk’) is the most important principle of the NHS. Since 1999, the NHS
has also been charged with contributing to the reduction of avoidable inequalities in health, or the
promotion of ‘health equity’ (a ‘vertical’ definition of equity).
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It was only in the 1980s that a sustained critique developed in the UK of the ‘equal access for equal need’
principle, first because such ‘horizontal’ definitions of equity were considered to be mutually incompatible –
equality of expenditure for equal need not necessarily translating into equity of access or equity of
treatment5,6 – and, second, for failing to consider need in terms of capacity to benefit, an approach that
(a) promoted ‘efficiency’ and (b) lent itself to the more ‘ethical’ objective of achieving health equity or
equality in terms of health outcomes.7–10
In 1997, Mooney and Jan11 observed that ‘vertical’ equity considerations had tended to be overlooked in
the health policy literature. Reviewing both literature and policy developments since, the reverse would
appear to be true. Compared with a substantial body of literature exploring the case for distributing health
care so as to secure a more equal distribution of health,6–28 it is today quite difficult to find any literature
that asserts the moral and philosophical case for health-care equity.29,30 Indeed, the concept has been
roundly attacked: ‘Slavish devotion to time-honoured principles of allocation in proportion to need and
equal universal access should be avoided. They are misleading principles’;8 ‘[T]he equal access for equal
need objective can be seen as a piece of grand or flamboyant rhetoric of symbolic politics, representing a
misreading, or at least an oversimplification, of history’.31
This raises the question of whether or not health-care equity is still a normative goal of the NHS. If it is not,
then the overall purpose of this project – to examine equity in the utilisation of cardiovascular and mental
health services in England – might be considered to be of little policy relevance. Yet we concur with Sen32
that accepting the importance of health equity does not mean that the relevance of other claims such as
non-discrimination in the delivery of health care should be denied. We also propose that, although
the principle of universalism has been criticised in recent years,33 there remains a public understanding that
access to key services such as the NHS are a ‘right’ in the ‘just’ society.29,34 This suggests that, although
they receive relatively little attention in contemporary academic literature, traditional conceptions of social
justice around notions of equality, social rights, non-discrimination and universalism35,36 have not been
entirely abandoned.
There are, however, debates about the extent to which public perspectives on ‘fairness’ reflect Fabian
notions of equality and universalism or targeted approaches to welfare. Although several studies suggest
that the public supports the understanding that the NHS should provide care from cradle to grave and
respond to the ‘rule of rescue’ (i.e. giving priority to those in immediate need),28,37–40 others note that
public preferences suggest a willingness to give higher priority to some categories of people than others,
including those who are socioeconomically disadvantaged.41–54 Interestingly, persistent media storylines
about inequalities in health-care equity may have played a role in this. The narrative is as follows: if the
‘inverse care law’ characterises access to NHS services, then people living in deprived areas are
disadvantaged not only with respect to their health outcomes but also in their access to health care.
According to compensatory principles of social justice, this makes a strong case for positively targeting NHS
resources at the poor.
A shifting policy context
Policy-makers also appear to have accepted that English NHS resources should be positively targeted at
deprived areas in order to address the dual aims of promoting health equity and addressing unmet need.
Responding to academic interest in the potential for incorporating equity weights into cost-effectiveness
analysis,55–57 NICE recently set out proposals to incorporate social value judgements in its methods for
appraising health technologies. These included an attempt to capture the difference between people’s
relative production and consumption of resources, through, for example, a treatment enabling a patient to
return to work and thereby pay more tax or contribute more to family finances.58,59
The NICE was responding to early criticisms that measures of cost-effectiveness such as cost per
quality-adjusted life-year (QALY) do not always account for what matters to patients, their families and
society. In a major review of oral and written evidence from patients, patient organisations, pharmaceutical
companies and academics, the House of Commons Health Committee had noted that ‘Many witnesses
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argued that the exclusion of societal gains compromised the validity of QALY-based cost-effectiveness
calculations’ (contains Parliamentary information licensed under the Open Parliament Licence v3.0).60 NICE
was undoubtedly placed in a difficult position.61 That said, its willingness to so explicitly favour the young,
using a rationale of ‘productivity ageism’,62 does raise questions about the extent to which the principle of
non-discrimination continues to have resonance among senior policy-makers.
The approach taken to NHS resource allocation has strongly responded to the policy requirement to reduce
inequalities in health,63 recent research concluding that increasing the proportion of resources allocated to
deprived areas between 2001 and 2011 was associated with a reduction in absolute health inequalities
from causes amenable to health care.64 In fact, this is open to interpretation. As the authors themselves
acknowledge, one cannot rule out the possibility that the associations they observed were attributable to
other factors that pose health risks. More problematically, although absolute differences in health between
areas reduced, relative inequalities remained constant. As absolute declines will always be greater where
the starting point is higher (put simply, a 10% decline in a mortality rate of 40 per 100,000 will be greater
than a 10% decline in a mortality rate of 20 per 100,000), it is not at all clear that additional investment
led to a reduction of health inequalities. Finally, the conclusions conflict with those of a recent study that
found no relationship between Quality and Outcomes Framework (QOF) achievement and reduced
mortality, which appeared to be driven by factors outside primary care such as declining rates of
smoking.65 Thus, the jury is still out on whether or not health care can address inequalities that are
fundamentally embedded within the unequal structures of society.32,66–68
In 2013, the assumption of unmet need became a primary justification for continuing to positively target
NHS funding at deprived areas. The stimulus for this was the introduction of separate budget streams
for NHS England and Public Health England (PHE), which threatened to reduce the funding of more
deprived Clinical Commissioning Groups (CCGs), who stood to lose previous health inequality adjustments
to local authorities (LAs). To prevent this from happening, the finance director of the NHS made assurances
that areas with worse outcomes would not receive less NHS funding, as the new formula would adjust for
a health economy’s unmet need, where life expectancy suggests that people are not accessing health
services.69 Against this background, it is important to explore whether or not evidence of socioeconomic
bias in access to care supports this assumption.
If evidence suggests that there is a pro-rich bias in the access to and utilisation of NHS care, it is interesting
to ask why this is the case and what policy-makers can further do to address inequity. This is because
highly deprived areas have already benefited from very high allocations (Table 1). Although the budgets
given to inner-London primary care trusts (PCTs) distort the national picture, the figures in Table 1 have
been symptomatic of a pattern in which young, deprived populations with lower crude but high
standardised rates of illness and death have received and spent significantly higher NHS allocations than
their older, more affluent counterparts (which have higher crude but lower standardised illness rates).
The profound redistribution towards deprived areas that occurred after 2002 was largely due to a technical
flaw in the way in which the ‘AREA’ (Allocation of Resources to English Areas) formula76 was implemented.
Rather than proportionately reflecting the effects of age and deprivation in influencing health service need,
the formula effectively cancelled out the effect of age through the sequential inclusion of deprivation
indicators.77–79 Although subsequent formulae attempted to address this,80,81 the overall distribution of NHS
resources has remained largely unchanged, in part owing to the inherent circularity of utilisation-based
formula,82–85 and in part because, for mainstream policy-makers, allocations made with respect to
deprivation appear to have looked ‘about right’.86 This very positive targeting of funding does raise
questions as to whether or not and why Tudor Hart’s ‘law’ should continue to be a defining feature of
the NHS.
BACKGROUND AND OVERVIEW
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Shifting patterns of morbidity: implications for working at the ‘deep end’
There are, however, a number of factors that may account for the durability of inverse care. The first
relates to shifting patterns of morbidity. The reasons why deprivation has been strongly correlated with
standardised but not crude morbidity and mortality are that (a) for most conditions (mental health being a
notable exception), demographic gradients in health have been steeper than socioeconomic gradients87 –
in other words, as people get older, they are more likely than young people to develop conditions such as
heart disease and cancer; and (b) there is a negative correlation between the geographical pattern of social
deprivation and age in England, with deprived areas tending to have younger populations and affluent
areas tending to have older populations.
Yet disease patterns are changing. Rising rates of obesity among children and younger people are already
altering the epidemiology of chronic diseases such as diabetes and coronary heart disease (CHD), and the
prevalence of obesity is positively associated with deprivation.88–92 There has also been a significant increase
in levels of anxiety and depression in adolescents93 and in the number of people seeking treatment
for mental health problems.94 Between 2008–9 and 2010–11, the number of registered patients
suffering from depression increased by 11.5% nationally and the number of prescriptions written for
antidepressants rose by one-fifth. Psychological distress is associated with both low socioeconomic status
and unhealthy behaviours such as tobacco and alcohol consumption,95 which, in turn, increase the risk of
physical health problems such as CHD, hypertension and diabetes. There is strong evidence of a
relationship between comorbidity and socioeconomic status, with people in deprived areas having a higher
prevalence of both physical and mental health disorders96–98 and incurring higher health-care costs.99
The significance of these trends is that they are particularly likely to be managed in general practice. In
2006, the Royal College of General Practitioners (RCGP) estimated that up to one-third of the 280 million
consultations in primary care annually have a significant mental health component.100 RCGP Scotland has
been particularly vocal about the challenges of working at the ‘deep end’, where patients suffering from
physical, emotional, psychological, financial and social problems, including problems related to substance
misuse, present additional demands.101 Given the level of demand, it is argued that there is a mismatch
between need and resource, GPs having insufficient time to get to the bottom of their patients’ problems.
The RCGP102 is one of a number of important bodies, including The King’s Fund,103 to have argued that
there are fewer GPs, relative to need, in areas of deprivation.
Notwithstanding concerns about the medicalisation or ‘public healthification’104 of social problems and life
events,105,106 there is no doubt that highly deprived populations can have complex and demanding service
needs. However, the quantification and, by implication, understanding of the gap between needs and
provision in deprived areas has been problematic. For example, the 2010 White Paper Healthy Lives,
Healthy People107 reproduced two maps of Birmingham. The first showed the prevalence of CHD in
2008–9, according to GP QOF data. The second showed mortality (standardised) from CHD in 2007–9,
according to data from the Office for National Statistics (ONS). On both maps, deprivation is indicated.
The title of the figure suggests ‘stark differences’ between the locations of CHD patients who have been
diagnosed by their GPs and the locations where CHD mortality is highest, implying inverse care. In fact,
a comparison of QOF prevalence with crude CHD mortality shows a good fit, suggesting that GPs in
deprived parts of Birmingham are providing good access to diagnosis for those at risk of heart disease.
Similarly, the widely cited ‘Darzi Report’ based its analysis of inverse care on the ratio of GPs per head of
AREA-weighted population.108 This found that areas such as Mid-Devon PCT had over twice as many GPs
per head of weighted population as Oldham PCT. Subsequent analysis using condition-specific QOF
prevalence rates as denominators drew rather different conclusions.109 Thus, for some conditions, such as
chronic obstructive pulmonary disease (COPD) and mental health, GPs in deprived areas did indeed face
much higher workloads than those in affluent areas. For other conditions, including cardiovascular disease
(CVD) and asthma, there was no significant difference, while with respect to cancer the pattern appeared
to be reversed. Once age was factored in, the picture became more complex; thus, GPs serving
demographically older populations – both affluent and disadvantaged – had higher caseloads of CVD,
BACKGROUND AND OVERVIEW
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COPD, cancer, dementia and chronic kidney disease (CKD) than GPs working with young deprived
populations. It was nevertheless the case that the worst problems arose where deprivation and
demography reinforced one another. Such practices, which tended to cluster in the northern cities and
some rural and coastal areas, had the highest workloads of all.
Implications for research
In 1972, Cochrane noted the divisions between researchers regarding the problem of equality in the NHS:
‘Richard Titmuss thunders and Julian Hart complains and it is sometimes difficult to see what sort of evidence
would satisfy them’.110 This observation seems as relevant today as it was 40 years ago. Although health-care
equity remains a core principle of the NHS, the pendulum appears to have swung away from support for
equal access for equal need and towards the argument that reducing health inequalities is the more ethical
goal. This has been particularly pronounced in academic discourse, though there are also signs of public
support for prioritising the socially disadvantaged. At the policy level, too, there is broad acceptance of the
argument that health-care resources should be distributed so as to reduce avoidable health inequalities. This,
together with assumptions about continuing inverse care, has resulted in the substantial redistribution of
NHS resources away from older, less deprived populations and towards younger, more deprived populations.
Despite the fact that considerable policy effort and financial resource has been targeted at addressing
socioeconomic inequalities in health and access to health care, the existence of inverse care remains a
conventional wisdom. However, it is important to acknowledge that some reported evidence of inequality
in access has been subject to statistical artefact. Furthermore, inverse care may apply to access to and
utilisation of care for some but not all clinical conditions. For example, there is clearly a subset of people
with mental health problems who have very high demands for support as a result of the copresence of
physical health problems, financial difficulties, social and emotional challenges, problems of substance
abuse and chaotic lifestyles. This has important implications for the workloads of GPs working at the ‘deep
end’, which may, in turn, impact on access for the wider population served by those GPs. For example, a
recent RCGP analysis based on the GP patient survey found that patients living in deprived areas waited
the longest for GP appointments.111 Against this, GPs working at the deep end may have lower caseloads
of other clinical conditions owing to the association between deprivation and younger demographical
profiles. We aim to explore this possibility through examining variations in access to two very different
groups of conditions: CVD and mental health.
It is also important to consider whether or not inequalities in access occur across the care pathway. If the
primary management of mental health is subject to inverse care, it does not necessarily follow that the
specialist management of mental health is biased against the poor. This is because different sets of factors
are likely to affect the uptake of services at different stages of the pathway to care. These include
candidacy and adjudication, concepts similar to those of Bradshaw’s seminal analysis.112 Candidacy refers
to the process by which people recognise their eligibility as candidates for health care and also to the ways
in which the health service identifies characteristics of candidacy that it then seeks to apply to individuals.3
By seeking health care, people are making a claim to candidacy for medical attention or intervention.
However, once they have gained entry to the health system, their health needs still need to be categorised
and acted on. This is called adjudication. It may be influenced by health professionals’ perceptions both of
the legitimacy of the expressed needs of different groups and of local service availability.
Although there are a number of related concepts regarding access to and use of health care, including
concordance and recursivity,113 empirical research which employs these concepts is still scarce. Moreover,
with the data sets available to us, it is not possible to operationalise such concepts in our own
investigation of variations in use. We have, therefore, taken a very simple approach to incorporating
understandings of candidacy and adjudication into our study, by structuring both the review findings and
our original research around different points on the care pathway: presentation, primary management and
specialist management.
DOI: 10.3310/hsdr04140 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 14
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Asthana et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
7
Aims and objectives
The overall aim of this project is to examine variations in the use of NHS care with respect to two very
different sets of conditions: CVD and common mental health disorders (CMHDs). We seek to explore the
extent to which variations in use (a) reflect underlying health-care need, (b) are characterised by systematic
inequalities according to socioeconomic status, age, sex, ethnicity and rurality, or (c) occur randomly. We
also seek to investigate if variations in use relative to need occur at different points of the care pathway
(i.e. presentation, primary management and secondary management of disease).
The objectives set out in our original protocol have been largely retained, although we have broadened
our focus from cardiac to cardiovascular care (and, indeed, we have also produced prevalence estimates
for diabetes) and narrowed our focus from ‘mental health’ to CMHDs. There were several reasons for this,
as follows.
With respect to CVD, diabetes is a known risk factor for CHD, hypertension and stroke. Some CVD
conditions are better defined and, for health survey respondents, more easily recognised than others. For
example, respondents are unlikely to self-report a serious condition such as a heart attack unless a
diagnosis to that effect has been received. Similarly, hypertension can be modelled on the basis of
measured blood pressure. By contrast, other self-reported measures may be subject to recall bias.
Interpretive issues affect all modelled prevalence estimates. Thus, the choice to develop a range of
alternative measures was made in part to ensure that we could properly test and compare them for
robustness. Third, it is more straightforward to link specific interventions to some but not all CVD
conditions (e.g. some drugs such as beta-blockers have multiple uses). Thus, again, examining use-to-need
ratios for a range of conditions allows us to select, for example, prescribing data that are relatively
unambiguous. We were also encouraged by colleagues at PHE to generate the wider range of prevalence
estimates as these, particularly for diabetes, are of key interest to the public health community.
With respect to mental health, the focus on CMHDs was driven by both methodological concerns and
implications for policy relevance. First, the confidence of predicted estimates will tend to be greater for
more common conditions than for those that are more rare. Second, CMHDs place by far the greatest
demands on NHS mental health services and are managed within both general practice and specialist
mental health services such as Improving Access to Psychological Therapies (IAPT). The roll-out of IAPT
makes it particularly important to examine whether or not people with needs in the community are
benefiting from these new services.
Finally, we have not, as originally intended, modelled the role of key supply-side factors (such as the
allocation of NHS resources and the availability, accessibility and configuration of services in different
localities). This has been an ambitious project and one for which we failed to anticipate the considerable
challenges of producing robust estimates of underlying needs. It is, moreover, one that has been affected
by personal circumstances. We nevertheless propose that the aims, methods and results remain coherent
and of use in supporting service planning.
BACKGROUND AND OVERVIEW
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Our objectives are:
l to review existing evidence of variations in access to and use of cardiovascular care and mental
health services
l to build on existing techniques of small-area estimation in order to develop robust estimates of
prevalence of CVD and CMHDs in populations served by general practices, PCTs and CCGs in England
l to obtain, and apply to appropriate populations and population cohorts, health service utilisation data
relevant to the health-care needs for which estimates have been produced, and thereby generate the
condition-specific use-to-need ratios that will be subject to statistical analysis
l to test whether variations in the use of cardiovascular and mental health services reflect underlying
differences in the health-care needs of general practices, PCTs and CCGs, relate to the
sociodemographic, socioeconomic, ethnic and geographical characteristics of populations, or
occur randomly
l to support service planning and delivery by disseminating, via PHE, estimates of health-care need using
geographic [lower-layer super output areas (LSOAs), middle-layer super output areas (MSOAs) and
above] as well as general practices, PCTs and CCGs
l to support efforts directed at ensuring an equitable provision of health-care services through
dissemination of our methods and results.
This report
The evidence on inequalities in access in general, and on cardiovascular and mental health services in
particular, is reviewed in Chapter 2. A detailed description of the data sources and methods is presented
in Chapter 3. In Chapter 4, we present the results of our analysis of variations in access to cardiovascular
care, and in Chapter 5 we present the results for mental health. In these chapters, findings are compared
with the results of previous studies, reported in Chapter 2. Finally, in Chapter 6, we provide an overview of
the key findings, summarise the main discussion points raised in earlier chapters, present implications for
policy and practice and list recommendations for further research.
The report is also supported by an extensive number of appendices which summarise our syntheses of
existing studies and which explain and describe our CVD, CVD-related and mental health prevalence
estimates [including the definition, provenance and prediction of modelled variables, predicted prevalence
rates for age–sex cohorts and overall, average rates by Index of Multiple Deprivation (IMD) quintile,
parameter estimates and plots at different scales of analysis, and prevalence maps].
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Chapter 2 Existing evidence of variations in access
to and use of NHS care
Introduction
In the introductory chapter, we noted growing support for prioritising health equity over health-care
equity. This, together with the assumption that access to and use of care continues to be characterised by
inverse care, has given rise to an acceptance that deprived areas require significantly higher levels of NHS
funding than their more affluent counterparts. Because there are doubts as to the extent to which the
NHS can reduce social inequality in health, unmet need becomes a central justification for positively
targeting funding. Against this background, it is important to establish the nature and quality of evidence
on variations in access. This is the aim of the present chapter, which asks:
l What evidence exists on variations in access to and use of NHS services and how has this impacted on
our understandings of health-care equity?
l What are the implications of the review findings for our own research on inequalities in utilisation of
cardiovascular care and mental health services?
Review strategy
Review framework
As noted in Chapter 1 (see Shifting patterns of morbidity: implications for working at the ‘deep end’),
evidence of the direction of inequality in access or use can vary according to the method used to establish
denominators of health service need. This is not always acknowledged in reviews of evidence. Indeed, very
little attention has been paid to the possibility of statistical artefact. We therefore propose that, in
reviewing evidence of variations in cardiovascular care and mental health, studies are examined for
methodological quality.
We decided to restrict the search period to 2004 onwards. This is, in part, in acknowledgement of key
policy changes in the NHS, not least with respect to the distribution of funding. It also reflects our
assessment of significant methodological progress in research over the past decade or so, particularly in
developing more direct measures of disease prevalence which, when applied to the investigation of
health-care equity, may address the fundamental difficulty of disentangling legitimate need from other
influences (see Methodological issues). Furthermore, devolution of the NHS has resulted in significant
differences in the health systems of the home countries.114 Consequently, we have excluded evidence that
focuses exclusively on Scotland, Wales or Northern Ireland. As Scottish researchers have shown an active
concern with ‘inverse care’,96,115–121 it is important to acknowledge that different search decisions (such as
admitting international evidence) are likely to have yielded different conclusions.
In addition to methodological concerns, some commentators have questioned whether the focus on
socioeconomic dimensions has given rise to an incomplete account of inequalities in access to and use of NHS
services.109 The key concern is that, owing to the ‘ongoing concern to demonstrate that socioeconomically
disadvantaged people are disadvantaged in their access to health care’,3 other dimensions of inequality may
have been overlooked. In their impressively wide-ranging review of evidence, Dixon-Woods et al.3 noted a
relative dearth of research evidence on ethnic variations in health service use and of access to health care
during childhood and older age, and the relative neglect of sex as a dimension in research on access to health
services. This does not accord with the findings of the Centre for Reviews and Dissemination (CRD) scoping
review,2 which suggested that a larger number of studies on cardiac care had focused on inequalities by age
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and sex than focused on socioeconomic status. Given this uncertainty about the possibility of research and,
indeed, publication bias (inconclusive or negative results being less likely to appear in the published literature
than evidence of inequality), we propose structuring the review around different dimensions of inequality:
socioeconomic, sociodemographic (sex and age), ethnic and geographical.
With exceptions,122,123 interpretation of variations in access and use is often insufficiently nuanced.
For example, lower-than-expected rates of specialist interventions such as coronary artery bypass grafts
(CABGs) and percutaneous transluminal coronary angioplasties are usually interpreted as a ‘bad thing’. An
alternative explanation is that the health of populations exhibiting lower-than-expected rates of secondary
care is being adequately managed in primary and community settings.124 It therefore becomes important to
establish exactly where on the care pathway inequalities arise.
Several authors propose that the model ‘candidacy’ should be used to conceptualise access to health care
at different points.3,113 This captures the idea that people need to recognise their eligibility as candidates
for health care and then have their candidacy assessed and acted on (adjudicated). The approach
recognises that variations in treatment arise from interactions between supply and demand and
accommodates the fact that barriers to access can occur across the pathway to care. For example, the
decision to seek help in the first place may be influenced by individual patients’ knowledge, information,
their evaluation of the seriousness of their problem, their judgement of the ability of the health service to
respond, psychological factors such as lack of embarrassment or fear, and practical issues such as the need
to rely on public transport or to arrange childcare/time off work. Once patients have gained entry to the
system, the categorisation and disposal of their health needs depends to some extent on their ability to
present in ways that health professionals find credible and legitimate. In turn, the way in which health
professionals categorise health needs may be affected by their perceptions of patient preferences, technical
eligibility and moral or social ‘deservingness’. Capacity factors (such as length of time available for
consultations, availability of tests and perceptions and/or experience of poor local capacity) may also play
an important role in shaping clinicians’ decisions to open up the pathway to treatment.
Concepts of candidacy and adjudication are not easy to operationalise in a review of largely quantitative
research. Thus, in order to examine how variations in access may manifest at different points on the care
pathway, we have structured the reviews of primary studies around presentation, primary management
and specialist treatment.
Finally, reviews of existing research (see Review evidence of variations in access to and use of NHS care)
suggest that there is uneven evidence with respect to clinical condition. There has been a strong
concentration on cardiac care and, within this specialty, on determining whether access or use varies
according to socioeconomic status. Evidence in other areas appears to be weak, though there has been a
focus on ethnic variations in use of mental health services. Thus, although the decision to focus on cardiac
care and mental health was made at the outset (with a subsequent decision to broaden the first category
to cardiovascular care), we nevertheless propose that these present good contrasting areas with respect to
existing evidence.
Review strategy
We have essentially drawn together four sets of reviews. These are (a) summaries of existing review
studies, (b) evidence of geographical variations in access to and use of NHS care, (c) primary studies of
variations in access to and use of cardiovascular care and (d) primary studies of variations in access to and
use of mental health services. Our aim was to retrieve articles or reports that provided quantitative
evidence of variations in access to and use of cardiovascular care or mental health services in England
(though qualitative evidence that shows a clear direction of inequality has been admitted).
EXISTING EVIDENCE OF VARIATIONS IN ACCESS TO AND USE OF NHS CARE
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Data sources
The following databases were used in the search: Applied Social Sciences Index and Abstracts, MEDLINE,
PubMed, EMBASE, Social Sciences Citation Index (Web of Science), Cumulative Index to Nursing and Allied
Health Literature, PsycINFO, SOCindex and EThOS (national thesis service). Website searches (general and
targeted) were also conducted in order to search for grey literature. Targeted websites included The King’s
Fund, the York Research Database, Cambridge Centre for Health Services Research, Health Services
Management Centre (Birmingham), National Institute for Health Research (ETS), the Health and Social Care
Information Centre (HSCIC), Department of Health, National Audit Office, University College London Institute
of Health Equity, Nuffield Trust, Health Foundation and Dr Foster. The searches were carried out between
September 2015 and February 2015. Data published between 2004 and 2014 were accepted for inclusion.
Search strategy
Searches used a combination of strategies: key phrase searching (with and without Boolean search
functions), backwards and forwards citation tracking and hand-searching of key journals. Combinations of
key phrases were used (see Appendix 1), including terms relating to setting (NHS, UK, England); access
(inverse care, inverse care law, access, accessibility, variation, inequ*, equality, equity, differences, postcode
lottery, unmet need, utilisation, utilization, use, uptake, discrimination); type of service [health check,
screening, help seeking, primary, general practice, general practitioner, secondary, hospital, tertiary,
prescribing, ECG, Coronary Heart Disease/CHD prescribing, cardiovascular/CVD prescribing, primary
prevention, secondary prevention, QOF, lipid lowering prescribing, statin, angiotensin/ACEI/ARB,
beta/β-blocker, surgery, revascularization, angioplasty, percutaneous coronary intervention/PCI, coronary
artery bypass, cardiac resynchronization therapy (CRT), pacing device, defibrillator, blood pressure monitoring,
cholesterol management, thrombolysis]; type of disease (cardiovascular, coronary heart, angina, myocardial
infarction, heart failure, hypertensive, hypertension, heart failure, stroke); and nature of inequality
(socioeconomic, socio-economic, depriv*, poverty, income, gender, women, men, male, female, older
people, old age, age, ageism, ethnic*, rural). Multiple combinations were used, for example including more
than one access term in a search.
The use of such a lengthy set of search terms reflects the fact that a wide range of keywords has been
used to classify literature that was of interest to this study. Many of the search terms did not prove to be
particularly discriminative, yielding both relevant and irrelevant material. For example, references to
inequality or variation apply to literature on both health care and health outcomes; the term ‘access’
retrieves articles on, for example, surgical technique, while searching for literature on drugs such as
beta-blockers, angiotensin-converting-enzyme (ACE) inhibitors and angiotensin receptor blocker (ARB)
drugs produces research relating to circulatory and non-circulatory conditions.
Such considerations might suggest the need for a more refined search strategy. However, we found that
the use of a more focused set of search term combinations omitted articles that we knew to be relevant.
Thus, the decision was taken to err on the side of inclusion. To reduce the time taken to conduct the
search (not least because there was a high degree of overlap between different databases) and to
encourage a more formative approach, we did not quantify the initial sweep of studies. In the context of
a wide-ranging search (which initially retrieved thousands of potentially relevant hits), we believe that such
an exercise would be meaningless. The fact that all of the articles selected for inclusion are listed (see
Appendices 2–25) also allows for transparency with respect to either judging the quality of the search or
updating the material.
The full text of the remaining studies was then reviewed with a view to excluding those which were
considered to raise questions about methodological quality. In fact, this task was not at all straightforward.
With growing acknowledgement of the difficulties of establishing a baseline of expected use against which
actual use can be compared,122,124 there has been distinct improvement in the methodological quality of
research in this field. For example, few of the reviewed papers compared, for example, deprivation
and/or standardised mortality against crude intervention rates, a clear-cut case for exclusion. Judging the
legitimacy of other approaches proved more challenging. For example, several studies have used
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administrative data on use (e.g. QOF-recorded prevalence or admission rates) to establish denominators of
need. Some, including members of our own team, strongly believe that, because all activity data will be
influenced by biases in supply and demand, needs estimates should be derived independently of such data.
Others disagree. Given such differences of opinion, we decided to appraise studies for methodological
quality, but we have not excluded articles and reports which we consider to raise methodological questions.
In tabulating the results, we have instead flagged such studies.
Finally, it should be noted that both the methodological quality and use of key phrases were more
consistent with respect to CVD than to mental health. We feel it likely that our findings on cardiovascular
care are largely reproducible, in other words that different researchers would identify and review a very
similar set of papers relating to equity of access and utilisation. We are more concerned about the
reproducibility of our findings on access to mental health services, not least because our approach to
searching this field yielded very few formal studies of use relative to need. Part of the issue here appears to
be the lack of appropriate denominators of need against which to compare use.
Review of reviews
In order to seek out review studies, we supplemented the searches for primary studies with a rapid search
of electronic databases and websites (see above), search combinations including ((health services
accessibility, equity, inverse care, variation, inequ*, access, utilisation) or ((inequ*, variation,
access)+ (socioeconomic/socio-economic, depriv*, social, gender, ethnic))) AND (NHS, UK) AND (review).
We found few reviews of literature on variations in access to NHS care, perhaps reflecting the tendency of
review studies, especially systematic reviews, to search international evidence. Perhaps there is also a
growing acceptance of the limitations of using systematic reviews to investigate outcomes that are shaped
by context-specific factors such as health system organisation.125
In order to ensure that we were not missing key articles, we screened literature on clinical areas other than
cardiovascular health and mental health conditions, further combinations including (access, variation,
inequ*) AND (hip replacement, diabetes, renal disease, cancer care) AND (review). This yielded several
reviews that comprised UK studies on variations in access and use for a range of clinical conditions.126–130
However, our focus is on health-care equity in the NHS. Thus, we concluded that these international
studies, many of which also include evidence from, for example, the USA, were too broad to be admitted.
Review evidence of variations in access to and use of NHS care
Reviews2,3,123,131–143 of studies investigating variations in access to and/or use of NHS services are
summarised in Appendix 2. This is structured chronologically in order to examine whether or not the
content and tone of reporting has changed since the 1990s.
We begin with the 1998 report by Goddard and Smith.131 Although this was produced somewhat before
the period under investigation, the report and its findings are worth highlighting for a number of reasons.
First, the work was important in policy terms, an amended version being submitted to the Acheson Inquiry
into Health Inequalities the same year. Second, the report outlined a set of particular population groups
that evidence suggested might be subject to inequities in access: geographical (e.g. between regions or
between urban and rural areas), social (e.g. by class or income), ethnic, age and sex. Third, a key
conceptual distinction was drawn between the roles of demand- and supply-side factors in giving rise to
inequality. Factors identified – such as perceived benefit of treatment and cost to the individual (such as
travel or loss of earnings) – map on well to subsequent understandings of the ways in which patients
establish candidacy.3 Fourth, the report and a related paper that was published from it122 highlighted
important methodological weaknesses in many of the studies they reviewed, not least the failure to control
adequately (if at all) for need. The clarity with which the authors discussed the methodological difficulties
of examining access/use in relation to need may well have played a role in the significant improvement
there has been in the methodological quality of empirical studies in the intervening period.
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With regard to its key findings (which focused on literature published from 1990 onwards), the review
found no systematic evidence of socioeconomic inequity at the aggregate level of GP, outpatient and
inpatient consultations. Indeed, higher rates of GP consultation were noted for the socially disadvantaged,
particularly in relation to mental health. Socioeconomic inequalities in access did appear to exist at
specialty level, for example for elective surgery and cardiac care. Ethnic differences were reported, with
particularly high rates of utilisation (such as compulsory detection) for schizophrenia among young black
men and relatively low rates of GP consultation among people of Chinese or African origin. The review
found that investigations and surgical interventions for CHD had been widely examined, evidence
suggesting that older people and women had poorer access than younger people and men. Finally, while
data were acknowledged to be poor, lower levels of preventative activity (such as breast cancer screening,
cervical cancer screening and immunisation) appeared to be reported in inner-city areas (associated with
both ethnicity and deprivation), with implications for early detection.
As an overall observation, Goddard and Smith131 noted the relative wealth of studies examining variations
in access to cardiac care, compared with other specialties. Mental health was identified as a particularly
difficult area, owing to the challenges of establishing indicators of need for services. Against this
background, it is not surprising that two of the review studies we have identified focus explicitly on
variations in access to cardiac care. In 2003, CRD in York published a scoping review of evidence of
inequities in access to cardiac services.2 This comprised UK publications from 1995 onwards (n= 105) and,
like the earlier York study, categorised studies by geography, ethnicity, socioeconomic status, age and sex.
The CRD review retrieved more publications on inequalities in access to tertiary cardiac services and in the
primary setting than on those in emergency hospital care and cardiac rehabilitation. A larger number of
studies had focused on inequalities by age and sex than by socioeconomic status, geography and ethnicity.
However, the review did not outline the direction of inequality found in these studies. The authors noted
that most of the evidence came from uncontrolled observational studies, which they considered to be less
robust than prospective controlled studies. This may explain why they did not report actual findings.
By contrast, Quatromoni and Jones138 reported that, of the UK studies they examined, all but one144
reported similar socioeconomic inequalities in relation to uptake of invasive coronary procedures to those
seen in the USA. On balance, studies also suggested that waiting times for IPCs were higher among the
socioeconomically deprived. Like Dixon-Woods et al.,3 our assessment of the literature on access to and
use of cardiac care is that the results are more contradictory (see Variations in access to and use of
cardiovascular care in England: what does the evidence tell us?). This partly reflects improvements in the
methodological design of projects over time; it is important to note that Quatromoni and Jones did not
assess the validity of the methods used in reported studies. Furthermore, their review does omit several
studies published during the same period that did not find strong evidence that deprived populations were
significantly less likely to receive invasive coronary procedures in relation to need.145–148
With the exception of Dixon-Woods et al.,3 who considered evidence on inequalities to be highly
equivocal, the key findings of more recent reviews are much the same as those reported by Goddard and
Smith.131 Thus:
l Access to GP services is found to be broadly equitable with respect to socioeconomic status136,140 and
there is no systematic evidence of ethnic inequalities with respect to access to primary care.3,132,137,140
l There is stronger evidence that the uptake of many preventative services is poorer among low-income
and some ethnic groups (inverse prevention law) and that the use of accident and emergency (A&E)
services is higher.3,136,137
l Evidence of sex and age variations is mixed; there are concerns about the underdiagnosis and
underutilisation of cardiac interventions for both women and older people, and the underdiagnosis of
mental health problems among older people,3,137,140 although women may be more willing to seek help
for mental health problems.139
DOI: 10.3310/hsdr04140 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 14
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Asthana et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
15
l With respect to specialist services, the evidence base remains stronger for cardiac care than for other
specialties. Reviews suggest that there are lower rates of cardiac intervention among the deprived
relative to need.136,138,142
l Evidence of socioeconomic inequalities in tertiary access for other clinical conditions is very weak,
although concerns have been raised about lower rates of hip replacement in deprived areas123,142
and variation between ethnic groups for voluntary and compulsory admissions for mental
health problems.133,134
Review evidence of variations in the access to and/or use of NHS care would, therefore, suggest that
evidence of inverse care is mixed. Although earlier research examined rates of GP consultation on
aggregate (and tended to find a pro-poor bias), the past decade has seen a substantive body of work on
what QOF data tell us about inequalities in access and outcomes. This suggests that there are now
negligible differences in the achievement of QOF indicators between deprived and less deprived areas,
although gaps may remain in the quality of care by age and sex. Preventative care (whether provided in
the primary setting or elsewhere) does remain a consistent cause of concern, reviews suggesting that an
inverse prevention law has been at work for some time.
With respect to inequalities in access to and/or use of tertiary care, the findings appear to be mixed. There
has been a particular concentration of research on cardiac interventions and, with some exceptions,3
reviewers conclude that the evidence points to inequity by socioeconomic status, age and sex. Other than
the specific examples of lower rates of hip replacement in deprived areas and higher rates of mental health
admissions among black people, further evidence that the NHS’s hospitals systematically discriminate
against particular population groups is very limited.
Geographical variations in access to and use of NHS care
In addition to research that has sought to explore socioeconomic, ethnic and demographic inequalities in
access and use, a growing number of reports describe the significant geographical variation that exists
with respect to NHS care (by which we mean variation between areas that is not explained by population
characteristics such as socioeconomic or sociodemographic status). This partly reflects improvements in the
availability of geographically referenced data. Since the NHS Information Centre Health and its successor
body, the HSCIC, were established (in 2005 and 2013, respectively), the quantity and quality of data on
health-care delivery have expanded dramatically.
As Appleby et al.123 noted, it is hard to find examples of, for example, inpatient hospital activity, where
there is little or negligible variation, although owing to the difficulties of controlling out legitimate sources
of variation, it is also hard to identify how much geographical disparity is unwarranted or ‘bad’. That said,
the scale of variation that persists in, for example, age–sex standardised rates of intervention is startling.141
For example, a report by The King’s Fund found a 15-fold variation in rates of percutaneous coronary
intervention (PCI) between PCTs (2009–10), while rates of knee replacement revision, CABG and
hip-replacement revision varied seven- to ninefold.123 As all of these procedures are generally recognised to
be clinically effective and rates are age–sex standardised, this scale of variation is difficult to justify.
The importance of mapping out variations in access to and/or use of NHS care has been acknowledged by
the publication of the first NHS Atlas of Variation in Healthcare in 2010,149 part of the Department of
Health’s QIPP (Quality, Innovation, Productivity and Prevention) Right Care Programme. A total of 34
topics, selected by clinicians as being important to their specialty, were mapped by PCT with a view to
helping commissioners address unwarranted variation by improving local commissioning and resource
allocation – although there are questions as to the extent to which the Atlas has been used to this
purpose.150 A further extended Atlas was published in 2011,151 mapping variation across 71 indicators, and
a follow-on series of thematic Atlases (on children and young people, diabetes, respiratory disease, liver
disease, kidney disease and diagnostic services) has since been released.152–157
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The NHS Atlases and other official publications158–164 reveal widespread variations in rates of activity across
different specialties (for a summary of findings, see Appendix 3). Given the care that has been given to
improving nominator-to-denominator ratios in assessing use relative to need, the scale of variation is of
concern. However, as noted, although these Atlases can throw light on inappropriately low – and high –
rates of utilisation, they do not distinguish between legitimate and illegitimate (or ‘bad’) variation.165
Moreover, although some findings have been further explored with respect to a relationship with
deprivation, no further modelling has been undertaken with respect to relationships between geographical
variation and other population characteristics. Thus, it is impossible to know whether variations are due to
differences in patient and/or clinician choice of therapy (preference-sensitive care) or differences in a local
area’s capacity to deliver care (supply-sensitive care).
Methodological issues
As noted above, a key contribution of Goddard and Smith122 has been to highlight the methodological
difficulties associated with the practical investigation of health-care equity, especially those associated with
establishing expected levels of health service ‘need’ against which actual use can be compared.124,166 In
addition to key conceptual questions, such as whether need relates to an individual’s level of illness or to
their capacity to benefit from treatment, a large number of measurement issues arise, primarily around the
use of proxy indicators to establish a baseline of expected use against which actual use can be compared.
There are also debates about the relative merits of individual- and population-based studies.
Early studies of variations in access and use
Until the 1990s, research on inequalities in access to and/or use of NHS care was hampered by the lack of
readily available indicators of need. With the exception of bespoke surveys, such as the British Regional
Heart Study (BRHS) (see Health survey data), studies were limited to examining variations in general
utilisation. The General Household Survey (GHS) was used by several researchers to this end.167–171 As this
collected evidence on self-reported morbidity [acute sickness and limiting long-term illness (LLTI)], use of
primary, outpatient and inpatient care and socioeconomic status, it allowed ratios to be calculated for the
relationship between need and use by different socioeconomic groups. Different studies using the GHS
nevertheless drew different conclusions about whether there was pro-rich or pro-poor bias in use of care.
This mainly reflected the way in which researchers chose to adjust for differences in morbidity.
By the 1990s, there was a growing interest in undertaking what Dixon et al.136 refer to as ‘micro-studies’,
or studies of variations in access to particular services. In some cases, individual-level data were used to link
‘need’, usually defined in terms of initial presentation (diagnosis or admission), to subsequent use of
investigations or treatment.172–175 At the time, however, national sources of data lacked sociodemographic
or residential details of patients or were insufficiently complete and accurate for use.176 As a result, most
studies of this kind were based on locally negotiated access to data.
Proxies for need: the use of mortality and deprivation
To make studies more generalisable, many researchers turned to area-level proxies of need, most
particularly mortality and deprivation. Mortality rates have been widely used in the investigation of
inequalities in access and use, particularly to cardiac care, reflecting the fact that mortality data are
routinely available, can be decomposed by age and sex and reflect cumulative morbidity. Against this,
mortality is a better proxy for diseases where case fatality is high than for conditions such as CHD where
mortality statistics will fail to reflect the full extent of non-fatal morbidity and, by implication, health service
need. The validity of using mortality as a need indicator may also be affected by social differences in
survival rates, studies finding that the least affluent patients tend to experience the worst outcomes.177–181
This may reflect poorer access and use of health services. However, if factors such as comorbidity, smoking
status and obesity are more important in influencing survival outcomes, mortality statistics will illegitimately
weight need in favour of deprived groups.
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Such objections aside, one fundamental consideration in using mortality to investigate inequalities in health
service use relative to need is the importance of ensuring comparability in the expression of the denominator
(need) and nominator (use). Unfortunately, research using mortality rates as a proxy for CHD service need
has been rather inconsistent in this respect, which means that findings should be interpreted with caution.
Some studies145,147 have appropriately explored whether or not the relationship between standardised
CHD/ischaemic heart disease mortality and standardised intervention rates varies by deprivation. Others have
not directly adjusted intervention rates by need in order to examine variations in use relative to need by
population characteristics, but have compared standardised intervention rates with (a) standardised mortality
rates (SMRs) and (b) socioeconomic measures separately,146,172,182 while still others have concluded that a lack
of association between SMRs and crude intervention rates is indicative of inequity.183–186 However, for many
diseases, there is a poor relationship between crude and standardised CHD mortality. This means that
research examining the association between SMRs and crude rates of procedures is not comparing like with
like and should not be cited as yielding evidence of the inverse care law.
It would appear that some evidence on inequalities in access to cardiac care – which has been a particular
focus for researchers seeking to investigate variations in access to NHS care – has been subject to statistical
artefact. This seems to stem from an assumption that standardised measures are synonymous with need
for health care. According to Goddard and Smith,122 the weight of evidence relating to the treatment of
CHD suggests that ‘admissions, rates of investigation and revascularisation do not match the higher levels
of need experienced by the most disadvantaged groups compared with more affluent groups’ (our
emphasis). Indeed, the fact that SMRs are subject to profound social gradients has led to the assumption
that deprivation itself may act as a valid proxy for health service need. For example, a lack of general
association between deprivation and CHD prescribing187 has been interpreted as suggestive of inequity
due to an expectation that the most deprived areas have the highest levels of CHD need. Yet because
deprived populations also tend to be young populations, they do not necessarily have the highest burden
of disease in crude terms. This makes the simple comparison of deprivation scores against crude
intervention rates, as in the influential Acheson Report,188 problematic.
Health survey data
As noted above, one advantage of surveys such as the GHS is that they offer a way to directly link
self-reported morbidity with health service use at the individual level. Large population surveys are costly to
administer. Thus, although some, such as the Health Survey for England (HSfE), are conducted annually,
bespoke studies are rare.
An important exception is the BRHS, a prospective survey of middle-aged men drawn from general
practices in 24 British towns. Originally recruited in 1978–80, surviving participants continue to be followed
up by the University College London team managing the study. The vast majority of the team’s outputs
relate to risk factors and outcomes. However, several important papers have been published on inequalities
in access to and/or use of care.189–195
These and other survey-based studies have mixed results. Thus, although Morris et al.193 reported that men
of lower socioeconomic status in the BRHS who experienced angina or myocardial infarction (MI) had a
lower incidence of revascularisation, analysis of the Whitehall II prospective cohort study of civil servants
found no association between individual socioeconomic position, undiagnosed angina196 and use of
cardiac procedures or secondary prevention drugs in relation to need.144 No statistically significant
socioeconomic differences were found in the uptake of secondary prevention medication relative to need
in the BRHS192 or the 1998 round of the HSfE.197 Evidence of ethnic inequalities is also equivocal. In the
Whitehall II study, South Asians tended to be more likely to have cardiac procedures and to be taking
more secondary prevention drugs than white participants, even after adjustment for clinical need,144 while
analysis of four waves of HSfE data found little evidence of ethnic inequalities in the use of primary and
secondary health services.198 Against this, another analysis of HSfE data found that low-income individuals
and those from ethnic minorities are more likely to consult their GP but less likely to receive all forms of
secondary care.199
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The validity of deriving needs estimates from self-reported survey data has been debated. Reviews of
self-rated health research suggest statistically strong associations with future mortality200,201 and many
studies comparing health service records with self-reports find high levels of agreement.202–205 However,
there are concerns that the ability and/or willingness of people to make accurate accounts of their health
status may differ according to personal characteristics such as sex206 and education.202,204,207–209 If this is the
case, use-to-need ratios could be overestimated for less advantaged groups.
Such considerations make the HSfE particularly valuable. This does not comprise only self-reported health
(in some cases using internationally validated instruments such as the Rose Angina Questionnaire) and
health care; it supplements self-reported measures with various physiological measurements, such as
cholesterol level, blood pressure, lung function tests and waist-to-hip ratio (taken during a nurse visit).
Linkage to cancer registrations and Hospital Episode Statistics is expected to make this an even more
powerful tool with which to examine relationships between need and use. Against this background, it is
not surprising that the HSfE has been used as the data source for several prevalence models that have
been developed for the Association of Public Health Observatories (APHO) – now part of PHE – including
COPD, diabetes, CHD, hypertension and CVD.210–215
Administrative data
In addition to proxy measures and survey-based indicators (individual and modelled), researchers examining
variations in access and use have turned to existing administrative data, the quality of which has vastly
improved in the past decade, to establish denominators of need. Here, the focus is on whether or not
patients with a particular diagnosis receive the same level of care, regardless of personal characteristics. For
example, a study in Nottinghamshire used admission rates for MI and angina as a proxy for practice-level
prevalence.216 This found that although deprived practices had a higher estimated prevalence of severe
ischaemic heart disease, they had lower angiography rates. By contrast, research undertaken in East
London which used nitrate prescriptions and admissions for MI as measures of need found no evidence
that practices serving more deprived populations had lower-than-expected rates of angiography.217 The
NHS Atlases of Variation also use several denominators based on presentation (e.g. patients with a
ST-elevation MI diagnosis, patients admitted with stroke).151
The use of admission rates as a proxy for prevalence is not without its limitations. This approach is valid
only if all patients with a given level of morbidity access hospital services to a uniform extent. Given what
we know about socioeconomic and other differences in the relative use of elective and emergency care,218
it is unlikely that this condition is met. If, for example, deprived patients are more likely to be admitted to
hospital with more severe disease, then there may be clinically appropriate differences in the subsequent
uptake of hospital procedures. The impact of supply on expressed demand should also be acknowledged.
Insofar as QOF data offer an estimate of disease prevalence at the primary level, they may be less likely to
be influenced by biases in supply and demand than are data on hospital-level admissions. However,
because they can capture only patients who access primary care and who are accurately diagnosed, QOF
data are not immune to these problems. If deprived patients are less likely to consult their GPs, or if the
availability and/or quality of primary care is poorer in deprived areas, then GPs may be more effective at
picking up and recording disease burden among more affluent patients and their families.219,220 The extent
to which these factors affect QOF-derived prevalence estimates is unclear. As noted above, data on
primary care utilisation suggest that socially disadvantaged people make as good, if not better, use of
general practice as other population cohorts.193 At the same time, there is a mismatch between, for
example, QOF-recorded CHD and APHO-modelled CHD estimates,151 suggesting that there may be random
or systematic differences between community and recorded prevalence.
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Variations in access to and use of cardiovascular care in
England: what does the evidence tell us?
Overview of studies
In total, we found 123 studies that had investigated inequalities in access to and/or use of cardiovascular
services.109,138–140,144,184,185,191–195,198,215,217,219–326 These are described in Appendices 4–14 and summarised here
in Table 2. The bracketed numbers refer to the number of studies that found evidence of inequality in
access or use (for people of lower socioeconomic status, older people, women, non-white patients and by
geography). The total number of counts in the table is higher than the number of studies because, for
example, some studies examined more than one dimension of inequality. Although our search is not
directly comparable with that of CRD,2 which examined research on cardiac services only, it is interesting to
note that more studies were published in the decade 2004–14 (n= 188 counts) than in the previous
decade 1995–2003 (n= 105 counts). This suggests that, notwithstanding the overall sway of interest in
health inequalities, health-care equity remains a focus of concern among health services and
related researchers.
There has, however, been a refocusing with respect to dimensions of inequality. As noted in Review
evidence of variations in access to and use of NHS care, the CRD review found that a higher number of
studies had explored inequalities with respect to age (30%) and sex (28%) than socioeconomic status
(19%), geography (15%) and ethnicity (8%) of 165 counts, excluding studies on undefined ‘vulnerable
groups’.2 In our review, the respective breakdown was 15%, 20%, 35%, 19% and 11% of total counts
(n= 187). Thus, we note a significant shift in focus away from sex and age inequalities and towards
socioeconomic status and ethnicity.
With respect to type of service, our results are not comparable with those of the CRD study. The latter
study categorised studies according to whether they examined primary/secondary prevention, emergency
hospital care, tertiary cardiac services, cardiac rehabilitation or other services. In order to capture the
concept of candidacy and adjudication at different stages of the care pathway, we have instead
categorised studies with respect to a focus on presentation, primary management and specialist treatment
of CVD. The studies we retrieved on patients accessing emergency services tended to focus on whether or
not there was a relationship between rates of elective and unplanned admissions and quality of primary
care. We have thus classed these as primary management studies. Further, we have included studies on
cardiac rehabilitation in the group on specialist treatment.
If we group the CRD studies on the same basis (i.e. include studies on emergency hospital care within
primary management and studies on cardiac rehabilitation within specialist treatment), there is a similar
breakdown of focus. A total of 16% of total studies in our review related to presentation of CVD, 45%
related to primary management and 39% related to specialist treatment. In the CRD review, approximately
51% and 49% of studies examined primary management and specialist treatment, respectively.2
TABLE 2 Summary of included studies according to stage on care pathway and nature of inequality in access to
and use of cardiovascular care
Stage of care pathway Socioeconomic Age Sex Ethnicity Geography Total
Presentation 12 (5) 2 (0) 9 (7) 7 (2) 0 30 (14)
Primary management 36 (15) 12 (11) 14 (7) 16 (7) 5 (5) 84 (45)
Specialist treatment 18 (10) 12 (11) 14 (12) 13 (7) 16 (16) 73 (56)
Total 66 (30) 26 (22) 37 (26) 36 (16) 21 (21) 187 (115)
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The direction of inequality
The tables of included studies in Appendices 4–14 are colour-coded to indicate (under lead author) whether
or not the study found inequality in access/use, with lower rates among those of lower socioeconomic
status, older people, women and non-white patients. Evidence of geographical variation is also flagged.
Light green indicates evidence of inequality, blue indicates no evidence of inequality and dark green
indicates evidence that rates are higher for those of lower socioeconomic status, older people, women
and non-white patients (i.e. inequality in a different direction from that flagged as light green). Where
methodological observations are made on studies, these are also highlighted in blue, though we have not
changed the ‘colour’ of the study’s main findings, even if we consider the methodology to be flawed.
Given the powerful meta-narrative of inverse care in the field, the results are surprising. Of the 65 studies
examining variations according to socioeconomic status, 46% (n= 30) reported evidence of poorer
access/use among socially disadvantaged groups.109,138,140,184,193,219,220,224,226,229,233,242–244,249,252,253,261,262,
263,268,269,284,287,288,291,293–296 Forty-four per cent (n= 16/36) of the studies examining ethnic variations found
poorer access/use among non-white groups.223,234,237,241,243,252,258,261,278,283,297,306,308,309,311,312 By contrast,
73% (26/37) of studies investigating sex variations found that women were less likely to enjoy the same
level of access/use as men139,223,225,231,232,234–236,258,263,270–273,290,291,294,296–302,305,306 and 81% (22/27) of
studies investigating age differentials found that older people had poorer access/use than
younger people.191–195,252,253,258,260,263,273,275,284,290,291,294–296,301,303,305,306
Presentation of cardiovascular problems
More studies examining variations in the presentation of CVD focused on socioeconomic status than other
categories. Fewer than half found evidence of inverse care. This may reflect improved detection of disease
within the community over time. For instance, using 2005–6 QOF data, the gap between estimated
(APHO) and reported prevalence of CHD and hypertension increased with population deprivation and was
higher among practices in more deprived areas.224 By contrast, a comparison of NHS Health Check coverage
(2011–12) against expected (APHO) cardiovascular health need found that coverage was significantly higher
in PCTs in the most deprived areas than in those in the least deprived.222 Some studies225,228 agree that
people from less advantaged communities are more likely to access CHD risk-screening programmes, while
others disagree.219,226,227 Thus, the direction (if any) of socioeconomic inequality in presentation of CVD
remains unclear.
Although the wider literature on sex differences in help-seeking for CVD is conflicting,236,327 the evidence of
this review suggests that women delay help-seeking longer than men. This appears to be the result of
biological differences rather than sex constructions, with, for example, women experiencing more atypical
symptoms of CHD.139,231,235,236 Against this, there is also evidence of the underpresentation of hypertension
in men.139 A review article219 also suggests that men (socially disadvantaged men, single men, non-white
men) are less likely to attend health checks, though much of the evidence drawn on in this review comes
from outside the UK. Youth also appears to be a factor lowering rates of presentation, at least
among men.222,233
With respect to ethnicity, several studies suggest high levels of presentation among South Asian
patients,227,233 perhaps because of awareness about increased risk. Galdas et al.238 attributed a greater
willingness to seek help among South Asian men to different attitudes towards masculinity. During
semistructured interviews, white men linked a reluctance to disclose symptoms and a delay in seeking
treatment to fears of being seen to be weak. By contrast, Indian and Pakistani men emphasised wisdom,
education and responsibility for the family and their own health as more valued masculine attributes, and
this contributed to a greater willingness to seek medical help. However, other studies found no ethnic
differences in presentation228,239 while still others found higher delays between the onset of symptoms of
acute ST-elevation MI and arrival time at hospital among South Asians.234 One study examining delay in
presentation after an acute stroke also found that patients of black ethnicity had higher pre-hospital delays.237
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Primary management of cardiovascular disease
Again, more studies examining variations in the primary management of CVD focused on socioeconomic
status than on other categories, 42% finding evidence of inverse care (it should be noted that some of
these are methodologically flawed). Several studies note small but significant residual differences in the
quality of primary care after the introduction of QOF, favouring less deprived groups,140,242–244,249,262
although others suggest that socioeconomic differences have significantly narrowed over time.247,248,250
Studies that have focused on prescribing (e.g. of lipid-lowering drugs or prescribing for heart failure) have
mixed results, some finding no difference in prescribing rates,194,255,258,260 some finding higher rates in more
deprived communities,241,256 and others reporting lower rates.233,252,253,263 Several studies have also looked at
emergency admissions for CVD and proposed that the lack of association between quality scores and
admission rates suggests that the quality of primary care is not a significant factor behind higher rates of
admission among the socially deprived,245,246,251,259,265 although there is some evidence that small practice
size may play a role in variation.269
Evidence of variations in primary management by age and sex is more consistent. Several studies suggest
that men are significantly more likely than women to undergo detailed risk factor assessment for
CVD,223,272 even when doctors are presented with identical symptoms in both sexes,270,271 although Laverty
et al.274 noted that men are less likely than women to receive blood pressure monitoring, a sex gap that
seems to be increasing over time. Evidence of sex differences in prescribing is more mixed, some studies
noting lower rates for women258,263,272,273 and others finding no differences by sex.194,260,275 There is,
however, consistent evidence that rates of prescribing are lower than expected among
older people.191,192,195,252,253,258,260,263,273,275
Just under half of studies of primary management by ethnicity report evidence of inequality. A study based
in Lambeth283 found that blood pressure monitoring was similar across ethnic groups and as good as, if
not better, for black patients as for white. However, some inequalities were found (e.g. blood pressure
control was poor in Caribbean patients with CHD) compared with white patients. Two studies in
Wandsworth also noted ethnic variations in blood pressure control,274,280 while Ashworth et al.243 found
that, across England as a whole, practices performing less well in terms of blood pressure monitoring were
those with higher proportions of black or black British residents in the local population. No association was
found in this study with South Asian ethnicity. Indeed, notwithstanding questions about constraints to
British South Asians’ claims to candidacy,278 there is some evidence to suggest that the quality of
cardiovascular care is higher among South Asian than white populations.144,258,281 Against this, there is
evidence that black African/Caribbean patients may be prescribed fewer lipid-modifying and other CVD
drugs.258 Fleetcroft et al.252 also noted lower levels of prescribing in areas in which ethnic minority
populations are higher, although this study did not distinguish between ethnic groups.
Specialist management of cardiovascular disease
A total of 77% of studies examining variations in access to and/or use of specialist care found evidence of
inequality, a higher percentage than for presentation and primary management. Again, many of the
studies examining socioeconomic variations are methodologically flawed, though confidence can be placed
in some evidence of inverse cardiac care.193,194,296 Evidence of socioeconomic inequality in the management
of stroke appears to be more consistent, studies finding that patients of lower socioeconomic status are
significantly less likely to have received brain imaging284,291 or swallow tests at first stroke.287
As in earlier stages of the care pathway, evidence of sex and age variations in specialist management is
strong and consistent. Women are significantly less likely to receive CABGs and percutaneous transluminal
coronary angioplasty (PCTAs)193,298,301,305,306 and have longer door-to-balloon times for primary PCI.296 Sex
disparities have also been noted in interventions for acute coronary syndromes,299 heart failure300 and
stroke.301 Use of cardiac rehabilitation has been found to be higher among men than women.290,297,302
Older patients are also found to be discriminated against with respect to revascularisation,193,294,296,301,305
interventions for other cardiovascular conditions284,291,303
and cardiac rehabilitation.290,297
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With some exceptions,306,308,309 most studies suggest that South Asians have high levels of access to or use
of specialist care.135,217,295,307,310 By contrast, studies suggest that black patients have lower rates of specialist
use than expected.284,311
Geographical variations in access to and use of cardiovascular care
It is worth noting that, in addition to studies demonstrating variations in access according to
socioeconomic or sociodemographic status, evidence suggests that very significant geographical variation
exists with respect to access to and/or use of cardiovascular care (see Appendices 3, 13 and 14). Evidence
is strongly suggestive of a ‘postcode lottery’ with respect to cardiovascular care. However, more research is
required to examine whether variation is random, or reflects more systematic influences.
To conclude this section, compared with the focus on socioeconomic deprivation, the possibility that
inequality in access to and use of cardiovascular care may be structured around age and sex has received
little attention. Yet our review finds that published evidence finds that women and older people in
particular experience poorer access to health. The question is whether or not our own empirical
assessment of variations in access to cardiovascular care supports the review’s findings.
Variations in access to and use of mental health services in
England: what does the evidence tell us?
Overview of studies
In total, we found 101 studies113,328–427 that had investigated inequalities in access to and/or use of mental
health services in England (or which presented review articles comprising a large proportion of English
studies). These are described in Appendices 15–25 and summarised in Table 3. Again, the bracketed
numbers refer to the number of studies that found evidence of inequality in access/use (for people of
lower socioeconomic status, older people, women, non-white patients and by geography). With respect to
mental health, however, the interpretation of ‘inequality’ is not straightforward. For example, there have
been long-standing concerns that people from ethnic minorities have been preferentially ‘psychiatrised’,
with excessive numbers of patients inappropriately being given a diagnosis of schizophrenia in particular,
and, having received this diagnosis, a disproportionate number have been forcefully detained, medicated
with antipsychotic drugs and involuntarily admitted into secure hospitals under sections of the Mental
Health Act.428,429 Against this background, evidence of higher rates of hospitalisation has been interpreted
in the review as evidence of inequality.
As Table 3 shows, the breakdown of mental health studies with respect to type of service, type of
inequality and direction of inequality is very different from that of studies of variations in access to and/or
use for CVD. First, the largest category of interest is that of ethnic variations in access (35% of the total),
followed by age variations (23%). Only 18%, 14% and 11% of studies focused on socioeconomic,
geographical or sex variations, respectively. Second, a significantly higher proportion of studies explored
variation in access to and/or use of specialist services (55%). This reflects the way in which mental health
services are configured; even those provided in the community tend to be delivered by specialist teams as
TABLE 3 Summary of included studies according to stage on care pathway and nature of inequality in access to
and use of mental health services
Stage of care pathway Socioeconomic Age Sex Ethnicity Geography Total
Presentation 4 (2) 8 (5) 7 (1) 19 (17) 0 38 (25)
Primary management 11 (4) 8 (8) 2 (2) 9 (7) 5 (4) 34 (25)
Specialist management 13 (5) 20 (10) 9 (1) 28 (12) 16 (18) 88 (46)
Total 28 (11) 36 (23) 18 (4) 56 (36) 21 (21) 160 (96)
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opposed to GPs. Finally, it should be noted that reviewed studies on variations in access to/use of mental
health services included a far higher proportion of local studies (e.g. based on one mental health centre)
than did research on CVD.
The direction of inequality
Mental health services also appear to be characterised by different dimensions of inequality. As with CVD,
a high proportion of studies examining age variations found evidence of inequality (64%) in mental health
services. Sixty-four per cent of studies examining ethnic variations also found evidence of inequality,
supporting concerns about cultural misunderstandings, coupled with institutional racism.430 Thirty-nine
per cent of studies examining socioeconomic differences reported poorer access/use among socially
disadvantaged groups, suggesting that the classic understanding of inverse care is not as strong a
dimension of inequality. There is, moreover, little evidence that women experience poorer access to/use of
mental health services (22% of studies). Care should be taken in interpreting these summary results, given
the methodological difficulties of examining mental health service use relative to need. It is, nevertheless,
interesting that a similar proportion of studies of mental health services report inequality (60%) as studies
of access/use for CVD (62%).
Presentation of mental health problems
The review offers some insights into the nature of inequality of access to/use of mental health care.
With respect to initial presentation, older age, male sex and being a member of an ethnic minority are
all associated with lower rates of help-seeking behaviour. Indeed, if male sex is counted as a source of
vulnerability, 76% of studies examining variations in presentation of mental health problems found
evidence of inequality.
Studies suggest that older patients are sensitive to the stigma of formally diagnosed mental illness,431 are
reluctant to recognise and name depression432,433 and, in consequence, are less likely to seek help,434 even
for serious mental health problems.435 According to an Age Concern report,436 only one-third of older
people with depression ever discuss it with their GP. Younger men are also disproportionately deterred
from seeking help for mental health problems because of stigma.433,437 Similar themes have emerged in
studies of help-seeking behaviour by ethnic minority groups. Some note that, like older people, people
from ethnic minority groups may prefer to seek help for physical rather than mental health symptoms;338
may not even conceptualise their distress as a biomedical problem;329,438 may be sensitive to the stigma of
formal mental illness;113,333,336,433 and may feel guilt and shame about seeking help outside the family.278,339,341
In addition, experiences of racism and discrimination may deter black people from accessing services.335
Primary management of mental health problems
In contrast to evidence on cardiovascular care, relatively few studies examined variations in the primary
management of mental health. This may reflect the segregation of mental health services from general
health services although, as noted in Chapter 1 (see Understanding variations in the use of NHS care:
a shifting context? and Shifting patterns of morbidity: implications for working at the ‘deep end’),
mental health appears to be an underlying factor in a large proportion of primary care consultations.
The treatment of dementia is an exception with respect to research effort. People with this disease living
both in the community and in care homes are likely to be under the care of their GP. Most antidepressant
prescribing also takes place within the primary setting.
Of the studies examining variations in primary management, 73% find inequality. Socioeconomic status
appears to be an exception here, with only one-third of studies finding evidence of inverse care. By
contrast, all studies that examined age or sex variations found that older people and women received
poorer access to primary management, and three-quarters of studies which examined variation by ethnicity
found poorer access/use for non-white groups. Again, care should be taken in interpreting these summary
findings owing to the small number of studies in each category and the methodological difficulties of
adjusting for mental health need.
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Evidence of the primary management of mental health problems among older people does, nevertheless,
raise concerns. As noted above, a review by Age Concern436 found that only one-third of older people
with depression ever discuss it with their GP. Of these, only half (or about 15% of all older people with
depression) are diagnosed and receive treatment; for example, referrals to psychological therapies are low
for older people.431 Age Concern notes that fewer than half of people with dementia will ever receive a
diagnosis. There are also concerns about inappropriate prescribing for older people.346,355,356,358
With regard to ethnicity, studies suggest that the prescribing of antidepressants and tranquillisers is lower
than expected in areas with high percentages of black or Asian people.242,345,350,355,362 On the other hand,
inappropriate prescribing also seems to be lower for people from ethnic minorities.348 A second area of
concern relates to care pathways and the possibility that the dissatisfaction of black people with primary
care services is one factor behind more coercive pathways into secondary care.359,361
Specialist management of mental health problems
A lower proportion of studies examining variations in access to/use of specialist services find evidence of
inequality (52%) than studies examining presentation and primary management of mental health
problems. If evidence of geographical variation is excluded, 40% of studies find inequality. Again, this
seems to be at odds with the meta-narrative of inverse care in the field.
It is, nevertheless, important to distinguish between types of specialist service. A wide range of
community-based services were examined in the reviewed studies, including IAPT services, assertive
outreach, early-intervention services, crisis resolution and home treatment (CRHT) services and
psychological support for cancer patients. In total, there were 24 studies of specific community services
(some papers reported on more than one service), half of which examined IAPT services. Fifteen studies
focused on inpatient mental health services, including pathways to admission.
Interpreting evidence of socioeconomic inequalities in access to and use of specialist mental health services
is complicated by the methodological quality of studies. Several do not directly adjust for health service
need. Findings are, moreover, contradictory. Thus, although some364,372 propose that deprived people are
less likely to access psychotherapy services, others suggest that the IAPT initiative is addressing inverse care
and that there is now a pro-poor socioeconomic gradient in public psychotherapy treatments which is
widening over time.365,367 Against this, one study found that patients from areas of high deprivation
entered a local IAPT service with more severe depression than patients from areas of low and
medium deprivation.370
With respect to age, several studies note a discrepancy between the prevalence of mental disorders in
older people and the provision of treatment,354,367 reflecting a general failure to prioritise the development
and integration of specialist services for this group.354,377,386,387,436 According to Age Concern,436 only 6% of
older people with depression receive specialist mental health care. Only a small minority of older people
who take their own lives have been in contact with specialist mental health services, although most have
diagnosable mental health problems; and there are fewer community mental health teams, crisis resolution
teams and assertive outreach teams for older people than for younger people. Despite the roll-out of IAPT
services, access/use in later life has been lower than expected,383 raising concerns that, although public
bodies are not allowed to discriminate access to services on the basis of age, IAPT services continue to be
targeted at populations of working-age adults. Finally, concerns have been raised about access to specialist
services for older people living in care homes.386 One postal survey of care-home managers found that the
frequency of visits by and direct access to old-age psychiatrists was very poor. A total of 38% of managers
reported that their homes ‘never’ received any visits from old-age psychiatrists and only half described the
current frequency of visits as adequate, suggesting high levels of unmet need.427
In contrast to strong evidence of ethnic inequalities in the presentation and primary management of
mental health problems, only 43% of studies examining specialist services found evidence of inequality.
Again, results are mixed. Some studies suggest that use of IAPT services is lower than expected among
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minority groups.364,398 As ethnicity does not predict IAPT non-attendance,374 this may suggest that ethnic
variations are occurring at the level of referral. On the other hand, variations in, for example, help-seeking
behaviour between ethnic groups may account for the difference. Examining users of CRHT, early
intervention, assertive outreach and IAPT, Glover et al.397 found lower rates for Indian and Chinese groups
and higher rates for black Caribbean and black African groups than for white British groups. Several
studies suggest that, although black British groups have similar or higher rates of use,391 Asian groups may
be underutilising community services.399,402,406
A distinct subset of studies of ethnic variations in access to/use of specialist services focus on the use of
inpatient mental health services. Black Caribbean and black African communities are over-represented in
psychiatric and secure mental health hospitals in England and Wales.403,407 Pathways to care differ between
ethnic groups, with black patients being more likely to access via emergency medical services and to have
experienced involvement of criminal justice agencies.396 Mann et al.404 noted that the odds of black African
early-intervention service users being detained were three times higher than for white British patients.
Similarly, Weich et al.374 found significantly higher rates of compulsory admission for patients of black,
Asian and mixed ethnicity, patients of black ethnicity being almost three times more likely to be admitted
compulsorily than white patients. Although one recent study408 found that ethnicity was not an
independent predictor of detention following a Mental Health Act428 assessment, it is possible that the
denominator used (those identified as needing an assessment) is biased. Thus, the evidence does point to
a higher rate of detention and hospitalisation among black groups. Compulsory admission is not
necessarily synonymous with coercion and dissatisfaction with services. One study found no association
between ethnicity and patient perception of coercion at admission or during the first 4 weeks after
admission,389 while a study of satisfaction with inpatient treatment for first-episode psychosis found that,
although black patients were less satisfied than white patients with specific aspects of treatment,
particularly medication, they were equally satisfied with nursing and social care.392
Studies of ethnic variations in length of hospital admission also reported mixed findings; Mohan et al.405
suggested that intensive treatment leads to a significant reduction in hospital days for African Caribbean
patients compared with white patients, while Poole et al.369 found that younger inpatients, who were
often of black and minority ethnic background, had longer admissions. There is also a suggestion that
black inpatients of mental health services have higher levels of unmet needs.393,400
Geographical variations in access and use
It is worth noting that, in addition to studies demonstrating variations in access and use according to
socioeconomic or sociodemographic status, evidence suggests that very significant geographical variation
exists with respect to NHS mental health services. There is wide variation in mental health expenditure
between areas, which cannot be explained entirely by differences in levels of need, differences in volume
of activity or differences in efficiency.415 In 2006–7, for example, Islington PCT spent 4.6 times more per
head (£474) on mental health than East Riding of Yorkshire PCT (£103). Adjusting for the weighted
capitation population (which, we have noted, is a contestable denominator) reduced the gap to 2.9-fold,
or £332 and £114, respectively.414
There is evidence of substantial geographical variations in rates of diagnosis, prescribing and use of
specialist services. According to Department of Health estimates, the diagnosis-to-estimated-prevalence
ratio of dementia varies from 39% in the worst performing areas to 75% in the best.160 During the period
between October and December 2012–13, antidepressant prescribing rates varied from 71 items per 1000
people in NHS Brent to 331 items per 1000 people in NHS Blackpool. Generally, there were lower levels of
prescribing in London and higher rates in the North East.161 Directly standardised rates of use of mental
health services range from 6831 per 100,000 in Brighton and Hove to 1323 per 100,000 in Shropshire
County; and the average number of people who have completed IAPT per quarter ranges from 2241 in
Eastern and Coastal Kent to 102 in Hillingdon.159 These are large variations which should be further
investigated with a view to examining whether they are random (i.e. suggestive of a ‘postcode lottery’) or
subject to systematic biases.
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Conclusion
We suggested in Chapter 1 that the inverse care law has come to operate as a meta-narrative in
understandings of health-care equity. The evidence provided in this chapter suggests that sex and age are
more powerful determinants of inequity with respect to cardiovascular care; and that age and ethnicity
are the key dimensions of inequity with respect to mental health services. What is clear, moreover, is that
there is significant unexplained geographical variation in access to and use of NHS services, which is
strongly suggestive of a ‘postcode lottery’.
Evidence also varies with respect to stage on the care pathway. Access to and use of cardiovascular
services appears to be more inequitable for specialist services than for primary care, while studies of mental
health services suggest that inequality is more likely to occur during presentation or primary management.
The fact that inequity may manifest in different ways in different areas of specialty has received little
attention. Our reviews suggest that the way in which people claim candidacy and are adjudicated within
the system is likely to vary by clinical condition.
The reviews suggest that there are several research questions that need to be answered with respect to
variations in access and use. Unfortunately, our study design does not allow us to address all of these. As
this is an ecological study, we cannot explore sex variations at primary level (insofar as the sex distribution
of general practice and CCG populations does not vary substantially and prescribing data are not broken
down by sex). Given consistent evidence of sex disparities in the management of cardiovascular health, this
is unfortunate. Any evidence we present with respect to socioeconomic or ethnic disparities in access is
also potentially prone to the problem of ecological fallacy. Yet it is important to avoid exaggerating the
pitfalls of ecological bias and underestimating the potential strengths of population-based research. The
NHS is financed and organised on a geographical basis. As health service use is likely to be influenced by
its supply, it is legitimate to question whether, for example, deprived populations have higher or lower
rates of use than expected. A further advantage of population-based research is that it can offer insights
into the presence or otherwise of variations across the country. This avoids the potential problem of
making hasty generalisations on the basis of individual-level studies, which are often too small or too
localised to warrant a general conclusion.
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Chapter 3 Estimating local disease prevalence
rates: methodology
Introduction
A key difficulty for studies of health-care equity has been the lack of robust measures of the underlying
health-care needs of populations at appropriate geographic and organisational scales. Reflecting the
‘frustration’ noted by Smith et al. concerning the lack of ‘detailed public health data analysis for
population needs assessment’,439 many analysts of health-care equity have thus turned to a range of proxy
measures, including mortality,101,107,145–147,172,182–186,293,295 deprivation,187,188 utilisation-based measures such as
inpatient admissions216,217 and QOF-registered disease prevalence.109,243,289 Although proxy measures of
need for health-care services are readily available, problems associated with their use are self-evident.
Mortality may be a reasonable proxy for diseases where case fatality is high, but for most conditions,
including those on which we focus, namely CVD and CMHDs, mortality statistics will fail to reflect the full
extent of non-fatal morbidity and, by implication, health service need. Deprivation, meanwhile, is a poor
proxy for a population’s need for health-care services (henceforth simply ‘need’) because, with the notable
exception of CMHDs, demographic gradients in disease prevalence tend to be steeper than socioeconomic
gradients. Needs tend to vary, in other words, with regard to the age profile of populations rather than
with respect to levels of deprivation. Additionally, health encounter data can provide a meaningful guide
to variations in need for health care only if all patients with a given level of morbidity access health services
to a uniform extent, or if a method can be found to isolate and discount the effect of supply and demand
on health service utilisation – a profoundly difficult task.
A lack of suitable measures of the underlying health-care needs of populations has also meant that studies
of health equity have tended to focus on investigating ‘within-system’ inequalities in access to and use of
care, that is, the extent to which particular treatments and/or procedures are provided relative to the
number of people admitted with a particular diagnosis. Such audits (e.g. the proportion of stroke patients
admitted to specialist units or the proportion of patients with diabetes receiving NICE-recommended care
processes) are now relatively widespread and are commonly used in indicator data sets, but they do not
address the extent to which the underlying health needs of different populations are being met at various
stages of the health-care pathway. For this there is no alternative but to compare measures of the use
being made of defined health services against modelled estimates of the health-care needs of populations.
Here, the concern is with issues of (a) unmet need – that is, the extent to which the number of people
accessing care falls short of the number expected to have a particular health-care need; and (b) inequalities
in the uptake of care – that is, the extent to which unmet need varies according to the socioeconomic,
demographic or geographical circumstances of different populations.
Recognising the obvious lack of suitable measures, the Public Health Observatories (and, more latterly, PHE)
have, in recent years, developed and made available a wide range of disease prevalence estimates at a variety
of scales. These include estimates of COPD, diabetes, CHD, hypertension and CVD,210–215 all of which purport
to offer direct and independent estimates of the prevalence of specific conditions: ‘direct’ in the sense
that they are based on modelling responses to survey questions (or, occasionally, biometric assessments) which
explicitly address various aspects of individuals’ health; and ‘independent’ in the sense that, because they
have been derived from large-scale surveys of household populations rather than from health service
encounter data, they should not be influenced by the processes of candidacy and adjudication that affect the
use of those services.
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The data currently available via PHE are, however, not without serious shortcomings. In the first place, all
(particularly the mental health estimates) are based on relatively old data. An issue in its own right, this
also means that, with the exception of the updated diabetes estimates, all predate the most recent NHS
reorganisation and are thus available for PCTs rather than CCGs. Second, all are based on restricted sets of
predictor variables (the CKD model uses just age and sex, while even the most ambitious, the COPD
model, based on 2001 data, uses only age, sex, ethnicity, rurality, smoking status and deprivation score –
where smoking status is itself a regional-level modelled estimate). Third, all are based on a priori
assumptions about the most useful survey response variable to use. The diabetes model, for instance, is
based on self-reported doctor-diagnosed diabetes and/or nurse-measured glycated haemoglobin of
≥ 6.5%. This, as discussed below, is but one of a number of possible definitions which could be used to
model how many people have a diabetes health-care need. Finally, all of the modelled prevalence rates
have been generated by applying individual-level model parameters to population-level covariate data.
The fundamental problem is that any shortcomings in the data and/or methods used to generate
prevalence estimates, which are then used to measure or proxy variations in the need for specific types of
health care, can result in spurious conclusions regarding health-care equity. Evidence of precisely this is
presented in the following two chapters, but the nature of the problem is obvious. If modelled prevalence
estimates fail to fully capture variations in underlying need, then the element of need that is missed will be
carried over into comparisons between the modelled need estimates and data on health service activity.
For instance, if a modelled estimate fails to fully capture the extent to which socioeconomic deprivation
affects the prevalence of a particular condition, then, even if different populations make equitable use of
health services, the use of that modelled estimate will make it appear as if more deprived communities are
making greater use of health services than might otherwise have been expected.
Confidence in the capacity of the modelled prevalence estimates to adequately capture local variations in
morbidity is, thus, crucial to any subsequent empirical analysis of use-to-need ratios. Without reliable
reference data against which to assess the modelled estimates – and such simply do not exist – building
confidence rests on demonstrating the intrinsic suitability and utility of the modelling strategy adopted
and, as far as possible, with a post-hoc assessment of face-validity of the final estimates vis-à-vis what is
known about the use made of health services. This latter issue is addressed in some depth in the following
chapters in which, in addition to exploring evidence of systematic and stochastic variations in use relative
to need, we attempt to assess how well, overall, the various estimates predict variations in service use,
particular with respect to QOF registration data on the number of people with relevant conditions who are
known to general practices.72,440 We recognise that the number of people who are QOF registered will
reflect local case finding and, as such, will respond to the very issues of candidacy and adjudication which
we seek to address, but they are, however flawed, the only available comparator data.
In the absence of reliable comparator data, and being able to draw only tentative conclusions from any
comparison with QOF registration data, confidence in the estimates must, therefore, largely rest with the
suitability and utility of the estimation methodology that underpins them. For this reason, by far the
greatest part of this project was concerned with the development of a robust and sensitive approach to
modelling large-scale survey data and applying the resulting parameter estimates to appropriate local
covariate data which describe the sociodemographic characteristics of local populations.
Methodology overview
Although it was clear that it would be necessary to develop an alternative approach to estimating the need
for health-care services, we have nevertheless followed the lead of PHE in assuming that specific health-care
needs can be measured, or proxied, by recourse to appropriate disease prevalence rates. We also follow
their lead in relying on the evidence of large-scale survey data on the relationship between individuals’
health status and their economic and sociodemographic circumstances, although, as discussed below
(see Determining appropriate need indicators), we sought to avoid a priori decisions about which particular
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survey questions (or biometric evidence) would best reflect variations in need. We differ from previous
studies, however, in terms of the statistical models used and, in particular, in the way in which the
resulting model parameter estimates have been deployed.
The approach adopted may be described in general terms as a ‘bottom-up’ estimation of population-level
disease prevalence through the aggregation of modelled individual-level disease risk estimates. In essence,
this proposes that large-scale survey data can be used to model the risk that different individuals (defined
in terms of the type of area in which they live as well as with respect to their sociodemographic
characteristics) will exhibit or develop particular diseases, conditions or relevant health-risk behaviours and,
by applying the resulting model parameter estimates to all individuals in any given population, that it is
then possible to derive estimates of the overall prevalence of those diseases, etc. It is this focus on
aggregating individual-level disease risk, along with a concern to consider a variety of potential indicators,
or ‘markers of need for health-care services’, which distinguishes this approach from other studies using
large-scale survey data to estimate the prevalence of disease. Recognising the need to capture and
disseminate some sense of the uncertainty of the final estimates, we also introduced bootstrapping as a
means of transmitting to the local estimates model-level information regarding predictive uncertainty.
The methodological and computational challenges raised have been significant, and in this section we aim
to (a) describe this ‘bottom-up’ or ‘individual-level’ approach in detail, (b) consider key aspects concerning
its practical implementation, and (c) highlight to what extent the nature of the sources, analytical methods
and necessary assumptions may affect the final estimates. This section is accompanied by appendices
detailing, as a matter of formal record, the parameter estimates used in the estimation of the 41 mental
health and 24 CVD-related indicators (see Appendices 26 and 27). These appendices include maps of the
prevalence of each of the indicators at LSOA level, and plots of how the estimates vary at the MSOA, LA,
CCG and regional [previously known as Government Office Regions (GORs)] levels. These maps and plots
provide some indication of the scale and nature of variation, an issue also addressed by a final table
provided for each indicator, namely how overall and age-/sex-specific prevalence rates vary according to
LSOA-deprivation quintile.
The appendices, of course, merely summarise the prevalence estimates that have been produced for
12 age-/sex-defined cohorts (namely males and females aged 16–24 years, 25–34 years, 35–49 years,
50–64 years, 65–74 years and ≥ 75 years), as well as for the adult population as a whole, for a wide variety
of spatially and organisationally defined units, as listed below:
l 2011 LSOAs (n= 32,844)
l 2011 MSOAs (n= 6791)
l CCGs (geographically defined) as of April 2013 (n= 211)
l higher-tier LAs as of December 2012 (n= 152)
l lower-tier LAs as of December 2012 (n= 326)
l regions (ex-GORs) as of December 2010 (n= 9)
l MSOAs as of December 2004 (n= 6781)
l general practice populations as defined by the April 2011 attribution data set (n= 8352)
l CCGs (April 2013) as aggregated GP populations (n= 211)
l PCTs (April 2012) as aggregated GP populations (n= 151)
l Strategic Health Authorities (SHAs) (April 2012) as aggregated GP populations (n= 10).
A select range of estimates are to be disseminated via PHE’s web-based local health tool.441 All estimates
can also be obtained directly from the authors.
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Small-area estimation
The approach adopted falls within a well-established tradition known as small-area estimation,442,443 and
we retain this term, although the method is often, as here, used to estimate prevalence rates for
organisationally as well as spatially defined populations. Thus, while our estimates for LSOAs and MSOAs
refer to the populations living in geographic units formally defined by the ONS, and estimates for
lower- and higher-tier LAs and regions (GORs) are aggregations thereof, those for general practice
populations refer to patients registered with those practices, wherever they might live. PCTs, CCGs and
SHAs can be defined either as aggregations of constituent practice populations or with respect to people
living within defined boundaries. In this study, which utilises NHS data on 2011–12 practice populations
(see 2011 census data and the 2011–12 Attribution Data Set and The 2011–12 Attribution Data Set), PCTs
(as of April 2012) are defined with respect to practice populations and all prevalence estimates used
to generate the PCT-level use-to-need ratios discussed in Chapter 4 are based on this definition. It is less
obvious whether CCG-level use-to-need ratios should be based on geographically or organisationally
defined populations. However, as the NHS reorganisation that led to the replacement of PCTs by CCGs
postdates the 2011–12 Attribution Data Set (ADS) data, the changing number and composition of
practices is likely to render a GP-based definition of more recent CCG populations problematic. We have
thus adopted a geographic definition for CCG populations, based on the LSOA-to-CCG lookup table
provided on the ONS Open Geography Portal.444 This is important, for, as discussed in 2011 census data
and the 2011–12 Attribution Data Set, prevalence estimates generated for geographic units (LSOA and
above), which take the 2011 census as the population denominator, differ from those generated for
practice-based populations, which take the 2011–12 ADS as their population denominator.
In general terms, small-area estimation has gained traction because it can be used to derive local area
estimates from surveys initially designed to provide national estimates.439–444 In the present study, as with its
use in generating the prevalence estimates currently made available by PHE, its particular attraction lies
with the fact that it offers a methodology for deriving direct estimates of disease prevalence that, in theory
at least, are independent of issues of candidacy and adjudication. A wide range of specific methodologies
have been used to implement small-area estimation,445–449 unified by the general idea that parameters
derived from survey-based models of, for instance, health status, can be applied to local area covariate
data in order to estimate the likely burden of ill health in those areas. Simpler forms of estimation assume
that prevalence rates for survey populations can be applied to the demographic and socioeconomic profiles
of areas without adjusting for any additional area effect (e.g. PHE’s CKD prevalence model noted above).
More complex designs incorporate both area- and individual-level covariates, implying that the risk of an
individual experiencing a particular cardiac or mental health condition must be conceptualised as a
function of both their individual characteristics (age, sex, social status, etc.) and the socioeconomic and
environmental characteristics of where they live. Such an approach is necessary given the evidence (albeit
contested) that ‘place matters’ with respect to both cardiac health450,451 and mental health.452,453
Small-area estimation thus comprises two key components: modelling large-scale survey data (our
particular approach is detailed in Modelling large-scale surveys) and then applying the resulting parameter
estimates to local population covariate data (detailed in Small-area estimation: prediction). For us, however,
a key intermediate stage is to describe the detailed composition of local populations. This constitutes an
essential stage in the ‘bottom-up’ estimation of aggregated individual-level disease risk estimates, insofar
as administrative data, such as the 2011 census, do not describe the local populations with the level
of detail required. For instance, our HSfE-based model predicting the likelihood that individuals have
experienced symptoms of angina and/or MI includes, as detailed in Appendix 26, factors relating to age
(16–24 years, 25–34 years, 35–49 years, 50–64 years, 65–74 years, 75–84 years or ≥ 85 years), sex (male
or female), ethnicity (white, mixed, black, Asian or other), self-reported health status (very good, good, fair,
bad or very bad), whether or not a limiting long-standing illness (LLTI) is reported (yes or no), tenure
(owner–occupier, social tenant or private tenant/other) and, finally, the deprivation quintile of the person’s
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place of residence. This model describes, incorporating interaction effects as appropriate, the specific
likelihood of illness associated with 10,500 different ‘person-types’ (i.e. 2100 different ‘person-types’ based
on individual characteristics, each of which can be then be living in a LSOA with an IMD score that falls
into one of the five deprivation quintiles.).
Although this offers an impressively nuanced perspective on the relationship between the
sociodemographic characteristics of individuals and their risk of disease, as it stands these likelihood
estimates cannot be applied to local populations. The UK census describes such populations only in terms
of a series of cross-tabulations, and, to ensure disclosure control, the smaller the area the less precise the
categories used. For instance, at LSOA level, Table LC3206EW (describing the total, rather than household,
population in terms of ‘age by sex by ethnicity by general health status by LLTI’) has just three adult age
categories (16–49 years, 50–64 years and ≥ 65 years) and three general health categories (combining, on
the one hand, ‘very good’ and ‘good’ health, and, on the other, ‘very bad’ and ‘bad’ health). To overcome
this limitation, and thereby allow us to apply the 10,500 disease likelihood estimates to appropriate counts
of the number of people in households in each local population, we have implemented a form of
microsimulation. This, as described in Microsimulation for small-area estimation, results in a full description
of the sociodemographic composition of each local population.
First, however, we commence with a brief description of the sources used to generate the prevalence rates
detailed in Appendices 26 and 27. These comprise a number of large-scale survey data sets as well as the
2011 census and 2011–12 ADS, which provide covariate data on local populations.
Sources
Large-scale survey data sets
The key evidential constraint in small-area estimation is that the factors used to model whether or not an
individual exhibits a particular response characteristic, for example reporting a particular health condition
or meeting some biometric threshold such as blood pressure > 140/90mmHg, must align with covariate
data available for the populations for which estimates are to be produced. The practical implications of this
in terms of modelling are discussed below, but it does demand that any survey data used in small-area
estimation includes information on the sociodemographic characteristics of respondents, which aligns with
data provided by 2011 census, the principal source of information on the sociodemographic characteristics
of local populations. This does not pose any general problem, as most large-scale surveys aim to obtain
such data, although there are particular issues, discussed in Modelling large surveys, concerning the use of
different response options for the general health question and difficulties matching LLTI data from the
census with cognate survey data.
The principal determinant of which large-scale surveys were included in this study was thus whether they
contained recent data relevant to cardiovascular and/or mental health. Having interrogated the range of
data sets available through the UK Data Service, we list in Table 4 those that have been used to provide
data relevant to a range of response items which, in principle, might be expected to relate to CVD
and CMHDs.435,454–468
DOI: 10.3310/hsdr04140 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 14
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Asthana et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
33
The total number of individuals and households listed in Table 4 is, however, somewhat moot, as the size
of the samples extracted for modelling each response variable varies hugely. These samples include, as
discussed below, a maximum of one adult respondent (aged ≥ 16 years) per English household for whom
valid data are available. For instance, almost all adult respondents to the HSfE provide information on LSI,
whereas only a subset are visited by a nurse and tested for blood pressure. As a result, whereas the HSfE
LSI data set comprises 28,340 individuals, the data set for ‘nurse-measured’ blood pressure comprises only
12,103 respondents. Full details concerning the 24 CVD and CVD-related response items listed in Table 5,
and the 41 mental health-related items listed in Table 6, are provided in Appendices 26 and 27. The
appendix entries include a detailed description of the precise question or biometric measure used to derive
each response variable, along with a full description of predictor variables included in each model and the
size and demographic composition of the underlying sample.
The Health Survey for England, 2006–11
The HSfE, which has been running as an annual survey since 1991, is the principal data set on the health
of people living in households in England. In addition to a core set of questions (including with respect to
self-reported LSI), the HSfE focuses on a particular topic each year, including CVD in 1993–4, 1998,
2003 and 2006, and CVD risk factors in 2007. Since 2001 it has included people of all ages, and it has
periodically included boost surveys to better capture the health characteristics of particular groups,
including children in 2005–7 and people from ethnic minorities in 1999 and 2004.
A key initial decision concerned the period to be covered in this study, balancing the benefits of larger
samples against evolving patterns of morbidity. Having extracted and undertaken a preliminary assessment
of data going back to the first years of the survey, it was decided to restrict the modelling to data relating
to 2006 onwards. Choosing this date, which means that both the 2003 focus on CVD and the 2004
ethnic boost have been missed, was partly to ensure that shifting relationships between key predictor
variables and CVD and mental health morbidity did not compromise the eventual predictions. It was
mostly, however, a pragmatic response to the fact that it was from 2006 that LSOA-level deprivation data
were included. As detailed in Appendices 26 and 27 with respect to each of the modelled response items,
local deprivation often (although not always) has a statistically significant effect on morbidity. Its inclusion
in models used to predict the prevalence of disease at very local levels is, obviously, crucial.
Uniquely, the HSfE combines questionnaire-based answers (including with respect to clinical symptoms of,
inter alia, angina and MI) with nurse-administered physical measurements and the analysis of blood
samples. Along with its underlying focus on disease risk factors, this means that the HSfE represents a
TABLE 4 Large-scale survey data sets used in the study
Survey Date Individuals Households
HSfE 2006 21,399 11,073
HSfE 2007 14,386 8018
HSfE 2008 22,623 11,887
HSfE 2009 8602 4702
HSfE 2010 14,112 7648
HSfE 2011 10,618 5334
APMS 2007 7403 7403
UK Household Longitudinal Study, wave 1 2009–11 50,994 30,005
UK Household Longitudinal Study, wave 2 (new entrants) 2010–12 13,603 8016
UK Household Longitudinal Study (waves 1 and 2) 2009–12 17,640 1028
APMS, Adult Psychiatric Morbidity Survey.
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TABLE 5 Cardiovascular disease and CVD-related items extracted from large-scale data sets
CVD estimate Response item
1 Diabetes as a self-reported LSI (HSfE, 2006–11)
2 Stroke as a self-reported LSI (HSfE, 2006–11)
3 High blood pressure as a self-reported LSI (HSfE, 2006–11)
4 CHD (heart attack/angina) as a self-reported LSI (HSfE, 2006–11)
5 Heart failure as a self-reported LSI (HSfE, 2006–11)
6 CVD as a self-reported LSI (HSfE, 2006–11)
7 Heart/circulatory disease as a self-reported LSI (HSfE, 2006–11)
8 CVD or diabetes as a self-reported LSI (HSfE, 2006–11)
9 Nurse-measured high blood pressure (HSfE, 2006 and 2009–11)
10 Nurse-measured high blood pressure or using BP medication (HSfE, 2006 and 2009–11)
11 Clinical evidence of current treated or untreated high blood pressure (HSfE; 2006 and 2009–11)
12 History of treated/untreated high blood pressure (HSfE, 2006 and 2009–11)
13 CHD (angina or MI) symptoms (HSfE, 2006 and 2011)
14 Clinical evidence of current CHD (HSfE, 2006 and 2011)
15 Any evidence of current CHD (HSfE, 2006 and 2011)
16 Any history of CHD (HSfE, 2006 and 2011)
17 Ever been diagnosed with CHD (HSfE, 2006 and 2011)
18 Ever been diagnosed with CVD (HSfE, 2006 and 2011)
19 Ever been diagnosed with high blood pressure (HSfE, 2006 and 2009–11)
20 Ever been diagnosed with diabetes (HSfE, 2006 and 2009–11)
21 Diagnosed and undiagnosed diabetes (HSfE, 2006 and 2009–11)
22 Adults 25–74 years with > 10% risk of CHD in next 10 years (HSfE, 2006 and 2009–11)
23 Adults 25–74 years expected to develop CHD in the next 10 years (HSfE, 2006 and 2009–11)
24 Three or more of the five NICE CVD modifiable risk factors (HSfE, 2006 and 2009–11)
TABLE 6 Mental health items extracted from large-scale data sets
Mental health
estimate Response item
1 CIS-R score of ≥ 12 (APMS, 2007)
2 CIS-R score of ≥ 18 (APMS, 2007)
3 CIS-R score of ≥ 12 or any mental health treatment (APMS, 2007)
4 CIS-R score of ≥ 18 or any mental health treatment (APMS, 2007)
5 Generalised anxiety disorder symptoms in past week (APMS, 2007)
6 Mixed anxiety/depressive disorder symptoms in past week (APMS, 2007)
7 Depressive episode symptoms in past week (APMS, 2007)
continued
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TABLE 6 Mental health items extracted from large-scale data sets (continued )
Mental health
estimate Response item
8 Symptoms of generalised anxiety disorder, mixed anxiety/depressive disorder or a depressive episode
in past week (APMS, 2007)
9 Symptoms of a neurotic disorder in past week (APMS, 2007)
10 ‘Possible’ psychiatric morbidity (GHQ12 score of ≥ 4) (HSfE, 2006 and 2008–10)
11 ‘Probable’ psychiatric morbidity (GHQ12 score of ≥ 6) (HSfE, 2006 and 2008–10)
12 Psychiatric morbidity (GHQ12 score of ≥ 8) (HSfE, 2006 and 2008–10)
13 ‘Possible’ psychiatric morbidity (GHQ12 score of ≥ 4) or prescribed drugs (HSfE, 2006 and 2008–10)
14 ‘Probable’ psychiatric morbidity (GHQ12 score of ≥ 6) or prescribed drugs (HSfE, 2006 and 2008–10)
15 Psychiatric morbidity (GHQ12 score of ≥ 8) or prescribed drugs (HSfE, 2006 and 2008–10)
16 ‘Possible’ psychiatric morbidity (GHQ12 score of ≥ 4) (UKHLS, wave 1, 2009–11)
17 ‘Probable’ psychiatric morbidity (GHQ12 score of ≥ 6) (UKHLS, wave 1, 2009–11)
18 Psychiatric morbidity (GHQ12 score of ≥ 8) (UKHLS, wave 1, 2009–11)
19 ‘Possible’ psychiatric morbidity (GHQ12 score of ≥ 4) or prescribed drugs (UKHLS, wave 1, 2009–11)
20 ‘Probable’ psychiatric morbidity (GHQ12 score of ≥ 6) or prescribed drugs (UKHLS, wave 1, 2009–11)
21 Psychiatric morbidity (GHQ12 score of ≥ 8) or prescribed drugs (UKHLS, wave 2, 2010–12)
22 ‘Possible’ psychiatric morbidity (GHQ12 score of ≥ 4) (UKHLS, wave 2, 2010–12)
23 ‘Probable’ psychiatric morbidity (GHQ12 score of ≥ 6) (UKHLS, wave 2, 2010–12)
24 Psychiatric morbidity (GHQ12 score of ≥ 8) (UKHLS, wave 2, 2010–12)
25 ‘Possible’ psychiatric morbidity (GHQ12 score of ≥ 4) or prescribed drugs (UKHLS, wave 2, 2010–12)
26 ‘Probable’ psychiatric morbidity (GHQ12 score of ≥ 6) or prescribed drugs (UKHLS, wave 2, 2010–12)
27 Psychiatric morbidity (GHQ12 score of ≥ 8) or prescribed drugs (UKHLS, wave 2, 2010–12)
28 Diagnosed with clinical depression (UKHLS, wave 1, 2009–11)
29 Currently with diagnosed clinical depression (UKHLS, wave 1, 2009–10)
30 Ever been diagnosed with clinical depression (UKHLS, waves 1 and 2)
31 Incidence of diagnosis of clinical depression (UKHLS, waves 1 and 2)
32 Incidence of diagnosis of current clinical depression (UKHLS, waves 1 and 2)
33 Moderate/extreme anxiety/depression (HSfE, 2006, 2008 and 2010–11)
34 Extreme anxiety/depression (HSfE, 2006, 2008 and 2010–11)
35 Self-reported moderate/extreme anxiety/depression or prescribed drugs (HSfE, 2006, 2008 and
2010–11)
36 Self-reported extreme anxiety/depression or prescribed drugs (HSfE, 2006, 2008 and 2010–11)
37 Self-reported ‘ever had a mental health issue’ (APMS, 2007)
38 Self-reported ‘mental health issue’ in last 12 months (APMS, 2007)
39 Self-reported ‘mental health issue’ first experienced at least 1 year previously (APMS, 2007)
40 Self-reported ‘mental health issue’ first experienced at least 5 years previously (APMS, 2007)
41 Self-reported long-standing mental health problem (HSfE, 2006–11)
APMS, Adult Psychiatric Morbidity Survey; CIS-R, Clinical Interview Schedule – Revised; GHQ12, 12-item General Health
Questionnaire; UKHLS, UK Household Longitudinal Study.
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particularly valuable source of information on patterns of CVD and CVD-related morbidity. As listed in
Table 5 and detailed in Appendix 26, response items derived from the HSfE range from self-reported LSI
and doctor-diagnosed illness, through a variety of items based on biometric measures (blood pressure and
diabetes) and reported clinical symptoms (CHD), to a number of derived items describing the prevalence of
key risk factors. These are detailed in the appendix, which provides a full description of precisely what
questions, or other evidence, have been used to derive each response item. The appendix also details the
particular factors incorporated in each predictive model which, in the case of those based on data drawn
from the HSfE, include age band, sex, ethnicity, general health status, LLTI, tenure and the IMD quintile of
the respondent’s LSOA of residence.
Other potential predictor variables were investigated, notably highest qualifications, economic activity
status and the National Statistics Socio-economic Classification, but the key requirement that these should
align with equivalent data presented in the 2011 census could not be fulfilled. Use of those predictor
variables that have been included in the various models was largely straightforward, with the exception of
the LLTI variable. The 2011 census introduced a new version of the LLTI question with three possible
responses, namely that the respondents’ ‘day-to-day activities’ were ‘limited a lot’, ‘limited a little’ or not
limited. The HSfE between 2006 and 2011, meanwhile, retained the original yes/no response option to this
question. Although we have incorporated LLTI in the models (recognising its predictive importance across
many of the response items), the fact that we have had to merge the census ‘limited a lot’ and ‘limited a
little’ categories does blur the relationship between the model-based and the census-based factors. The
fact of the matter is that often subtle differences in question phrasing or, as in this case, the response
options available can affect how individuals respond to survey/census questions. Nevertheless, although an
analysis of age-/sex-specific responses to the HSfE and census LLTI questions show that the two are not
precisely cognate, the discrepancy does not appear excessive and we retain this information for modelling
and estimation.
Throughout the period 2006–11 the HSfE was based on a stratified random probability sample of English
households, with up to four respondents being drawn from each selected household. Unfortunately, using
the full data set would risk introducing a household-level bias whereby ‘within household’ respondents are
more likely to share health characteristics than ‘between household’ respondents. Although including
‘household’ as a random effect in a generalised linear mixed model could account for, and exclude, such
an effect, this proved computationally extremely demanding and time-consuming and, in the context of
the present analysis, did not offer a practical solution. Instead, we randomly selected a single respondent
from each household. Although, as detailed in Appendix 26, this significantly reduces the size of the
sample available for modelling each response item, it was judged a reasonable pragmatic solution.
Finally, the HSfE is also notable for its underlying focus on risk factors affecting morbidity, including with
respect to CVD and CHD. Taking advantage of the data available, and responding to an interest expressed
by colleagues in PHE, we have generated local estimates relating to three risk-based response items,
namely the number and proportion of adults aged 25–74 years with at least a 10% risk of developing
CHD in the next 10 years; the number and proportion actually expected to develop CHD in the next
10 years; and, finally, the number and proportion of adults aged ≥ 16 years with three or more of the
five NICE CVD modifiable risk factors. These are not considered further in this report, as they do not
correspond to particular areas of health service activity and are not, therefore, used in the chapters
addressing health-care equity. They nevertheless represent an important resource for public health
practitioners and commissioners, particularly given the evidence adduced in the following two chapters
supporting the underlying efficacy of our approach to small-area estimation.
The Adult Psychiatric Morbidity Survey 2007
The Adult Psychiatric Morbidity Survey (APMS) 2007 was the third in a series of psychiatric morbidity
surveys of adults living in private households in England. The previous two were undertaken in 1993 and
2000 but, in view of the rapidly changing prevalence of CMHDs, these were discounted from inclusion in
this study. The APMS 2007 provides the most recent evidence available on psychiatric morbidity in English
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households and is presented as the primary source of information on the prevalence of both treated and
untreated psychiatric disorders and their associations. Sampling one adult aged ≥ 16 years per household,
it has no upper age limit and provides a sample of 7403 individuals. As with both the HSfE and the UK
Household Longitudinal Study (UKHLS, also known as ‘Understanding Society’), it proved impossible to
align data collected on educational qualifications, economic activity and National Statistics Socio-economic
Classification with the way in which apparently equivalent data are presented in the 2011 census. The
APMS 2007 also uses the Short Form questionnaire-12 items version of the general health status question,
referring to ‘excellent’, ‘very good’, ‘good’, ‘fair’ and ‘poor’ categories rather than the ‘very good’, ‘good’,
‘fair’, ‘bad’ and ‘very bad’ categories given in the census. These are incompatible and, thus, although
general health status is a strong predictor of morbidity, it cannot be used in any of the models based on
APMS 2007 data.
Also problematic is the lack of a simple question on whether or not an individual has what they consider
to be a LLTI. The APMS 2007 instead uses a series of questions under the ‘activities of daily living’ section,
asking respondents whether they have ‘no difficulty at all’, ‘some difficulty’ or ‘a lot of difficulty’ with
respect to a series of defined activities. Although the use of three categories aligns with the 2001 census
[which we collapse into a two-category distinction between (a) ‘not limited’ and (b) ‘limited a little’ or
‘limited a lot’], directing respondents to consider specific activities does mean that this question is not
precisely cognate. Nevertheless, the age/sex profile of responses is broadly similar between the APMS 2007
and the 2011 census and we have thus decided to include activities of daily living-derived LLTI data as a
satisfactory surrogate for census LLTI covariate data.
In other respects the use of APMS 2007 data is straightforward, including the fact that only one person is
interviewed from each household and, as a result, there was no need to take a one-person-per-household
subsample to avoid a possible household effect.
The UK Household Longitudinal Study (‘Understanding Society’), waves 1
and 2
The two waves of the UKHLS included in this study differ from the other surveys used in this study in that
they were part of an ongoing longitudinal survey which originated as the British Household Panel Survey
(BHPS) in 1991. The UKHLS took over with an entirely new cohort sampled from 2009. The second wave
of the UKHLS (which commenced in 2010) then included about one-third of first-wave respondents
along with 10,543 surviving members from the old BHPS. The second-wave sample was augmented by
2393 people joining the already-sampled households.
The UKHLS surveys are, however, used in this study as two separate cross-sectional studies, as detailed in
the relevant appendix entries (see Appendix 27). The exception is the construction of a special combined
data set to deal with the fact that the ‘clinical depression’ question asked in the second wave asked
whether or not the respondent had been diagnosed only ‘since their last interview’. It is necessary here, as
detailed in Appendix 27, to link to a respondent’s previous response in order to establish whether or not
they had ever been diagnosed with clinical depression.
As with the APMS 2007, the UKHLS uses the Short Form questionnaire-12 items version of the general
health status question, which is not compatible with the 2011 census version. This variable has not,
therefore, been included in the models of disease likelihood. There is also no question directly equivalent
to the LLTI question used in the 2011 census. In this case, respondents are asked to consider whether or
not any of the ‘long-standing’ health problems to which they had already alluded meant that they had
‘substantial difficulties’ with respect to a series of specified activities. As with the APMS 2007, this does
not align with the much simpler wording used by the 2011 census, but the age–sex profile of the
LLTI/noLLTI responses that can be derived using this information is close enough to that given in the census
to warrant using this important predictor of morbidity in our models of disease likelihood.
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The UKHLS differs from the other surveys used in this study in that the IMD score for each respondent’s
LSOA of residence is available. As detailed in Appendix 27, models constructed using data drawn from the
UKHLS thus use actual IMD scores rather than merely the IMD score quintile, which is all that is available
for the HSfE and the APMS 2007.
Finally, as in the HSfE, the UKHLS interviews multiple respondents per household. To avoid any risk of
biasing the parameter estimates due to household-level covariance, we have randomly selected a single
individual per household for inclusion in the analytical data set. This, along with the fact that we also include
only people living in England, significantly reduces the size of the UKHLS data set as used in this study.
2011 census data and the 2011–12 Attribution Data Set
The Decennial Census, 27 March 2011
Whereas the large-scale survey data sets discussed above underpin the modelling component of small-area
estimation, the 2011 census provides, alongside information on the age–sex composition of practice
populations, the covariate data that underpin the prediction component of small-area estimation. As noted,
the key requirement for small-area estimation is that it must be possible to describe local populations in
terms of the factors used when modelling response items in the survey data. In practice, this means that a
process of iterative reconciliation takes place in order to identify a set of factors which can be derived for
both the survey and the census data. As a general rule, however, it is the census that constrains both which
variables can be used and the level of detail that can be obtained. Thus, whereas survey-based models
might show, for instance, that smoking is a strong predictor of CHD, this is of no value with respect to
small-area estimation, as we have no reliable covariate data on the number of smokers in local populations.
Moreover, even with respect to information included in the census, the census will, to avoid potential
disclosure, tend to provide much less information than the survey data sets. For instance, survey data sets
invariably provide information on the actual age of respondents, but census cross-tabulation tables
(particularly the more useful three- and four-way tables and particularly with respect to smaller units such as
LSOAs) are much less forthcoming. The important ‘age by sex by ethnicity by general health status’ table,
for instance, categorises age as 0–15 years, 16–49 years, 50–64 years and ≥ 65 years.
Identifying a suitable set of factors is thus an essentially straightforward, if time-consuming, process of
establishing which of the many published LSOA-level census tables, taken together and iteratively
reconciled with one another through microsimulation (see Microsimulation for small-area estimation),
provide the most detailed available description of local populations. The 2011 census tables used in this
study are listed in Table 7.469
Although the census itself was undertaken on 27 March 2011, the publication of data took place over
subsequent years, with the LSOA-level tables arriving in the public domain somewhat later than expected.
This did impact on the study, but it was deemed essential to use LSOA-level (rather than MSOA-level) data
because of the likely importance of local place-level effects on morbidity. One of the shortcomings of
previous studies, and of the estimates currently available via PHE, is the scale at which modelled parameter
estimates are applied and the resulting sensitivity of the estimates to the impact of deprivation. The IMD,
a widely used measure of multiple aspects of local social, economic and environmental deprivation, is
explicitly calculated with respect to LSOAs.70 This reflects the assumption that deprivation, insofar as it
affects various aspects of people’s lives, including their health, is likely to operate at a very local scale. The
many IMD-based indicators published for higher geographies, including those for MSOAs, are based on a
(usually population-weighted) average of the constituent LSOA IMD scores. The crucial sensitivity of the
IMD score to very local impacts on people’s health is, thus, lost. Only by applying the model parameter
estimates, including those relating to IMD, to individuals in LSOAs is it possible to retain all information
about the effect of local deprivation on morbidity. For that reason, as detailed in Small-area estimation:
prediction, the LSOA is the scale at which estimates are generated, with estimates for all higher
geographies being simple aggregations of the estimates for their constituent LSOAs.
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TABLE 7 2011 census tables used to microsimulate LSOA-level covariate data
Table title and population scope Variable Factor categories
LC1105EW
Residence type by sex by age Residence Household; communal establishment
All usual residents Age (years) 0–15; 16–24; 25–34; 35–49; 50–64; 65–74; 75–84; ≥ 85
Sex Male; female
LC2101EW
Ethnic group by sex by age Age (years) 0–24; 25–49; 50–64; ≥ 65
All usual residents Sex Male; female
Ethnicity White; mixed; Asian; black; other
LC2301EW
Ethnic group by [. . .] by general health Ethnicity White; mixed; Asian; black; other
All usual residents Health Very good; good; fair; bad; very bad
LC3205EW
Long-term health problem by ethnic
group by sex by age
Age (years) 0–15; 16–49; 50–64; ≥ 65
Sex Male; female
All usual residents Ethnicity White; mixed; Asian; black; other
LLTI LLTI; no LLTI
LC3206EW
General health by ethnic group by sex
by age
Age (years) 0–15; 16–49; 50–64; ≥ 65
Sex Male; female
All usual residents Ethnicity White; mixed; Asian; black; other
Health Very good or good; fair; bad or very bad
LC3302EW
Long-term health problem by general
health by sex by age
Age (years) 0–15; 16–24; 25–34; 35–49; 50–64; 65–74; 75–84; ≥ 85
Sex Male; female
All usual residents in households Health Very good or good; fair; bad or very bad
LLTI LLTI; no LLTI
LC3408EW
Long-term health problem by tenure
by age
Age (years) 0–15; 16–49; 50–64; ≥ 65
Tenure Owner occupier; social rented; private/other
All usual residents in households LLTI LLTI; no LLTI
LC3409EW
General health by tenure by age Age (years) 0–15; 16–49; 50–64; ≥ 65
All usual residents in households Health Very good or good; fair; bad or very bad
Tenure Owner occupier; social rented; private/other
LC4203EW
Tenure by [. . .] by ethnic group Tenure Owner occupier; social rented; private/other
All usual residents in households Ethnicity White; mixed; Asian; black; other
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The 2011–12 Attribution Data Set
In contrast to working with the nested hierarchy of geographic units running from LSOAs to regions,
producing estimates for GP populations and, as aggregations thereof, PCT, organisationally-defined CCG
and SHA populations, relies on evidence supplied to us by the NHS on the age (5-year bands), sex and
MSOA of residence of patients registered with GP practices in April 2011.470 This is known as the ADS,
and the NHS reconciles these data to align with ONS 2010 mid-year population estimates for LAs. This
reconciliation was deemed necessary, as the number of patient registrations was greater than the number
of people estimated by the ONS to be living in England and Wales, the discrepancy being explained by
factors such as people leaving the country without informing their GP.
The problem, however, is that the overall age–sex profile of household residents listed on the ADS differs
somewhat from the age–sex profile of household residents derived from contemporary, though at the time
unavailable, census data. As illustrated in Table 8, the 2011 census data imply a somewhat older
population profile than do the data from the ADS, raising concerns that the known propensity for young
adults to ignore the ostensibly compulsory census may have been more significant than is generally
recognised, that list inflation is cohort specific, or perhaps that the ONS mid-year population estimates had
by 2010 become unrealistic.
Without compelling evidence on how (if at all) the census and/or ADS data should be adjusted, we must take
the available demographic data at face value. Where estimates are generated for spatial units defined in
terms of the geography of the 2011 census (i.e. with respect to 2011 LSOAs, 2011 MSOAs, geographically
defined CCGs, higher- and lower-tier LAs, 2001 MSOAs and regions) model parameter estimates are applied
to population covariate data derived from the census. Where estimates are generated for NHS organisational
units, namely general practices, PCTs, organisationally defined CCGs and SHAs, model parameter estimates
are applied to population covariate data derived from the ADS. As the population profiles differ, so do the
resulting prevalent estimates.
The scale of the problem can be illustrated with respect to estimates of the overall number of people
expected to self-report ‘diabetes as a long-standing illness’. Thus, using a census-based population
denominator the overall national prevalence rate for adults aged ≥ 16 years is 5.2% [95% confidence
interval (CI) 4.6% to 5.8%]. This compares with an overall prevalence of 4.7% (95% CI 4.4% to 5.0%) if
the somewhat younger ADS-based population denominator is used.
This serves to emphasise the crucial importance of reliable demographic data, though this issue affects our
estimates no more or less than any others. Throughout this report we refer to the prevalence rate
appropriate to the geographical or organisational unit under discussion. Appendices 26 and 27 refer to
prevalence estimates generated using the 2011 census.
TABLE 8 Age–sex population distribution in the 2011 ADS and 2011 census
Age band (years)
Females, % Males, %
ADS Census ADS Census
16–24 7.2 6.4 7.2 6.5
25–34 8.6 7.9 8.7 7.8
35–49 13.1 13.0 14.0 12.6
50–64 11.0 11.7 11.2 11.2
65–74 5.3 6.1 5.0 5.6
≥ 75 5.2 6.5 3.7 4.6
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Modelling large-scale surveys
Model specification and fitting
In all cases except modelling the risk that individuals aged 25–74 years will develop CHD over the next
10 years, the response variables in which we are interested are binary, for example whether or not an
individual reports a LSI or provides a high blood pressure reading. The predictor variables are generally
categorical (e.g. the seven age bands or the five general health bands), the only exception being the actual
IMD scores, as opposed to IMD score quintiles, that are available for models utilising UKHLS survey data.
As a result, the vast majority of the models constructed here are logistic regression models (i.e. generalised
linear regression models using a binomial link function). The ‘risk of CHD over the next 10 years’ model
was also a generalised linear model, this time generalised by use of a reciprocal gamma link function.
All models were fitted to the survey data using the R Statistics glm function (The R Foundation for
Statistical Computing, Vienna, Austria). Importantly, all potential individual-level main effects (i.e. excluding
those which were not, as discussed above, sufficiently cognate with equivalent census variables) have been
included in all models. These variables are statistically significant across most models, suggesting that they
are closely associated with the general health status of individuals, but for some conditions traditional
approaches to model specification would exclude one or other of the main effects. They key here is to
recognise that the models being constructed are for predictive rather than explanatory purposes.
Generalised linear regression is commonly used as a tool for identifying statistically significant relationships
between potential predictor variables and a particular response variable. In such circumstances the rigorous
use of model selection criteria is a crucial and widely used method for ensuring model parsimony, with the
researcher then focusing on the effect (‘other things being equal’) that individual predictor variables have
on the response variable. The goal is to ensure that overfitting the model does not result in the
identification of potentially spurious causal relationships.
In this study the goal – specifying a suitable predictive model rather than identifying plausible casual
relationships between individual predictor variables and the response variable – suggests a somewhat
different approach. The local areas for which predictions are required vary hugely, and often quite
uniquely, in terms of their sociodemographic composition. To exclude information about relationships
between predictor and response variables, even if not formally significant, risks dampening the predictive
power of the models with respect to specific areas. For instance, ethnicity and tenure are not uncommonly
statistically insignificant predictors of variations in morbidity and would be removed using standard model
selection criteria, but this would mean that potentially useful predictive information regarding, say,
predominantly Asian populations living in rented accommodation would be lost. There may be very few
such areas, but only if evidence of the individually weak relationships is retained is it possible to capture
the potential impact of unusual social circumstances on disease prevalence. Moreover – and this is key –
nothing is risked by including such variables in predictive models. If there is uncertainty surrounding the
effect of a particular parameter, then that uncertainty will be taken into the final prevalence estimates by
means of bootstrapping, as described in Capturing uncertainty: a bootstrapping approach.
All of the generalised linear models thus include all available main effects, but thereafter the potential
relevance of all potential one-way interaction effects was tested using the Akaike information criterion.
The set of one-way interaction effects which minimised the Akaike information criterion were thus used,
alongside the available main effects, in the final predictive model for each of the response items being
considered. A full description of each model is provided in Appendices 26 and 27, with a table giving
(to four decimal places) the estimates, standard errors and upper and lower 95% CIs associated with each
factor (relative to its reference). More immediately useful in terms of judging the relative importance of
the various factors, we also in each case provide a plot of the parameter estimates. Interpreting these
parameter plots is relatively straightforward, with the width of the 95% CI illustrating the degree of
uncertainty associated with each parameter estimate, and whether or not it ‘crosses zero’, indicating
whether or not the factor is statistically significant. Thus, in Figure 1, which replicates the parameter plot
given in the appendix for ‘diabetes as a LSI’, it is clear that, relative to people aged 16–24 years
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(the reference group), increasing age is very strongly associated with an increased likelihood of reporting
diabetes as a LSI (at least until the ≥ 85 years cohort). Males are also more likely to report diabetes as a LSI,
as are people of black and Asian ethnicity, those with poor general health, those who report a LLTI, and
those who live in rented accommodation (relative to owner–occupiers). As with most of the models, the
effect of deprivation is muted once individual-level sociodemographic variables are included, although it is
clearly present.
It is important to recognise that no direct causal relationship (or direction) is being claimed. The proposed
model ‘merely’ offers the best means of utilising data (available for local areas) for predicting whether or
not an individual will exhibit or develop a particular disease, condition or health-risk behaviour. To that
extent, it does not matter, for instance, that it is having diabetes that, in causal terms, means that an
individual is more likely to have a LLTI. From a predictive perspective, when one is able to use only data
available for local areas, if an individual has a LLTI then this increases the likelihood that they will have
diabetes – as it does, of course, across many of the other CVD/CVD-related and mental health problems
considered in this study. At an individual level this is of limited utility, but when likelihood estimates
(derived using all available sociodemographic data) are applied to populations, this allows us to predict
how many adults are likely to have diabetes, or any of the other conditions in which we are interested.
The only complication when interpreting this, and most other parameter plots, is allowing for the possible
impact of interaction effects. In this instance, although there is much uncertainty as to the exact scale of
the effect, various combinations of age and LLTI, and of general health and LLTI, are included as having a
statistically significant relationship with the likelihood that an individual will report diabetes as a LLTI. The
complication is that these interact with the respective main effects, although in this instance the overall
picture remains quite clear.
One final aspect of model fitting needs to be noted. All the surveys which provided data to this study
utilised a stratified random probability sample to select households. This approach incorporates a
geographic ‘primary sampling unit’ (PSU) in the sampling framework which, in theory, could result in some
covariance. To test whether or not PSU membership explains any of the variation in each response variable,
we fitted a ‘mixed’ model equivalent to the final generalised linear model. This generalised linear mixed
model, implemented in R Statistics using the glmer function of the lme4 package,471 incorporated the PSU
as a random effect and the size of that effect was considered. This was invariably statistically insignificant
and could be discounted.
From parameter estimates to disease likelihoods
An exploration of the various tables and plots in Appendices 26 and 27 will illustrate the nature of the
relationships which underpin the estimation of local disease prevalence rates, but it should be reiterated
that these are essentially ‘predictive’ rather than ‘explanatory’ models. Indeed, in a very real sense it is
quite unimportant whether or not the particular phenomena represented in the final models are, in
themselves, causally related to morbidity. Rather, they represent the best fitted solution for predicting
variations in morbidity using only variables for which cognate census-derived covariate data are also
available. The issue is now how best to utilise the information captured by the survey-based models for
predicting disease prevalence in small populations.
As outlined in the introduction to this chapter, the approach adopted is to use the parameter estimates to
calculate the likelihood that different types of person, as defined by each model, will have a particular
condition or disease. Thus, the model for ‘diabetes as a LSI illustrated by Figure 1 comprises six individual-
level variables and a total of 24 factors: age band with seven factors (16–24 years, 25–34 years,
35–49 years, 50–64 years, 65–74 years, 75–84 years and ≥ 85 years); sex with two factors (male and
female); ethnicity with five factors (white, mixed, black, Asian and other); general health status with five
factors (very good, good, fair, bad and very bad health); LLTI with two factors (yes and no); and tenure
with three factors (owner–occupier, social renting and private renting/other). This, in fact, defines
7 × 2 × 5 × 5 × 2 × 3= 2100 ‘person-types’ for whom a specific disease likelihood can be calculated;
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this rises to 10,500 person types once one includes reference to the IMD quintile of the LSOA in which an
individual lives. Different models will generate likelihood estimates for a different number of person-types
depending on the number of factors in the model, but in all cases a rich description of how disease
likelihood varies across the sociodemographic spectrum is provided. The particular advantage of this
approach is that, in association with the use of interaction effects, the full compositional diversity of
different populations can be incorporated into the final estimates of disease prevalence.
Microsimulation for small-area estimation describes how suitable local covariate data are obtained, and
Small-area estimation: prediction describes how the person-type disease likelihood estimates are attached
to those covariate data to finally derive the required local prevalence estimates, but a key difficulty with
this process is how to incorporate parameter uncertainty into those prevalence estimates. Figure 1 makes
clear that, even for clearly statistically significant parameters such as age, there is still considerable
uncertainty around the actual parameter estimate.
Capturing uncertainty: a bootstrapping approach
Although this study commenced with the intention of using an explicitly Bayesian approach, in practice this
proved problematic, principally because of the computational demands of Markov chain Monte Carlo
which, in the context of fitting multiple models with many parameters and with respect to relatively large
data sets, proved too time-consuming. The perceived advantage of a Bayesian approach had been that, in
explicitly generating posterior distributions for small-area estimates, it offered a suitable framework for
capturing model uncertainty in the final estimates. Retaining this focus on understanding estimate
uncertainty was deemed essential, and thus we turned to an alternative method of inferring the precision
of the estimates based on a well-established technique known as bootstrapping.
The classic illustration of bootstrapping concerns estimating the mean height of people worldwide. We
cannot measure the heights of all people in the global population, so instead we sample only a tiny part of
the population and measure the height of the people within that. From this sample of n individuals a
single mean height is obtained, but we have no sense of how reliable that mean estimate actually is. The
bootstrap approach involves multiple resampling (with replacement) from the original sample to obtain a
large number of bootstrap samples, from each of which we derive a mean height. From this set of
‘bootstrapped’ means we can calculate both an overall ‘point estimate’ and 2.5% and 97.5% quantiles to
indicate the range over which we are 95% confident that the actual global mean lies (assuming, of course,
that we had taken a suitably representative sample in the first place).
The key feature of the bootstrap approach as applied here is that, following standard practice, multiple
bootstrap (‘with replacement’) samples were taken of the original survey data set (retaining the PSU
structure to reflect the underlying sampling methodology) and each was then used to generate a new set
of model parameter estimates. Given the time available, 220 bootstrap samples, and, thus, 220
independent sets of parameter estimates, were obtained for each model. This is a very small number
compared with most bootstrap procedures (which typically extract thousands of samples) and the precision
of the upper and lower 95% CIs will be affected, but it is worth emphasising that each bootstrap sample
is used to generate 220 sets of likelihood estimates for each and every one of the 10,500 person-types,
and that these are then aggregated to generate the 220 sets of estimates for all LSOAs, MSOAs and
higher geographies. Although this massively increases the computational burden, it enables us to extract
summary statistics to capture how model-based uncertainty affects the final estimates at all scales. Thus, as
detailed in Small-area estimation: prediction, the range within which 95% of the 220 bootstrap-based
estimates lie provides a good, albeit approximate, empirical measure of the 95% credible interval. (The
term ‘credible interval’, rather than ‘confidence interval’, is preferred, as it represents a region, sometimes
known as the ‘credible region’, of the predictive distribution defined by the 0.025 and 0.975 quantiles.)
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Microsimulation for small-area estimation
As noted above, a ‘bottom-up’ approach to small-area estimation requires that the disease ‘likelihood
estimates’ calculated for each of the individual ‘person-types’ defined at the modelling stage can be
applied to appropriate counts of the number of such ‘person-types’ in each LSOA. The principle is
straightforward: if there is a 0.2 risk that a particular type of person (defined in terms of age, sex, general
health and whatever other variables are included in the model) has a particular disease, and there are 10
such people in a particular LSOA, then 2 of the 10 people in the LSOA might be expected to have the
disease. Summing the results of this calculation across all ‘person-types’ provides an estimate of the total
number of people in the LSOA with the disease, and dividing by the relevant population denominator
provides the required prevalence rate. The implementation of this algorithmic process is described in
Small-area estimation: prediction, but it fundamentally depends on being able to fully describe the
composition of the relevant population; not just in terms of a series of cross-tabulations available for 2011
census data, but in terms of the number of people in each uniquely defined person-type category.
In other words, to take a trivial example, rather than knowing how many males and females there are in
a particular area and, separately, how many people report having ‘very good’, ‘good’, ‘fair’, ‘bad’ and
‘very bad’ health, we now need to know how many males have very good health, how many females have
very good health, and so on. In general terms, we need to utilise the information available in existing
census tables on the aggregate characteristics of LSOA populations (so-called ‘marginal distributions’) to
derive an estimate of the underlying, and unknown, ‘full joint distribution’.
An approach generically known as ‘iterative proportional fitting’ has long been used to combine marginal
distributions (including two-, three- and four-way joint distributions) to derive full joint distributions. Such
approaches are often constrained to a dependency structure derived from an analysis of individual-level
sample data, such as is provided for the 2001 census data by the Individual Sample of Anonymised
Records. Unfortunately, when the analysis was undertaken, sample-based micro data were not yet
available for the 2011 census and, as a result, our implementation iterative proportional fitting cannot
utilise such information.
We have thus developed a form of iterative proportional fitting which seeks to iteratively assign individuals
to cells in the full joint distribution in such a way as to minimise a test statistic which sums the aggregate
difference between the resulting ‘provisional’ marginal estimates and the ‘known’ marginal totals taken
from the census tables listed in Table 4. At each iteration, individuals are moved between cells to minimise
the test statistic until, in theory, an allocative solution is found in which the full joint distribution matches
in all respects what is known, through the census-based marginal totals, about a population.
At the heart of this approach is a (0,1) relational matrix linking each person-type with each of the ‘known’
marginal totals. Table 9 provides a (highly) simplified illustration of how this matrix allows the estimated
number of people in each marginal total (the right-hand column) to be related to the known marginal
totals (the penultimate row). This example assumes there to be three census tables through which we
know there are 51 males and 49 females; 75 people aged 16–54 years and 25 people aged 55–74 years;
and 53 people with a LLTI and 47 people without. Although the tables tell us nothing about the full
distribution, by iteratively moving individuals between person-types (using a constrained ‘random walk’) we
can calculate, as given in the final row of the table, how close the estimated number of people in each
person-type category is to a fitted solution. The goal, of course, is to determine an allocation which results
in a set of estimated marginal totals that equals, or very closely approximates, the set of known marginal
totals. In this case a ‘fitted’ solution would be achieved (i.e. with all column ‘absolute differences’= 0)
using the person-type counts given in brackets.
In reality the process is significantly more complex, involving a link matrix with 21,000 ‘person-type’ rows
[covering the 10,500 person types described above living in (a) households and (b) communal
establishments] and 384 ‘marginal total’ columns (relating to census table marginal totals). The iterative
process was extremely computationally demanding, not least because it had to be replicated for each of
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the 32,844 LSOAs for which prevalence estimates were to be produced. It was eventually scripted using a
new high-level, high-performance dynamic programming language for technical computing known as
Julia472 and, in practice, we allowed the iteration to terminate when the sum of absolute differences
(across all 384 columns) fell below five. The length of time it took to achieve a perfect solution could not
be justified given that the original census data had been perturbed to ensure confidentiality.
The key point is that any final ‘fitted’ solution constitutes a detailed description of the composition of an
area which matches, or almost matches, what is known (through available census tables) about an LSOA.
We can then apply modelled likelihood estimates for each ‘person-type’ to appropriate count data. This,
we believe, greatly increases the specificity of the final estimates, particularly with respect to the way in
which parameter interaction effects will play out in different areas. It is, however, important to recognise
that multiple solutions (at least in theory) will exist to any given set of marginal totals. This implies
additional uncertainty to the final estimates which have not been fully investigated and which are not
captured by the formal estimate CIs.
Small-area estimation: prediction
The prediction component of small-area estimation is an entirely straightforward and algorithmic process,
even though it raises, once again, substantial computational challenges. Modelling large-scale surveys
described how appropriate models were specified and fitted to large scale-survey data with a view to
producing up to 10,500 person-type specific disease ‘likelihood’ estimates for each of the 65 response
items considered. It also described how bootstrapping was, in each case, used to generate 220
independent estimates which captured model parameter uncertainty. Microsimulation for small-area
estimation, meanwhile, described how available multivariate census tables were used to ‘microsimulate’
a full joint distribution for each LSOA which, in effect, provides a description of the detailed
TABLE 9 Iterating marginal total estimates using a link matrix
Person-type category
Link matrix Estimated number
of people in
categoryM F 16–54 years 55–74 years LLTI No LLTI
M, 16–54 years, LLTI 1 0 1 0 1 0 ←27 (26)
M, 16–54 years, no LLTI 1 0 1 0 0 1 ←14 (15)
M, 55–74 years, LLTI 1 0 0 1 1 0 ←7 (5)
M, 55–74 years, no LLTI 1 0 0 1 0 1 ←5 (5)
F, 16–54 years, LLTI 0 1 1 0 1 0 ←14 (16)
F, 16–54 years, no LLTI 0 1 1 0 0 1 ←16 (18)
F, 55–74 years, LLTI 0 1 0 1 1 0 ←8 (6)
F, 55–74 years, no LLTI 0 1 0 1 0 1 ←9 (9)
Estimated marginal count
of persons
↓ ↓ ↓ ↓ ↓ ↓
53 47 71 29 56 44 Sum of absolute
differences
Known marginal count 51 49 75 25 53 47
Absolute difference 2 2 4 4 3 3 →18
F, female; M, male.
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sociodemographic composition of each LSOA. Now the task is ‘simply’ one of applying the appropriate
disease likelihood risks to the relevant counts of the number of people in each person-type category in
each LSOA, and then summing the products to determine how many people in each LSOA (and higher
unit) are likely to have the disease.
Here, the issue is how, precisely, should those disease risk likelihood estimates be applied? The fact of the
matter is that a particular individual will either have a disease or not have a disease. They will not have
0.2 of a disease, even if that is the underlying probability. As simply summing the probabilities of illness
multiplied by the number of individuals to which they applied would underestimate the uncertainty implicit
in the likelihood estimates, a more appropriate approach is to predict for each individual in the population
(on the basis of their individual disease likelihood) whether or not they have the disease/condition in
question, and then sum these predictions. This, of course, is a Bernoulli trial, and now the overall
prevalence rate is not simply the sum of ‘likelihoods × counts’, but rather the sum of the outcomes of
Bernoulli ‘coin tosses’ applied to each and every individual in the population.
In this way, we capture not only model uncertainty by replicating the process for each of the 220
bootstrapped data sets – resulting in 220 independent sets of parameter estimates which are used to
compute 220 independent disease risk estimates for each of the 10,500 person-types – but also the
inherent uncertainty concerning whether or not an individual, with a particular risk, will have the disease.
The outcomes of the Bernoulli trials are then summed for 12 age-/sex-defined cohorts, and for the overall
population, in each LSOA and all higher units. This results, in each case, in 220 bootstrap-based estimates
of the number of people we predict will have the disease or condition in question. The final step,
therefore, is to describe the resulting distributions in terms of the range within which 95% of the values
fall. These summary data are then retained and constitute the information to be made available via PHE’s
local health website.441
To clarify, therefore, the MSOA, LA, CCG and all other estimates have not been generated by statistically
amalgamating LSOA-level summary estimates, but by directly undertaking Bernoulli trials, based on
appropriate disease risk likelihoods, with respect to all individuals within the units in question. It is worth
noting that smaller credible intervals (explicitly the range within which 95% of the 220 bootstrapped
estimates fall) are obtained for larger populations purely because variability induced by bootstrapping and
the Bernoulli trial is dampened. Underlying model uncertainty remains the same throughout, resulting in a
less dramatic improvement in estimate precision than might have been expected.
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Chapter 4 Investigating equity in the utilisation of
cardiovascular services
Introduction
The aim of this chapter is to determine the extent to which variations in the presentation and management
of CVD reflect underlying differences in the health-care needs of populations. To this end, we have
rejected the use of administrative data to proxy need (as this, we argue, runs the risk of reflecting both
unmet need and unjustified supply) and have instead developed modelled estimates of cardiovascular
need. The methods used to this end were described in Chapter 3. In this chapter we (a) test the estimates
and select which, of a number of various indicators, we will use in our investigation of use relative to need,
and (b) investigate the extent to which PCT- and practice-level variations in the presentation, primary
management and specialist management of diabetes, CHD, hypertension and stroke can be explained by
underlying need and/or population characteristics (deprivation, age, ethnicity and rurality).
The importance of capturing health-care needs
As discussed in Chapter 2 (see Methodological issues and Administrative data), one approach to exploring
issues of equity has been to use administrative data as denominators of need.205,213,291,295,299–301,305,306,311
Here, ‘prevalence rates’ refer to, for example, QOF ‘prevalence’ rates (the number of people on GP
registers for particular conditions such as depression, CHD or hypertension) or the proportion of hospital
patients admitted with a particular diagnosis (such as angina). This can throw light on variations in access
and use once patients are ‘within’ the health service, for example the extent to which particular treatments
and/or procedures are provided relative to the number of people admitted with a particular diagnosis. It
does not, however, address the extent to which different populations and cohorts use health services
relative to the underlying prevalence of illness because expressed demand inevitably incorporates both
unmet need and unjustified supply.
Primary care trust- and CCG-level modelled disease prevalence rates disseminated by the Public Health
Observatories and, more latterly, PHE, try to get around this problem by modelling direct estimates of
disease prevalence within the community.210–215,473 These have not, however, been widely used in studies of
health service equity211,215,222,474–476 and, as discussed below, there are some questions regarding their
relative reliability for underpinning studies of health service equity.
Ignoring access to and use of health services relative to underlying needs is a problem in its own right as it
leaves unexplored a key aspect of access, but it has a broader significance insofar as variations in rates of
specific treatments and/or procedures within the health service must, to some degree, reflect variations in
initial presentation. This is not simply because, at an individual level, belated presentation is likely to result
in the need for higher levels of health care at a later date. Even allowing for this, if a smaller proportion of
any given population is presenting with early and/or minor symptoms, this will tend to ‘weight’ the cohort
and make it appear that, relative to the number of people who have actually presented, a higher level of
care is being provided. The potential contradiction is obvious, and there is a real danger that one is not
comparing like-with-like denominator populations when examining ‘within-system’ variations. The point is
that it is difficult to adequately interpret ‘within-system’ variations in the use of particular treatments
without reliable evidence on underlying needs in the broader community.
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Estimating the prevalence of particular diseases and conditions in the community is thus key to any full
understanding of health-care equity, as well as, of course, of potential significance for public health
planning and the commissioning of services. Developing a robust approach for generating prevalence
estimates for small populations and, more specifically, redressing the effective absence of such data for key
cardiovascular and mental health conditions has been a core project objective. To that end a range of
prevalence estimates have been produced. The problem, though, is how can one assess the reliability of
those prevalence estimates as a baseline for studies of equity of use of specific health services?
Cardiovascular disease prevalence estimates:
testing for reliability
The lack of a gold standard
The fact of the matter is that there is no ‘gold standard’ measure of disease prevalence against which to
assess the prevalence estimates. Indeed, if there were, those estimates would immediately become
redundant. Legitimacy can only flow from methodological rigour (the subject of the previous chapter) and,
problematically, a somewhat circular comparison with available utilisation data. This is circular (and
problematic) in the sense that, although the prevalence rates are to be used as a measure of underlying
illness (need) in an assessment of how health service use varies relative to need, the only evidence we have
on variations in illness lies with data collected by the NHS about people who have actually accessed some
form of health care. This is not optimal, but it is inescapable.
The fundamental problem is, thus, that it is impossible to prove whether or not discrepancies, whether
systematic or stochastic, are due to inadequacies in the need estimates or because of variations in uptake
relative to need. However, although definitive proof may be elusive, we would argue that confidence in
the legitimacy and usefulness of the prevalence estimates generated can be obtained by comparing them
in detail against a variety of measures of health service utilisation. We acknowledge that, for any particular
scenario, contradictory interpretations can always be placed on the same observations – discrepancies
between need estimates and utilisation data could be due to inadequacies in the needs estimates or
because of local variations in access – but it is the overall weight of evidence in the context of a coherent
explanatory narrative that matters.
Quality and Outcomes Framework data
In this section, therefore, we compare our CVD need estimates with QOF disease registration data. The
QOF database72,440 publishes counts of people on each practice disease register and, using denominators
based on overall or age-specific patient populations, practice-level prevalence rates. As practices are paid
for keeping the registers, and as the number of people on their disease registers is used to calculate
payments within each of the clinical indicator groups, the policy intention is that registers are properly kept
and that efforts are made to ensure that as many patients as possible with the specified conditions are
identified and registered. As a result QOF-based prevalence rates have been used as a source of proxy data
on the level of health-care need in different populations.140,243,247,259,262,289,477
There are, however, significant problems with the use of QOF disease registers, both generally and as a
comparator against which to assess the reliability of our model-based need estimates. The first is their
provenance as a tool designed to influence and reward GP behaviour. This can have very specific
implications, such as the fact that an individual can be included on the diabetes register only if the practice
has established not only that a patient has diabetes, but whether the diabetes is type 1 or type 2. A more
fundamental problem is that QOF prevalence rates will reflect variations in case finding. One consequence
is that they tend to increase over time (inclusion of registers within the QOF payments system was, in
part, intended to improve case finding). More significantly, case finding will also vary in response to factors
such as the time, commitment and resource GPs direct towards such activity as well as, no doubt, the
responsiveness of the populations being served.
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A further issue is the fact that no information is available on the age–sex profile of patients included on
the various QOF disease registers.478 The published QOF prevalence rates are ‘crude’ rates affected by
differences in, or changes to, the demographic composition of practice populations. Practices, PCTs and
CCGs have very different populations and variations in ‘crude’ QOF prevalence rates are as likely to reflect
varying demographic structures as any genuine difference in the health status of populations. Indeed, the
stronger a disease’s demographic gradient, the more problematic will be the QOF prevalence rate.
Such problems notwithstanding, the QOF registers explicitly count the number of people ‘known’ by GPs
to have a series of specific conditions and, as such, represent a key measure of primary presentation.
We can thus simultaneously ‘test’ our estimates by assessing whether or not they broadly align with the
number presenting and, by focusing on the differences between presentation (QOF registration) and
underlying need (modelled prevalence estimates), can begin to investigate the nature and scale of
variations in the utilisation of primary care.
Determining appropriate need indicators
Although we are principally concerned (as detailed below) with comparing how counts and rates vary at
more local levels (practices, PCTs and CCGs), we must first establish which of the modelled prevalence
rates are likely to provide the most reliable guide to variations in the underlying prevalence of the
conditions for which suitable QOF data are available, namely diabetes, CHD, hypertension, stroke and, in
Chapter 5, depression. As argued in Chapter 3 (see Methodology overview), it was not possible to
determine a priori which of the prevalence rates that could be derived from large-scale survey data would
provide the most ‘useful’ indicators of health-care needs. Thus, a range of alternative prevalence rates have
been modelled – distinguished by definitional differences and/or because they have been drawn from
different surveys using different predictor variables. This is of particular relevance to depression (see
Chapter 5, Variations in the use of mental health services relative to need), where a large and very diverse
range of prevalence rates is available and where there is scant a priori evidence on which to choose
between them.
The only sensible approach to deciding between the alternative prevalence rates as potential indicators of
‘health service needs’ is to incorporate an assessment of how well they compare with the QOF registration
data. This is not the only consideration, for there are often definitional differences that affect how the
estimates should be interpreted (such as the distinction between biometric, diagnosis-based and
self-reported LSI measures), but it is nonetheless important that a convincing explanatory narrative can link
any putative measure of ‘health service need’ with the only proxy source we have on the number of
people known to have such a need, namely the number of people on QOF registers.
Diabetes
Although diabetes is not classed as a ‘cardiovascular disease’, colleagues at PHE encouraged us to
generate diabetes prevalence estimates as diabetes is of key interest to the public health community.
Furthermore, key aspects of the disease make it a useful benchmark condition against which to compare
modelled and QOF prevalence rates. First, diabetes is a well-recognised condition and individuals
responding to the HSfE are likely to be using the term in a way that is directly and unequivocally
comparable with its use in the QOF. Prescribing and inpatient utilisation data relating to diabetes are
relatively unambiguous (unlike a number of CVD drugs that can be prescribed for a range of clinical
conditions). The QOF diabetes register also refers to an age-defined cohort (albeit of patients aged
17 years or older, whereas our modelled estimates relate to people aged 16 years or older).
As Table 10 shows, the overall number of patients estimated to have diabetes in the community (however
defined) is very similar to the overall number of people on the QOF register. This implies relatively good
case-finding in primary care settings although, as might be expected, the number of people estimated to
have ‘doctor diagnosed or undiagnosed diabetes’ slightly exceeds the number who have been diagnosed
with diabetes, who report diabetes as a LSI, or who appear on the QOF register.
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The crucial question, though, is the extent to which each of these potential needs indicators correlates
with QOF registrations at practice and PCT level. We consider below how use-to-need rates vary at practice
and PCT level with respect to a range of health service activities, but here we examine how estimated
counts of the underlying number of people with diabetes in practices and PCTs compare with counts of
the number of people on the QOF diabetes disease register. Correlation statistics for count data can
mislead because of the overwhelming effect of population size on the number of people with any given
condition, but this nevertheless avoids any potential bias arising from different demographic profiles. If the
modelled estimates are accurate, and are thus a useful guide to variations in the need for services, they
should be highly predictive of the number of people who are QOF registered.
Alongside overall QOF and modelled estimate prevalence rates, Table 11 records PCT-level ratios of QOF
and modelled prevalence with respect to each of the potential definitions of needs. For instance, in terms
of the need indicator based on the number of people estimated to have diabetes as a LSI, there is a
1.77-fold variation in PCT-level registrations per expected (modelled) case (from 0.91 registrations per case
and 1.77 registrations per case). Table 11 also reports the extent to which the QOF registration counts are
correlated with the various estimates of the number of people with diabetes. Thus, 97.5% of the variation
in QOF registrations can be explained by the need indicator based on the LSI indicator. This is a somewhat
larger proportion than either of the alternatives, based on ‘doctor-diagnosed diabetes’ and a composite
measure of ‘diagnosed and undiagnosed diabetes’, which explain 95.9% and 96.8% of the variation in
QOF registration counts, respectively. All three definitions of need generate estimates that are much better
at predicting QOF registrations than the size of the underlying ‘at-risk’ populations, which accounts for
‘just’ 93.5% of PCT-level variation. This is also true at practice level (n= 8067), with the ‘LSI’ indicator
explaining 90.8% of the variation in practice-level QOF registration counts, compared with just 75.9%
explained by the size of the ‘at-risk’ population.




Registrations per expected case Count correlation
Mean Minimum–maximum Variation R % R2
Total QOF population (≥ 17 years) 5.8 – – – 0.967 93.5
Adults reporting diabetes as a LSI 4.7 1.20 0.91–1.61 1.77 0.988 97.5
Adults ever been doctor-
diagnosed with diabetes
5.2 1.08 0.85–1.84 2.16 0.979 95.9
Adults with diagnosed or
undiagnosed
6.5 0.88 0.63–1.12 1.78 0.984 96.8




Patients (≥ 17 years)
on register QOF prevalence rate, %
Diabetes mellitus 2010–11 44,291,915 2,455,937 5.5
Diabetes mellitus 2011–12 44,569,825 2,566,436 5.8
Potential diabetes needs indicators (2001 ADS population ≥ 16 years= 44,813,241)
Modelled prevalence Predicted cases (≥ 16 years) Prevalence rate, % (95% CI)
As a LSI 2,118,013 4.7 (4.4 to 5.0)
Doctor diagnosed 2,577,799 5.2 (4.6 to 5.8)
Diagnosed and undiagnosed 2,900,779 6.5 (5.9 to 7.0)
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It is perhaps surprising that the estimates based on LSI should prove more effective at predicting variations
in QOF registrations than either of the alternatives, which, after all, incorporate information on actual
diagnosis. This may be attributable to the fact that many more survey responses are available with respect
to ‘diabetes as a LSI’ (n= 29,905) than to either ‘doctor-diagnosed diabetes’ (n= 18,684) or ‘diagnosed
and undiagnosed diabetes’ (n= 11,061). As a direct result, LSI -based estimates are more precise (as
detailed in Appendix 26) and the relationship with the phenomenon being described less subject to
less uncertainty.
Choosing which prevalence rate best proxies needs is a balance between definitional, evidential and
predictive considerations. ‘Diabetes as a LSI’ is perhaps a less satisfactory definition of underlying morbidity
than one which includes a biometric assessment of clinical diabetes (e.g. ‘diagnosed and undiagnosed
diabetes’), and it does give rise to estimates that are somewhat lower than indicated by QOF registrations
(4.7% as opposed to 5.8%). However, in this case the extent to which it predicts variations in QOF
registrations suggests that it offers the most appropriate ‘needs indicator’ for our analysis of the factors
which influence variations in QOF registration, prescribing and inpatient activity. Such interpretative issues
affect decisions about all of the modelled prevalence estimates. In order to make these as transparent as
possible, information about the definition, provenance and prediction of modelled variables is provided in
Appendix 26.
Coronary heart disease
Once again a number of modelled prevalence rates are available as potential ‘needs indicators’ for CHD.
These are based on the following definitions:
(a) ‘CHD as a LSI’ – explicitly including ‘heart attack’, ‘angina’, ‘coronary thrombosis’ and ‘MI’; the only
difficulty here is that coding is of respondent descriptions and this may not always be clinically precise
enough to categorise as CHD.
(b) ‘Doctor-diagnosed CHD’ – respondents stating that a health professional had diagnosed ‘angina or a
heart attack (including MI and coronary thrombosis)’.
(c) ‘CHD symptoms (angina and/or MI)’ – respondents reporting that they have ever had chest pain in
sternum, sternum lower or anterior lower chest and in the left arm (possible angina) or have had
severe pain across the front of their chest lasting half an hour or longer (possible MI).
(d) ‘Clinical evidence of CHD’ – respondents who have ever had symptoms of angina and/or MI (as
above), who are currently taking drugs for CHD (see Appendix 26 for details), or who have recently
(past 12 months) been diagnosed with angina or having had a heart attack.
(e) ‘Current evidence of CHD’ – extends the ‘clinical evidence’ definition to include respondents who
self-report angina and/or heart attack as a LSI.
(f) History of CHD’ – extends the ‘current evidence’ definition to include respondents who have ever
been diagnosed with angina or having had a heart attack (rather than being restricted to those
diagnosed in the past 12 months).
As shown in Table 12, national prevalence rates (for adults aged ≥ 16 years) based on these definitions range
from 2.0% to 12.5% as opposed to the national QOF CHD prevalence rate of 3.4% (for people of all ages).
As with diabetes, the modelled estimate of the number of people living with CHD as a long-standing
disease is somewhat lower than the number of patients on the QOF disease register. In both cases this
probably reflects the way respondents to the HSfE respond to a question that asks them to record as a LSI
anything that ‘has troubled you over a period of time, or that is likely to affect you over a period of time’.
For some, a well-controlled condition may not be seen as ‘troubling’, though a GP should still place them
on the CHD register. This would also explain why a substantial proportion of people who report having
been diagnosed with CHD fail to report it as a LSI.
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The 3.4% QOF prevalence rate for people of all ages equates, in broad terms, to a rate of about 4.2% for
adults aged 16 years or older. It is interesting that this falls short of the proportion of people estimated to
have been doctor diagnosed (5.4%), though this may simply be due to this estimate being based on a
lifetime recall of ever having had the disease compared with the people being entered onto the register
since it was implemented in 2004–5.
The QOF rate also falls short of the proportion of people expected to have CHD symptoms, and a long
way short of the remaining measures. This tallies with previous research comparing modelled APHO CHD
prevalence and diagnosed prevalence215 and is indicative of significant levels of undiagnosed and
unrecognised CHD in the community. In Chapter 5 (see Common mental health disorder prevalence
estimates: testing for reliability) we examine whether or not there is any evidence of systematic variations
in unmet need, but it is again first necessary to determine which of the prevalence rates is likely to provide
the most useful measure of health service needs.
Following the approach described with respect to diabetes, and referring to the information summarised
on Table 13, in this case it is ‘doctor-diagnosed’ CHD which most closely predicts PCT-level variations in
QOF registrations (% R2= 97.4%). This is, of course, exactly what one should expect given that the
definitions are precisely cognate. It would, however, obviously be problematic to use such an explicitly
utilisation-based measure of needs as the basis for assessing how use varies relative to needs. A case could
again be made for using the LSI definition as a proxy needs indicator, as this exhibits the least variation
in registrations per expected case and, after ‘doctor diagnosis’, best explains variations in the overall
number of registrations at PCT level. In this case, however, the overall prevalence rate falls so far short
of the QOF registration rate that it seems more appropriate to use ‘clinical evidence of CHD’ as the basis
on which to measure health service needs. This captures whether people have ever had symptoms of
angina or MI, are taking prescribed drugs for CHD, or have recently been diagnosed with angina or having
had a heart attack.
The ‘clinical evidence of CHD’-based definition explains 95.6% of the variation in PCT-level QOF
registrations, considerably more than the 85.4% explained simply with respect to the number of people
aged 16 years or older. The ‘clinical evidence’ definition of CHD prevalence also explains far more of the
variation in QOF counts at practice level (n= 8068), in this case 90.4% compared with the 68.7% that can
be explained with reference to the number of ‘at-risk’ people in each practice.
TABLE 12 Quality and Outcomes Framework register data and comparator modelled estimates: CHD




the register QOF prevalence rate, %
CHD 2010–11 55,169,643 1,877,518 3.4
CHD 2011–12 55,525,732 1,875,548 3.4
Potential CHD needs indicators (2001 ADS population ≥ 16 years= 44,813,241)
Modelled prevalence Predicted cases (≥ 16 years) Prevalence rate, % (95% CI)
As a LSI 909,846 2.0 (1.9 to 2.2)
Doctor-diagnosed CHD 2,406,474 5.4 (4.9 to 5.8)
CHD symptoms (angina/MI) 3,769,658 8.4 (7.8 to 9.0)
Clinical evidence of CHD 5,213,527 11.6 (10.9 to 12.4)
Current evidence of CHD 5,294,388 11.8 (11.1 to 12.5)
History of CHD 5,616,107 12.5 (11.8 to 13.3)
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Hypertension (high blood pressure)
High blood pressure is also a well-defined and widely recognised condition which respondents to the HSfE
might be expected to report reliably, although it should be noted that the QOF threshold for high blood
pressure is 150/90mmHg, compared with the 140/90mmHg threshold used in the HSfE. Also blurring
precise comparability is the fact that clinical hypertension requires elevated readings to be obtained on
more than one occasion, whereas the survey-based designation of high blood pressure is based on a
one-off reading.
Once again, as illustrated in Table 14, considerably fewer people report high blood pressure as a LSI than
appear in the QOF hypertension disease register, presumably for the same reasons as given above. What is
most notable, however, is the very much higher number of people estimated to have high blood pressure
when that estimate is derived from variables relating to nurse measurement or diagnosis. Here, the
alternative estimates are based on:
(a) ‘nurse-measured high blood pressure’ – the number of survey respondents with a systolic reading of
> 140mmHg and/or a diastolic reading of > 90mmHg
(b) ‘nurse-measured high blood pressure or blood pressure drugs’ – which extends the definition to
include respondents taking diuretics, beta-blockers, ACE inhibitors, calcium channel blockers or ‘other
blood medication’ specifically intended to control high blood pressure
(c) ‘clinical evidence of high blood pressure’ – which further incorporates respondents diagnosed with
current high blood pressure
(d) ‘any evidence of high blood pressure’ – which finally includes respondents who have ever been
diagnosed with high blood pressure or who report it as a LSI.
These definitions may appear progressively inclusive, but it is important to recognise that they also differ in
terms of potential utilisation and social bias and their interpretation is not entirely straightforward. For
instance, although nurse-measured blood pressure data may seem free of bias – they are effectively based
on blood pressure readings taken from a random sample of household residents – in fact a proportion of
people will have normotensive blood pressure only because they are on medication. As an individual’s
recognition that they need to seek treatment may not be socially neutral, and may furthermore reflect the
availability and accessibility of appropriate health care, this measure would, somewhat perversely, tend to
underestimate the needs of populations which are actually receiving high levels of support through
prescribing and the associated primary management of hypertension. It would seem reasonable, therefore,
to include people who report that they are currently taking prescription drugs to control blood pressure.




Registrations per expected case Count correlation
Mean Minimum–maximum Variation R % R2
Total QOF population (all ages) 3.4 – – – 0.918 84.3
Total population ≥ 16 years 4.2 – – – 0.924 85.4
Adults reporting CHD as a LSI 2.0 2.02 1.32–2.54 1.92 0.980 96.0
Adults ever been doctor
diagnosed with CHD
5.4 0.78 0.48–0.97 2.02 0.987 97.4
Adults with angina/MI symptoms 8.4 0.49 0.24–0.66 2.75 0.966 93.4
Adults with clinical evidence of
CHD
11.6 0.35 0.19–0.45 2.37 0.978 95.6
Adults with current evidence of
CHD
11.8 0.35 0.19–0.44 2.32 0.979 95.8
Adults with any history of CHD 12.5 0.33 0.18–0.42 2.33 0.979 95.9
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But, if so, what about individuals who have been diagnosed with hypertension but who (possibly because
of non-pharmacological treatments and/or lifestyle changes) do not provide a high blood pressure reading
to the nurse administering the HSfE? They too have demonstrably made demands on health services
(at the very least having been diagnosed by a health professional), even though to include them risks
incorporating additional supply-side bias. Finally, what about those who return a normal blood pressure
reading but who report high blood pressure as a LSI? There may be socioeconomic and/or demographic
bias in how individuals respond to the LSI question, but, arguably, if a respondent states that a condition
has ‘troubled’ them over a period of time, they have, by definition, a health-care need.
Given the possible sources of bias it is perhaps surprising that, as shown in Table 15, all of the definitions
generate estimates that prove to be extremely powerful at predicting PCT-level QOF registration counts.
From a public health perspective there may be a case for adopting the most inclusive ‘any evidence’
definition, but marginally the best predictor of variations in PCT-level registration is based on ‘clinical
evidence’ of diagnosed or undiagnosed high blood pressure. This predicts a remarkable 99.2% of the
variation in PCT-level QOF registrations. The advantage of using this prevalence rate as a ‘needs indicator’
for hypertension is illustrated effectively by Figure 2. This contrasts scatterplots of QOF registrations against
(a) at-risk populations (people aged ≥ 16 years) and (b) the estimated number of people with hypertension.
The former is relatively effective (predicting 94.3% of the variation in QOF registrations), but use of the
‘clinical evidence’-based measure of needs drags the outliers into an almost straight line. Using this
indicator of needs has an equally dramatic impact with respect to practices (n= 8181), for which 77.8%
of the variation in QOF registration counts can be explained by variations in the size of the underlying
‘at-risk’ practice populations, as opposed to 94.1% if one uses the number of people expected to have
hypertension in each practice.
Interestingly, although we have evidence of high levels of unmet need (the QOF ‘all-ages’ rate of 13.6% is
broadly equivalent to about 17% for adults aged 16 years and older, which is far short of the estimated
32.5% of people aged ≥ 16 years with hypertension), there is, nevertheless, a very strong relationship
between, on the one hand, the modelled estimate of the number of people with hypertension and, on the
other hand, the number of patients with hypertension who are ‘known’ to primary care services. This, we
would argue, is strongly indicative that the modelled estimates are fundamentally robust and that case
finding is relatively consistent at both PCT and practice level. It does not, in other words, seem plausible
that any misestimation of the number of people with hypertension should be so effectively balanced by an
opposite and equal variation in rates of case finding.





the register QOF prevalence rate, %
Hypertension 2010–11 55,169,643 7,460,497 13.5
Hypertension 2011–12 55,525,732 7,567,965 13.6
Potential hypertension needs indicators (2001 ADS population ≥ 16 years= 44,813,241)
Modelled prevalence Predicted cases (≥ 16 years) Prevalence rate, % (95% CI)
As a LSI 3,010,018 6.7 (6.5 to 7.0)
Nurse-measured 9,251,361 21.5 (20.2 to 21.5)
Nurse-measured or on blood pressure drugs 13,408,487 30.1 (29.4 to 30.7)
Clinical evidence 14,473,610 32.5 (31.9 to 33.0)
Any evidence 16,101,059 36.1 (35.4 to 35.7)
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FIGURE 2 Primary care trust-level QOF registrations against population and modelled estimate denominators:
hypertension. (a) Population (≥ 16 years) against QOF registrations, 2011–12; and (b) estimate (≥ 16 years) against
QOF registrations, 2011–12.




Registrations per expected case Count correlation
Mean Minimum–maximum Variation R % R2
Total QOF population (all ages) 13.6 – – – 0.971 94.3
Total population ≥ 16 years 16.9 – – – 0.974 94.9
Adults reporting hypertension as
a LSI
6.7 2.50 1.99–2.88 1.45 0.994 98.8
Adults with nurse-measured
hypertension
21.5 0.81 0.59–0.95 1.61 0.995 99.0
Adults with nurse-measured or
taking drugs for hypertension
30.1 0.56 0.42–0.66 1.55 0.996 99.2
Adults with clinical evidence of
hypertension
32.5 0.52 0.40–0.61 1.53 0.996 99.2
Adults with any evidence of
hypertension
36.1 0.47 0.35–0.54 1.57 0.995 99.1
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Stroke
The final QOF register which provides relevant comparator data on CVD-related morbidity is the Stroke and
Transient Ischaemic Attack (TIA) Disease Register. In this case only one prevalence rate is available as a
potential needs indicator, based on the number of people reporting a stroke (including cerebral
haemorrhage and cerebral thrombosis) as a LSI. As shown in Table 16, the resulting prevalence rate is
significantly lower than the number of patients on the QOF stroke and TIA disease register. This reflects
the pattern found with diabetes, CHD and hypertension, and, once again, no doubt reflects how
respondents have interpreted whether an illness ‘has troubled you over a period of time, or that is likely to
affect you over a period of time’.
This disparity does not, of course, mean that local estimates of the number and proportion of people living
with stroke as a LSI cannot be used to proxy variations in the need for appropriate health-care services.
Indeed, as with respect to the other conditions for which we have ‘LSI’ estimates, the very fact that the
condition ‘troubles’ respondents implies a need for health care. More generally, however, the issue is
whether or not the relationship between reporting stroke ‘as a LSI’ and the need for relevant health-care
services is socially and demographically invariant.
In fact, as shown in Table 17, the number of people estimated to be living with stroke as a LSI condition is
very strongly predictive of PCT-level variations in the number of people on the QOF register. Thus, whereas
the number of people in ‘at-risk’ populations aged ≥ 16 years predicts only 88.3% of the variation in QOF
registrations, the estimated number of people living with stroke as a ‘LSI’ predicts 98.3% of the variation.
Figure 3 graphically illustrates the far better relationship achieved by the needs indicator compared with
using a simple ‘at-risk’ population. This is also apparent at practice level, where practice-level counts of
people aged ≥ 16 years explains 69.4% of the variation in the number of people QOF registered,
compared with 91.4% of variation explained by modelled estimates of the number of people in each
practice living with stroke as a LSI.
TABLE 16 National QOF register data and comparator modelled estimates: stroke
QOF register Practice population (all ages) Patients on the register QOF prevalence rate, %
Stroke and TIA 2010–11 55,169,643 944,099 1.7
Stroke and TIA 2011–12 55,525,732 964,273 1.7
Potential stroke needs indicator (2001 ADS population ≥ 16 years= 44,813,241)
Modelled prevalence Predicted cases (≥ 16 years) Prevalence rate, % (95% CI)
As a LSI 424,768 0.95 (0.78 to 1.14)
TABLE 17 Primary care trust-level 2011–12 ratios of QOF: modelled prevalence: stroke
Denominator population Prevalence rate, %
Registrations per expected case
Count
correlation
Mean Minimum–maximum Variation R % R2
Total QOF population (all ages) 1.74 – – – 0.933 87.0
Total population ≥ 16 years 2.15 – – – 0.939 88.3
Adults reporting stroke as a LSI 0.95 2.23 1.69–2.76 1.63 0.991 98.3
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Comparison with existing prevalence estimates
It is necessary to conclude this assessment of the ‘competence’ of our modelled needs indicators by
comparing them with the only available alternative measures of modelled prevalence, namely the various
prevalence estimates published by PHE. Prevalence models for hypertension and CVD were produced at
around the same time that we commenced this project.213,214 As in our approach, these models were
developed from data from the HSfE. However, different modelling strategies have been used (see Chapter 3,
Introduction). Moreover, the existing PHE estimates have been made available at PCT level and are in the
process of being converted to CCG level. However, they are not available for LSOAs and MSOAs and,
therefore, cannot be used to model variation in utilisation at a finer geographical level.
Table 18 compares our modelled estimates with those of PHE for each of the four conditions for which we
have appropriate QOF registration data. The ‘need estimate only’ correlation (r) and associated ‘proportion
of variance explained’ (% R2) statistics describe how well (a) the PHE and (b) our Plymouth estimates of
health service need predict PCT-level variations in QOF registration rates. In each case the Plymouth
estimate significantly outperforms the equivalent PHE estimate, often markedly so. For instance, whereas
published PHE modelled estimates of the prevalence rate for stroke explain 52.4% of the variation in































































Estimated count of adults (> 16 years) with a stroke (000)
(b)
FIGURE 3 Primary care trust-level QOF registrations against population and modelled estimate denominators:
stroke. (a) Population (≥ 16 years) against QOF registrations, 2011–12; and (b) estimate (≥ 16 years) against QOF
registrations, 2011–12.
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As they are, in and of themselves, better predictors of variations in QOF registrations rates, it is highly likely
that the Plymouth estimates are better indicators of underlying morbidity across all four conditions. This is
reinforced by the evidence given on the right-hand side of Table 18, which describes the outcome of
stepwise-selection-based linear regression modelling of QOF registration rates relative to underlying
per-capita morbidity (‘need’) and a series of measures which attempt to capture the sociodemographic and
geographical characteristics of PCTs. Specifically, the percentage of PCT populations of Asian or British
Asian ethnicity (‘Asian’); the percentage of black or black British ethnicity (‘black’); the percentage aged
< 50 years (‘pop < 50’); a measure of average deprivation for the PCT; and, finally, the percentage of PCT
populations living in LSOAs defined as ‘rural’.
The first column describes the total variation in PCT-level QOF registration rates that is explained by the
final linear regression model, while the remaining columns give the standardised coefficient values for all
model parameters. For instance, with respect to diabetes (the only one of the conditions for which PHE
estimates are available for CCGs), when using currently available PHE prevalence estimates, an initial ‘need
estimate only’ % R2 value of 58.9% rises to 67.3% once ‘Asian’, ‘pop < 50’ and ‘IMD’ factors are included
in the model. In this case the parameter coefficients suggest that QOF registration was higher than
expected in PCTs serving more deprived populations (with higher IMD scores) and with a higher
percentage of people of Asian or British Asian ethnicity, and lower than might have been expected in PCTs
with younger populations.
This can be compared with the model based on Plymouth estimates, which explains a somewhat larger
75.1% of the variation in PCT-level QOF registration rates and, crucially, incorporates a somewhat different
set of parameter estimates in the final predictive model. The effect of deprivation (IMD) disappears, although
rates remain higher than expected in PCTs serving populations with a higher percentage of people of Asian
ethnicity, and lower than expected in PCTs serving younger populations. There is now also some evidence of
relative under-registration in PCTs with a higher percentage of people of black or black British ethnicity.
TABLE 18 Explaining PCT-level variation in QOF registration rates using PHE and Plymouth needs indicators
Condition
Need estimate only
Full linear regression model predicting utilisation
% R2
Significant coefficients (standardised)
R % R2 Need Asian Black Pop < 50 IMD Rural
Diabetes 2012–13 CCGs (n= 211)
(a) PHE estimates 0.763 58.0 67.3 0.386 0.307 – –0.595 0.419 –
(b) Plymouth estimates 0.804 64.5 75.1 0.720 0.463 –0.112 –0.239 – –
CHD 2011/12 PCTs (n= 151)
(a) PHE estimates 0.768 58.7 87.4 –0.212 – –0.310 –1.071 0.634 –0.105
(b) Plymouth estimates 0.930 86.3 89.6 0.734 0.106 –0.192 –0.160 – –
Hypertension 2011–12 PCTs (n= 151)
(a) PHE estimates 0.889 78.9 86.4 – 0.092 0.117 –1.281 0.293 –0.170
(b) Plymouth estimates 0.931 86.6 89.3 1.359 – 0.113 0.286 – –0.114
Stroke 2011–12 PCTs (n= 151)
(a) PHE estimates 0.724 52.4 90.6 –0.122 –0.083 –0.189 –0.975 0.404 –
(b) Plymouth estimates 0.935 87.4 90.4 0.273 –0.075 –0.154 –0.588 0.213 –
Pop, population.
Model-based estimates of the PCT-level prevalence of CHD, hypertension and stroke are disseminated by PHE.479 Updated
CCG-level modelled estimates for diabetes have been produced by the National Diabetes Information Service and are
available via PHE’s National Cardiovascular Intelligence Network website.480
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There is much to glean from this table, but two sets of interrelated observations stand out. First, the
Plymouth need estimates are always better predictors of variations in QOF registration rates than the PHE
estimates and, moreover, whereas the former are generally incorporated as the most important factor in
the linear regression model, the PHE need estimates behave erratically. The PHE need estimate is thus
excluded from the hypertension model, and incorporated as a negative parameter in both the CHD and
the stroke models. Second, although the final linear regression models tend to explain a similar amount of
the variation of PCT-level QOF registration rates, the factors included in the models do differ. Most
significantly, deprivation is always incorporated as a positive factor in the PHE models, but appears in only
one of the Plymouth models (for stroke). The point here is that if, as seems extremely likely, the PHE
estimates fail to fully capture variations in the underlying prevalence of these four conditions, then little
can be concluded from any analysis of variations in use relative to need. In this case, for instance, the
apparent relatively higher-than-expected rates of QOF registration in areas of high deprivation are almost
certainly spurious.
In contrast, using the Plymouth estimates offers a very much more satisfactory explanation of variations in
QOF registration rates across all four conditions. In particular, the fact that one gets consistently large and
positive standardised ‘need’ parameter values and, conversely, almost invariably much smaller parameter
values associated with all other parameters except ‘pop < 50’ is strongly suggestive of measures which
genuinely capture variations in underlying morbidity.
There is every reason, therefore, to believe that these needs indicators can be used to study variations in
access to, and uptake of, health services relative to need. This is the subject of Variations in the use of
cardiovascular care relative to need, though it should be noted that the foregoing discussion also serves to
demonstrate the intrinsic value of the estimates to the public health community and commissioners of local
NHS services. With precisely the same methodology being used to produce prevalence rates for a wide
range of geographical and organisational units (LSOAs, MSOAs, upper- and lower-tier LAs, regions,
general practices, PCTs, CCGs and SHAs), many of which are to be made available via PHE’s Local Health
website (www.localhealth.org.uk/), these prevalence rates constitute a robust evidence base for future
investigations into health service equity at a variety of scales and using a variety of measures of service use,
performance and outcomes.
Conclusion
This part of the chapter has been primarily concerned with (a) identifying which of the range of prevalence
rates available for diabetes, CHD, hypertension and stroke should be used as needs indicators, and
(b) establishing whether or not there is prima facie evidence that the selected indicators are sufficiently
robust and unbiased to provide a suitable basis for assessing variations in health service utilisation relative
to need. As noted in The lack of a gold standard, in one sense the latter is an impossible goal, as there can
be no definitive empirical proof that the modelled estimates accurately describe variations in the underlying
morbidity of populations. Nevertheless, the extent to which variations in the number of patients on the
various QOF registers are so strongly related to estimates of the underlying number of people with relevant
conditions lends some initial support to the veracity of the estimates.
The count-based correlations and associated R2 statistics considered above are, however, of only limited
utility to this study. The overwhelming significance of the relative size of different PCTs and practices on
the number of people who are QOF registered (or who utilise other health services) means they impart an
impression of strength of association which is not matched when rates, rather than counts, are compared.
Standard measures of inequality such as the Gini coefficient (or, for that matter, other measures, such as
the Theill and Atkinson Indices which similarly aim to describe how an outcome, such as use of health-care
services, is distributed between cohorts481–484) are also of only limited analytical utility.
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In terms of Gini coefficients, access to primary health care at PCT level (as measured by QOF registration
relative to our condition-specific needs estimates) appears very equitable. With a scale that runs from 0
(complete equality) to 1 (complete inequality), the coefficients for diabetes, CHD, hypertension and stroke
are 0.0497, 0.0884, 0.0358 and 0.0549, respectively. Indeed, in each case the ‘Lorenz curve’, which plots
the cumulative proportion of PCT-level QOF registrations against the cumulative number of people in PCTs
estimated to have each condition, is very close to the 45° ‘line of equality’. As might be expected, greater
inequalities of access to primary health care is apparent at practice level, with Gini coefficients for diabetes,
CHD, hypertension and stroke of 0.1105, 0.1290, 0.0948 and 0.1393, respectively.
Gini coefficients and associated plots of health-care inequality (using Lorenz curves) can thus be used to
illustrate how, in general terms, equity of use relative to estimated need varies between different
conditions (Figure 4) or, for each condition, between different stages of the care pathway (Figure 5), but
this does not help us to understand the sociodemographic dimensions of inequalities. To that end
‘concentration indices’ have often been used which, in the present context, would describe the extent to
which inequalities in use-to-need ratios are associated with particular factors,483,485 generating, for instance,
measures of ‘deprivation-related’ health-care inequality or ‘age-related’ health-care inequality. Our
preferred approach, however, has been to utilise regression models to isolate and quantify the
independent effect of the different factors, that is, once the role of other factors in predicting variations in





































































FIGURE 5 Condition-specific inequality (Lorenz) curves for QOF registrations and prescribing and secondary
programme budget expenditure. (a) Diabetes; (b) CHD; (c) hypertension; and (d) stroke. (continued )
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FIGURE 5 Condition-specific inequality (Lorenz) curves for QOF registrations and prescribing and secondary
programme budget expenditure. (a) Diabetes; (b) CHD; (c) hypertension; and (d) stroke.
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Thus, in the next section, which turns to consider evidence of equity with respect to the uptake of services
associated with the care of patients with diabetes, CHD, hypertension and stroke, we examine how
per-capita QOF registration rates, along with other per-capita utilisation rates, compare with per-capita
estimates of underlying morbidity. Linear regression modelling is used to establish whether measures
summarising the age composition, ethnicity, deprivation or rurality (a systematic as opposed to random
measure of geography) of practices and PCTs can account for any of the variation in the relationship
between estimated service need and recorded service use. An important aspect of this modelling is to
construct a coherent and convincing narrative which demonstrates that the modelled estimates capture as
much as possible of any systematic sociodemographic and spatial variation in underlying morbidity,
ensuring that any remaining unexplained variation in the relationship between use and needs is
attributable to patterns of unmet need rather than to inadequacies in the underlying need estimates.
This is crucial to the entire project, as any systematic failure of the needs indicator will result in spurious
relationships between use and need.
Variations in the use of cardiovascular care relative to need
Introduction
As noted in Chapter 1 (see Implications for research), in order to capture the possibility that inequalities in
access and use occur in different ways at different stages of the care pathway, we have explored evidence
with respect to presentation, primary management and secondary management (Table 19). For each of the
disease conditions under consideration, variations in presentation are explored by examining variations in
QOF-recorded prevalence relative to modelled prevalence. Primary management is measured by examining
rates of prescribing and Programme Budget Category (PBC) expenditure on prescribing.486 British National
TABLE 19 Utilisation indicators for diabetes and cardiovascular care




Prescribing of diabetic use drugs;
insulin; other anti-diabetic drugs
PBC prescribing (£) for diabetes
Hospital admission for diabetes: any
diagnosis; main diagnosis; main diagnosis for
emergency admission
PBC diabetes secondary (£)
CHD QOF-registered
CHD (2011–12)
Prescribing of ACE inhibitors; aspirin;
beta-blockers; bendroflumethiazide;
lipid-lowering drugs; statins
PBC prescribing (£) for CHD
Hospital admission for angina or acute MI:
any diagnosis; main diagnosis; main
diagnosis for emergency admission
Hospital admission for CABG procedure:
main admission; emergency admission
Hospital admission for PCI: main admission;
emergency admission




Prescribing of ACE inhibitors; ARBs;
calcium channel blockers; thiazide
diuretics
PBC prescribing (£) for problems of
circulation; CHD; cerebrovascular;
other circulation
Hospital admission for hypertension: any
diagnosis; main diagnosis; main diagnosis for
emergency admission
PBC secondary (£) for problems of





Prescribing of oral anticoagulants;
antiplatelets; warfarin
PBC prescribing (£) for
cerebrovascular
Hospital admission (stroke as main diagnosis)
Emergency admission (stroke as main
diagnosis)
PBC cerebrovascular secondary (£)
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Formulary (BNF)487 codes for drugs examined in each category are listed in Tables 20–23. Finally, variations
in secondary management are examined with respect to elective and emergency admissions, the utilisation
of specific procedures, and PBC secondary expenditure.
Variations in use relative to need: diabetes
Diabetes has been included in the study for reasons outlined in Chapter 1 (see Aims and objectives), not
least because it is an important risk factor for CHD, hypertension and stroke. Table 20 shows the results of
full linear regression modelling to predict per-capita service use for diabetes at PCT level, and Table 21
predictions at general practice level (n= 6984). The ‘need’ parameter is the estimated per-capita rate of
diabetes, using the LSI definition. The first thing to note is that, taken on its own, the underlying
prevalence of diabetes explains 62.1% of the variation of PCT-level QOF registration rates, suggesting that
a good deal of the variation in presentation can be explained by underlying need. As might be expected,
the percentage of variation that is predicted at practice level is smaller (44.5%).
Although underlying prevalence accounts for the greater proportion of presentation relative to need at
both PCT and practice levels, additional factors increase the variance explained (to 75.6% between PCTs
and 57.6% between practices). As indicated by the standardised coefficients given in Table 20, both the
proportion of people of Asian or British Asian ethnicity and the percentage of people under the age of
50 years contribute to the explanation of variations in PCT-level QOF registration rates. At practice level
(see Table 21), diabetes registration is also significantly higher than one might expect among Asian
populations. However, registrations are also higher in deprived and rural communities, and lower in
practices with larger percentages of black populations.




Full linear regression model predicting utilisation
% R2
Significant coefficients (standardised)
R % R2 Need Asian Black Pop < 50 IMD Rural
QOF register 2011–12 0.789 62.1 75.6 0.623 0.559 – –0.394 – –
Prescribing
Diabetic use (NIC) 0.674 45.0 60.1 0.239 0.643 – –0.758 0.302 –
Insulin (NIC) 0.574 32.5 49.7 0.531 0.335 –0.451 – – 0.174
Other antidiabetic (NIC) 0.546 29.3 45.4 0.506 0.406 – – – –
PBC prescribing expenditure486
Diabetes 0.612 37.0 51.4 0.562 0.461 –0.154 – – –
Diabetes (ICD-10: E10–14) patients488
Any diagnosis; all patients 0.718 51.2 63.8 0.690 0.139 –0.452 – 0.310 –0.0194
Main diagnosis; all patients 0.331 10.4 18.0 0.195 –0.285 – – – –
Main diagnosis; emergency 0.504 25.4 45.6 0.277 –0.284 – – 0.477 –0.168
PBC secondary expenditure486
Diabetes 0.123 – 27.8 – –0.241 0.451 – 0.345 –
ICD-10, International Classification of Diseases, Tenth Edition; NIC, net ingredient cost; pop, population.
Stepwise parameter selection used to identify significant linear predictors of per-capita utilisation. The ‘need’ parameter is
the number with the disease (estimated as described in the text) as a per-capita rate.
Prescription data extracted from GP-level monthly presentation data489 [search terms in square brackets):
l diabetic use: BNF 6.1 [0601]
l insulin: BNF 6.1.1 [060101]
l other antidiabetic drugs: BNF 6.1.2 [060102].
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As one moves up the care pathway, the percentage of variance that can be explained by either estimated
prevalence or additional factors falls. With respect to diabetic prescribing items, for example, < 50% of the
variation at PCT level can be explained by underlying need alone. However, once additional variables are
factored in, prediction improves [e.g. to 60.1% for PCT-level variations in prescribing of diabetic drugs
(BNF 6.1487)]. Prediction is far poorer at practice level (25.9% for diabetic drugs). Again, significantly higher
rates of prescribing among Asian populations appear to play an important role in improving explanation of
overall variance. Here, however, additional factors emerge as explanatory variables. Prescribing rates are
significantly higher in deprived and rural communities, and lower in practices with larger percentages of
black populations. However, younger communities continue to appear to be underserved, albeit with
mixed results, with practices with a higher percentage of adults under the age of 50 years being less likely
to prescribe diabetic drugs (BNF 6.1487) and other antidiabetic drugs (BNF 6.1.2487) but more likely to
prescribe insulin (BNF 6.1.1487). It is important to note that, although these coefficients are significant
(i.e. p< 0.05), their contribution, compared with underlying need, is small.
With regard to secondary care, the direction of some of these coefficients changes. Importantly, PCTs and
practices with a higher percentage of Asian populations now have lower-than-expected rates of admission
(elective and emergency) for a main diagnosis of diabetes and lower PBC expenditure on the disease. By
contrast, PCTs with a higher percentage of black populations have higher PBC expenditure on hospital
care (data available at PCT level only). This suggests that relative mix of care may be a key factor in
understanding variations in the appropriateness of NHS care provided. High rates of presentation and
prescribing among Asian populations and lower-than-expected rates of secondary care suggest that,
among this population, diabetes may be better managed within primary and community settings than
among other population groups. Against this, more deprived PCTs and practices have higher-than-
expected rates of both prescribing and secondary care (particularly with respect to emergency admission
for diabetes as a main diagnosis); and PCTs and practices with higher black populations have lower
utilisation rates than expected in both primary and secondary care.




Full linear regression model predicting utilisation
% R2
Significant coefficients (standardised)
R % R2 Need Asian Black Pop < 50 IMD Rural
QOF register 2011–12 0.667 44.5 57.6 0.604 0.391 –0.128 – 0.089 0.062
Prescribing
Diabetic use (NIC) 0.509 25.9 37.7 0.366 0.344 –0.194 –0.077 0.243 0.084
Insulin (NIC) 0.424 17.9 25.8 0.437 0.127 –0.282 0.127 0.165 0.138
Other antidiabetic (NIC) 0.416 17.3 33.6 0.183 0.427 –0.002 –0.191 0.273 –
Diabetes (ICD10: E10–14) patients488
Any diagnosis; all patients 0.668 44.6 52.6 0.590 0.156 –0.262 – 0.228 –
Main diagnosis; all patients 0.290 8.4 16.2 0.319 –0.186 –0.043 0.206 0.215 0.040
Main diagnosis; emergency 0.255 6.5 18.9 0.264 –0.142 –0.063 0.227 0.275 –
ICD-10, ICD-10, International Classification of Diseases, Tenth Edition; NIC, net ingredient cost.; pop, population.
Stepwise parameter selection used to identify significant linear predictors of per-capita utilisation. The ‘need’ parameter is
the number with the disease (estimated as described in the text) as a per-capita rate.
Prescription data extracted from GP-level monthly presentation data489 [search terms in square-brackets]:
l diabetic use: BNF 6.1 [0601]
l insulin: BNF 6.1.1 [060101]
l other antidiabetic drugs: BNF 6.1.2 [060102].
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Finally, it is worth pointing out that, although full linear regression modelling can throw light on variations
in access and use according to population characteristics, a significant percentage of variation remains
unexplained. This may be indicative of random variation (i.e. a ‘postcode lottery’). However, as we explore
with respect to CHD, systematic regional differences in use relative to need may complicate the picture.
This is discussed in the following section.
Variations in use relative to need: coronary heart disease
Variations in the presentation of coronary heart disease
At the PCT level, estimated prevalence of CHD (based on the clinical evidence definition) explains a very
high percentage (86.3%) of variations in QOF registrations (Table 22). Once additional factors are
accounted for, 89.6% of variance can be explained. At practice level (n= 7848), variance explained by
underlying need (65.4%) increases to 70.5% in the full linear regression model (Table 23). Again,
registration (relative to need) is significantly higher than one might expect among Asian populations and
significantly lower in PCTs with higher percentages of black and younger populations at both scales of
analysis. These results correspond with those of several published studies that note significantly higher
levels of presentation among South Asians227,233 and lower CHD QOF registrations than expected among
younger people.222,233 The lack of evidence on socioeconomic differences in registration also accord with
the rather mixed findings reported in Chapter 2 (see Variations in access to and use of cardiovascular care
in England: what does the evidence tell us? and The direction of inequality, Presentation of cardiovascular
problems), some studies finding that the gap between modelled and registered prevalence was higher
among practices in more deprived areas224 and others finding that people from less advantaged
communities are more likely to present to, for example CHD risk-screening programmes.225,228 We have not
found published evidence that suggests that black populations are less likely to present for CHD.
Variations in the primary management of coronary heart disease
The modelled needs estimates explain far less of the variance in primary management at practice level than
at PCT level (e.g. 69.7% and 28.9%, respectively, of variation in prescribing of ACE inhibitors). Again,
prescribing data at both scales of analysis suggest higher-than-expected rates among Asian populations
and lower-than-expected rates (with the exception of beta-blockers and bendroflumethiazide) among
younger and black populations, though it is important to note that these additional factors explain a
relatively small proportion of overall variance. Variations in prescribing according to deprivation and rurality
are mixed. Practices serving more deprived populations prescribe less bendroflumethiazide than expected
but more lipid-lowering drugs, including statins, while practices serving rural populations prescribe
higher-than-expected levels of bendroflumethiazide and aspirin, but lower levels of beta-blockers,
lipid-lowering drugs and statins.
Again, these findings accord with those of some but not all published studies (see Chapter 2, Variations in
access to and use of cardiovascular care in England: what does the evidence tell us? and The direction of
inequality, Primary management of cardiovascular disease). Equal or better primary management of CHD
for South Asian populations has been reported in several studies,144,198,229,253,258,279,281 as have lower rates of
prescribing among black populations.241,258 The findings of published studies on variations in primary
management by socioeconomic status are, like our own results, mixed, with some finding lower
prescribing rates among deprived populations233,252,253,262,263 and others finding no difference or a positive
association in prescribing and referral rates by social deprivation.144,241,256,258,264,266,267 Our finding that
practices serving younger populations have significantly lower prescribing rates for CHD drugs than
expected does conflict with the results of published studies, which report consistent evidence that rates of
CHD prescribing are lower than expected among older people.191,192,195,252,253,258,272,273,275
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Full linear regression model predicting utilisation
% R2
Significant coefficients (standardised)
R % R2 Need Asian Black Pop < 50 IMD Rural
QOF register 2011–12 0.930 86.3 89.6 0.734 0.106 –0.192 –0.160 – –
Prescribing
ACE inhibitors (NIC) 0.836 69.7 75.6 0.575 0.146 – –0.444 – –
Aspirin (NIC) 0.912 83.0 86.5 0.745 0.194 –0.117 –0.250 – –
Beta-blockers (NIC) 0.869 75.3 79.7 0.790 – –0.142 –0.136 –
Bendroflumethiazide (NIC) 0.773 59.5 66.6 0.538 – – –0.248 – 0.142
Lipid-lowering drugs (NIC) 0.654 42.4 45.0 0.527 – – –0.281 – –0.273
Statins (NIC) 0.659 43.1 43.1 0.659 – – – – –
PBC prescribing expenditure486
CHD 0.628 39.0 42.7 0.696 – – – – –0.212
Angina or acute MI (ICD-10: I20–21) patients (main diagnosis)488
Any admissions 0.805 64.6 64.6 0.805 – – – – –
Emergency admissions 0.821 67.3 67.3 0.821 – – – – –
CABG (OPCS-4 operation codes K40–46) patients490
Any admissions 0.593 34.8 40.4 0.430 0.279 – –0.412 – –
Emergency admissions 0.200 4.0 5.9 – – –0.188 – 0.68 –
PCI (OPCS-4 operation codes K49–50, K75) patients490
Any admissions 0.543 35.2 42.4 0.242 0.361 – –0.649 – –
Emergency admissions 0.326 10.0 12.4 0.437 0.206 – – – –
PBC secondary expenditure486
CHD –0.013 – – – – – – – –
ICD-10, International Classification of Diseases, Tenth Edition; NIC, net ingredient cost; OPCS-4, Office of Population
Censuses and Surveys Classification of Interventions and Procedures version 4; pop, population.
Stepwise parameter selection used to identify significant linear predictors of per-capita utilisation. The ‘need’ parameter is
the number with the disease (estimated as described in the text) as a per-capita rate.
Prescription data extracted from GP-level monthly presentation data489 [search terms in square-brackets]:
l ACE inhibitors: BNF 2.5.5.1 [0205051]
l aspirin: [0209000A0]
l beta-blockers: BNF 2.4 [0204]
l bendroflumethiazide: 0202010B0
l lipid-lowering drugs: BNF 2.12 [0212]
l statins – following Fleetcroft,252 comprises atorvastatin [0212000B0], fluvastatin [0212000M0], pravastatin
[0212000X0], rosuvastatin [0212000AA], simvastatin [0212000Y0] and simvastatin and ezetimibe [0212000AC].
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Variations in the secondary management of coronary heart disease
With respect to secondary management of CHD, the percentage of variance explained by both underlying
need and the full model falls away significantly. This is likely to reflect the fact that ‘within-system’
management is a more important determinant of need for specialist CHD services than underlying
prevalence. However, in contrast to our findings on diabetes, significantly higher rates of presentation
and prescribing in South Asian populations are not accompanied by lower rates of inpatient use. Practices with
high South Asian populations have higher-than-expected rates of admissions for CABG and PCI, the latter on
an elective and emergency basis. This corresponds with the results of several studies that find higher cardiac
procedure rates among South Asian populations,144,217,295,307,310 although some studies suggest lower rates
of use relative to need,306 particularly for cardiac rehabilitation297,309 (which we do not have data for).




Full linear regression model predicting utilisation
% R2
Significant coefficients (standardised)
R % R2 Need Asian Black Pop < 50 IMD Rural
QOF register 2011–12 0.809 65.4 70.5 0.680 0.102 –0.219 –0.117 – –
Prescribing
ACE inhibitors (NIC) 0.538 28.9 30.8 0.403 0.059 – –0.217 – –
Aspirin (NIC) 0.752 56.6 61.2 0.647 0.195 –0.115 –0.177 – 0.058
Beta-blockers (NIC) 0.672 45.1 51.0 0.433 – –0.161 –0.258 – –0.070
Bendroflumethiazide (NIC) 0.534 28.5 32.8 0.497 – 0.063 –0.101 –0.132 0.059
Lipid-lowering drugs (NIC) 0.535 28.6 32.2 0.140 0.059 –0.084 –0.525 0.200 –0.166
Statins (NIC) 0.534 28.5 31.9 0.117 0.065 –0.076 –0.550 0.225 –0.137
Angina or acute MI (ICD-10: I20–21) patients (main diagnosis)488
Any admissions 0.620 38.4 42.1 0.596 0.171 –0.163 – 0.084 0.083
Emergency admissions 0.614 37.7 41.6 0.597 0.182 –0.168 – 0.080 0.066
CABG (OPCS-4 operation codes K40–46) patients490
Any admissions 0.291 8.5 12.6 0.376 0.156 – – –0.197 0.067
Emergency admissions 0.077 0.6 0.8 0.118 0.030 0.031 – –0.055 –0.037
PCI (OPCS-4 operation codes K49–50, K75) patients490
Any admissions 0.206 4.2 15.7 0.326 0.228 0.154 –0.069 –0.280 0.166
Emergency admissions 0.245 6.0 8.6 0.153 0.155 – –0.205 – 0.031
ICD-10, International Classification of Diseases, Tenth Edition; NIC, net ingredient cost; OPCS, Office of Population
Censuses and Surveys Classification of Interventions and Procedures version 4; pop, population.
Stepwise parameter selection used to identify significant linear predictors of per-capita utilisation. The ‘need’ parameter is
the number with the disease (estimated as described in the text) as a per-capita rate.
Prescription data extracted from GP-level monthly presentation data489 [search terms in square-brackets]:
l ACE inhibitors: BNF 2.5.5.1 [0205051]
l aspirin: [0209000A0]
l beta-blockers: BNF 2.4 [0204]
l bendroflumethiazide: 0202010B0
l lipid-lowering drugs: BNF 2.12 [0212]
l statins: following Fleetcroft,252 comprises atorvastatin [0212000B0], fluvastatin [0212000M0], pravastatin [0212000X0],
rosuvastatin [0212000AA], simvastatin [0212000Y0] and simvastatin and ezetimibe [0212000AC].
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In other respects, we have very little evidence of systematic bias in the secondary management of CHD.
Practices serving deprived populations have higher-than-expected rates of emergency admissions for
CABG, a trend that has been previously observed,245,259,265 although it is important to note that such studies
find that there is little evidence to suggest that the clinical quality of primary care plays a role in this.
Again, practices serving younger populations have lower-than-expected rates of elective CABGs and PCIs,
a finding that is difficult to square with the results of published studies that suggest that older patients are
more likely to be discriminated against with respect to revascularisation.243,335,337,342,346 This could reflect
differences in clinical need, with community and/or primary management being more appropriate and
effective among younger patients (it is important to note that the modelled estimate is of underlying
prevalence of CHD in the community).
As Hospital Episode Statistics (HES) provide the age and sex of patients (unlike QOF registration and
prescribing data), it is possible to explore some of these contradictions (Table 24), although the results are
difficult to interpret. First, with the exception of PCI among males, underlying need appears to account for
greater variance in younger age cohorts than older cohorts. As a higher correlation (% R2) between need
and utilisation implies that utilisation is more ‘equitable’ (insofar as a greater proportion of the variation in
rates of use is ‘explained’ by variations in underlying need), this may indicate a greater disconnect between
disease prevalence and secondary use of cardiac care at older ages.




Full linear regression model predicting utilisation
% R2
Significant coefficients (standardised)
R % R2 Need Asian Black IMD Rural
Acute MI/angina patients
Males, 50–64 years 0.507 25.2 41.1 0.574 0.511 –0.338 NS NS
Males, 65–74 years 0.416 17.3 25.7 NS NS NS 0.512 NS
Males, ≥ 75 years 0.417 16.8 19.5 0.518 0.206 NS NS NS
Females, 50–64 years 0.532 28.3 40.7 0.394 NS –0.355 0.335 NS
Females, 65–74 years 0.549 30.1 42.6 0.504 NS –0.370 0.260 NS
Females, ≥ 75 years 0.243 5.3 20.1 0.524 0.240 –0.304 NS NS
CABG patients
Males, 50–64 years 0.178 3.2 21.7 NS 0.377 –0.280 0.319 NS
Males, 65–74 years 0.108 1.2 7.1 0.199 0.283 NS NS NS
Males, ≥ 75 years 0.186 0.0 NS NS NS NS NS NS
Females, 50–64 years 0.598 35.8 36.7 0.474 0.182 NS NS NS
Females, 65–74 years 0.444 19.2 19.2 0.444 NS NS NS NS
Females, ≥ 75 years 0.117 1.4 NS NS NS NS NS NS
PCI patients
Males, 50–64 years 0.210 4.4 24.0 NS 0.377 –0.280 0.324 NS
Males, 65–74 years –0.292 8.5 16.4 –0.192 0.316 NS NS NS
Males, ≥ 75 years –0.430 18.0 18.0 –0.430 NS NS NS NS
Females, 50–64 years 0.562 31.6 40.5 NS NS –0.202 0.685 NS
Females, 65–74 years 0.401 15.5 15.5 0.401 NS NS NS NS
Females, ≥ 75 years 0.138 1.9 8.2 NS 0.296 NS NS NS
NS, not significant.
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For younger women, rates of admission for angina (aged 50–64 and 65–74 years) are higher than expected
in deprived areas, as are rates of PCI among women aged 50–64 years. Admissions for angina/acute MI,
CABG and PCI are lower than expected for younger black men (aged 50–64 years). Black women of all ages
have lower-than-expected rates of angina/MI admissions, and younger black women (aged 50–64 years)
have lower-than-expected admissions for PCI. Finally, Asian men under the age of 74 years have
higher-than-expected rates of CABG and PCI, while the pattern for Asian women is more mixed.
Is there a ‘geography’ to variations in cardiac care?
As noted above, although the modelled estimates predict a good proportion of variance, particularly at
earlier stages of the care pathway, a significant percentage of variation remains unexplained. Although this
may be indicative of random variations in medical practice, we propose that there may also be regional
variations in utilisation relative to need, which cannot be explained by their compositional
(i.e. socioeconomic, sociodemographic and ethnic) characteristics.
Maps of QOF registrations (Figure 6), PBC prescribing (Figure 7), PBC secondary expenditure (Figure 8) and
total CHD expenditure (Figure 9) by expected CHD case suggest that the North East has relatively high
levels of use of cardiac care, as do parts of the South East and South Central regions. By contrast, the East
of England, South West and East and West Midlands have relatively low levels of use. Interestingly,
FIGURE 6 Map of QOF CHD registrations72 per expected CHD case. Contains Ordnance Survey data © Crown
copyright and database right 2012.
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FIGURE 7 Map of PBC CHD prescribing expenditure486 per expected CHD case. Contains Ordnance Survey data ©
Crown copyright and database right 2012.
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FIGURE 8 Map of PBC CHD secondary expenditure486 per expected CHD case. Contains Ordnance Survey data ©
Crown copyright and database right 2012.
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although rurality did not emerge as a significant factor explaining variation in use relative to need, several
‘shires’ (Shropshire, Herefordshire, Worcestershire, Warwickshire, Leicestershire, Northamptonshire,
Staffordshire, Derbyshire, Norfolk and Devon) have lower levels of CHD expenditure than expected by their
caseloads. This does not appear to be explained by higher levels of prescribing, which might be expected
to reduce levels of secondary use in these areas (see Figure 4).
One factor that may be worth further investigation is the role of per-capita funding. Referring back to
Table 1, which compared allocations for PCTs with the youngest and the oldest demographies, it is worth
noting that, apart from North Staffordshire and Devon (which, respectively, received per capita allocations
of £1614 and £1506 in 2010–11), all of the shires listed above received < £1500 per head for their
Hospital and Community Health Services. By comparison, all of the PCTs (n= 12) in the North East SHA,
12 of 14 in Yorkshire and the Humber, 23 of 24 in the North West, 6 of 8 in the South East, and 30 of 31
in London received higher funding allocations.
FIGURE 9 Map of PBC CHD total expenditure486 per expected CHD case. Contains Ordnance Survey data © Crown
copyright and database right 2012.
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Variations in use relative to need: hypertension
Variations in the presentation of hypertension
At the PCT level, estimated prevalence of hypertension (based on the clinical evidence definition) explains a very
high percentage (86.6%) of variations in QOF registrations (Table 25). Once additional factors are accounted
for, prediction increases to 89.3% of explained variance. At practice level (n= 7848), variance in presentation
explained by underlying need (56.1%) increases to 57.6% in the full linear regression model (Table 26).
Of the factors that yield significant standardised coefficients at the PCT and practice levels, underlying
need accounts for most explainable variation in presentation. Smaller but significant coefficients are found
for percentage of black population and percentage of population aged < 50 years, both of which are
associated with higher presentation rates than expected. Presentation of hypertension in more rural PCTs
and practices is significantly lower than expected, although again the coefficients are small.




Full linear regression model predicting utilisation
% R2
Significant coefficients (standardised)
R % R2 Need Asian Black Pop < 50 IMD Rural
QOF register 2011–12 0.931 86.6 89.3 1.359 – 0.113 0.286 – –0.114
Prescribing
ACE inhibitors NIC 0.852 72.5 76.2 0.971 – – – 0.133 –0.134
ARBs NIC 0.630 39.3 39.3 0.630 – – – – –
Calcium channel NIC 0.842 70.7 75.6 0.912 – – – 0.235 –
Thiazide diuretics NIC 0.747 55.5 58.1 0.937 – 0.256 – – –
PBC prescribing expenditure486
Problems of circulation 0.766 58.4 68.3 0.947 – – – 0.228 –0.191
CHD 0.566 31.6 46.5 0.634 – –0.207 – 0.282 –0.232
Cerebrovascular 0.673 44.7 61.6 0.550 – –0.332 – 0.416 –
Other circulation 0.876 76.5 81.1 0.987 – – – 0.117 –0.99
Hypertensive disease (ICD-10: I10–13, I15) patients488
Any diagnosis/all admissions 0.706 49.5 57.8 0.920 – – – – –0.363
Main diagnosis/all admissions 0.096 – 22.3 0.546 – 0.313 – 0.311 –0.211
Main diagnosis/emergency –0.132 – 22.0 – – – – 0.475 –
PBC secondary expenditure486
Problems of circulation 0.461 20.7 25.9 0.701 0.188 – – – –0.214
CHD 0.152 – – – – – – – –
Cerebrovascular 0.343 11.2 11.2 0.343 – – – – –
Other circulation 0.215 – 12.4 – – – –0.343 0.383 –
ICD-10, International Classification of Diseases, Tenth Edition; NIC, net ingredient cost; pop, population.
Stepwise parameter selection used to identify significant linear predictors of per-capita utilisation. The ‘need’ parameter is
the number with the disease (estimated as described in the text) as a per-capita rate.
Prescription data extracted from GP-level monthly presentation data489 [search terms in square-brackets]:
l ACE inhibitors (all): BNF 2.5.5.1 [0205051]
l ARBs: BNF 2.5.5.2 [0205052]
l calcium channel blockers: BNF 2.6.2 [020602]
l thiazide diuretics: BNF 2.2.1 [020201].
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Variations in the primary management of hypertension
Different patterns of primary management are observed among Asian populations for hypertension from
those for diabetes and CHD. At the practice level of analysis, prescribing rates of calcium channel blockers
and thiazide diuretics are lower than expected, although Asian populations receive higher than expected
rates of ARBs and the standardised coefficient for ACE inhibitors does not reach significance. The findings
for black populations are mixed, with lower-than-expected rates of prescribing of ACE inhibitors being
found, against higher-than-expected rates of thiazide diuretics. Results in the published literature on the
primary management of hypertension are also mixed (although most studies focus on blood pressure
monitoring rather than prescribing). For example, Schofield et al.283 found that, although blood pressure
monitoring was similar across ethnic groups and as good, if not better, for black patients as for white,
blood pressure control was poor in Caribbean patients with CHD. Similarly, Lee et al.280 noted statistically
significant short-term reduction in systolic BP in white and black but not in south Asian patients with
hypertension. By contrast, Nazroo et al.198 observed no ethnic inequalities for the clinical outcomes of care
for hypertension, while Ashworth et al.243 report that practices performing less well in terms of blood
pressure monitoring were those with higher proportions of black or black British residents in the
local population.
With respect to deprivation, both the PCT- and practice-level analyses find higher rates of ACE inhibitor
and thiazide diuretics than expected in deprived populations. PBC expenditure is also higher in more
deprived PCTs. Although this conflicts with earlier studies,243 others have noted a reduction in the
socioeconomic gap in the quality of primary care for CVD over time.247,248,250 Thus, the results do not
challenge expectations. More surprising, perhaps, is our finding that, in more rural practices, levels of
prescribing of hypertensive drugs (ACE inhibitors, ARBs and thiazide diuretics) are lower than expected.




Full linear regression model predicting utilisation
% R2
Significant coefficients (standardised)
R % R2 Need Asian Black Pop < 50 IMD Rural
QOF register 2011–12 0.749 56.1 57.6 0.817 – 0.048 – 0.081 –0.052
Prescribing
ACE inhibitors NIC 0.531 28.2 30.4 0.404 – –0.059 –0.172 0.192 –0.034
ARBs NIC 0.472 22.5 24.5 0.090 0.146 – –0.493 – –0.054
Calcium channel NIC 0.615 37.8 39.8 0.541 –0.049 – –0.106 0.177 –
Thiazide diuretics NIC 0.475 22.6 23.5 0.525 –0.042 0.107 – – –0.035
Hypertensive disease (ICD10: I10–13, I15) patients488
Any diagnosis/all admissions 0.713 50.9 57.1 0.921 – –0.039 0.134 0.162 –0.130
Main diagnosis/all admissions 0.089 0.8 11.9 0.163 0.092 0.136 –0.140 0.250 –0.069
Main diagnosis/emergency 0.012 – 7.5 0.186 0.070 0.143 0.140 – –0.078
ICD-10, International Classification of Diseases, Tenth Edition; NIC, net ingredient cost; pop, population.
Stepwise parameter selection used to identify significant linear predictors of per-capita utilisation. The ‘need’ parameter is
the number with the disease (estimated as described in the text) as a per-capita rate.
Prescription data extracted from GP-level monthly presentation data489 [search terms in square-brackets]:
l ACE inhibitors (all): BNF 2.5.5.1 [0205051]
l ARBs: BNF 2.5.5.2 [0205052]
l calcium channel blockers: BNF 2.6.2 [020602]
l thiazide diuretics: BNF 2.2.1 [020201].
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Variations in the secondary management of hypertension
Hypertension does not tend to be ‘managed’ within the secondary care setting. Thus, it is not surprising
that admissions with the main diagnosis of hypertension are poorly explained by the needs estimates.
Interestingly, however, > 50% of variations in admissions where hypertensive disease is recorded in any
analysis can be explained by % R2. Although the coefficients are small, it is also worth noting that
emergency admissions (main diagnosis hypertensive disease) are significantly higher in practices with
higher Asian, black and young populations and lower in more rural practices.
Variations in use relative to need: stroke
At the PCT level, estimated prevalence of hypertension (based on the clinical evidence definition) explains a
very high percentage (87.4%) of variations in QOF registrations (Table 27). Once additional factors are
accounted for, prediction increases to 90.4% of explained variance. At practice level (n= 7839), variance in
presentation explained by underlying need (57.1%) increases to 60.1% in the full linear regression model
(Table 28).
Although stroke registration and prescribing at practice-level is higher than expected in more deprived
areas, younger age and ethnicity emerge as consistently significant coefficients of lower use. In this case,
both black and Asian populations appear to have lower QOF registrations and lower prescribing of oral
anticoagulants and warfarin than expected. Antiplatelet prescribing is also lower than expected among
black populations.




Full linear regression model predicting utilisation
% R2
Significant coefficients (standardised)
R % R2 Need Asian Black Pop < 50 IMD Rural
QOF register 2011–12 0.935 87.4 90.4 0.273 –0.075 –0.154 –0.588 0.213 –
Prescribing
Oral anticoagulants NIC 0.677 45.5 55.3 – –0.149 – –0.638 – –
Antiplatelets NIC 0.843 70.9 76.4 0.927 – – – 0.171 –0.118
Warfarin NIC 0.740 54.5 63.3 – –0.141 –0.186 –0.544 – –
PBC prescribing expenditure486
Cerebrovascular 0.493 24.1 46.0 – – –0.598 – –0.181 –
Stroke (ICD-10: I60–64) patients488
Main diagnosis all patients 0.916 83.8 86.2 0.338 – –0.680 – 0.244 –
Main diagnosis emergency 0.917 84.0 86.6 0.323 –0.083 –0.646 – 0.277 –
PBC secondary expenditure486
Cerebrovascular 0.810 65.4 69.8 0.497 – –0.493 – 0.292 –0.192
ICD-10, International Classification of Diseases, Tenth Edition; NIC, net ingredient cost; pop, population.
Stepwise parameter selection used to identify significant linear predictors of per-capita utilisation. The ‘need’ parameter is
the number with the disease (estimated as described in the text) as a per-capita rate.
Prescription data extracted from GP-level monthly presentation data489 [search terms in square-brackets]:
l oral anticoagulants: BNF 2.8.2 [020802]
l antiplatelets: BNF 2.9 [0209]
l warfarin: [0208020V0].
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Hospital admissions for stroke are also lower than expected for Asian and younger patients, although the
standardised coefficients for percentage black population do not reach significance. Again, admissions for
stroke are higher than expected among deprived practices. This finding conflicts with that of Chen et al.,287
who found that deprived patients had statistically significant reductions in odds of being admitted
to hospital.
Conclusion
As noted above, the higher the correlation (% R2) between underlying needs and utilisation, the greater
the proportion of the variation in per capita use that can be ‘explained’ by variations in per-capita need.
We interpret this to mean that the higher the percentage R2 statistic, the more ‘equitable’ the utilisation.
It is thus encouraging that variation in several indicators of use is largely explained by underlying need.
For example, the underlying prevalence of health-care needs explains (% R2) between 62.1% (diabetes)
and 87.4% (stroke) of the variation in PCT-level QOF registration rates and between 44.5% (diabetes) and
65.4% (CHD) of the variation in practice-level registrations. Full linear regression modelling (i.e. including
measures of deprivation, demography, Asian and black ethnicity and rurality) increases prediction to
between 75.6% (diabetes) and 90.4% (stroke) at PCT level and to between 57.6% (diabetes) and 70.5%
(CHD) at practice level. These are encouraging results.
As one moves up the care pathway, the percentage of variance that can be explained by either estimated
prevalence or additional factors declines, although at the PCT level, prediction (full model) exceeds 50%
for a number of use indicators, including drugs for diabetic use and PBC diabetic prescribing (diabetes);
ACE inhibitor, beta-blocker, aspirin and bendroflumethiazide prescribing (CHD) and admissions for main
diagnosis angina/acute MI (CHD); ACE inhibitor, calcium channel blockers, thiazide diuretic and PBC all
circulatory/cerebrovascular prescribing (hypertension); and oral anticoagulant, antiplatelet, warfarin and
PBC cerebrovascular prescribing as well as hospital admissions (stroke).




Full linear regression model predicting utilisation
% R2
Significant coefficients (standardised)
R % R2 Need Asian Black Pop < 50 IMD Rural
QOF register 2011–12 0.756 57.1 60.1 0.401 –0.087 –0.091 –0.314 0.130 0.036
Prescribing
Oral anticoagulants NIC 0.410 16.8 22.0 – –0.069 –0.056 –0.367 0.050 0.085
Antiplatelets NIC 0.622 38.6 43.4 0.399 – –0.078 –0.298 0.285 –0.083
Warfarin NIC 0.626 39.2 46.2 0.192 –0.113 –0.082 –0.366 0.032 0.059
Stroke (ICD-10: I60–64) patients488
Main diagnosis: all patients 0.647 41.9 43.2 0.377 –0.025 – –0.325 0.148 –
Main diagnosis: emergency 0.647 41.8 43.2 0.385 –0.030 – –0.313 0.151 –
ICD-10, International Classification of Diseases, Tenth Edition; NIC, net ingredient cost; pop, population.
Stepwise parameter selection used to identify significant linear predictors of per-capita utilisation. The ‘need’ parameter is
the number with the disease (estimated as described in the text) as a per-capita rate.
Prescription data extracted from GP-level monthly presentation data489 [search terms in square-brackets]:
l oral anticoagulants: BNF 2.8.2 [020802]
l antiplatelets: BNF 2.9 [0209]
l warfarin: [0208020V0].
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Against this, the regression models yielded a number of significant (p< 0.05) standardised coefficients,
which suggest systematic inequalities in utilisation. In some cases, populations make greater use of services
than expected, and in other cases they make less. There are further insights to be gleaned from the data
and considerable scope for more modelling (e.g. to incorporate supply-side factors; and to use funnel plots
to examine how much variation at practice level we might expect to observe by chance). Nevertheless, the
results include some important findings.
Key findings
l PCTs and practices with higher Asian populations have higher-than-expected rates of diabetes
presentation and prescribing and lower-than-expected rates of secondary care.
l PCTs and practices with higher black populations have lower-than-expected rates of CHD presentation
and prescribing (for four of the six items examined) and higher-than-expected rates of emergency
admissions for CABG and any admission for PCI.
l There are pronounced geographical variations in use relative to need for CHD care. The North East has
relatively high levels of use of cardiac care, as do, at least with respect to PBC secondary and total
expenditure, parts of the South East and South Central regions. Rural (shire) areas have low levels of
use relative to need.
l With the exception of lower-than-expected rates of prescribing among younger and rural practice
populations, evidence of inequality in the management of hypertension is mixed.
l Both black and Asian populations have lower QOF registrations of stroke and lower prescribing of oral
anticoagulants and warfarin than expected. Younger populations have lower presentation and
prescribing rates. Secondary care use is also lower than expected among ethnic populations.
l Across the four categories, deprivation does not emerge as a consistent predictor of lower use relative
to need. Deprived practices make higher use than expected for diabetes, hypertension and stroke.
However, they have lower-than-expected rates of CABG and PCI interventions.
l There is little evidence of inequality among older populations, which conflicts with a key finding of the
literature review.
DOI: 10.3310/hsdr04140 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 14
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Asthana et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
79

Chapter 5 Investigating equity in the utilisation of
mental health services
Introduction
The aim of this chapter is to determine the extent to which variations in the presentation and management
of CMHDs reflect underlying differences in the health-care needs of populations. To this end, we have
again rejected the use of administrative data to proxy need (as this, we argue, runs the risk of reflecting
both unmet need and unjustified supply) and have instead developed modelled estimates of CMHDs. The
methods used to this end have been described in Chapter 3. In this chapter we (a) evaluate the estimates
and select which, of a number of various indicators, we will use in our investigation of use relative to need;
and (b) investigate the extent to which CCG-, PCT- and practice-level variations in the presentation and
primary and specialist management of CMHDs can be explained by underlying need or population
characteristics (deprivation, age, ethnicity and rurality). Although we have hitherto focused on health
service data for 2011–12 (to align with estimates that were generated using 2011 census data and
calculated using ADS practice population denominators for 2011–12), in this section we recognise the fact
that mental health service data are rapidly improving and have, thus, also used 2012–13 data. This was
specifically in order to include important data on the utilisation of Community Mental Health and IAPT
services. These more recent data refer to CCGs rather than to PCTs.
Common mental health disorder prevalence estimates:
testing for reliability
Determining appropriate need indicators
Identifying a suitable indicator to describe how CMHDs vary between populations is complicated by the
wide range of possible survey-based measures which, unlike the CVD prevalence rates considered in
Chapter 4, are likely to be describing very different phenomena. Thus, although, for instance, CHD as a LSI
represents a particular type of need which differs in important ways from evidence that an individual has
had symptoms of CHD, it was nevertheless reasonable for us to treat both as potential proxies for the
same underlying condition. This is less obviously the case with respect to mental health.
The nature of the problem is illustrated by the diversity of rates obtained using definitions ranging from
rather narrowly conceived concepts such as ‘doctor-diagnosed clinical depression’ through to very broadly
defined measures capturing how individuals respond to questions about their current level of anxiety
and/or depression. Thus, although only about 2.3% of adults are estimated to be ‘extremely anxious or
depressed’, and 4.0% are ‘currently diagnosed with clinical depression’, some 21.7% are estimated to be
‘moderately or extremely anxious and/or depressed’, a figure which rises to 24.2% if one includes people
who, though not reporting being anxious or depressed, are nevertheless taking prescribed medication for
anxiety or depression (see Tables 29 and 30).
The various indicators can also bear very little relation to one another in terms of their descriptions of how
mental health needs vary between populations. For instance, the definition based on individuals scoring
≥ 12 on the revised Clinical Interview Schedule (CIS-R) returns an overall national prevalence rate of 6.4%,
compared with the 21.5% prevalence rate with respect to people who report ‘ever having had a mental
health issue’. Both are derived from an analysis of the 2007 APMS, but the resulting CCG-level prevalence
estimates are completely unrelated (with a correlation coefficient of –0.009). Whatever phenomena they
are describing, they are clearly very different phenomena. More to the point, it is quite uncertain which, if
any, is likely to provide the best measure, or proxy, of variations in health service needs.
DOI: 10.3310/hsdr04140 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 14
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Asthana et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
81
As with respect to our investigation of CVD and related conditions, the absence of any clear a priori criteria
on which to base the choice between the alternative prevalence rates means that it is necessary to
consider how well they predict variations in health service activity, once again, of course, acknowledging
the essentially circular logic that the subsequent analysis of inequalities in utilisation will depend on
use-to-need ratios that are based on a need indicator which, in part, has been chosen because it best
mirrors variations in health service utilisation.
To that end we generated 41 different sets of prevalence rates across the whole range of geographies and
organisational structures in which we are interested (LSOAs, MSOAs, upper- and lower-tier LAs, regions,
general practices, PCTs, CCGs and SHAs). Apart from four very specific definitions, which are unlikely
to relate to broader data on health service activity (namely generalised anxiety disorder, mixed
anxiety/depressive disorder, symptoms of a depressive episode, and a combined measure which
captures whether or not an individual has exhibited symptoms of any of these conditions), these are
summarised in Tables 29 and 30.
TABLE 29 Mental health prevalence rate estimates: clinical depression, self-reported and CIS-R
Potential depression needs indicators (2001 ADS population ≥ 16 years= 44,813,241)
Modelled prevalence Predicted cases
Prevalence rate, %
(95% CI)
Diagnosed clinical depression (UKHLS wave 1) 2,878,388 6.4 (6.0 to 6.8)
Current diagnosed clinical depression (UKHLS wave 1) 1,793,194 4.0 (3.7 to 4.3)
Ever diagnosed clinical depression (UKHLS waves 1 and 2) 3,241,959 7.2 (6.5 to 8.0)
Diagnosed clinical depression 1 year incidence (UKHLS waves 1 and 2) 929,515 2.1 (1.7 to 2.6)
Current diagnosed clinical depression incidence (UKHLS waves 1 and 2) 653,100 1.5 (1.2 to 1.8)
Moderate/extreme anxiety/depression (HSfE) 9,729,483 21.7 (21.1 to 22.3)
Extreme anxiety/depression (HSfE) 1,033,069 2.3 (2.1 to 2.5)
Moderate/extreme anxiety/depression or drugs (HSfE) 10,844,470 24.2 (23.5 to 24.8)
Extreme anxiety/depression or mental health drugs (HSfE) 3,864,945 8.6 (8.2 to 9.0)
‘Ever had a mental health issue’ (APMS) 9,630,160 21.5 (20.4 to 22.5)
‘Mental health issue’ in last 12 months (APMS) 5,178,544 11.6 (10.7 to 12.5)
‘Mental health issue’ first experienced ≥ 1 year ago (APMS) 4,427,746 9.9 (9.1 to 10.7)
‘Mental health issue’ first experienced ≥ 5 years ago (APMS) 2,998,412 6.7 (6.1 to 7.3)
As a LSI (HSfE) 1,756,157 3.9 (3.6 to 4.2)
Neurotic disorder symptoms (APMS) 7,628,839 17.0 (16.0 to 18.1)
CIS-R score of ≥ 12 (APMS) 7,112,795 15.9 (14.8 to 17.0)
CIS-R score of ≥ 18 (APMS) 3,470,033 7.7 (6.9 to 8.6)
CIS-R score of ≥ 12 or any mental health treatment (APMS) 8,745,221 19.5 (18.4 to 20.6)
CIS-R score of ≥ 18 or any mental health treatment (APMS) 5,750,602 12.8 (12.0 to 13.7)
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In addition to a series of self-reported measures (e.g. ‘ever having had a mental health issue’) and number
addressing doctor-diagnosed clinical depression (the full details of which are provided in Appendix 27),
these include estimates based on a standard instrument used to assess the presence of a CMHD, the
CIS-R, and one designed to identify the presence of non-psychotic minor psychiatric disorders, the 12-item
General Health Questionnaire (GHQ12). But even here there are issues concerning (a) which thresholds
should be used – for instance, a CIS-R score of ≥ 12 indicates the presence of a CMHD while a score of
≥ 18 has been taken to indicate a CMHD in ‘need of treatment’; (b) whether or not it is appropriate to
‘adjust’ responses by taking into account the fact that individuals may score below any given threshold
because they are on medication and are thus, by definition, already receiving (presumably necessary)
health care; and (c) evidence of survey-specific effects on scores (with, for instance, precisely the same
GHQ12 instrument generating somewhat different results in the HSfE and the two waves of the UKHLS).
TABLE 30 Mental health prevalence rate estimates: GHQ12
Modelled prevalence Predicted cases Prevalence rate, % (95% CI)
‘Possible’ psychiatric morbidity (GHQ12 score of ≥ 4)
HSfE (2006, 2008–10) 7,047,454 15.7 (15.2 to 16.2)
UKHLS (wave 1, 2009–10) 7,815,929 17.4 (16.8 to 18.1)
UKHLS (wave 2, 2010–11) 8,288,777 18.5 (17.4 to 19.5)
‘Possible’ psychiatric morbidity (GHQ12 score of ≥ 4) or currently prescribed mental health drugs
HSfE (2006, 2008–10) 8,953,543 20.0 (19.4 to 20.6)
UKHLS (wave 1, 2009–10) 10,592,530 23.6 (22.5 to 25.0)
UKHLS (wave 2, 2010–11) 10,792,295 24.1 (23.1 to 25.0)
‘Probable’ psychiatric morbidity (GHQ12 score of ≥ 6)
HSfE (2006, 2008–10) 4,462,361 10.0 (9.5 to 10.4)
UKHLS (wave 1, 2009–10) 4,897,092 10.9 (10.4 to 11.5)
UKHLS (wave 2, 2010–11) 5,420,520 12.1 (11.2 to 13)
‘Probable’ psychiatric morbidity (GHQ12 score of ≥ 6) or currently prescribed mental health drugs
HSfE (2006, 2008–10) 6,617,226 14.8 (14.2 to 15.3)
UKHLS (wave 1, 2009–10) 7,799,102 17.4 (16.3 to 18.5)
UKHLS (wave 2, 2010–11) 8,166,994 18.2 (17.4 to 19.0)
Psychiatric morbidity (GHQ12 score of ≥ 8)
HSfE (2006, 2008–10) 2,776,746 6.2 (5.8 to 6.6)
UKHLS (wave 1, 2009–10) 2,893,221 6.5 (6.1 to 6.9)
UKHLS (wave 2, 2010–11) 3,407,967 7.6 (6.9 to 8.4)
Psychiatric morbidity (GHQ12 score of ≥ 8) or currently prescribed mental health drugs
HSfE (2006, 2008–10) 5,321,483 11.9 (11.4 to 12.3)
UKHLS (wave 1, 2009–10) 6,295,494 14.0 (13.1 to 15.0)
UKHLS (wave 2, 2010–11) 6,665,881 14.9 (14.3 to 15.5)
GHQ12, 12-item General Health Questionnaire.
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Comparisons with Quality and Outcomes Framework registration data
The overall national prevalence rates associated with each of the defined measures listed in Tables 29 and 30
can be compared with QOF disease register rates of 11.2% and 11.7% in 2010–11 and 2011–12,
respectively, and then 5.8% and 6.5% in 2012–13 and 2013–14 (Table 31). The halving of the rate between
2011–12 and 2012–13 was owing to a change in the definition of who was to be included on the register,
which now excludes any patients identified prior to April 2006. This change emphasises the fact that a
comparison with national prevalence rates is somewhat moot; what matters is the extent to which variations
in QOF registration can be explained. Here, in marked contrast to what was found with respect to
cardiovascular and related conditions, it is apparent (with respect to 2011–12 PCT-level data, Table 32, or with
respect to 2012–13 data, Table 33), that none of the modelled prevalence rates performs particularly well.
These tables describe how much interPCT and interCCG variation exists in terms of the ‘registration per
expected case’ ratios constructed using the different prevalence rates, and this is invariably far higher than
was found with respect to the cardiovascular and related conditions considered in the previous chapter.
The degree of variation is generally lower in 2012–13, by which time the new criteria for QOF registration
had been introduced, even though this was with respect to a greater number of CCGs (n= 211) than PCTs
(n= 151). In 2011–12 it was the ‘extreme anxiety/depression or using mental health drugs’ definition
which resulted in the least variation; in 2012–13 it was one of the ‘doctor-diagnosed clinical depression’
definitions. Also notable is how poorly correlated the PCT- and CCG-level QOF count data are with the
variously defined modelled counts of people with mental health problems. As previously noted (see
Chapter 4, Conclusion), correlations based on count data tend to be exceptionally high at PCT or CCG
levels because of the overwhelming effect of population size on the number of people with any given
condition. Yet the highest correlation statistic for 2011–12 was 0.959 (R2= 92.0%) and in 2012–13 it was
0.958 (R2= 91.7%). This contrasts markedly with, for instance, the fact that it was possible to explain
99.2% of the variation in the number of people on PCT-level QOF hypertension registers.
The fact of the matter is that most (though not all) of the modelled prevalence estimates prove to be very
poor at predicting how many people in each PCT or CCG will be QOF registered with depression. Indeed,
in 2011–12 only 10 of the 32 measures (Table 32) are more effective than a simple count of the ‘at-risk’
population (people aged ≥ 16 years) in each PCT, although in 2012–13 (and with respect to CCGs) this
rises to 16 of the 32 putative measures of health-care needs (Table 33). The indicators perform equally
poorly at practice level, with the best (‘ever had a mental health issue’) explaining only very slightly more of
the variation in the number of people on the QOF depression register than does a simple count of practice
‘at-risk’ populations (63.9% as opposed to 61.6% in 2012–13).
Two quite different interpretations could be placed on this. First, although the method clearly proves
perfectly adequate at capturing relative levels of underlying cardiovascular and related morbidity, some
aspect of the way in which people respond to questions about their mental health undermines the use of
the resulting data for predictive purposes. This is, of course, plausible, but it seems far more likely that the
problem lies with variations in QOF case finding, particularly as all of the modelled prevalence rates are
significantly more effective at predicting CCG-level variations in the number, and proportion, of people
accessing community mental health and IAPT services. The vast majority are also far more effective at
predicting CCG-level variations in the number of people using secondary mental health services.
TABLE 31 National QOF depression register data
QOF register Practice population (≥ 18 years) Patients on the register QOF prevalence rate, %
Depression 2010–11 43,578,391 4,878,188 11.2
Depression 2011–12 43,855,136 5,123,948 11.7
Depression 2012–13 44,238,483 2,582,233 5.8
Depression 2013–14 44,667,478 2,912,592 6.5
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TABLE 32 Selected PCT-level (n= 151) estimates of the number of people with depression and QOF count
data, 2011–12
Depression register Rate, %
Registrations per expected case Count correlation
Mean
Minimum–
maximum Variation R % R2
Total QOF population (≥ 18 years) 11.7 – – – 0.945 89.3
CIS-R score of ≥ 12 15.9 0.71 0.24–1.23 5.13 0.881 77.7
CIS-R score of ≥ 18 7.7 1.47 0.43–2.76 6.42 0.811 65.7
CIS-R score of ≥ 12 or any treatment 19.5 0.57 0.20–0.96 4.80 0.909 82.7
CIS-R score of ≥ 18 or any treatment 12.8 0.87 0.30–1.45 4.83 0.920 84.6
CMHD symptoms 15.1 0.74 0.26–1.27 4.88 0.898 80.6
Neurotic disorder symptoms 17.0 0.66 0.23–1.12 4.87 0.899 80.8
GHQ12 score of ≥ 4 (HSfE) 15.7 0.71 0.26–1.12 4.31 0.922 85.0
GHQ12 score of ≥ 6 (HSfE) 10.0 1.12 0.39–1.81 4.64 0.908 82.4
GHQ12 score of ≥ 8 (HSfE) 6.2 1.80 0.61–2.99 4.90 0.881 77.6
GHQ12 score of ≥ 4 or drugs (HSfE) 20.0 0.56 0.21–0.84 4.00 0.944 89.1
GHQ12 score of ≥ 6 or drugs (HSfE)a 14.8 0.75 0.30–1.12 3.73 0.950 90.3
GHQ12 score of ≥ 8 or drugs (HSfE)a 11.9 0.93 0.38–1.38 3.63 0.952 90.7
GHQ12 score of ≥ 4 (UKHLS 2) 18.5 0.61 0.23–1.00 4.35 0.930 86.5
GHQ12 score of ≥ 6 (UKHLS 2) 12.1 0.93 0.34–1.55 4.56 0.923 85.2
GHQ12 score of ≥ 8 (UKHLS 2) 7.6 1.48 0.55–2.40 4.36 0.929 86.3
GHQ12 score of ≥ 4 or drugs (UKHLS 2) 24.1 0.47 0.18–0.76 4.22 0.939 88.2
GHQ12 score of ≥ 6 or drugs (UKHLS 2)a 18.2 0.61 0.25–0.96 3.84 0.949 90.0
GHQ12 score of ≥ 8 or drugs (UKHLS 2)a 14.9 0.75 0.30–1.15 3.83 0.952 90.6
Diagnosed clinical depression (UKHLS 1)a 6.4 1.73 0.72–2.60 3.61 0.958 91.9
Current clinical depression (UKHLS 1)a 4.0 2.77 1.03–4.41 4.28 0.946 89.5
Diagnosed clinical depression (UKHLS 1 and 2)a 7.2 1.54 0.63–2.23 3.70 0.956 91.3
Diagnosed clinical depression (UKHLS 1 and 2) 2.1 5.41 1.82–8.91 4.90 0.927 85.9
Current clinical depression (UKHLS 1 and 2) 1.5 7.73 2.56–12.65 4.94 0.910 82.9
Moderate/extreme anxiety/depression 21.7 0.51 0.20–0.79 3.95 0.939 88.1
Extreme anxiety/depression 2.3 4.85 1.56–8.52 5.46 0.856 73.3
Moderate/extreme anxiety/depression or drugsa 24.2 0.46 0.18–0.71 3.94 0.947 89.7
Extreme anxiety/depression or drugsa 8.6 1.29 0.54–1.84 3.41 0.959 91.9
‘Ever had a mental health issue’a 21.5 0.52 0.23–0.83 3.61 0.959 92.0
‘Mental health issue’ in last year 11.6 0.96 0.38–1.51 3.97 0.944 89.2
‘Mental health issue’ for ≥ 1 year 9.9 1.12 0.44–1.76 4.00 0.944 89.1
‘Mental health issue’ for ≥ 5 years 6.7 1.66 0.65–2.56 3.94 0.947 89.7
As a LSI 3.9 2.83 0.99–4.61 4.66 0.918 84.3
a Estimate is more effective than a simple count of the ‘at-risk’ population (people aged ≥ 16 years) in each PCT.
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TABLE 33 Selected CCG-level (n= 211) estimates of the number of people with depression and QOF count
data, 2012–13







maximum Variation R % R2
Total QOF population (≥ 18 years) 5.8 – – – 0.937 87.8
CIS-R score of ≥ 12 15.9 0.36 0.16–0.77 4.82 0.892 79.6
CIS-R score of ≥ 18 7.7 0.75 0.29–1.61 5.54 0.839 70.3
CIS-R score of ≥ 12 or any treatment 19.5 0.28 0.14–0.61 4.50 0.916 83.9
CIS-R score of ≥ 18 or any treatment 12.8 0.43 0.20–0.90 4.49 0.924 85.5
CMHD symptoms 15.1 0.37 0.17–0.80 4.65 0.906 82.2
Neurotic disorder symptoms 17.0 0.33 0.15–0.71 4.60 0.908 82.5
GHQ12 score of ≥ 4 (HSfE) 15.7 0.34 0.17–0.72 4.25 0.925 85.6
GHQ12 score of ≥ 6 (HSfE) 10.0 0.55 0.26–1.14 4.39 0.911 83.0
GHQ12 score of ≥ 8 (HSfE) 6.2 0.89 0.40–1.85 4.59 0.887 78.6
GHQ12 score of ≥ 4 or drugs (HSfE)a 20.0 0.27 0.14–0.55 3.97 0.944 89.1
GHQ12 score of ≥ 6 or drugs (HSfE)a 14.8 0.36 0.18–0.72 3.90 0.947 89.6
GHQ12 score of ≥ 8 or drugs (HSfE)a 11.9 0.44 0.23–0.88 3.85 0.947 89.7
GHQ12 score of ≥ 4 (UKHLS wave 2) 18.5 0.29 0.15–0.64 4.17 0.936 87.5
GHQ12 score of ≥ 6 (UKHLS wave 2) 12.1 0.45 0.23–0.99 4.27 0.929 86.4
GHQ12 score of ≥ 8 (UKHLS wave 2) 7.6 0.71 0.37–1.53 4.12 0.934 87.2
GHQ12 score of ≥ 4 or drugs (UKHLS wave 2)a 24.1 0.22 0.12–0.48 4.12 0.943 88.9
GHQ12 score of ≥ 6 or drugs (UKHLS wave 2)a 18.2 0.29 0.15–0.62 3.99 0.951 90.4
GHQ12 score of ≥ 8 or drugs (UKHLS wave 2)a 14.9 0.36 0.19–0.74 3.93 0.952 90.7
Diagnosed clinical depression (UKHLS wave 1)a 6.4 0.85 0.46–1.73 3.77 0.958 91.7
Current clinical depression (UKHLS wave 1)a 4.0 1.36 0.67–2.82 4.18 0.946 89.5
Diagnosed clinical depression (UKHLS waves 1 and 2)a 7.2 0.75 0.41–1.56 3.84 0.956 91.4
Diagnosed clinical depression (UKHLS waves 1 and 2) 2.1 2.66 1.20–5.72 4.78 0.930 86.5
Current clinical depression (UKHLS waves 1 and 2) 1.5 3.78 1.67–8.10 4.86 0.915 83.7
Moderate/extreme anxiety/depressiona 21.7 0.25 0.13–0.51 3.98 0.940 88.4
Extreme anxiety/depression 2.3 2.42 1.02–4.92 4.81 0.867 75.2
Moderate/extreme anxiety/depression or drugsa 24.2 0.22 0.11–0.45 3.97 0.947 89.6
Extreme anxiety/depression or drugsa 8.6 0.6 0.31–1.17 3.80 0.950 90.3
‘Ever had a mental health issue’a 21.5 0.25 0.13–0.51 3.95 0.958 91.7
‘Mental health issue’ in last yeara 11.6 0.47 0.25–0.97 3.84 0.947 89.6
‘Mental health issue’ for ≥ 1 yeara 9.9 0.55 0.29–1.13 3.90 0.946 89.4
‘Mental health issue’ for ≥ 5 yearsa 6.7 0.81 0.43–1.63 3.82 0.946 89.4
As a LSI 3.9 1.4 0.65–2.84 4.37 0.921 84.9
a Estimate is more effective than a simple count of the ‘at-risk’ population (people aged ≥ 16 years) in each CCG.
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Comparisons with other indicators of mental health service use
Moving away from a focus on count data, Table 34 summarises the extent to which the various per-capita
modelled estimates predict CCG-level variations in per-capita (a) QOF registration; (b) prescribing [net
ingredient cost for BNF 4.4.1–4.1.3 (hypnotics and anxiolytics) and BNF 4.3.1–4.3.4 (antidepressant
drugs)];487 (c) uptake of specialist community mental health-care services (based on the combined number
TABLE 34 Explaining CCG-level variations in per-capita utilisation data





CIS-R score of ≥ 12 0.0% 0.3% 14.9% 32.5%
CIS-R score of ≥ 18 0.2% 0.0% 17.8% 32.1%
CIS-R score of ≥ 12 or any treatment 0.4% 0.2% 18.1% 32.0%
CIS-R score of ≥ 18 or any treatment 3.6% 4.4% 23.1% 27.0%
CMHD symptoms 0.1% 0.0% 16.6% 31.1%
Neurotic disorder symptoms 0.0% 0.0% 16.6% 31.4%
GHQ12 score of ≥ 4 (HSfE) 3.7% 4.2% 22.2% 29.2%
GHQ12 score of ≥ 6 (HSfE) 3.4% 3.8% 21.1% 29.0%
GHQ12 score of ≥ 8 (HSfE) 1.9% 2.0% 19.2% 29.4%
GHQ12 score of ≥ 4 or drugs (HSfE) 11.6% 17.9% 22.5% 18.8%
GHQ12 score of ≥ 6 or drugs (HSfE) 18.8% 30.0% 21.4% 12.3%
GHQ12 score of ≥ 8 or drugs (HSfE) 21.3% 34.9% 21.2% 10.1%
GHQ12 score of ≥ 4 (UKHLS wave 2) 0.4% 1.3% 13.0% 29.5%
GHQ12 score of ≥ 6 (UKHLS wave 2) 1.6% 3.4% 9.9% 28.5%
GHQ12 score of ≥ 8 (UKHLS wave 2) 0.0% 0.1% 15.7% 28.9%
GHQ12 score of ≥ 4 or drugs (UKHLS wave 2) 1.1% 1.4% 20.2% 27.1%
GHQ12 score of ≥ 6 or drugs (UKHLS wave 2) 11.5% 17.8% 25.2% 14.8%
GHQ12 score of ≥ 8 or drugs (UKHLS wave 2) 15.6% 24.8% 23.8% 10.0%
Diagnosed clinical depression (UKHLS wave 1) 26.3% 38.3% 23.8% 8.1%
Current clinical depression (UKHLS wave 1) 15.6% 22.6% 25.9% 15.7%
Diagnosed clinical depression (UKHLS waves 1 and 2) 22.2% 32.3% 25.9% 11.9%
Diagnosed clinical depression (UKHLS waves 1 and 2) 2.3% 2.5% 18.3% 16.6%
Current clinical depression (UKHLS waves 1 and 2) 0.7% 0.5% 16.7% 17.6%
Moderate/extreme anxiety/depression 6.3% 9.1% 22.1% 23.8%
Extreme anxiety/depression 5.5% 7.4% 23.8% 27.7%
Moderate/extreme anxiety/depression or drugs 12.7% 20.2% 22.7% 17.5%
Extreme anxiety/depression or drugs 27.6% 47.5% 18.1% 3.9%
‘Ever had a mental health issue’ 30.4% 46.0% 12.2% 0.2%
‘Mental health issue’ in last year 13.6% 18.7% 26.7% 21.0%
‘Mental health issue’ for ≥ 1 year 14.8% 21.1% 26.4% 19.2%
‘Mental health issue’ for ≥ 5 years 19.0% 27.8% 25.7% 15.5%
As a LSI 13.6% 19.8% 26.4% 19.8%
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of people accessing Community Mental Health and IAPT services); and (d) use of specialist secondary care
services (based on the number of people in contact with secondary mental health services). As intimated
by the foregoing discussion, most of the modelled estimates simply do not correlate with CCG-level
variations in QOF registration rates. This is also true with respect to CCG-level variations in per-capita
prescribing costs. Nevertheless, a small number of modelled prevalence rates estimates do stand out. The
estimate based on self-reported ‘ever had a mental health problem’ is the best predictor of CCG-level
per-capita variations in QOF registrations (R= 0.551; R2= 0.304). This is the second best predictor of
variations in per-capita prescribing costs (R= 0.678; R2= 0.460), with the best being self-reported ‘extreme
anxiety and/or depression (r= 0.689; r2= 0.474). It seems reasonable to presume that these indicators, at
least to a degree, are capturing variations in the CMHDs that are being picked up in general practice.
What is intriguing is that these potential ‘need indicators’ are relatively poor at describing variations in the
use of specialist community and secondary services. For these services, other prevalence rates are far
more predictive.
Thus, in stark contrast to its lack of explanatory power with respect to QOF registration and prescribing,
the most effective predictor of CCG-level variations in the number of people in contact with secondary
services is that based on the number of people with a CIS-R score of ≥ 12 (R= 0.570; R2= 0.324). With
respect to specialist community services, three self-reported measures stand out: from the APMS, having
(a) ‘had a mental health issue in the last 12 months’ (R= 0.517; R2= 0.267) and (b) having a ‘mental
health issue first experienced at least a year ago’ (R= 0.514; R2= 0.264); and, from the HSfE, (c) reporting
‘mental health’ as a LSI (R= 0.514; R2= 0.264).
It seems, therefore, that quite different prevalence rates ‘best’ predict variations in the use of services at
different points on the health-care pathway and, moreover, that perhaps one should abandon the idea of
testing equity of utilisation against a single measure (or proxy) of mental health needs. Arguably,
‘unexplained variation’ in health service use should instead be calculated with reference to service-specific
needs indicators. This implies that to predict the underlying number of people with depression (and, thus,
how many people expected to be on the QOF depression register) it is necessary to use the prevalence rate
based on people reporting that they had ‘ever had a mental health issue’. In order to examine variations in
net ingredient cost (NIC) prescribing, meanwhile, the most appropriate prevalence rate would be based on
people reporting that they currently suffer ‘extreme anxiety and/or depression or are taking prescribed
mental health medication’. With respect to number of people expected to require community mental
health/IAPT services, the preferred ‘need indicator’ would be the prevalence rate based on self-reported
‘having had a mental health issue in the last 12 months’, while for an analysis of utilisation of specialist
inpatient services it is to the prevalence rate based on people with a CIS-R score of ≥ 12 that we should
turn as the most appropriate measure of underlying need.
This is the approach taken in Chapter 4 (see Cardiovascular disease prevalence estimates: testing for
reliability) where, as in the analysis of cardiovascular and related conditions, the goal is to account for
variations in use-to-need ratios in terms of the socioeconomic, sociodemographic and geographic
characteristics of CCGs and practices. We recognise, however, that in taking this approach we risk
confusing de facto relationships with what might be clinically desirable. Thus, with respect to each area of
service activity Cardiovascular disease prevalence estimates: testing for reliability in Chapter 4 examines
how use-to-need ratios vary using a needs indicator which, over the country as a whole, best predicts how
that particular type of health service activity varies. Concepts of ‘higher-than-expected’ or ‘lower-than-
expected’ use-to-need ratios must, thus, be interpreted as being relative to the current norm, rather with
respect to, for instance, some agreed definition of the underlying mental health needs that such services
should be addressing. Although this is entirely reasonable, as it allows us to identify whether there are
socioeconomic, sociodemographic or other characteristics which influence the utilisation of care relative to
current norms, the limitations of such an approach must be recognised.
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Comparison with existing prevalence estimates
Before reporting the analysis of use relative to need for mental health services, it is worth assessing the
relative ‘competence’ of our modelled needs indicators by comparing them with the only currently
available measure of community prevalence of CMHDs.491 This, produced by Glover for the North East
Public Health Observatory (NEPHO), is available via PHE’s Disease Prevalence Models website, although it
has not been included on its Community Mental Health Profiles website. The latter presents QOF
prevalence data as well as prevalence estimates based on responses to the GP Patient Survey, both of
which, of course, capture only those who are ‘known’ to GPs. Glover’s estimates model community
prevalence (i.e. underlying need) and, as such, are the only directly applicable comparator against which to
assess the Plymouth mental health estimates.
Table 35 describes the extent to which the NEPHO and Plymouth needs indicators predict, either on their
own or as part of linear regression models incorporating a variety of contextual factors, PCT-level
per-capita variations in (a) the number of people on the QOF Disease Register and (b) NICs for BNF
4.4.1–4.1.3 (hypnotics and anxiolytics) and BNF 4.3.1–4.3.4 (antidepressant drugs).487 The ‘need estimate
only’ correlation (r) and associated adjusted proportion of variance explained (% R2) statistics describe how
well the Plymouth and NEPHO estimates predict PCT-level variations. In each case the Plymouth-based
estimate wholly outperforms the NEPHO estimate. Indeed, the NEPHO estimate is not statistically correlated
with PCT-level per-capita variation in QOF registration, and stepwise linear regression model selection fails
to include the NEPHO estimate with respect to both QOF registration and prescribing costs. Using this
measure, factors such as ethnicity and deprivation become the sole explanatory variables.
By contrast, the Plymouth estimates of underlying need explain 37.2% of variation with respect to both
QOF registration and PBC prescribing. Here, stepwise model selection retains the needs indicators,
alongside the percentage black or black British population and, in the case of prescribing, the IMD score.
Importantly, although using the Plymouth needs indicator makes very little difference to the amount of
variation that can be explained, it significantly alters how one interprets use relative to need. With respect
to QOF registration, for instance, the inference to be drawn using the NEPHO prevalence is that
registration tends to be higher than expected in more deprived areas (i.e. with higher IMD scores). With
recourse to the Plymouth needs indicator, IMD disappears as a significant effect in the linear regression
model. Here, the higher needs of more deprived populations are being directly captured in the needs





Full linear regression model predicting utilisation
% R2
Significant coefficients (standardised)
R % R2 Need Asian Black Pop < 50 IMD Rural
PCT-level analysis (n= 151) using the Plymouth needs estimates
QOF PCT Register 2011–12 0.613 37.2 42.9 0.409 – –0.320 – – –
PBC prescribing 0.610 37.2 57.9 0.330 – –0.409 – 0.527 –
PCT-level analysis (n= 151) using NEPHO estimates of per capita with neurotic symptoms
QOF PCT Register 2011–12 0.051 – 40.3 – –0.318 –0.467 – 0.212 –
PBC prescribing 0.172 2.3 57.9 – –0.309 –0.435 – 0.695 –
pop, population.
The following need indicators were used:
l QOF registration: per-capita ‘ever had a mental health issue’
l NIC prescribing: per-capita reporting ’extreme anxiety and/or depression or taking prescribed mental health medication.
NEPHO estimates for CMHDs, along with a methodological summary by Glover,491 are available on the PHE/NEPHO
‘Mental Health Observatory Briefs’ website.492
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indicator and are not being left to be picked up in apparently higher rates of use relative to need. This is
clearly a spurious relationship, and we conclude that the Plymouth estimates offer a far more robust
indicator of the underlying prevalence of mental health needs than the only currently available alternative.
Variations in the use of mental health services relative to need
Introduction
As with CVD, we have explored evidence of variations in use with respect to presentation, primary
management and secondary management in order to examine whether or not variations occur at different
levels of the care pathway. Presentation is captured by QOF registrations for depression. NIC prescribing
data have been extracted from GP-level monthly presentation data489 and refer to BNF 4.4.1–4.1.3
(hypnotics and anxiolytics) and BNF 4.3.1–4.3.4 (antidepressant drugs).487 Data on patients attending
community mental health services have been extracted from CCG Indicator 2.9; data on patients accessing
IAPT services have been extracted from CCG Indicator 2.10; and data on people in contact with secondary
mental health services have been extracted from CCG Indicator 2.17. All data sets refer to 2013–14 and all
are available via the HSCIC Indicator Portal.71
Variations in the presentation of common mental health disorders
At the CCG level, estimated prevalence of CMHD (based on ‘ever had a mental health issue’) explains
30.4% of variations in QOF registrations (Table 36); at PCT and practice levels, 37.2% and 14.9% are,
respectively, explained. These are poorer predictions than achieved with respect to CVD. Once additional
factors are accounted for, prediction increases to 35.3%, 42.9% and 17.0% at CCG, PCT and practice
levels. Thus, a large proportion of the variation in QOF registrations is unexplained.




Full linear regression model predicting utilisation
% R2
Significant coefficients (standardised)
R % R2 Need Asian Black Pop < 50 IMD Rural
CCG-level analysis (n= 211)
QOF CCG register 2012–13 0.551 30.4 35.3 0.355 – –0.333 – 0.190 –
Prescribing (NIC) 0.689 47.2 58.2 0.283 –0.251 –0.428 – 0.230 –
Community/IAPT services 0.516 26.3 26.3 0.516 – – – – –
Secondary services 0.570 32.2 32.2 0.570 – – – – –
PCT-level analysis (n= 151)
QOF PCT register 2011–12 0.613 37.2 42.9 0.409 – –0.320 – – –
PBC prescribing 0.610 37.2 57.9 0.330 – –0.409 – 0.527 –
PBC secondary 0.515 26.0 33.2 1.288 – – – –0.810 –
Practice-level analysis (n= 7848)
QOF CCG register 2012–13 0.386 14.9 17.0 0.366 0.058 –0.123 – – –
Prescribing 0.270 7.3 18.5 0.193 –0.232 –0.195 – 0.193 –
pop, population.
The following need indicators were used:
l QOF registration: per-capita ‘ever had a mental health issue’
l NIC prescribing: per-capita reporting ’extreme anxiety and/or depression or taking prescribed mental health medication
l community mental health/IAPT services: self-reported as ’having had a mental health issue in the last 12 months
l secondary services: CIS-R score of ≥ 12.
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At all three scales of analysis, areas with higher percentages of black populations have significantly lower
QOF-recorded depression than expected. This corresponds with the results of many studies that find that
being a member of an ethnic minority is associated with lower rates of help-seeking behaviour for mental
distress.330,332,336,341,433 At practice level, however, we find that areas with higher percentages of Asian
populations have significantly higher-than-expected rates of diagnosis. One qualitative study we reviewed
found that GP consultation rates were higher in depressed people of Pakistani origin because they
consulted more often for bodily symptoms.338
At CCG level, more deprived areas have higher registrations than expected. This does not contradict the
findings of the literature, in part because very few studies appear to have looked at socioeconomic
differences in help-seeking behaviour for mental health problems. The two studies that did directly
examine this found that the socially disadvantaged were more likely to seek formal help.434,437
In the literature we reviewed, age emerged as a significant factor in help-seeking behaviour and studies
suggested that older patients are sensitive to the stigma of formally diagnosed mental illness,431 are
reluctant to recognise and name depression432,433 and, in consequence, are less likely to seek help.434–436
Younger men are also reported to be disproportionately deterred from seeking help for mental health
problems by stigma.433,437 In our analysis, however, there is no evidence to suggest that younger or older
populations have differential rates of diagnosis relative to need. This may be attributable to the use of
large-scale survey data as the basis for modelling needs, insofar as it is plausible that whatever sensitivities
affect individuals’ propensity to seek clinical help will also affect how they respond to questions about their
mental health status.
Variations in the primary management of common mental health disorders
Estimated prevalence (based on those reporting extreme anxiety and/or depression or taking prescribed
mental health medication) is a significant predictor of variations in net ingredient prescribing costs for
hypnotics, anxiolytics and antidepressants (BNF 4.4.1–4.1.3 and 4.3.1–4.3.4487) at CCG level, explaining
47.2% of variation. At practice level, however, only 7.3% of the variation in prescribing is explained.
This reflects partly the less precise modelled prevalence estimates available at the practice level, but also
presumably significant local variations in prescribing practice. The PBC data for 2011–12 are for a broader
‘mental health’ category,486 but here, too, a significant proportion of variation can be explained by the
prevalence-based need indicator (37.2%).
At all three scales, the percentage of population that is black is an important predictor in the linear
regression of variations in per-capita prescribing (with areas with higher proportions of black/black British
populations having lower-than-expected rates of prescribing). This corresponds with evidence from the
National Psychiatric Morbidity Surveys, which found that black people were less likely to be taking
antidepressants than their white counterparts after controlling for symptom severity.332,355 Reviewed
evidence also suggests that prescribing for anxiety and depression is significantly lower in areas with higher
percentages of Asians.345,362 This corresponds to our findings at CCG and practice levels.
Levels of prescribing are significantly higher than expected in more deprived CCGs, PCTs and practices.
Again, this tallies with the conclusion of published studies that find no evidence of inverse care in the
treatment of moderate and severe depression.345,349,351 Unlike in the published literature, we find no
evidence of systematic undertreatment of older populations.
Variations in the specialist community management of common mental
health disorders
Expanding services in the community to address problems of anxiety and depression has been an
important policy priority. Since its inception in 2008, the IAPT programme has expanded significantly.
By 2012,493 more than 1 million people had been in receipt of IAPT services, over 680,000 completing a
course of treatment, with recovery rates in excess of 45%.
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Reviewed studies suggest that the IAPT initiative is addressing inverse care and that there is now a
pro-poor socioeconomic gradient in public psychotherapy treatments which is widening over time.365,367
We find no evidence of systematic bias – by socioeconomic status, age, ethnicity or rurality – in rates
of use relative to need. Thus, IAPT would appear to be an equitable, if geographically varied (see
The geography of variations in mental health service use relative to need), service.
Variations in the secondary management of common mental
health disorders
As with respect to community/IAPT services, there is little evidence that the number of people in contact
with secondary mental health services varies according to population characteristics at the CCG level.
Thus, stepwise linear model selection rejected the inclusion of any parameters other than underlying need,
implying that none of the unexplained variation in use-to-need ratios is systematically related to any of the
sociodemographic factors offered to the model. In contrast, however, the stepwise linear regression model
of variations in PCT-level PBC expenditure on secondary services in 2011–12 does reveal the IMD as a
significant coefficient. This suggests that the PCTs serving more deprived communities are spending
significantly less than expected. As the CCG data refer to numbers of patients, whereas the PCT data refer
to expenditure, these results can be reconciled if levels of presentation are broadly as might be expected in
areas with relatively deprived populations, but less is then spent on those who do access secondary services.
The geography of variations in mental health service use
relative to need
The key observation to draw from the foregoing analysis is that, although the various needs indicators
explain only a limited proportion of the variation in health service activity, introducing factors describing
key aspects of CCG, PCT and practice populations to linear regression models does relatively little to
improve matters. At CCG level, variations in NIC prescribing are best predicted, but even here
incorporating factors describing the ethnic composition and level of deprivation of CCGs increases the
amount of variation that can be explained only from 47.2% to 58.2%. Models describing variations in
QOF Registration, the use of specialist community services and the number of people in contact with
specialist secondary services can only account for 35.3%, 26.3% and 32.2% of variance, respectively.
There is some evidence that rates of QOF registration and prescribing tend to be lower than expected in
areas with large black populations, and higher than expected in areas serving more deprived populations,
but the overall picture is one of unexplained variation.
This is reflected in the following CCG-level maps of variations in QOF Registrations relative to the expected
number of people who have ‘ever had a mental health issue’ (Figure 10); net ingredient prescribing costs
on hypnotics, anxiolytics and antidepressants relative to the number of people who report being currently
‘extremely anxious and/or depressed’ (Figure 11); and, finally, the number of patients in contact with
specialist community services relative to the number of people expected to have ‘had a mental health issue
in the last 12 months’ (Figure 12). Each presents something of a patchwork, with presentation, prescribing
and community treatment rates varying markedly from place to place. Yet there is, perhaps, one key
underlying geographical component which is interesting both in its own right and because it may have led,
at least in part, to some of the relationships observed in the linear models described above. The 32 CCGs
in the London Commissioning Board Area cover approximately 15% of the population, but rates of both
QOF Registration and prescribing (relative to need) are very much lower than in the country as a whole
(respectively 21.7% as opposed to 25.2%; and £54.30 per ‘expected’ person as opposed to £71.21).
As illustrated by Figure 11, this ‘London effect’ is particularly marked with respect to prescribing, where 17
of the 20 CCGs with the lowest prescribing rates relative to need are to be found in the London area.
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FIGURE 10 Clinical Commissioning Group-level variations in QOF depression registered patients440 per expected
person ‘who has ever had a mental health issue’. Contains Ordnance Survey data © Crown copyright and database
right 2012.
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FIGURE 11 Clinical Commissioning Group-level variations in NIC prescribing on hypnotics, anxiolytics and
antidepressants489 per expected person who is ‘extremely anxious/depressed’. Contains Ordnance Survey data ©
Crown copyright and database right 2012.
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FIGURE 12 Clinical Commissioning Group-level variations in patients in contact with specialist community services158
per expected person who has ‘had a mental health issue in the last 12 months’. Contains Ordnance Survey data ©
Crown copyright and database right 2012.
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It appears there is strong evidence that in London, relative to national norms, utilisation of primary care
and prescribing relative to need is much lower than might be expected, perhaps suggesting a local mental
health service that is unable to adequately meet the primary care needs of its client population. In terms of
the number of people accessing specialist community services, however, the overall London use-to-needs
ratio is only slightly lower than the national average (38.7% as opposed to 41.2%) and, as illustrated by
Figure 12, this includes considerable CCG-level diversity.
Beyond this London effect, it is difficult to point convincingly to any particular geographical tendency save
that of great diversity. This is perhaps best illustrated by looking at the most local scale, namely how
practice-level QOF Registration and prescribing rates vary relative to need (Figures 13 and 14, respectively).
These maps are, of course, seriously compromised by the fact that they attempt to include information on
nearly 8000 practices, but such notwithstanding, the degree of local variation is apparent. Even within
London, where CCG-level QOF Registration and prescribing rates relative to need are almost invariably
much lower than might be expected, there is still considerable practice-level diversity, though the generally
lower level of QOF Registration and prescribing in the capital remains apparent.
Thus, compared with patterns of use relative to need across the cardiovascular and related conditions
considered in Chapter 4, the situation with respect to mental health is much more variable. It appears that
there is a genuine ‘postcode lottery’, with access and uptake of services varying in ways that are only partly
related to need and, save a possible serious underprovision of services relative to need in London, only
marginally affected by the socioeconomic, demographic or geographical factors considered here. There
may, of course, be very local (sub-CCG) organisational issues at work which we have, as yet, been unable
to address.
Conclusion
If, as argued above, higher percentage R2 correlation coefficient values between per-capita needs and
per-capita utilisation rates are indicative of a more ‘equitable’ use of health-care services relative to need,
then it is of some concern that variation in mental health service use is poorly explained by underlying
need. As the addition of potential explanatory factors does little to improve matters, the overall picture is
one of unexplained variation.
Key findings
l Rates of QOF registration and prescribing tend to be lower than expected in areas with large
black populations.
l Rates of QOF registration and prescribing tend to be higher than expected in areas serving more
deprived populations.
l Our findings of lower rates of mental health use among black populations and higher rates among
deprived populations corresponds with existing literature. However, there is little evidence of inequality
among older populations, which conflicts with a key finding of the literature review.
l There appears to be a ‘London effect’, with rates of QOF prevalence and particularly prescribing being
much lower than expected in London than in the country as a whole.
l There is considerable practice-level variation in use relative to need, even within London and other
major cities.
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Figure 13 Practice-level variations in QOF Depression Registered Patients443 per 
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FIGURE 13 Practice-level variations in QOF depression registered patients440 per expected person ‘who has ever had
a mental health issue’. Contains Ordnance Survey data © Crown copyright and database right 2012.
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 Northern Cities 




FIGURE 14 Practice-level variations in NIC prescribing on hypnotics, anxiolytics and antidepressants489 per expected
person who is ‘extremely anxious/depressed’. Contains Ordnance Survey data © Crown copyright and database
right 2012.
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Chapter 6 Summary, conclusions and implications
for policy and research
Introduction
The fact that this study has found little consistent evidence that deprived populations make lower than
expected use of cardiovascular and mental health services may be surprising to those with an interest in
health policy and health services research. The inverse care law has become a powerful meta-narrative in
accounts of variations in access to and use of health care. Indeed, comments by senior NHS/Department of
Health representatives, prominent medical commentators and politicians suggest that the idea that
socioeconomically disadvantaged people are also disadvantaged in their access to health care is accepted
by the mainstream. In the 2014 annual lecture to the Health Service Journal, Simon Stevens, Chief
Executive of NHS England, referred to ‘some inner city areas where the inverse care law has persisted for
years, you have an under-doctored area that is hard to recruit to, where perhaps there have been quality
and access concerns’.494 Iona Heath, ex-president of the RCGP, nominated by Pulse495 as the third most
influential GP in the UK, has been passionate about the injustice of inverse care:
There is a desperate need to distribute health services resources according to need . . . Poorer people
. . . need commensurately more access – not less as now . . . Why is Julian Tudor Hart’s inverse care
law so pervasive even within the NHS . . .?496
Despite presiding over a significant redistribution of NHS resources towards deprived areas, the New Labour
government also expressed concerns about inequity with respect to access to health care. Writing in 2006,
Patricia Hewitt, the then Secretary of State for Health, claimed: ‘We’ve achieved a great deal, but there’s
more to do. The “inverse care law”, whereby communities with the greatest health needs get the poorest
services, still applies . . . Our White Paper will address these historic injustices’.497 There are, however, few
signs that professional bodies such as the RCGP believe that the injustice of inverse care has been addressed.
As noted in Chapter 1, problems of access in deprived areas have been highlighted in several recent RCGP
reports,101,102 with associated calls for GP funding to be more strongly weighted towards deprivation.
It is not only policy circles that accept the conventional wisdom of inverse care. In an editorial comment
about research evidence on variations in health service use in Canada, Hutchison notes that some studies
‘show greater use of hospital services by those with lower income after controlling for healthcare need –
perhaps calling into question the adequacy of existing measures of need’ (our emphasis).498 This illustrates
the ongoing tendency to believe that more intensive use of health services by lower income groups is
always appropriate, and raises a wider issue with respect to research design and interpretation. As we
proposed in Chapter 1, taken-for-granted assumptions can shape researchers’ choices about the way in
which they pose research questions, design studies and interpret results or, in the case of editorial teams,
make decisions about what to publish. Thus, if inequalities in access are to be properly understood and
acted on, it is important that research is objective and robust.
Producing such evidence has been the aim of this project, a key rationale of which was our concern about
the way in which the use of proxy measures for health service need may have given rise to findings that
are subject to statistical artefact. Although, as we discuss below, it is important to examine ‘within-system’
inequalities in access to and utilisation of care, for example the extent to which particular hospital
treatments and/or procedures are provided relative to the number of people admitted with a particular
diagnosis, it is also important to acknowledge that such data will incorporate both unmet need and
unjustified supply. In other words, they may bias our understanding of the extent to which services are
being accessed relative to underlying need.
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Against this background, we have sought to produce modelled estimates of health service need that are
independent of unmet need and supply and to analyse those estimates against measures of health service
utilisation. The focus on CVD and CMHD has allowed us to explore our hypothesis that the nature and
direction of variations in access and use are likely to vary according to clinical conditions. Available data
sets on utilisation (which are particularly rich with respect to CVD) have allowed us to examine whether or
not variations in use relative to need differ at different points of the care pathway. Reflecting a concern
that other dimensions of inequality may have been relatively neglected owing to a prevailing concern with
inverse care, we have also explored the extent to which the ethnic, age and geographical characteristics of
populations explain variations in use relative to underlying need.
Summary and discussion of findings
Estimating local disease prevalence
The decision to use a ‘bottom-up’ approach to estimating population-level disease prevalence through the
aggregation of modelled individual-level disease risk estimates raised significant methodological and
computational challenges. We were nevertheless concerned to produce estimates that were independent
of issues of candidacy and adjudication. We have also sought to avoid a priori decisions about which
particular survey questions (or biometric evidence) would best reflect variations in need and have instead
made post-hoc assessments of the face-validity of the final estimates vis-à-vis a suboptimal but
unavoidable comparison with available utilisation data. We have been clear about the fact that, in the
absence of ‘gold-standard’ comparator data, confidence in the estimates must ultimately rest with the
suitability and utility of the estimation methodology that underpins them. It is nevertheless encouraging
that we were able to construct need estimates for CVD, diabetes, CHD, hypertension and stroke that are
significantly better predictors of variations in QOF registration rates than the currently available PHE
estimates. Furthermore, whereas the Plymouth estimates were generally incorporated as the most
important factor in linear regression modelling of variations in health service utilisation, the PHE need
estimates behaved erratically. We have little doubt that these new estimates offer a step-change
improvement in our knowledge concerning the distribution of CVD and CVD-related needs.
The mental health estimates are more difficult to assess. Forty-one different estimates were produced,
which give rise to a diversity of prevalence rates, not all of which even relate to each other. As predictors
of QOF prevalence, they perform poorly. Indeed, in stark contrast to hypertension, CHD and diabetes,
there is surprisingly little relationship between the proportion of patients on QOF Depression Registers and
estimates of either (a) the number who report having ‘ever been diagnosed’ with depression or (b) any of
a large number of self-reported or schedule-based assessments of the presence of a CMHD. For instance,
at practice level, the strongest correlation with QOF registration rates is with the proportion of people who
report that they ‘had ever had a mental health issue’ (R= 0.386; R2= 0.149).
Prevalence rates based on established schedule-based assessments of the presence of CMHDs are even
less well correlated with QOF registration rates. For instance, correlation with GP-level estimates of the
proportion of people with a CIS-R score of ≥ 12 (commonly taken to indicate the presence of a
non-psychotic psychiatric disorder) is R= 0.088 (R2= 0.008), while correlation with the estimated proportion
of people scoring ≥ 18 (indicative of a non-psychotic psychiatric disorder in need of treatment) is only
marginally better at R= 0.121 (R2= 0.015). The CIS-R interview captures a wide range of non-psychotic
mental health disorders, but the subset concerned with ‘symptoms of a depressive episode’ generates a set
of estimates which are only marginally better correlated with QOF Depression Register rates (r= 0.124;
r2= 0.015). Estimates of the proportion of people with a GHQ12 score of ≥ 4 (indicating possible
psychological disturbance or mental ill health) are similarly poorly correlated with QOF rates
(R= 0.134; R2= 0.018).
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The overwhelming impression is that our modelled estimates of the prevalence of depression (and
non-psychotic mental illness generally) bear very little relation to QOF registration rates; but is this because
of a complete failure of our approach to capture variations in CMHD morbidity, or because QOF
registration of depression is profoundly variable?
In the first place, it would be surprising if the underlying approach, demonstrably effective with respect to
hypertension, CHD and diabetes, should fail with respect to mental health. Thus, although it is possible
that the way in which people respond to questions about their mental health may undermine the use
of the resulting data for predictive purposes, the fact of the matter is that the same data sources are used,
the same method of deriving individual-level risk estimates is employed, and those estimates are then
applied to the same microsimulated populations. Second, some of the modelled estimates for CMHDs
perform much more creditably with respect to other measures of health service use. For instance, in stark
contrast to their lack of association with CCG-level QOF registration (R=−0.005), estimates of the
proportion of adults with a CIS-R score of ≥ 12 are much better correlated with estimates of
the proportion of adults in contact with secondary services (R= 0.570; R2= 0.322). Similarly, although the
proportion of adults reporting that they ‘had a mental health issue in the last 12 months’ is relatively
poorly correlated with QOF registration rates at CCG-level (R= 0.379; R2= 0.143), it is a better predictor of
the proportion of adults accessing community mental health or IAPT services (R= 0.516; R2= 0.263).
CCG-level prescribing, meanwhile, correlates relatively well with CCG-level estimates of the proportion of
adults per capita reporting ‘extreme anxiety and/or depression or taking prescribed mental health
medication’ (R= 0.689; R2= 0.472).
These associations are not as close as those found with respect to diabetes, hypertension and CHD, but
they do indicate that the proportion of adults QOF registered with depression is likely to be a poor
indicator of underlying rates of depression, let alone of non-psychotic mental illness more generally. In
other words, much of the discontinuity between our estimates of need and QOF registration rates is likely
to lie with practice- and PCT-/CCG-level variations in case finding.
One cannot, of course, attribute ‘truth’ to the modelled estimates of need and we recognise that the
mental health estimates are, by their nature, more problematic than those for CVD. Indeed, given ongoing
debate about the construct validity and reliability of psychiatric diagnostic categories and criteria (diagnosis
itself purportedly lacking a gold standard), the hope of producing clear and uncontested indicators of
mental health service need was perhaps naive. Yet there were some encouraging findings, not least the
fact that the modelled prevalence rates were significantly more effective than both QOF prevalence and
the existing Public Health Observatory estimate at predicting CCG-level variations in the number and
proportion of people accessing community mental health and IAPT services, as well as at predicting
variations in secondary mental health service use.
We thus argue that the Plymouth estimates are based on methodological rigour and offer useful measures
of underlying need with respect to both CVD and CMHDs. They may not be definitive, but need estimates
are required for planning, commissioning and evaluative purposes and, for the present, there is no
plausible alternative means of quantifying the underlying ‘need’ for health-care services.
Understanding the distribution of health service need
To this end, an important finding is the significant variation that exists in the geographical distribution of
CVD and CMHD. Reflecting the relative contributions of age, deprivation, ethnicity, etc. in disease risk, the
prevalence of most CVD conditions is largely driven by demography and exacerbated by poverty. Thus,
the highest prevalence rates of diabetes (a risk factor for CVD) are to be found in Lincolnshire, Newcastle
and Tyneside, North Devon and Cornwall, areas in which older age profiles and deprivation combine to
increase disease risk. Stroke and hypertension prevalence show similar patterns, although more coastal
areas (with ageing demographies) show up on the maps of high prevalence. It is, however, important to
note that not all CVD prevalence estimates are distributed in this way. For example, self-reporting a
heart/circulatory disease as a self-reported LSI shows a distinct north (high)/south (lower) pattern.
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Mental health, by contrast, has a strongly urban distribution. This is particularly the case when based on
CIS-R ≥ 12 and ≥ 18 criteria, although most of the prevalence estimates show a similar pattern (although
Lincolnshire also appears to be a high-prevalence area). Symptoms of a depressive episode slightly bucks
this trend, with high rates being found in demographically older coastal areas such as Cornwall, Devon,
Norfolk, Kent and, again, Lincolnshire.
The main conclusion to be drawn here is that the distribution of crude prevalence varies by clinical
condition. Moreover, the pattern of CVD prevalence is not cognate with patterns of standardised morbidity
and mortality which have been increasingly deployed as proxies for health service ‘need’. It is important
that service planners and commissioners recognise this difference. As standardised rates effectively design
out the effects of age, they are poor proxies for the crude prevalence of (and, by association, health service
need for) diseases where risk is highly age-related. There is a need for greater clarity about the purpose
and impact of age standardisation and we believe that our prevalence estimates and maps will make a
contribution towards this end.
Existing literature on variations in access and use
As noted above, taken-for-granted assumptions can shape researchers’ choices about the way in which
they pose research questions, design studies and interpret results. In our review of existing literature, we
found that studies that had explored inequalities in access to and use of CVD care were more likely to
have focused on socioeconomic status, while studies on access to/use of mental health services were more
likely to have focused on ethnicity.
Study design can influence the eventual evidence base, though we note a distinct improvement in the
methodological quality of studies since the 1990s. Accepting published literature at face value, reviewed
studies suggest that older age and female sex are the key dimensions of inequality with respect to CVD
care; and older age and non-white ethnicity are the key dimensions of inequality with respect to mental
health services. For both CVD and mental health, very significant unexplained geographical variation exists
in utilisation. Evidence of socioeconomic bias in access and/or utilisation is more ambiguous
and contradictory.
The methodological quality of studies is better for CVD than for CMHD. Most accounts of mental health
use do not adjust for underlying need, in part, no doubt, because of the hitherto lack of robust estimates
of need.
Analysis of use relative to need
Relating use to stage on the care pathway
As noted in Chapter 1, we have proposed that the model of candidacy and adjudication provides a useful
framework by which to understand that inequalities in use can arise at different stages of the care
pathway. In order to access services, people need to recognise their eligibility as candidates for health care
in the first place. Delay, denial, confusion about symptoms, embarrassment or a preference for
self-management can influence decisions to seek help, as can practical issues such as the need to arrange
childcare/time off work. Problems that arise before GPs become involved can be addressed through
sensitive and targeted health service interventions (such as awareness campaigns and support for
transport). However, they cannot be simply attributed to inequalities in health service availability.
Once patients have gained entry to the system, the categorisation and disposal of their health needs
depends to some extent on their ability to present in ways that health professionals find credible and
legitimate. In turn, the way in which health professionals categorise health needs may be affected by
pre-existing attitudes, perceptions of patient preferences, technical eligibility and knowledge and/or
experience of local capacity. These are important issues of concern from a policy perspective insofar as
practitioner attitudes and health service capacity are within the remit of those deciding matters relating to
professional practice, resource allocation and so on. In understanding the factors that shape clinicians’
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decisions to open up the pathway to treatment, it is also important to note that there is not always a
clearly cut boundary in the locus of decision-making. Thus, although GPs are usually responsible for initial
referral to specialist care, it is the specialists themselves who determine access to secondary-level treatments.
As a large-scale, statistical investigation, we acknowledged from the outset that the study would not yield
in-depth qualitative evidence of the ways in which candidacy is recognised and asserted, how people are
categorised and disposed by health professionals, or of interactions between these processes. However,
by potentially identifying systematic effects at different stages of the pathway to care, we did hope to gain
insights into key points of candidacy and adjudication that would lend themselves to further quantitative
and qualitative research.
Variations in disease presentation
For both CVD and CMHDs, we have sought to examine where inequalities arise at different stages of the
care pathway. Using QOF registration as a measure of presentation is not an ideal method of capturing
help-seeking behaviour, as it is an outcome of the decision by patients to access primary care, of GPs to
make a diagnosis and, of course, of the proper maintenance of QOF registers. However, in view of the
financial incentives associated with the QOF and evidence that, over time, variations in the achievement of
QOF indicators have significantly declined (suggesting a greater consistency of recording and practice),
we propose that QOF data are the best available measure of primary presentation.
The findings suggest that the level of unmet need (where modelled estimates exceed diagnosed
prevalence) varies from condition to condition. We found that the overall number of patients estimated to
have diabetes in the community (using different definitions) is very similar to the overall number of people
on the QOF register. This may reflect the fact that this disease produces distinct symptoms (e.g. feeling
very thirsty, passing more urine than usual, feeling tired all the time) that are likely to promote
help-seeking behaviour. Diabetes is also a well-defined condition that is straightforward to diagnose.
This is not to say that there is no inequality in the presentation and diagnosis of diabetes. In terms of the
need indicator based on the number of people reporting diabetes as a LSI (the most effective estimate at
predicting variations in QOF registrations), there is a 1.77-fold variation in PCT-level registrations per
expected (modelled) case. Moreover, although registration is significantly higher than one might expect
among Asian populations and in deprived and rural communities, it is significantly lower in practices with
larger percentages of black populations. At PCT level, there is also some evidence to suggest that, relative
to underlying need, younger populations are less likely to be diagnosed with diabetes. As noted above,
this statistical analysis does not allow us to conclude whether variations in modelled versus diagnosed
prevalence arise from demand- or supply-side factors. It nevertheless provides some pointers for future
research and policy (see Implications for further research).
Hypertension is also a well-defined condition. However, in many cases, it has no symptoms that would
lead people to consult their GP. Thus, while our needs estimate based on ‘clinical evidence’ of diagnosed
or undiagnosed high blood pressure predicts 99.2% and 77.8% of the variation in QOF counts at PCT and
practice levels, it also yields evidence of high levels of unmet need. The modelled prevalence rate (aged
≥ 16 years) of 32.3% greatly exceeds the QOF prevalence rate of 13.6%. This suggests underdiagnosis of
58% of expected cases, compared with 45% of expected cases in the 2011 NHS Atlas for Variation. In our
study, there is a 1.53-fold variation in PCT-level registrations per expected (modelled) case, compared with
a 1.7-fold variation in the NHS Atlas for Variation. Again, of the factors that yield significant standardised
coefficients at the PCT and practice levels, underlying need accounts for most explainable variation in QOF
registration. Smaller but significant coefficients are found for percentage black population and percentage
population under 50 years, both of which are associated with higher presentation rates than expected.
Presentation of hypertension in more rural PCTs and practices is significantly lower than expected,
although again the coefficients are small. It is interesting to note that population characteristics associated
with underdiagnosis vary between diabetes and hypertension, and tempting to suggest that whereas the
former reflects individuals’ willingness to respond to specific symptoms, the latter may reflect the extent to
which GPs proactively identify the presence of an often asymptomatic condition.
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A number of modelled prevalence rates are available as potential ‘needs indicators’ for CHD. Using ‘clinical
evidence of CHD’ as the basis on which to measure health service needs, we estimate a prevalence rate of
11.6% among those aged ≥ 16 years. This compares with the national QOF CHD prevalence rate of
around 4.2% aged ≥ 16 years, again suggesting significant levels of underdiagnosis (64% of expected
cases). The modelled prevalence rate of doctor-diagnosed CHD (5.4%) is far closer to QOF prevalence.
However, we have questioned whether or not such an explicitly utilisation-based measure of needs should
be used as the basis for assessing how use varies relative to need. Using the clinical evidence measure,
there is a 2.37-fold variation in PCT-level registrations per expected cases (which compares with a 2.7-fold
variation in the 2011 NHS Atlas of Variation). Modelling variations in use relative to need, we found that
QOF registration is significantly higher than one might expect among Asian populations and significantly
lower in PCTs with higher percentages of black and younger populations at both PCT and practice levels.
We found no evidence of socioeconomic differences in QOF registration.
Although the number of people estimated to be living with stroke as a LSI condition is very strongly
predictive of PCT-level variations in the number of people on the QOF register, the overall estimated
prevalence (1.0%) is much lower than the overall QOF registration rate (1.7%). The prevalence estimate is,
nevertheless, a good predictor (% R2= 98.3%) of PCT-level variation in QOF counts and, thus, can be used
to explore variations in the health-care use relative to underlying need. Here, we find a 1.63-fold variation
in PCT-level registrations of stroke per expected cases and, although stroke registration and prescribing at
the practice level of analysis are higher than expected in more deprived areas, younger age and ethnicity
emerge as consistently significant coefficients of lower use. In this case, both black and Asian populations
appear to have lower QOF registrations than expected.
Across all of the CVD and CVD-related conditions that we analysed, ethnicity emerged as a consistent
predictor of variations in use relative to need. This possibility has received far less attention than that of
socioeconomic variations in utilisation. We consider it to be an important finding, as is the evidence that
patterns of use appear to vary between South Asian and black populations. There has been a tendency in
the past to group different ethnic groups into one category. The results of this research suggest the need
for a more nuanced approach and for further investigation into whether differences in help-seeking
behaviour between different ethnic groups reflect cultural, economic or health service factors.
Turning to CMHDs, as noted above, the prevalence estimates were far less effective at predicting variations
in QOF registrations. Even the best predictor, namely the proportion of adults who report that they ‘ever
had a mental health issue’, explains only 30.4%, 37.2% and 14.9% of variation in QOF registration rates
at CCG, PCT and practice level, respectively. Once additional factors describing key aspects of
demography, ethnicity, deprivation and rurality are incorporated in a linear regression model, the
proportion of variation in QOF registration that can be explained at CCG, PCT and practice level rises only
to 35.3%, 42.9% and 17.0%, respectively.
A large proportion of the variation in QOF registrations thus remains unexplained at all levels, which may
suggest the need for some caution in interpreting the findings. Thus, although it is plausible that, at local
levels, the proportion of people being QOF registered fluctuates randomly, it is equally plausible that there
are factors at work here that we have not been able to incorporate in this analysis. If so, then once included
they may well affect the independent effect of factors such as deprivation and ethnicity. That said, our
finding that areas with higher percentages of black populations have significantly lower QOF-recorded
depression than expected does correspond with the results of many studies that find that being a member of
an ethnic minority is associated with lower rates of help-seeking behaviour for mental distress. Again,
however, the need for a more nuanced account is indicated. At practice (but not PCT/CCG) level, for
example, we find that areas with higher percentages of Asian populations have significantly higher-than-
expected rates of QOF registration. At all scales of analysis, more deprived areas have higher registrations
than expected, which again corresponds to literature that suggests that the socially disadvantaged are more
likely to seek formal help for mental health problems. In contrast to published literature, however, we found
no evidence to suggest that younger or older populations have differential rates of diagnosis relative to need.
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Variations in primary management
As one moves up the care pathway, the percentage of variance that can be explained by estimated
prevalence tends to fall (particularly with respect to CVD and CVD-related conditions). The data that are
available to us cannot explain the extent to which unexplained variation is legitimate (patients with ostensibly
similar diagnoses requiring different levels of treatment) or stems from inappropriate processes of adjudication
by clinical professionals. Nevertheless, we do find evidence of systematic variation, which raises concerns.
All of our measures of primary management relate to prescribing, which are measured by either rates of
prescribing of specific BNF categories or PBC expenditure. With respect to diabetes, we find similar
patterns to those relating to presentation of disease. Thus, rates of prescribing are significantly higher than
expected among Asian populations and in deprived and rural communities, and lower in practices with
larger percentages of black populations. With respect to the demography of communities, the results are
mixed, with practices with a higher percentage of adults under the age of 50 years being less likely to
prescribe diabetic drugs (BNF 6.1487) and other antidiabetic drugs (BNF 6.1.2487) but more likely to prescribe
insulin (BNF 6.1.1487).
Prescribing data for CHD also suggest higher-than-expected rates of primary management among Asian
populations and lower-than-expected rates among younger and black populations (although it is important
to note that these additional factors explain a relatively small proportion of overall variance). Variations in
prescribing according to deprivation and rurality are mixed according to type of medication, suggesting no
overall pattern with respect to socioeconomic status and geography. By contrast, primary management of
hypertension shows no clear pattern of ethnic variation, although rates of prescribing are higher than
expected in deprived communities and lower than expected in rural areas.
Rates of prescribing for stroke (at the practice level) are also higher than expected in more deprived areas.
In this case, however, younger age and ethnicity emerge as consistently significant coefficients of lower
use. Black and Asian populations appear to have lower prescribing of oral anticoagulants and warfarin
than expected. Antiplatelet prescribing is also lower than expected among black populations.
As noted above, the results on variations in use relative to need for CMHDs are more difficult to interpret.
Nevertheless, ethnicity again emerges as a consistent predictor. At CCG, PCT and practice levels, the
percentage of population that is ethnically black is an important predictor in the linear regression of variations
of per-capita prescribing (with areas with higher proportions of black/black British populations having
lower-than-expected rates of prescribing). This corresponds with evidence from the National Psychiatric
Morbidity Surveys. Reviewed evidence also suggests that prescribing for anxiety and depression is significantly
lower in areas with higher percentages of Asians, which corresponds to our findings at CCG and practice
levels. Levels of prescribing are significantly higher than expected in more deprived CCGs, PCTs and practices.
Again, this tallies with the conclusion of published studies that find no evidence of inverse care in the treatment
of moderate and severe depression. Unlike the published literature, we find no evidence of systematic
undertreatment of older populations. We do, however, note the presence of, and possible wider consequences
of, a ‘London effect’, where prescribing relative to need appears to be much lower than might be expected.
Variations in specialist management
Investigation of variations in use relative to need of specialist services provides some intriguing insights into
the role of the relative mix of care, particularly for diabetes. PCTs and practices with a higher percentage
of Asian populations have lower-than-expected rates of admission (elective and emergency) for a main
diagnosis of diabetes and lower PBC expenditure on the disease. By contrast, PCTs with a higher
percentage of black populations have higher PBC expenditure on hospital care (data available at PCT level
only). This suggests the possibility that, among Asian populations, diabetes may be better managed within
primary and community settings than it is among other population groups. Against this, more deprived
PCTs and practices have higher-than-expected rates of both prescribing and secondary care (particularly
with respect to emergency admission for diabetes as a main diagnosis), and PCTs and practices with higher
black populations have lower utilisation rates than expected in both primary and secondary care.
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With respect to the secondary management of CHD, the percentage of variance explained by both
underlying ‘need only’ and ‘full model’ falls away significantly. This is likely to reflect the fact that ‘within-
system’ management is a more important determinant of need for specialist CHD services than underlying
prevalence. Effective management within primary and community settings means that a good proportion
of patients with CHD can avoid hospital intervention. The fact that significantly higher rates of CHD
presentation and prescribing among South Asian populations are not accompanied by lower rates of
inpatient use does not necessarily undermine this argument. Given evidence that South Asians are at
excess risk of CHD for reasons that cannot be explained by conventional risk factors, and that they tend to
develop the condition at younger ages,477,478,491,493 their higher use of secondary interventions may well
reflect the challenges of developing optimal prevention regimes for this population. It is, nevertheless, the
case that the ‘relative mix’ explanation does not apply in other cases, such as that of stroke, for which
black populations have lower QOF registrations, lower prescribing of oral anticoagulants and warfarin and
lower secondary use than expected.
In addition to the role played by relative mix, we note that there may be regional variations in access
relative to need which cannot be explained by compositional (i.e. socioeconomic, sociodemographic and
ethnic) characteristics. For instance, the North East has relatively high levels of secondary expenditure on
cardiac care, as do parts of the South East and South Central regions. By contrast, ‘Shire England’ has
relatively low rates of secondary expenditure relative to need. It also has lower levels of prescribing, which
suggests that relative mix of care does not fully explain the pattern. There are a number of possible
explanations for this, of which we consider the funding context to deserve further investigation.
Turning to the specialist management of CMHDs, we find no evidence of systematic bias – by
socioeconomic status, age, ethnicity or rurality – in rates of IAPT uptake relative to need. In that sense this
would appear to be an equitable service, although there are geographical differences in service availability
which may reflect factors that have not been included in the linear regression model. There is also little
evidence that the number of people in contact with secondary mental health services varies according to
population characteristics at the CCG level, although, at the PCT level, areas serving more deprived
communities are spending significantly less than expected. Thus, we find an interesting contrast between
CVD and CMHD: although underlying prevalence appears to be a better predictor of need for more
specialist CMHD services, the opposite appears to be true for CVD. Here, the estimates are better at
predicting variations in presentation and primary care than hospital care. Differences in the relative
effectiveness of primary care services to reach people with needs (poor with respect to mental health
needs but much more equitably with respect to CVD and CVD-related conditions) may be part of the
explanation, as may differences in patterns of disease severity (e.g. by age) and the effectiveness of
primary management. Further work certainly needs to be done to examine variations in utilisation within
age cohorts.
Strengths and limitations
A key strength of the research project lies in its practical contribution. We aimed to support service
planning and delivery by disseminating, via PHE, estimates of CVD and CMHD health-care need at
different spatial scales. We have succeeded in this aim by (a) providing PHE with a range of Plymouth
needs estimates (for 24 CVD and CVD-related and 41 CMHD potential ‘markers of health-care need’) and
(b) making these available at a range of geographical levels (LSOAs, MSOAs, upper- and lower-tier LAs,
regions, general practices, PCTs, CCGs and SHAs). The latter point is important if constituencies outside
the NHS are to make use of the prevalence estimates, supporting, for example, key public health functions
that have now transferred to LAs. This approach also supports data linkage, which is particularly important,
as indicators of health and health service utilisation against which needs estimates might be compared are
made available for a range of different organisational and spatial units.
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We have also demonstrated the consequences of using different measures of need in studies of
health-care equity. The fact of the matter is that any shortcomings in the data and/or methods used to
generate need estimates will result in spurious conclusions regarding health-care equity. For instance, if an
estimate fails to fully capture the extent to which socioeconomic deprivation affects the prevalence of
a particular condition, then, even if different populations make genuinely equitable use of health services,
analyses based on that estimate will make it appear as if deprived communities are making greater use of
health services than might otherwise have been expected. Establishing robust denominators of need is
demonstrably sine qua non for any study of health-care equity.
This project has also served to demonstrate that needs estimation is perhaps more difficult than has been
generally recognised. Certainly we found that constructing the needs estimates detailed in this report
raised many more methodological and computational challenges than we had anticipated. We are satisfied
that we offer a step-change improvement in prevalence estimates for a variety of specific CVD, CVD-
related and mental health conditions, but we recognise that not all methodological issues have been fully
addressed (see Implications for further research). We also hope that our pedantic exploration of the wide
range of possible needs indicators (detailed in Appendices 26 and 27), and, in the main report, of the
range of assumptions that underpin the construction of the various prevalence estimates, serves to
emphasise the essentially contested nature of all needs estimates. Few studies of health-care equity pay
sufficient attention to the appropriateness of their particular needs denominator, or to the extent to which
its use may influence conclusions regarding patterns of health-care equity.
As a direct result of having to direct a very significant proportion of our research effort at developing a
robust, if not yet definitive, methodology for generating prevalence estimates at a variety of scales and
across a range of conditions, our ability to model demand- and supply-side factors influencing variations in
use relative to need has been constrained. This part of the project has been far less ambitious than
originally envisaged and, as detailed in Implications for further research, further research is needed to add
value to the wealth of data generated by this project.
While this clearly means we have been unable, as intended, to explore specific issues such as the potential
impact of service configuration and funding on health-care equity, it also means that our conclusions,
particularly with respect to mental health, regarding relationships (or lack of relationships) between
use-to-need ratios and sociodemographic factors must be treated with some caution. For instance, in the
case of mental health, the overall picture presented here is one of unexplained variation, particularly with
respect to the use of primary care services. This is an interesting and important finding because it hints
at local variations in medical practice that threaten the principle of equal access to equal needs. It is thus
clearly necessary, as noted in Implications for further research, to extend the analysis of variations in use
relative to need to include additional demand- and supply-side factors. In other words, further analysis may
show there to be significantly less unexplained variation in the use of primary mental health-care services
than currently appears to be the case.
Furthermore, until this further analysis is undertaken, it is not possible to entirely discount the possibility
that our current understanding of the role that demography, sex, ethnicity and deprivation play in
determining variations in use relative to need will change. For instance, the current analysis suggests that,
at GP level, relatively little variation in the use of primary care services for CMHDs can be explained by
variations in underlying need. The ‘full’ model, which incorporates ethnicity but ‘rejects’ the potential
contribution of demography, deprivation and rurality, is only marginally better. With substantial
unexplained residual variance, it is entirely plausible that further analysis will show supply-side factors to
play a significant role in determining variations in health service use relative to need. Indeed, as noted
below, this is an obvious and urgent issue to investigate. But, the fact is that, once such factors are
allowed for, it is possible that the significance (or lack thereof) currently ascribed to demography, ethnicity,
deprivation and rurality will change. This is important, for any policy response to inequalities in health care
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must be based on a convincing understanding of the underlying dimensions of those inequalities. With
respect to diabetes, hypertension, CHD and stroke, this requirement has been largely met, although we do
not discount the possibility that supply-side factors have a part to play. We are not convinced that the
same can yet be said for our understanding of the determinants of the use of mental health services.
Finally, we are aware of the limitations associated with this study as an ecological analysis. Throughout, we
have sought to describe observed relationships in terms of differences between populations. Thus, GPs
with a higher proportion of Asian patients have higher QOF diabetes and CHD registration rates than
might be expected, while GPs with a higher proportion of ethnically black patients tend to have lower QOF
diabetes and CHD registration rates. This is, we believe, strongly indicative that, relative to need, Asian
patients with these conditions are, individually, more likely to present to GPs and black patients are less
likely, but one must always recognise that our perspective is ecological rather than individual. In this
respect we are particularly concerned about the disconnect between our finding – that areas with older
populations are neither less nor more likely to use services than expected – and the results of the literature
search, which suggest that older age is a key dimension of inequality in access to/use of both CVD and
CMHD care. In general terms it is clearly necessary to explore the observed ecological relationships to
establish whether or not they reflect individual-level processes of candidacy and adjudication: in other
words, taking this large-scale quantitative study as the starting point for more detailed, possibly qualitative,
studies of how different individuals interact with health-care services.
Policy implications
As we noted in Chapter 1, policy-makers appear to have accepted the conventional wisdom of inverse
care. Having positively targeted funding for hospital and community services at deprived areas, there are
signs that GP funding may also be redistributed to better respond to deprivation. Yet, as this research
shows, a GP managing a high caseload of one condition may have a lower caseload of another.
We find that the geographical distributions of CVD and CMHDs are very different. CVD is higher in
demographically older areas, particularly deprived coastal towns. By contrast, the highest prevalence rates
of CMHD appear to be in major cities. Thus, although further targeting GP funding at deprivation will
address ‘deep-end’ problems of managing mental distress, it will take funding away from practices that are
managing high caseloads of degenerative chronic disease. There is an urgent need to establish the relative
burden that these and other conditions place on GPs, as ‘robbing Peter to pay Paul’ will not promote
equality of access for equal needs across the disease spectrum.
It is not, however, simply a question of understanding the relative burden that these conditions place on
GPs; it is also a matter of establishing the relative importance that the public believes should be attached
to these, and other, conditions. Thus, we also noted in Chapter 1 that in recent years the pendulum has
swung from support for horizontal equity towards the promotion of equality in terms of health outcomes.
Health economists have argued that this is supported by the public, with studies of public preferences
showing that there is a concern to reduce inequalities in health. Yet there is, inevitably, a problem in the
way in which preferences are framed.41 Although several studies have offered respondents an explicit
choice between maximising population health and reducing inequalities in health,37,42 these trade-offs are
described in general terms. This research offers the possibility of providing the public with explicit
evidence-based choices, specifically about the consequences of prioritising mental health problems over
chronic diseases such as CVD.
We note that ethnicity is a consistent predictor of variations in use relative to need, with areas with high
proportions of black populations having lower rates of use than expected. This is pronounced with respect
to variations in presentation of CVD and CMHDs, suggesting that efforts could usefully be targeted at
raising awareness, strengthening screening activity and so on in these areas and with respect to
these populations.
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Finally, given that this project has made available detailed data on the prevalence of CVD, CVD-related and
mental health conditions at a variety of organisational and spatial scales, commissioners (at both national
and CCG level) should be encouraged to utilise this information when making decisions regarding service
provision (including service configuration and funding).
Implications for further research
As noted above, a substantial proportion of our research effort was absorbed by the methodological and
technical challenges faced when seeking to generate robust prevalence estimates. The resulting estimates
offer a step-change improvement on what has hitherto been available with respect to CVD, CVD-related
and mental health conditions, but we recognise that not all methodological issues have been fully
addressed. Insofar as we also demonstrate that suboptimal needs denominators can seriously contaminate
health-care equity analyses, possibly removing or reversing the significance of individual factors, an obvious
and important area for further research must be to consider further those specific methodological issues
about which we have continuing concerns.
Enhancing prevalence estimation and exploiting the prevalence estimates
The final prevalence estimates rest on a proper understanding of the detailed sociodemographic
composition of local populations, and this was established through microsimulation. Four issues arise with
respect to microsimulation.
First, the ONS has recently published microdata for the 2011 census and these could significantly improve
the iterative process which reconciles the aggregate characteristics of LSOA populations detailed in
individual census tables to derive a description of the underlying, but unknown, ‘full joint distribution’
(see Chapter 3, Microsimulation for small-area estimation). As the microdata detail which of the myriad of
theoretically possible person-types actually occur (albeit within a 10% sample), this would constrain the
iterative allocation of individuals to cells so that cells known to be empty are not populated.
Second, microsimulation could be designed to reconcile tables across geographic levels (rather than just at
LSOA level, as undertaken here). Census tables for higher geographies tend to be more precise (e.g.
including all five general health categories in cross-tabulations rather than the three aggregated categories
commonly used at LSOA level). The simultaneous iterative allocation of individuals to cells at multiple levels
would add considerable computational burden, but this would ensure that the final microsimulation fits
with a considerably wider evidence base. In a similar vein, the ONS will produce commissioned
non-disclosive census tables (for a fee). A judicious choice of bespoke cross-tabulations at LSOA level or
above could be used to further widen the range of ‘marginal distribution’ totals with which the final ‘full
joint distribution’ would have to be reconciled.
Third, as noted in Chapter 3 (see Microsimulation for small-area estimation), in theory multiple solutions
(i.e. full joint distributions) could meet the constraints defined by any given set of marginal distributions.
It is intuitively likely that these will occupy a relatively small area within the multidimensional space defined
by the marginal distributions (i.e. by the census cross-tabulation tables), but this is an issue we have not
been able to explore in detail. Of particular concern is whether or not a variety of quite disparate solutions
exist, and whether or not the solution to which the iterative ‘random walk’ method converges depends on
its starting point. There is a need, in other words, to explore whether or not uncertainty surrounding the
microsimulation of local populations is significant and, if so, whether or not that should be incorporated in
the uncertainty surrounding the final prevalence estimates.
Finally, and more generally, a detailed description of the composition of local areas would be of value
across many areas of research and planning. Implementing and disseminating (via a suitable web tool) a
microsimulation covering all of the major sociodemographic variables, and reconciling a wide range of
census cross-tabulations, could add significant value to the census. Care would be needed to ensure
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non-disclosure, but, given the methodology, this should not be an issue. The potential insights and utility
of microsimulation is of growing interest, as recently summarised by Tanton and Edwards,499 and the
experience of this project suggests that developing a web-based microsimulation tool would both be
possible (if computationally demanding) and, if accompanied by an appropriate quantification of
uncertainty, provide an invaluable resource to any analyses which need to use data on the detailed
composition of local areas.
Turning to the modelling of survey data in order to estimate the likelihood that different individuals will
exhibit or develop particular diseases, we are conscious that a number of essentially pragmatic decisions
were made at various points. For instance, we decided not to request ‘special access’ survey data with
additional information about precisely where individual respondents lived. This was partly because of the
administrative difficulties and additional time involved, but primarily because, a priori, we decided not to
utilise mixed-methods models. The problem, as we saw it, was that incorporating place (e.g. LSOA of
residence) as a random effect in a mixed-effects model of needs risks introducing potential supply-side
factors. Thus, if where you live influences how readily you can access a GP, and access to a GP influences
the likelihood of being diagnosed with a condition (or, having been diagnosed, of reporting such as a
long-standing illness), then using place of residence as a random effect in a mixed-effects model would,
inevitably, incorporate this supply-side factor in the needs estimate. As a result it would most probably not
appear as a relevant factor when variations in health service use are compared with the needs estimate.
The point, however, is that the practical consequence of this, and the various other a priori decisions noted
in Chapter 3, should be explored further in order to establish the sensitivity of the final estimates to those
decisions. If the Plymouth estimates describing variations in the prevalence of CVD, CVD-related and
mental health are to be as widely used by researchers, commissioners and public health practitioners as we
believe they deserve, a thorough sensitivity analysis is possibly necessary.
Although, as detailed above, further research could be usefully directed towards the further improvement
and evaluation of the methodology, more notable areas for further research concern the opportunities that
arise now we have demonstrated that small-area estimation and microsimulation can be combined to
generate robust prevalence estimates. First is a simple extension of the approach to cover a wider range of
conditions. The various surveys used here, and particularly the HSfE, provide a wealth of evidence across a
wide range of diseases. Indeed, the extent to which self-reported long-standing health problems predict
variations in the use of health-care services for diabetes, hypertension, CHD and stroke is particularly
encouraging, given that self-reported LSI data are widely collected using a standard reporting framework
(Box 1). The methodology is perhaps not suited (or the results are maybe not useful) across all disease
areas, but there is clearly considerable scope for extending the range of conditions for which prevalence
estimates are produced and disseminated. In addition to that, of course, are a variety of doctor-diagnosed,
biometric and other survey-based sources of information which could be used to provide a far broader
understanding of how disease prevalence varies at various scales.
A second obvious use of the methodology would be to focus on risk factors. Responding to interest
expressed by colleagues in PHE, we used the Framingham Risk Calculator in conjunction with data from
the HSfE to produce estimates of the number and proportion of adults aged 25–74 years (a) with a > 10%
risk of developing CHD in the next 10 years, and (b) who would be expected to develop CHD in the next
10 years. We also produced prevalence estimates of the number and proportion of adults with three or
more of NICE’s five modifiable risk factors for CVD. Although detailed in Appendix 26, these have not
been discussed in the main report as they were peripheral to our main focus. Yet they are indicative of the
wider range of risk factors and health-risking behaviours, such as smoking, obesity and physical inactivity,
for which prevalence estimates could be produced. Although in many cases similar estimates already
exist,441 these are not always available at sub-LA level, are seldom based on recent data and rarely use
methods comparable with that developed as part of this study. Extending the current methodology to
cover such risk factors would, we believe, significantly strengthen the public health evidence base.
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BOX 1 Standard LSI code frame
1. Cancer.
2. Diabetes.
3. Other endocrine and metabolic diseases.
4. Mental illness, anxiety, depression nerves.
5. Mental handicap.
6. Epilepsy, fits and convulsions.
7. Migraine and headaches.
8. Other problems of the nervous system.
9. Cataract, poor eyesight and blindness.
10. Other eye complaints.
11. Poor hearing and deafness.
12. Tinnitus and noises in the ear.
13. Meniere’s disease and ear complaints causing balance problems.
14. Other ear complaints.
15. Stroke, cerebral haemorrhage and cerebral thrombosis.
16. Heart attack and angina.
17. Hypertension, high blood pressure and blood pressure problems.
18. Other heart problems.
19. Piles and haemorrhoids, including varicose veins in the anus.
20. Varicose veins and phlebitis in lower extremities.
21. Other blood vessels and embolic conditions.
22. Bronchitis and emphysema.
23. Asthma.
24. Hay fever.
25. Other respiratory complaints.
26. Stomach ulcer, abdominal hernia and rupture.
27. Other digestive complaints.
28. Complaints of bowel and colon.
29. Complaints of teeth, mouth and tongue.
30. Kidney complaints.
31. Urinary tract infection.
32. Other bladder problems and incontinence.
33. Reproductive system disorders.
34. Arthritis, rheumatism and fibrositis.
35. Back problems, slipped disc and spine/neck problems.
36. Other problems of bones, joints and muscles.
37. Infectious and parasitic disease.
38. Disorders of blood and blood-forming organs and immunity disorders.
39. Skin complaints.
40. Other complaints.
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A third important avenue for future research would be to address, head-on, precisely what the prevalence
of particular diseases might mean in terms of health-care needs. There are two issues here. First, what
health-care resources are actually used by individuals with specific self-reported, doctor-diagnosed or
biometrically assessed conditions? Second, to what extent is that resource use sociodemographically
invariant? Understanding these issues would be of particular interest to commissioners/planners of local
health-care services as well as to those responsible for the allocation of resources to CCGs and general
practices. For instance, it was noted above that although the further targeting of funding towards GPs
serving more deprived communities might help them to address the high level of mental distress that is
characteristic of such populations, in a zero-sum resource environment this would mean taking funding
away from practices serving less-disadvantaged, but older, populations. These practices are typically
managing higher caseloads of degenerative chronic disease. Establishing the prevalence of different
diseases in different practice populations, as we have done for mental health and CVD, takes us only part
of the way towards finding an equitable balance between these conflicting demands. What is also needed
is an understanding of the demands such patients typically make on various health-care services, and to
that end the recent linkage of HSfE respondents to HES data offers exciting new opportunities. Although
individuals’ responses to HSfE questions were unavailable when we undertook this project, it is now
possible to compare these with their use of inpatient, outpatient and accident and emergency services
both before and after they were surveyed. As this can be quantified using, for example, reference costs,
this means there is an opportunity to (a) investigate whether or not different types of person with any
given prevalence marker for various diseases or conditions (such as a self-reported LSI) make different
demands on NHS secondary services, and (b) utilise that information to translate cohort-level prevalence
counts into explicit resource need estimates which, crucially and uniquely, are independent of supply-
side influences.
This concern with how ‘raw’ prevalence counts relate to actual resource needs, and the extent to which
such might vary by age and/or socioeconomic factors, could also be addressed by focusing on comorbidity
and, where possible, symptom severity. Here the aim would be to replace models predicting the likelihood
that different person-types would have, say, CHD, with more nuanced models predicting the likelihood that
their CHD was accompanied by more or less complex health-care needs, which would primarily reflect the
extent to which their CHD was accompanied by other health problems. Although it would be difficult to
express such information in terms of actual costs, the aim would again be to provide local and national
commissioners with unbiased evidence on the relative needs of different populations. Determining an
equitable allocation of resources between very different populations – as illustrated above in terms of the
conflicting needs of young urban deprived populations with relatively high rates of mental illness as
opposed to less-deprived but older populations suffering high rates of chronic degenerative disease –
requires a far better evidence base than is currently available. This project’s approach to estimating the
prevalence of health-care needs in local areas suggests how this evidence base might be constructed and,
by incorporating HSfE-HES linkage and/or evidence on comorbidity, could be developed to provide the
information needed for the equitable allocation of NHS resources to CCGs and below.
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Further research into health-care equity
We have not been able to investigate all potential demand- and supply-side factors and the impact they
may have on the utilisation of health-care services. As discussed at length in Strengths and limitations, this
means that many of our findings, particularly with respect to mental health, must be treated as provisional.
The problem is that very little of the substantial GP- and PCT-/CCG-level variation in mental health service
use (relative to need) can be explained with reference to demography, ethnicity, deprivation or rurality.
Other factors may, or may not, be influencing the utilisation of primary and secondary mental health
services, but, until their role has been fully investigated, our conclusions regarding the significance, size
and even direction of the sociodemographic factors that have been considered must be considered
provisional. This, then, is our single most important recommendation for further research and, as such, it is
where our own future research plans focus. The fact of the matter, though, is that as the Plymouth
estimates will be publicly available, this is an issue which other researchers can also readily address. Indeed,
we hope that the availability of these estimates will encourage others to investigate issues surrounding
health-care equity in England, particularly with respect to mental health, for which evidence on local
variations in needs has hitherto been available.
Finally, this project has made genuine progress in identifying factors which are associated with variations in
health service use relative to need. Summary and discussion of findings summarises many of the principal
findings. However, as this is a large-scale ecological study investigating relationships between modelled
estimates of need and health service utilisation data, it has not been possible to investigate the underlying
processes which give rise to observed variations in health service use. As any policy response to inequalities
in the use of CVD and mental health services requires a detailed understanding of why they arise, it is now
clearly necessary to take the findings reported here as a starting point for a detailed investigation of
individual-level processes of candidacy and adjudication.
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Appendix 2 Review-level evidence of variations in
access to/use of NHS services
Primary
author Year Title Setting Findings




l Strongest evidence at specialty level,
especially with respect to cardiac care
(where socioeconomic, age, sex and
ethnic inequalities have been observed)
l No systematic evidence of socioeconomic
inequity at the aggregate level of GP,
outpatient and inpatient consultations
(higher rates of GP consultation by the
socially disadvantaged)
l Some ethnic groups less likely to use
services (e.g. Chinese people). High rates
of utilisation for schizophrenia among
young African Caribbean men are
of concern
l Evidence is very weak in several areas,
including mental health and long-term
care




n= 449 studies from
1995 to 2001
l There appear to be no general barriers
to the use of GPs (apart from for
non-permanent populations) and indeed
certain ethnic populations are high users.
However, diagnosis, communication
and referral/treatment patterns remain
important issues requiring further study
l Concerns about racial stereotyping
among staff providing mother and
child services
l Mixed evidence for tertiary services
l Substantial evidence of distinctly
different patterns of care for
mental health
CRD2 2003 Inequalities in access
to cardiac services:
a scoping review
n= 105 UK studies
from 1995 to 2003
l More published studies in the tertiary
and primary settings than elsewhere
l More studies on age and sex variations
than other aspects of inequality
Bhui133 2003 Ethnic variations in




n= 38 UK studies
from 1983 to 2000
l Strong evidence of variation between
ethnic groups for voluntary and
compulsory admissions, and some
evidence of variation in pathways to
specialist care. Few studies are of
high quality
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Primary
author Year Title Setting Findings










l Mixed findings on ethnic inequalities in
access to cardiac care
l No comprehensive studies of access to
cancer services, but national patient
surveys show higher levels of
dissatisfaction
l Non-insulin dependent diabetes is
underdiagnosed in Asian diabetes and
several studies report inadequate health
care for Asian and African Caribbean
diabetics and poor compliance arising
from lack of knowledge
l Mental health: higher rates than
expected of admission (especially
compulsory admission) among black
patients
Rowe135 2004 Social and ethnic
inequalities in the
offer and uptake of
prenatal screening
and diagnosis in the
UK: a systematic
review
n= 20 UK studies l Only six studies reported data on
prenatal testing according to women’s
social class or educational level. None
found any significant social inequalities
in testing
l Some studies suggested that women of
South Asian origin were less likely to be
offered and to receive prenatal testing
for haemoglobin disorders and Down
syndrome than white women
Dixon-Woods3 2005 Vulnerable groups








restricted to the UK)
l Variations in the supply of health services
(capacity, quality, resource allocation,
configuration) play a role in shaping
access
l There is a persistent meta-narrative of
inverse care, but much of the evidence is
contradictory and hard to interpret
l Evidence of inequalities in the supply of
GPs is mixed. More consistent evidence
that the socioeconomically deprived
(especially unemployed) make higher use
of GPs
l Evidence about socioeconomic variations
in the use of specialist services in
secondary and tertiary care is even more
equivocal and difficult to interpret than
that for GP care. Greatest body of work
has focused on cardiology where there is
no consistent evidence of inequality
l Stronger evidence that the uptake of
many preventative services is poorer
among low-income groups (inverse
prevention law) and use of A&E is
higher. Poorer groups may find it difficult
to mobilise the resources necessary to
assert candidacy by putting in an
appearance or responding to an
invitation to health services (resulting in
non-attendance), and may have
difficulties in particular in using less
permeable services
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Primary
author Year Title Setting Findings
l There are concerns that people who are
socioeconomically disadvantaged may
lack skills in demonstrating candidacy or
convincing health professionals of the
authenticity and legitimacy of their claim,
or in showing that they can convert
health care into health benefits (e.g. due
to comorbidities or health behaviours)
l Similar meta-narrative with regard to
ethnicity but, with the exception of
mental health care and preventative care,
evidence is mixed. Lack of recent,
good-quality research
l Older people: underdiagnosis and
utilisation for mental health problems.
Relative lack of access to specialist
interventions. Institutionalisation a key
risk factor
l Sex: evidence of lower access to
specialist cardiac interventions relative
to need














l Access to GP services is mildly pro-poor
or equitable
l Lower rates of cardiac intervention
among deprived relative to need
l Lower rates of elective surgery among
deprived relative to need
l Mixed evidence with regard to cancer
care
l Lower rates of uptake of preventative
services among deprived
Goddard137 2008 Quality in and













l After adjusting for need, there appears
to be higher rates of consultation in
primary care among some ethnic
minority groups than among similar
white groups (South Asians, Pakistani
Indian, Bangladeshi origin); and lower
rates in some groups, such as Chinese
people. Patterns are not always
consistent between sexes
l Utilisation of specialist outpatient and
inpatient care appears lower among
ethnic minority groups than equivalent
white groups but this is not consistent
across sex, age or specialism and many
studies have poor methodologies
l Most research effort on ethnic
inequalities has been in the area of
mental health disorders where there is a
generally consistent picture of greater
than expected rates of diagnosis and
compulsory forms of psychiatric
treatment among black patients than
among their white counterparts
l Mixed evidence with regard to age
l People with mental health disorders
receive less general health care,
particularly preventative health services
l Availability of specialist mental health
services is also apparently not distributed
geographically according to need
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Primary
author Year Title Setting Findings





between the USA and
the UK
n= 43 US and UK
studies
l Socioeconomic inequalities in (a) waiting
times for and (b) uptake of invasive
coronary procedures similar in the UK to
those seen in the USA




from 1998 to 2008
l Women with CHD are less likely than
men to be referred to specialists and
have their cholesterol recorded, and are
less likely to be prescribed some
medications
l Women are more likely than men to
enter weight management programmes
in the private sector and are also more
likely to be treated for weight problems
in primary care
l Owing to sex differences in willingness
to recognise a problem and to seek help,
and perhaps also assumptions of health-
care providers, men with depression and
anxiety are more likely than women
not to be diagnosed and this has
consequences for their treatment and
for outcomes
Appleby123 2011 Variations in health
care: the good, the
bad and the
inexplicable
l Significant variations exist between PCTs
in elective hospital admissions – it is hard
to find examples in which there is little or
negligible variation
l Greatest variation is apparent for PCI,
knee replacement revision, CABG and
hip replacement revision
l Even comparatively commonplace
procedures such as hip replacement,
cataract removal and cholecystectomy
show a fourfold variation across PCTs
l Significant variation between PCTs in use
of day case surgery – greatest variation
for tonsillectomy and laparoscopic
cholecystectomy
l Significant variation in rates of
low-effectiveness procedures, higher
rates in socioeconomically deprived areas
l Deprived areas have lower rates of
admission for hip replacement (no
association between deprivation and
access for knee replacement)
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Boeckxstaens140 2011 The equity dimension










l An age gap in the quality of health care
for CHD, diabetes and CVD documented
before the implementation of QOF. QOF
succeeded in reducing this age gap by
improving the quality of health care for
the oldest patients more than for the
younger patients
l Men seem to have benefited more from
QOF than women. Before the
introduction of the contract, men scored
significantly better on the quality of care
for CHD, CVD and diabetes. After QOF
introduction, all of the CHD and diabetes
indicators with a difference favouring
men persisted, and additionally, a
pro-male inequity occurred for a number
of other indicators. For CVD, the gap
became smaller but remained in favour
of men
l Pre QOF, a difference between deprived
and less deprived areas was found for a
relatively small number of quality
indicators related to CHD, diabetes and
CVD. Some indicators are even in favour
of the patients in the most deprived
areas. Shortly after the introduction of
QOF, some studies described a slight
increase in inequity. In addition, greater
variation in achievement between
practices was found with greater
deprivation. However, the gap existing in
the first year after the introduction of
QOF narrowed in the years after to
almost negligible differences for all of
the described conditions (due to greater
quality improvements in deprived areas)
l Pre QOF, CHD patients of South Asian
origin had better-controlled cholesterol
than white or black patients. After the
introduction of QOF, they even scored
better in three additional aspects of care.
For other indicators, results are scattered
Cheung141 2013 Unwarranted
variation in health





l Paucity of studies. Only 19 included
children in the title/abstract; five focused
on children < 18 years alone
l Unwarranted variation in effective care
between PCTs (e.g. rates of completion
of immunisation; proportion of known
diabetic children admitted to hospital for
diabetic ketoacidosis)
l Emergency admission rates to hospital
for children with asthma varies 25-fold
by PCT; for epilepsy, ninefold. Rates of
admission for bronchiolitis in children
varies 14-fold, and their length of stay by
nearly sixfold, rates which bear no
correlation to population indices of
socioeconomic deprivation
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Methods not outlined l Rates of ambulatory care sensitive
conditions (ACSCs), defined as
conditions for which hospital admission
could be prevented by interventions in
primary care (e.g. asthma, epilepsy,
diabetes) are much higher in deprived
areas
l Rates of primary hip replacement are
higher among those in higher
socioeconomic groups, but rates of knee
replacement appear to be higher in the
most deprived areas
l Rates of cardiac interventions are lower
in deprived areas
l Rates of elective admission are lower in
deprived areas
l People with cancer from deprived areas
are more likely to receive their diagnosis
in an emergency setting; mixed evidence
with regard to access to chemotherapy
Martins143 2013 Ethnic inequalities in
time to diagnosis of
cancer: a systematic
review





l Existing studies provide insufficient
evidence to confirm or refute ethnic
inequalities in diagnostic intervals of cancer
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Appendix 3 Geographical variations in access
by specialty
Cancer services
Source Denominator Nominator Finding





% receiving surgery 12.5–23.5% (1.9-fold variation)
Mental disorders






people aged 17 years
Unplanned readmissions
to mental health services
within 30 days
Indirectly standardised ratios vary from
24.9 in NHS East Riding Of Yorkshire




PCT population Rate of access to mental
health services
Directly standardised rates range from
6830.5 per 100,000 in Brighton and
Hove to 1322.6 per 100,000 in
Shropshire County
PCT Average number of
referrals to IAPT per
quarter
The highest referral count is in Eastern
and Coastal Kent with 5790 and the
lowest referral count is in Blackpool with
285 per quarter




The highest count is in Eastern and
Coastal Kent PCT with 2752 and the
lowest count in Blackpool with 170 per
quarter




The highest completion count is in
Eastern and Coastal Kent with 2241 and
the lowest count is in Hillingdon with
102 per quarter
PCT Average number of
referrals to IAPT that are
waiting more than
28 days
The highest referral count is in Surrey
with 3968 and the lowest rate in






Diagnosis rate The diagnosis to estimated prevalence
ratio varies from 39% in the worst
performing areas to 75% in the best
The Health Foundation









Large geographical variations in the rates
of prescribing. During the period
between October and December
2012–13, rates varied from 71 items per
1000 people in NHS Brent to 331 items
per 1000 people in NHS Blackpool.
Generally, there were lower levels of
prescribing in London and higher rates
in the North East. No significant
relationship between antidepressant
prescribing and IAPT uptake
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Source Denominator Nominator Finding
House of Commons
Library, 2014162
PCT % of referrals to IAPT
who are waiting more
than 28 out of 90 days
28 days: range from 86% in Durham,
Darlington and Tees to 24% in Lancashire




SHA Investment in mental
health, 2001–12
Investment ranged from £1,430,000 in










The average figure for England is £198.3
per head, while the weighted SHA
investment per head of weighted
population ranged from £180.9 to
£207.7. Five SHAs – West Midlands,
South West, London, South East Coast
and the North West – spent above the
national average of £198.3 and the
remaining five SHAs invest below the
national average. For the first time,
London has not reported the highest
investment per weighted head
Endocrine, nutritional and metabolic problems
Source Denominator Nominator Finding
NHS Atlas of Variation,
2011151
People in the National
Diabetes Audit (NDA)
with type 1 diabetes
% receiving all nine key
care processes
5.4–47.9% (ninefold). When the five
PCTs with the highest and lowest
percentages are excluded, the variation
is 2.6-fold. No statistically significant
correlation with deprivation
People in the National
Diabetes Audit (NDA)
with type 2 diabetes
% receiving all nine key
care processes
7–71.4% (10-fold variation). When the
five PCTs with the highest and lowest
percentages are excluded, the variation
is 2.1-fold. No statistically significant
correlation with deprivation
PCT population Directly standardised
rate of bariatric surgery
2007–8 to 2009–10
0.4–41.3 (93-fold variation). When the
five PCTs with the highest and lowest
percentages are excluded, the variation
is 19-fold




People in the National
Diabetes Audit (NDA)
% admitted to hospital
for diabetic ketoacidosis
(DKA) at least once by
PCT 2009/10
0.3–1.3% (fivefold variation)
People in the National
Diabetes Audit (NDA)
% who received renal
replacement therapy
(RRT) by PCT 2009–10
0.1–1.0% (10-fold variation)




drugs total NIC per
patient
£65–180 (2.8-fold variation). When the
five PCTs with the highest and lowest
percentages are excluded, the variation
is 2.1-fold
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Problems of circulation
Source Denominator Nominator Finding




QOF reported CHD 38.8–103.4% (2.7-fold variation). When
the five PCTs with the highest and
lowest percentages are excluded, the
variation is twofold




3–100% (34-fold variation). When the
five PCTs with the highest and lowest








11.4–196.8 pmp (17-fold variation).
When the five PCTs with the highest and











input; % mortality by
receipt of specialist input
57% of patients were seen by a
consultant cardiologist, 22% were seen
by a heart failure nurse specialist and 6%
were seen by any other consultant with
specialist skills for heart failure
management
Variation in mortality rates dependent on
specialist input: 14.4% of patients
receiving no specialist input died; 7.5%
of patients receiving specialist input died





% who spend 90% of
their time on a stroke
unit
31.5–100% (3.2-fold variation). When
the five PCTs with the highest and








% admitted to an acute
stroke unit within
4 hours of arrival at
hospital
21.7–84.5%





People who have an
acute stroke
% who spend ≥ 90% of
their stay on a stroke
unit
65.9–94.9%
pmp, per million population; STEMI, ST-elevation myocardial infarction.
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Problems of the respiratory system
Source Denominator Nominator Finding
NHS Atlas of Variation,
2011151
PCT population Directly standardised
rate of emergency
admissions to hospital in
people aged ≥ 18 years
with asthma
31.2–173.9 per 100,000 (sixfold
variation). When the five PCTs with the
highest and lowest percentages are
excluded, the variation is threefold








0.26–1.1 (4.1-fold variation). When the
five PCTs with the highest and lowest
percentages are excluded, the variation is
3.1-fold
Patients on GP COPD
and asthma registers
Average daily quantity
of combination (ICS and
LABA) inhalers
51,954 to 167,259 ADQ per 1000
patients (3.2-fold variation). When the
five PCTs with the highest and lowest
percentages are excluded, the variation is
1.9-fold
ICS, inhaled corticosteroid; LABA, long-acting beta-agonist.
Problems of the gastrointestinal system
Source Denominator Nominator Finding
NHS Atlas of Variation,
2011151
PCT population Directly standardised
rate of
cholecystectomies
51.1–170.8 (3.3-fold variation). When
the five PCTs with the highest and
lowest percentages are excluded, the
variation is 2.5-fold




PCT population Rate per million of liver
transplants from all
donors
4.5–28.5 (sixfold variation). When the
five PCTs with the highest and lowest
percentages are excluded, the variation is
3.7-fold
Problems of the musculoskeletal system
Source Denominator Nominator Finding
NHS Atlas of Variation,
2011151




1.3–18.2 per 100,000 population
(14-fold variation). When the five PCTs
with the highest and lowest percentages
are excluded, the variation is sevenfold
PCT population Directly standardised
rate of all diagnostic
knee arthroscopy
procedures
3.5–95.5 (27-fold variation). When the
five PCTs with the highest and lowest
percentages are excluded, the variation is
ninefold
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Diseases of the genitourinary system
Source Denominator Nominator Finding





of CKD by PCT
Reported prevalence of
CKD by PCT
0.3–1.4 (4.5-fold variation). When the
five PCTs with the highest and lowest




% of people starting
renal replacement
therapy for established
renal failure < 90 days
11.5–35.2 (3.1-fold variation)
PCT population Standardised pre-
emptive transplantation
0.1–3.5 (29-fold variation). When the
five PCTs with the highest and lowest
percentages are excluded, the variation is
11-fold
Children and young people
Source Denominator Nominator Finding






Expenditure (£) on child
community health
services
1.0–343.4 (354-fold variation). When the
five PCTs with the highest and lowest







% admitted to hospital
for diabetic ketoacidosis
5 years prior to the
end of the audit period
1 January 2009 to
31 March 2010
6.4–46.7 (sevenfold variation). When the
five PCTs with the highest and lowest




Rate of aural ventilation
tube (grommet)
insertion in children per
100,000 population
62.1–495.1 (eightfold variation). When
the five PCTs with the highest and
lowest percentages are excluded, the
variation is 4.6-fold
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Diagnostic services
Source Denominator Nominator Finding





Rate of MRI activity per
1000
22.8–99.0 (4.3-fold variation). When the
five PCTs with the highest and lowest




Rate of computed axial
tomography (CT) activity
per 1000
37.2–132.1 (3.6-fold variation); When
the five PCTs with the highest and





from arrival at hospital
to brain imaging
16–788 (49-fold variation). When the
five PCTs with the highest and lowest
percentages are excluded, the variation is
26-fold






1.6–10.0 (sixfold variation). When the
five PCTs with the highest and lowest
percentages are excluded, the variation is
4.3-fold





119.7–329.3 (2.8-fold variation). When
the five PCTs with the highest and
lowest percentages are excluded, the
variation is 1.9-fold
PCT population Rate of CT colonoscopy
procedures per 10,000
0.34–24.5 (73-fold variation). When the
five PCTs with the highest and lowest
percentages are excluded, the variation is
29-fold
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Appendix 23 Reviewed evidence of the specialist
management of mental health by ethnicity
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Appendix 24 Reviewed evidence of geographical
variations in the primary management of mental
health
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Appendix 25 Reviewed evidence of geographical
variations in the specialist management of mental
health
DOI: 10.3310/hsdr04140 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 14
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Asthana et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science


































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































DOI: 10.3310/hsdr04140 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 14
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Asthana et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science



































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































DOI: 10.3310/hsdr04140 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 14
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Asthana et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































NIHR Journals Library www.journalslibrary.nihr.ac.uk
266
Appendix 26 Cardiovascular disease and
cardiovascular disease-related prevalence estimates
Diabetes as a self-reported long-standing illness
(Health Survey for England, 2006–11)
FIGURE 15 Diabetes as a self-reported LSI: LSOA-level map. Contains Ordnance Survey data © Crown copyright and
database right 2012.
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Response variable definition, provenance and prediction
These estimates are based on respondents to the HSfE reporting that diabetes is one of up to six LSIs,
disabilities or infirmities, that is, one that ‘has troubled you over a period of time, or that is likely to affect
you over a period of time’. There was no necessity that the respondent considered the condition to be a
limiting illness.
The HSfE at this time includes multiple household respondents of all ages. The analytical data set was
drawn from the subset of respondents aged ≥ 16 years for whom data were available across all model
response and predictor variables, namely whether or not they responded to the LLTI question, whether
they provided responses to questions on age, sex, ethnicity, general health status, LLTI and tenure, and
whether or not information is available on the IMD quintile of their LSOA of residence (n= 57,363). To
avoid a potential household-level effect, a single, randomly selected adult is drawn from each household,
resulting in an analytical data set of 29,905 adults aged ≥ 16 years.















16–24 1361 4 0.3 16–24 1022 7 0.7
25–34 2655 24 0.9 25–34 1704 14 0.8
35–49 4471 85 1.9 35–49 3279 108 3.2
50–64 3767 204 5.1 50–64 3049 242 7.4
65–74 2045 231 10.1 65–74 1541 245 13.7
75–84 1591 186 10.5 75–84 942 147 13.5
≥ 85 624 41 6.2 ≥ 85 289 27 8.5




Model parameters (see below) are applied to microsimulated LSOA-level census data to produce estimates
of the number (and proportion) of people expected to report diabetes as a LSI in each age–sex cohort (and
overall) in each of the 32,844 English LSOAs. As discussed in the report, bootstrapping is used to derive
95% CIs for these estimates. The bootstrapped LSOA-level prevalence rate estimates are aggregated into a
number of higher geographies, namely for MSOAs, LAs, CCGs and regions (GORs), and are then used to
calculate 95% CIs for these higher-level estimates. Proportionate attribution is used to restructure the
estimates to align with 2001 MSOAs, as well as GP practice populations as defined by the 2011 NHS ADS.
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Table 38 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured by
the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444 adults)
in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived quintile; and
6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule, variations in
prevalence rates reflect variations in the socioeconomic composition of populations in the different types of
LSOA rather than variations in deprivation per se.
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TABLE 39 Parameter estimates: self-reported diabetes as LSI
Factor (reference group)
Model coefficients 95% CI
Estimate Standard error 2.5% CI 97.50%
(Intercept) –8.02423 0.52032 –9.04405 –7.00441
Age (16–24 years)
25–34 years 1.18027 0.54639 0.10935 2.25119
35–49 years 2.23172 0.51060 1.23094 3.23250
50–64 years 3.15269 0.50700 2.15898 4.14640
65–74 years 3.76816 0.50772 2.77302 4.76329
75–84 years 3.69604 0.51250 2.69154 4.70053
≥ 85 years 3.01419 0.55377 1.92879 4.09959
Sex (females)
Males 0.49556 0.06736 0.36353 0.62759
Ethnicity (white)
Mixed 0.30285 0.34006 –0.36368 0.96937
Black 0.61373 0.16950 0.28151 0.94596
Asian 0.97558 0.11934 0.74168 1.20949
Other 0.13442 0.47152 –0.78977 1.05861
General health status (very good)
Good health 1.31416 0.13971 1.04032 1.58800
Fair health 2.25396 0.14655 1.96671 2.54120
Bad health 2.67283 0.25268 2.17758 3.16809
Very bad health 2.81398 0.49056 1.85248 3.77547
LLTI (no LTTI)
LLTI 2.81184 0.69985 1.44014 4.18354
Tenure (owner–occupier)
Social rent 0.41757 0.08823 0.24464 0.59049
Private rent or other tenure –0.16827 0.16952 –0.50052 0.16398
LSOA deprivation quintile (least deprived quintile)
Second quintile 0.07939 0.09236 –0.10164 0.26041
Third quintile 0.13466 0.09164 –0.04495 0.31427
Fourth quintile 0.21888 0.09170 0.03914 0.39862
Fifth quintile (=most deprived quintile) 0.04396 0.09770 –0.14753 0.23545
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TABLE 39 Parameter estimates: self-reported diabetes as LSI (continued )
Factor (reference group)
Model coefficients 95% CI
Estimate Standard error 2.5% CI 97.50%
Interaction effects
Male and social rent (female/owner–occupier) –0.43283 0.12522 –0.67826 –0.18740
Male and private rent (female/owner–occupier) 0.19611 0.22210 –0.23921 0.63143
25–34 years and LLTI (16–24 years/no LLTI) –1.35165 0.71377 –2.75064 0.04733
35–49 years and LLTI (16–24 years/no LLTI) –1.67127 0.64981 –2.94491 –0.39763
50–64 years and LLTI (16–24 years/no LLTI) –1.97253 0.64082 –3.22854 –0.71653
65–74 years and LLTI (16–24 years/no LLTI) –1.89980 0.64093 –3.15602 –0.64358
75–84 years and LLTI (16–24 years/no LLTI) –2.03781 0.64542 –3.30283 –0.77279
≥ 85 years and LLTI (16–24 years/no LLTI) –1.97383 0.69176 –3.32969 –0.61798
Good health and LLTI (very good health/no LLTI) –0.44942 0.32863 –1.09354 0.19470
Fair health and LLTI (very good health/no LLTI) –0.78714 0.32291 –1.42003 –0.15424
Bad health and LLTI (very good health/no LLTI) –0.81093 0.38486 –1.56525 –0.05661
Very bad health and LLTI (very good health/no LLTI) –0.82214 0.57580 –1.95070 0.30642
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FIGURE 17 Self-reported diabetes as LSI: individual estimates and their 95% CIs. (a) MSOAs; (b) LAs; (c) CCGs; and
(d) regions (GORs).
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Stroke as a self-reported long-standing illness
(Health Survey for England, 2006–11)
FIGURE 18 Stroke as a self-reported LSI: LSOA-level map. Contains Ordnance Survey data © Crown copyright and
database right 2012.
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Response variable definition, provenance and prediction
These estimates are based on respondents to the HSfE reporting that a ‘stroke’ is one of up to six LSIs,
disabilities or infirmities, that is, one that ‘has troubled you over a period of time, or that is likely to affect
you over a period of time’. There is no necessity that the respondent considers the condition to be a
limiting illness.
The HSfE at this time includes multiple household respondents of all ages. The analytical data set is drawn
from the subset of respondents aged ≥ 16 years for whom data are available across all model response
and predictor variables, namely whether or not they responded to the LLTI question, whether they
provided responses to questions on age, sex, ethnicity, general health status, LLTI and tenure, and whether
or not information is available on the IMD quintile of their LSOA of residence (n= 57,363). To avoid a
potential household-level effect, a single, randomly selected adult is drawn from each household, resulting
in an analytical data set of 29,905 adults aged ≥ 16 years.















16–24 1365 0 0.0 16–24 1028 1 0.1
25–34 2677 2 0.1 25–34 1717 1 0.1
35–49 4547 9 0.2 35–49 3374 13 0.4
50–64 3938 33 0.8 50–64 3248 43 1.3
65–74 2250 26 1.1 65–74 1743 43 2.4
75–84 1730 47 2.6 75–84 1048 41 3.8
≥ 85 642 23 3.5 ≥ 85 308 8 2.5




Model parameters (see below) are applied to microsimulated LSOA-level census data to produce estimates
of the number (and proportion) of people expected to report a stroke as a LSI in each age–sex cohort
(and overall) in each of the 32,844 English LSOAs. As discussed in the report, bootstrapping is used to
derive 95% CIs for these estimates. The bootstrapped LSOA-level prevalence rate estimates are aggregated
into a number of higher geographies, namely for MSOAs, LAs, CCGs and regions (GORs), and are then
used to calculate 95% CIs for these higher-level estimates. Proportionate attribution is used to restructure
the estimates to align with 2001 MSOAs, as well as GP practice populations as defined by the 2011
NHS ADS.
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Table 41 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured by
the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444 adults)
in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived quintile; and
6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule, variations in
prevalence rates reflect variations in the socioeconomic composition of populations in the different types of
LSOA rather than variations in deprivation per se.
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TABLE 42 Parameter estimates: self-reported stroke as LSI
Factor (reference group)
Model coefficients 95% CI
Estimate Standard error 2.5% CI 97.50%
(Intercept) –9.50014 1.06674 –11.5910 –7.40932
Age (16–24 years)
25–34 years 0.34512 1.15610 –1.92083 2.61108
35–49 years 1.43970 1.02528 –0.56985 3.44925
50–64 years 2.26616 1.01147 0.28368 4.24864
65–74 years 2.59708 1.01280 0.61198 4.58217
75–84 years 2.98594 1.01194 1.00254 4.96934
≥ 85 years 2.97700 1.02311 0.97172 4.98229
Sex (females)
Males 0.66050 0.14465 0.37699 0.94401
Ethnicity (white)
Mixed –12.8044 325.2716 –650.337 624.7281
Black –0.00943 0.51826 –1.02523 1.00636
Asian –0.39052 0.46104 –1.29416 0.51312
Other –12.7936 434.0984 –863.626 838.0392
General health status (very good)
Good health 1.15148 0.38291 0.40098 1.90199
Fair health 1.96509 0.38182 1.21671 2.71346
Bad health 2.16646 0.40041 1.38166 2.95126
Very bad health 2.61358 0.41904 1.79226 3.43490
LLTI (no LTTI)
LLTI 1.46941 0.18087 1.11491 1.82391
Tenure (owner–occupier)
Social rent –0.04856 0.20663 –0.45355 0.35644
Private rent or other tenure 0.48888 0.30666 –0.11218 1.08994
LSOA deprivation quintile (least deprived quintile)
Second quintile 0.18811 0.19267 –0.18952 0.56575
Third quintile 0.08104 0.19882 –0.30865 0.47072
Fourth quintile 0.09571 0.20057 –0.29741 0.48883
Fifth quintile (=most deprived quintile) –0.17874 0.22277 –0.61537 0.25789
Interaction effects
Male and social rent (female/owner–occupier) –0.35111 0.28882 –0.91719 0.21497
Male and private rent (female/owner–occupier) –1.59649 0.59713 –2.76686 –0.42612
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FIGURE 20 Self-reported stroke as LSI: individual estimates and their 95% CIs: (a) MSOAs; (b) LAs;
(c) CCGs; and (d) regions (GORs).
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High blood pressure as a self-reported long-standing illness
(Health Survey for England, 2006–11)
FIGURE 21 High blood pressure as a self-reported LSI: LSOA-level map. Contains Ordnance Survey data © Crown
copyright and database right 2012.
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Response variable definition, provenance and prediction
These estimates are based on respondents to the HSfE reporting high blood pressure as one of up to six
LSIs, disabilities or infirmities; that is, one that ‘has troubled you over a period of time, or that is likely to
affect you over a period of time’. There is no necessity that the respondent considers the condition to be a
limiting illness.
The HSfE at this time includes multiple household respondents of all ages. The analytical data set is drawn
from the subset of respondents aged ≥ 16 years for whom data are available across all model response
and predictor variables, namely whether or not they responded to the LLTI question, whether or not they
provided responses to questions on age, sex, ethnicity, general health status, LLTI and tenure, and whether
or not information is available on the IMD quintile of their LSOA of residence (n= 57,363). To avoid a
potential household-level effect, a single randomly selected adult is drawn from each household, resulting
in an analytical data set of 29,905 adults aged ≥ 16 years.















16–24 1361 4 0.3 16–24 1028 1 0.1
25–34 2669 10 0.4 25–34 1709 9 0.5
35–49 4417 139 3.1 35–49 3279 108 3.2
50–64 3575 396 10.0 50–64 2907 384 11.7
65–74 1883 393 17.3 65–74 1493 293 16.4
75–84 1424 353 19.9 75–84 941 148 13.6
≥ 85 571 94 14.1 ≥ 85 279 37 11.7




Model parameters (see below) are applied to microsimulated LSOA-level census data to produce estimates
of the number (and proportion) of people expected to report high blood pressure as a LSI in each age–sex
cohort (and overall) in each of the 32,844 English LSOAs. As discussed in the report, bootstrapping is
used to derive 95% CIs for these estimates. The bootstrapped LSOA-level prevalence rate estimates are
aggregated into a number of higher geographies, namely for MSOAs, LAs, CCGs and regions (GORs), and
are then used to calculate 95% CIs for these higher-level estimates. Proportionate attribution is used to
restructure the estimates to align with 2001 MSOAs, as well as GP practice populations as defined by the
2011 NHS ADS.
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Table 44 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured by
the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444 adults)
in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived quintile; and
6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule, variations in
prevalence rates reflect variations in the socioeconomic composition of populations in the different types of
LSOA rather than variations in deprivation per se.
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TABLE 45 Parameter estimates: self-reported high blood pressure as a LSI
Factor (reference group)
Model coefficients 95% CI
Estimate Standard error 2.5% CI 97.50%
(Intercept) –7.35647 0.76286 –8.85168 –5.86125
Age (16–24 years)
25–34 years 0.68502 0.84678 –0.97468 2.34471
35–49 years 3.10297 0.76098 1.61145 4.59450
50–64 years 4.28386 0.75793 2.79830 5.76941
65–74 years 4.91661 0.75849 3.42997 6.40325
75–84 years 4.98012 0.76021 3.49010 6.47013
≥ 85 years 4.31465 0.77620 2.79330 5.83600
Sex (females)
Males –0.85960 1.13391 –3.08205 1.36286
Ethnicity (white)
Mixed 0.48230 0.34531 –0.19451 1.15911
Black 0.34554 0.20367 –0.05366 0.74473
Asian –0.14402 0.18514 –0.50690 0.21887
Other –1.35988 1.01783 –3.35483 0.63508
General health status (very good)
Good health 0.78469 0.09989 0.58890 0.98048
Fair health 1.28076 0.11407 1.05718 1.50435
Bad health 1.11981 0.26456 0.60128 1.63834
Very bad health 1.24532 0.56671 0.13456 2.35608
LLTI (no LTTI)
LLTI 2.12768 0.94571 0.27409 3.98127
Tenure (owner–occupier)
Social rent –0.15007 0.06306 –0.27368 –0.02646
Private rent or other tenure –0.18079 0.09711 –0.37112 0.00955
LSOA deprivation quintile (least deprived quintile)
Second quintile –0.00571 0.11123 –0.22373 0.21231
Third quintile 0.25458 0.10999 0.03901 0.47016
Fourth quintile 0.21706 0.11561 –0.00954 0.44366
Fifth quintile (=most deprived quintile) 0.03265 0.12725 –0.21676 0.28205
continued
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TABLE 45 Parameter estimates: self-reported high blood pressure as a LSI (continued )
Factor (reference group)
Model coefficients 95% CI
Estimate Standard error 2.5% CI 97.50%
Interaction effects
Mixed and LLTI (white/no LLTI) 0.02104 0.57080 –1.09773 1.13981
Black and LLTI (white /no LLTI) 0.81326 0.29719 0.23077 1.39576
Asian and LLTI (white /no LLTI) 0.88659 0.25958 0.37781 1.39537
Other and LLTI (white /no LLTI) 0.31735 1.44729 –2.51934 3.15404
LLTI and second quintile (no LLTI/least deprived) 0.33813 0.14886 0.04636 0.62990
LLTI and third quintile (no LLTI/least deprived) 0.19286 0.14970 –0.10056 0.48628
LLTI and fourth quintile (no LLTI/least deprived) 0.40369 0.14989 0.10991 0.69746
LLTI and fifth quintile (no LLTI/least deprived) 0.60557 0.15638 0.29907 0.91207
25–34 years and male (16–24 years/female) 1.35746 1.21547 –1.02486 3.73979
35–49 years and male (16–24 years/female) 0.88007 1.13122 –1.33711 3.09726
50–64 years and male (16–24 years/female) 1.02266 1.12632 –1.18493 3.23026
65–74 years and male (16–24 years/female) 0.78228 1.12704 –1.42671 2.99127
75–84 years and male (16–24 years/female) 0.41236 1.12904 –1.80056 2.62528
≥ 85 years and male (16–24 years/female) 0.64406 1.14345 –1.59710 2.88522
Male and second quintile (female/least deprived) –0.14177 0.14296 –0.42197 0.13843
Male and third quintile (female/least deprived) –0.48840 0.14537 –0.77334 –0.20347
Male and fourth quintile (female/least deprived) –0.32684 0.14616 –0.61332 –0.04035
Male and fifth quintile (female/least deprived) –0.20979 0.15113 –0.50600 0.08642
25–34 years and LLTI (16–24 years/no LLTI) –1.12875 1.03201 –3.15149 0.89399
35–49 years and LLTI (16–24 years/no LLTI) –2.02373 0.93026 –3.84704 –0.20043
50–64 years and LLTI (16–24 years/no LLTI) –2.07281 0.92326 –3.88239 –0.26322
65–74 years and LLTI (16–24 years/no LLTI) –2.17375 0.92404 –3.98488 –0.36263
75–84 years and LLTI (16–24 years/no LLTI) –2.08276 0.92575 –3.89722 –0.26830
≥ 85 years and LLTI (16–24 years/no LLTI) –1.68621 0.94219 –3.53290 0.16048
Good health and LLTI (very good health/no LLTI) –0.14192 0.22110 –0.57528 0.29144
Fair health and LLTI (very good health/no LLTI) –0.56433 0.22180 –0.99905 –0.12960
Bad health and LLTI (very good health/no LLTI) –0.44063 0.32630 –1.08018 0.19892
Very bad health and LLTI (very good health/no LLTI) –0.51854 0.60328 –1.70097 0.66388
Male and good health (female/very good health) 0.32130 0.15024 0.02682 0.61577
Male and fair health (female/very good health) 0.29530 0.15725 –0.01292 0.60352
Male and bad health (female/very good health) 0.16955 0.20101 –0.22442 0.56353
Male and very bad health (female/very good health) –0.29383 0.29936 –0.88058 0.29292
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25 – 34 years (16 – 24 years)
35 – 49 years (16 – 24 years)
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Social rent (owner–occupier)
Private rent (owner–occupier)
Second quintile (least deprived LSOA)
LLTI and second quintile (no LLTI/least deprived)
LLTI and third quintile (no LLTI/least deprived)
LLTI and fourth quintile (no LLTI/least deprived)
LLTI and fifth quintile (no LLTI/least deprived)
Third quintile (least deprived LSOA)
Fourth quintile (least deprived LSOA)
Fifth quintile (least deprived LSOA)
Mixed and LLTI (white/no LLTI)
Black and LLTI (white/no LLTI)
Asian and LLTI (white/no LLTI)
Other and LLTI (white/no LLTI)
25 – 34 years and male (16 – 24 years/female)
35 – 49 years and male (16 – 24 years/female)
50 – 64 years and male (16 – 24 years/female)
65 – 74 years and male (16 – 24 years/female)
75 – 84 years and male (16 – 24 years/female)
> 85 years and male (16 – 24 years/female)
Male and second quintile (female/least deprived)
Male and third quintile (female/least deprived)
Male and fourth quintile (female/least deprived)
Male and fifth quintile (female/least deprived)
25 – 34 years and LLTI (16 – 24 years/no LLTI)
35 – 49 years and LLTI (16 – 24 years/no LLTI)
50 – 64 years and LLTI (16 – 24 years/no LLTI)
65 – 74 years and LLTI (16 – 24 years/no LLTI)
75 – 84 years and LLTI (16 – 24 years/no LLTI)
> 85 years and LLTI (16 – 24 years/no LLTI)
Good health and LLTI (very good health/no LLTI)
Fair health and LLTI (very good health/no LLTI)
Bad health and LLTI (very good health/no LLTI)
Very bad health and LLTI (very good health/no LLTI)
Male and good health (female/very good health)
Male and fair health (female/very good health)
Male and bad health (female/very good health)
Male and very bad health (female/very good health)
– 2.5 0.0 2.5 5.0
Parameter estimate and 95% CIs
FIGURE 22 Parameter plots: self-reported high blood pressure as a LSI.
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FIGURE 23 Self-reported high blood pressure as a LSI: individual estimates and their 95% CIs: (a) MSOAs; (b) LAs;
(c) CCGs; and (d) and regions (GORs). BP, blood pressure.
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Coronary heart disease (heart attack/angina) as a self-reported
long-standing illness (Health Survey for England, 2006–11)
FIGURE 24 Coronary heart disease as a self-reported LSI: LSOA-level map. Contains Ordnance Survey data © Crown
copyright and database right 2012.
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Response variable definition, provenance and prediction
These estimates are based on respondents to the HSfE reporting that a heart attack or angina (CHD) is one
of up to six LSIs, disabilities or infirmities; that is, one that ‘has troubled you over a period of time, or that
is likely to affect you over a period of time’. There is no necessity that the respondent considers the
condition to be a limiting illness.
The HSfE at this time includes multiple household respondents of all ages. The analytical data set is drawn
from the subset of respondents aged ≥ 16 years for whom data are available across all model response
and predictor variables, namely whether or not they responded to the LLTI question, whether or not they
provided responses to questions on age, sex, ethnicity, general health status, LLTI and tenure, and whether
or not information is available on the IMD quintile of their LSOA of residence (n= 57,363). To avoid a
potential household-level effect, a single randomly selected adult is drawn from each household, resulting
in an analytical data set of 29,905 adults aged ≥ 16 years.















16–24 1365 0 0.0 16–24 1029 0 0.0
25–34 2679 0 0.0 25–34 1717 1 0.1
35–49 4548 8 0.2 35–49 3375 12 0.4
50–64 3913 58 1.5 50–64 3198 93 2.8
65–74 2186 90 4.0 65–74 1673 113 6.3
75–84 1669 108 6.1 75–84 1002 87 8.0
≥ 85 611 54 8.1 ≥ 85 300 16 5.1




Model parameters (see below) are applied to microsimulated LSOA-level census data to produce estimates
of the number (and proportion) of people expected to report a heart attack and/or angina (CHD) as a LSI
in each age–sex cohort (and overall) in each of the 32,844 English LSOAs. As discussed in the report,
bootstrapping is used to derive 95% CIs for these estimates. The bootstrapped LSOA-level prevalence rate
estimates are aggregated into a number of higher geographies, namely for MSOAs, LAs, CCGs and
regions (GORs), and are then used to calculate 95% CIs for these higher-level estimates. Proportionate
attribution is used to restructure the estimates to align with 2001 MSOAs, as well as GP practice
populations as defined by the 2011 NHS ADS.
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Table 47 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured by
the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444 adults)
in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived quintile; and
6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule, variations in
prevalence rates reflect variations in the socioeconomic composition of populations in the different types of
LSOA rather than variations in deprivation per se.
TABLE 47 Coronary heart disease as a self-reported LSI: cohort-specific and overall prevalence rates by IMD
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TABLE 48 Parameter estimates: CHD as a self-reported LSI
Factor (reference group)
Model coefficients 95% CI
Estimate Standard error 2.5% CI 97.50%
(Intercept) –11.0173 1.05431 –13.0838 –8.9509
Age (25–34 years)
35–49 years 2.62842 1.02564 0.61816 4.63868
50–64 years 4.38383 1.00529 2.41345 6.35420
65–74 years 5.23509 1.00484 3.26560 7.20459
75–84 years 5.36857 1.00530 3.39819 7.33895
≥ 85 years 5.38423 1.01058 3.40349 7.36497
Sex (females)
Males 1.26728 0.26650 0.74494 1.78962
Ethnicity (white)
Other –0.73480 0.26345 –1.25116 –0.21843
General health status (very good)
Good health 1.24911 0.25479 0.74972 1.74850
Fair health 1.99527 0.25534 1.49481 2.49573
Bad health 2.47480 0.26662 1.95222 2.99738
Very bad health 2.27282 0.29455 1.69551 2.85013
LLTI (no LTTI)
LLTI 0.85767 0.27328 0.32204 1.39330
Tenure (owner–occupier)
Social rent 0.14358 0.13700 –0.12494 0.41211
Private rent or other tenure –0.28401 0.29843 –0.86893 0.30090
LSOA deprivation quintile (least deprived quintile)
Second quintile 0.08205 0.34038 –0.58510 0.74919
Third quintile 0.15678 0.32764 –0.48540 0.79895
Fourth quintile 0.08322 0.35619 –0.61492 0.78135
Fifth quintile (=most deprived quintile) 0.74604 0.31754 0.12367 1.36841
Interaction effects
Male and second quintile (female/least deprived) –0.86778 0.31002 –1.47542 –0.26013
Male and third quintile (female/least deprived) –0.20396 0.30107 –0.79407 0.38614
Male and fourth quintile (female/least deprived) –0.83452 0.29767 –1.41794 –0.25109
Male and fifth quintile (female/least deprived) –0.25161 0.29766 –0.83503 0.33180
LLTI and second quintile (no LLTI/least deprived) 0.48404 0.33510 –0.17275 1.14083
LLTI and third quintile (no LLTI/least deprived) 0.20177 0.31117 –0.40813 0.81167
LLTI and fourth quintile (no LLTI/least deprived) 0.94541 0.34649 0.26628 1.62453
LLTI and fifth quintile (no LLTI/least deprived) –0.00500 0.29750 –0.58810 0.57810
Male and LLTI (female/no LLTI) –0.43820 0.20426 –0.83854 –0.03786
Male and social rent (female/owner–occupier) –0.28720 0.20366 –0.68638 0.11198
Male and private rent (female/owner–occupier) 0.67204 0.37290 –0.05885 1.40293
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FIGURE 26 Coronary heart disease as a self-reported LSI: individual estimates and their 95% CIs. (a) MSOAs;
(b) LAs; (c), CCGs; and (d) and regions (GORs).
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Heart failure as a self-reported long-standing illness
(Health Survey for England, 2006–11)
FIGURE 27 Heart failure as a self-reported LSI: LSOA-level map. Contains Ordnance Survey data © Crown copyright
and database right 2012.
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Response variable definition, provenance and prediction
These estimates are based on respondents to the HSfE reporting that a heart attack, angina or any one of
a number of other heart conditions classified as ‘other heart problems’ (listed below) is one of up to six
LSIs, disabilities or infirmities; that is, one that ‘has troubled you over a period of time, or that is likely to
affect you over a period of time’. There is no necessity that the respondent considers the condition to be a
limiting illness.
Examples given of other heart problems are aortic/mitral valve stenosis; aortic/mitral valve regurgitation;
aorta replacement; atrial septal defect; cardiac asthma; cardiac diffusion; cardiac problems, heart trouble
(not elsewhere specified); dizziness, giddiness, balance problems (nes); hardening of arteries in heart; heart
disease, heart complaint; heart failure; heart murmur, palpitations; hole in the heart; ischaemic heart disease;
pacemaker; pains in chest (nes); pericarditis; Saint Vitus dance; tachycardia, sick sinus syndrome; tired heart;
valvular heart disease; weak heart because of rheumatic fever; Wolff–Parkinson–White syndrome.
The HSfE at this time includes multiple household respondents of all ages. The analytical data set is drawn
from the subset of respondents aged ≥ 16 years for whom data are available across all model response
and predictor variables, namely whether or not they responded to the LLTI question, whether or not they
provided responses to questions on age, sex, ethnicity, general health status, LLTI and tenure, and whether
or not information is available on the IMD quintile of their LSOA of residence (n= 57,363). To avoid a
potential household-level effect, a single randomly selected adult is drawn from each household, resulting
in an analytical data set of 29,905 adults aged ≥ 16 years.















16–24 1358 7 0.5 16–24 1022 7 0.7
25–34 2660 19 0.7 25–34 1714 4 0.2
35–49 4509 47 1.0 35–49 3334 53 1.6
50–64 3800 171 4.3 50–64 3046 245 7.4
65–74 2057 219 9.6 65–74 1510 276 15.5
75–84 1480 297 16.7 75–84 846 243 22.3
≥ 85 538 127 19.1 ≥ 85 258 58 18.4




Model parameters (see below) are applied to microsimulated LSOA-level census data to produce estimates
of the number (and proportion) of people expected to report CHD and/or other heart problems as a LSI
in each age–sex cohort (and overall) in each of the 32,844 English LSOAs. As discussed in the report,
bootstrapping is used to derive 95% CIs for these estimates. The bootstrapped LSOA-level prevalence rate
estimates are aggregated into a number of higher geographies, namely for MSOAs, LAs, CCGs and
regions (GORs), and are then used to calculate 95% CIs for these higher-level estimates. Proportionate
attribution is used to restructure the estimates to align with 2001 MSOAs, as well as GP practice
populations as defined by the 2011 NHS ADS.
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Table 50 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured by
the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444 adults)
in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived quintile; and
6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule, variations in
prevalence rates reflect variations in the socioeconomic composition of populations in the different types of
LSOA rather than variations in deprivation per se.











































































































































































































DOI: 10.3310/hsdr04140 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 14
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Asthana et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
295
TABLE 51 Parameter estimates: self-reported heart failure as a LSI
Factor (reference group)
Model coefficients 95% CI
Estimate Standard error 2.5% CI 97.50%
(Intercept) –6.69103 0.40631 –7.48740 –5.89465
Age (16–24 years)
25–34 years 0.27096 0.44600 –0.60319 1.14511
35–49 years 0.47839 0.41008 –0.32537 1.28216
50–64 years 1.61736 0.39222 0.84860 2.38612
65–74 years 2.34731 0.39143 1.58010 3.11453
75–84 years 2.74956 0.39024 1.98468 3.51444
≥ 85 years 2.86345 0.39834 2.08270 3.64420
Sex (females)
Males 0.50602 0.54487 –0.56193 1.57396
Ethnicity (white)
Mixed 0.23214 0.37112 –0.49526 0.95953
Black –1.62162 0.39283 –2.39156 –0.85168
Asian –0.37804 0.19388 –0.75840 0.00161
Other –0.48676 0.61323 –1.68870 0.71517
General health status (very good)
Good health 1.14921 0.13485 0.88490 1.41352
Fair health 1.94149 0.13634 1.67427 2.20872
Bad health 2.33773 0.14826 2.04714 2.62831
Very bad health 2.47812 0.16849 2.14788 2.80835
LLTI (no LTTI)
LLTI 0.95930 0.06728 0.82742 1.09118
Tenure (owner–occupier)
Social rent 0.17090 0.08713 0.00012 0.34168
Private rent or other tenure –0.05095 0.16395 –0.37230 0.27040
LSOA deprivation quintile (least deprived quintile)
Second quintile –0.01863 0.08699 –0.18913 0.15188
Third quintile –0.00096 0.08761 –0.17268 0.17075
Fourth quintile –0.02961 0.08969 –0.20539 0.14617
Fifth quintile (=most deprived quintile) 0.07623 0.09328 –0.10659 0.25906
Interaction effects
25–34 years and male (16–24 years/female) –1.52537 0.77174 –3.03798 –0.01276
35–49 years and male (16–24 years/female) –0.00692 0.57718 –1.13820 1.12435
50–64 years and male (16–24 years/female) 0.12339 0.55153 –0.95760 1.20439
65–74 years and male (16–24 years/female) 0.20991 0.55135 –0.87073 1.29055
75–84 years and male (16–24 years/female) 0.07920 0.55137 –1.00149 1.15989
≥ 85 years and male (16–24 years/female) –0.43840 0.57231 –1.56012 0.68332
Male and social rent (female/owner–occupier) –0.31412 0.12454 –0.55822 –0.07003
Male and private rent (female/owner–occupier) 0.26411 0.22268 –0.17234 0.70055
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FIGURE 29 Heart failure as a self-reported LSI: individual estimates and their 95% CIs. (a) MSOAs; (b) LAs; (c) CCGs;
and (d) and regions (GORs).
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Cardiovascular disease as a self-reported long-standing illness
(Health Survey for England, 2006–11)
FIGURE 30 Cardiovascular disease as a self-reported LSI: LSOA-level map. Contains Ordnance Survey data © Crown
copyright and database right 2012.
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Response variable definition, provenance and prediction
These estimates are based on respondents to the HSfE reporting that a stroke, heart attack or angina
(CHD), or any one of a number of other heart conditions classified as ‘other heart problem’ (see previous
section), ‘piles’, ‘varicose veins/phlebitis in lower extremities’ or ‘other blood vessels/embolic’ (see below) is
one of up to six LSIs, disabilities or infirmities; that is, one that ‘has troubled you over a period of time, or
that is likely to affect you over a period of time’. There is no necessity that the respondent considers the
condition to be a limiting illness.
For piles/haemorrhoids, the example given was varicose veins in anus.
For varicose veins/phlebitis in lower extremities, the examples given were various ulcers and varicose eczema.
For other blood vessels/embolic, the examples given were arteriosclerosis, hardening of arteries (nes);
arterial thrombosis; artificial arteries (nes); blocked arteries in leg; blood clots (nes); Hand-Arm Vibration
Syndrome (white finger); hypersensitive to the cold; intermittent claudication; low blood pressure/
hypertension; poor circulation; pulmonary embolism; Raynaud’s disease; swollen legs and feet;
telangiectasia (nes); thrombosis (nes); varicose veins in oesophagus; and Wright’s syndrome.
The HSfE at this time includes multiple household respondents of all ages. The analytical data set is drawn
from the subset of respondents aged ≥ 16 years for whom data are available across all model response
and predictor variables, namely whether or not they responded to the LLTI question, whether or not they
provided responses to questions on age, sex, ethnicity, general health status, LLTI and tenure, and whether
or not information is available on the IMD quintile of their LSOA of residence (n= 57,363). To avoid a
potential household-level effect, a single randomly selected adult is drawn from each household, resulting
in an analytical data set of 29,905 adults aged ≥ 16 years.















16–24 1354 11 0.8 16–24 1020 9 0.9
25–34 2646 33 1.2 25–34 1712 6 0.3
35–49 4472 84 1.8 35–49 3302 85 2.5
50–64 3736 235 5.9 50–64 2973 318 9.7
65–74 2011 265 11.6 65–74 1444 342 19.1
75–84 1418 359 20.2 75–84 799 290 26.6
≥ 85 501 164 24.7 ≥ 85 243 73 23.1




Model parameters (see below) are applied to microsimulated LSOA-level census data to produce estimates
of the number (and proportion) of people expected to report CVD as a LSI in each age–sex cohort (and
overall) in each of the 32,844 English LSOAs. As discussed in the report, bootstrapping is used to derive
95% CIs for these estimates. The bootstrapped LSOA-level prevalence rate estimates are aggregated into a
number of higher geographies, namely for MSOAs, LAs, CCGs and regions (GORs), and are then used to
calculate 95% CIs for these higher-level estimates. Proportionate attribution is used to restructure the
estimates to align with 2001 MSOAs, as well as GP practice populations as defined by the 2011 NHS ADS.
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Table 53 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured
by the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444
adults) in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived
quintile; and 6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule,
variations in prevalence rates reflect variations in the socioeconomic composition of populations in the
different types of LSOA rather than variations in deprivation per se.
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TABLE 54 Parameter estimates: self-reported CVD as a LSI
Factor (reference group)
Model coefficients 95% CI
Estimate Standard error 2.5% CI 97.50%
(Intercept) –6.28725 0.33250 –6.93895 –5.63556
Age (16–24 years)
25–34 years 0.34472 0.35283 –0.34684 1.03627
35–49 years 0.58097 0.32586 –0.05772 1.21966
50–64 years 1.44387 0.31489 0.82669 2.06105
65–74 years 2.04848 0.31505 1.43099 2.66597
75–84 years 2.47720 0.31394 1.86188 3.09253
≥ 85 years 2.70555 0.32236 2.07373 3.33737
Sex (females)
Males 0.25149 0.45588 –0.64202 1.14501
Ethnicity (white)
Mixed –0.46799 0.52813 –1.50312 0.56715
Black –0.70740 0.31518 –1.32516 –0.08964
Asian –0.35227 0.23781 –0.81837 0.11383
Other –11.9396 125.24500 –257.4200 233.5407
General health status (very good)
Good health 1.12975 0.13776 0.85975 1.39975
Fair health 2.02454 0.14504 1.74026 2.30883
Bad health 2.91564 0.23779 2.44957 3.38170
Very bad health 3.24765 0.43798 2.38922 4.10609
LLTI [no LTTI)
LLTI 1.70721 0.22191 1.27226 2.14215
Social rent 0.00037 0.06224 –0.12161 0.12236
Private rent or other tenure –0.00433 0.10033 –0.20098 0.19232
LSOA deprivation quintile [least deprived quintile)
Second quintile 0.02439 0.07927 –0.13099 0.17976
Third quintile 0.06163 0.07962 –0.09443 0.21770
Fourth quintile 0.05843 0.08119 –0.10071 0.21756
Fifth quintile (=most deprived quintile) 0.11593 0.08499 –0.05065 0.28251
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TABLE 54 Parameter estimates: self-reported CVD as a LSI (continued )
Factor (reference group)
Model coefficients 95% CI
Estimate Standard error 2.5% CI 97.50%
Interaction effects
25–34 years and male (16–24 years/female) –1.44281 0.63789 –2.69308 –0.19255
35–49 years and male (16–24 years/female) 0.07781 0.48180 –0.86652 1.02214
50–64 years and male (16–24 years/female) 0.28905 0.46495 –0.62224 1.20035
65–74 years and male (16–24 years/female) 0.48273 0.46537 –0.42939 1.39484
75–84 years and male (16–24 years/female) 0.28919 0.46609 –0.62435 1.20272
≥ 85 years and male (16–24 years/female) –0.32647 0.48694 –1.28087 0.62793
Good health and LLTI (very good health/no LLTI) –0.47808 0.24026 –0.94900 –0.00717
Fair health and LLTI (very good health/no LLTI) –0.70989 0.23806 –1.176480 –0.24330
Bad health and LLTI (very good health/no LLTI) –1.23146 0.30601 –1.83124 –0.63169
Very bad health and LLTI (very good health/no LLTI) –1.37649 0.48403 –2.32520 –0.42779
Male and mixed (female/white) 1.16619 0.70167 –0.20909 2.54147
Male and black (female/white) –1.31878 0.67637 –2.64446 0.00691
Male and Asian (female/white) –0.12072 0.33727 –0.78176 0.54032
Male and other (female/white) 12.124980 125.24640 –233.3580 257.6079
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FIGURE 32 Cardiovascular disease as a self-reported LSI: individual estimates and their 95% CIs. (a) MSOAs;
(b) LAs; (c) CCGs; and (d) regions (GORs).
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Heart/circulatory disease as a self-reported long-standing
illness (Health Survey for England, 2006–11)
FIGURE 33 Heart/circulatory disease as a self-reported LSI: LSOA-level map. Contains Ordnance Survey data ©
Crown copyright and database right 2012.
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Response variable definition, provenance and prediction
These estimates are based on respondents to the HSfE reporting that CVD (see previous section) or high
blood pressure (hypertension) is one of up to six LSIs, disabilities or infirmities; that is, one that ‘has
troubled you over a period of time, or that is likely to affect you over a period of time’. There is no
necessity that the respondent considers the condition to be a limiting illness.
The HSfE at this time includes multiple household respondents of all ages. The analytical data set is drawn
from the subset of respondents aged ≥ 16 years for whom data are available across all model response
and predictor variables, namely whether or not they responded to the LLTI question, whether or not they
provided responses to questions on age, sex, ethnicity, general health status, LLTI and tenure, and whether
or not information is available on the IMD quintile of their LSOA of residence (n= 57,363). To avoid a
potential household-level effect, a single randomly selected adult is drawn from each household, resulting
in an analytical data set of 29,905 adults aged ≥ 16 years.















16–24 1350 15 1.1 16–24 1019 10 1.0
25–34 2636 43 1.6 25–34 1705 13 0.8
35–49 4339 217 4.8 35–49 3204 183 5.4
50–64 3381 590 14.9 50–64 2622 669 20.3
65–74 1667 609 26.8 65–74 1202 584 32.7
75–84 1134 643 36.2 75–84 684 405 37.2
≥ 85 427 238 35.8 ≥ 85 215 101 32.0




Model parameters (see below) are applied to microsimulated LSOA-level census data to produce estimates
of the number (and proportion) of people expected to report CVD or high blood pressure as a LSI in
each age–sex cohort (and overall) in each of the 32,844 English LSOAs. As discussed in the report,
bootstrapping is used to derive 95% CIs for these estimates. The bootstrapped LSOA-level prevalence rate
estimates are aggregated into a number of higher geographies, namely for MSOAs, LAs, CCGs and
regions (GORs), and are then used to calculate 95% CIs for these higher-level estimates. Proportionate
attribution is used to restructure the estimates to align with 2001 MSOAs, as well as GP practice
populations as defined by the 2011 NHS ADS.
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Table 56 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured by
the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444 adults)
in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived quintile; and
6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule, variations in
prevalence rates reflect variations in the socioeconomic composition of populations in the different types of
LSOA rather than variations in deprivation per se.
TABLE 56 Heart/circulatory disease as a self-reported LSI: cohort-specific and overall prevalence rates by IMD
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TABLE 57 Parameter estimates: heart/circulatory disease as a self-reported LSI
Factor (reference group)
Model coefficients 95% CI
Estimate Standard error 2.5% CI 97.50%
(Intercept) –5.56976 0.31175 –6.18079 –4.95873
Age (16–24 years)
25–34 years 0.30697 0.35463 –0.38809 1.00204
35–49 years 1.56286 0.30752 0.96012 2.16560
50–64 years 2.68393 0.30290 2.09024 3.27762
65–74 years 3.28657 0.30437 2.68999 3.88314
75–84 years 3.55983 0.30673 2.95865 4.16102
≥ 85 years 3.06663 0.3297 2.42041 3.71284
Sex (females)
Males 0.00264 0.43397 –0.84794 0.85322
Ethnicity (white)
Mixed 0.20666 0.30606 –0.39322 0.80654
Black 0.42884 0.17014 0.09537 0.76231
Asian –0.09794 0.15874 –0.40907 0.21319
Other –1.30352 0.74325 –2.76028 0.15325
General health status (very good)
Good health 0.85181 0.08409 0.68698 1.01663
Fair health 1.35562 0.09191 1.17549 1.53576
Bad health 1.61205 0.11405 1.38852 1.83558
Very bad health 1.68238 0.14954 1.38929 1.97547
LLTI (no LTTI)
LLTI 0.71164 0.44638 –0.16326 1.58654
Tenure (owner–occupier)
Social rent 0.00963 0.06558 –0.11891 0.13818
Private rent or other tenure –0.08618 0.10405 –0.29012 0.11775
LSOA deprivation quintile (least deprived quintile)
Second quintile 0.00138 0.09603 –0.18684 0.18960
Third quintile 0.16383 0.09603 –0.02438 0.35204
Fourth quintile 0.14159 0.10094 –0.05626 0.33944
Fifth quintile (=most deprived quintile) 0.06665 0.10867 –0.14635 0.27965
continued
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TABLE 57 Parameter estimates: heart/circulatory disease as a self-reported LSI (continued )
Factor (reference group)
Model coefficients 95% CI
Estimate Standard error 2.5% CI 97.50%
Interaction effects
25–34 years and male (16–24 years/female) –0.71303 0.52249 –1.73712 0.31106
35–49 years and male (16–24 years/female) 0.05043 0.42670 –0.78590 0.88675
50–64 years and male (16–24 years/female) 0.24070 0.41997 –0.58244 1.06384
65–74 years and male (16–24 years/female) 0.20565 0.42178 –0.62104 1.03234
75–84 years and male (16–24 years/female) –0.04057 0.42437 –0.87233 0.79119
≥ 85 years and male (16–24 years/female) –0.34762 0.44536 –1.22053 0.52530
25–34 years and LLTI (16–24 years/no LLTI) 0.03582 0.51484 –0.97326 1.04490
35–49 years and LLTI (16–24 years/no LLTI) –0.48779 0.44918 –1.36819 0.39261
50–64 years and LLTI (16–24 years/no LLTI) –0.54710 0.44132 –1.41208 0.31788
65–74 years and LLTI (16–24 years/no LLTI) –0.41937 0.44263 –1.28692 0.44819
75–84 years and LLTI (16–24 years/no LLTI) –0.40286 0.44439 –1.27385 0.46814
≥ 85 years and LLTI (16–24 years/no LLTI) 0.25405 0.46449 –0.65636 1.16445
Male and LLTI (female/no LLTI) 0.18611 0.09001 0.00968 0.36253
Male and social rent (female/owner–occupier) –0.23067 0.10302 –0.43259 –0.02876
Male and private rent (female/owner–occupier) –0.14230 0.15568 –0.44743 0.16282
LLTI and second quintile (no LLTI/least deprived) 0.22568 0.11842 –0.00643 0.45779
LLTI and third quintile (no LLTI/least deprived) 0.16628 0.11826 –0.06550 0.39806
LLTI and fourth quintile (no LLTI/least deprived) 0.32977 0.12052 0.09354 0.56599
LLTI and fifth quintile (no LLTI/least deprived) 0.30265 0.12325 0.06108 0.54421
Male and good health (female/very good health) 0.25148 0.12873 –0.00083 0.50380
Male and fair health (female/very good health) 0.40373 0.13921 0.13088 0.67658
Male and bad health (female/very good health) 0.30832 0.17381 –0.03235 0.64898
Male and very bad health (female/very good health) 0.19531 0.22776 –0.25109 0.64171
Male and mixed (female/white) 0.18608 0.49165 –0.77755 1.14970
Male and black (female/white) –0.78591 0.30367 –1.38110 –0.19072
Male and Asian (female/white) 0.10766 0.22648 –0.33625 0.55157
Male and other (female/white) 0.92182 0.93191 –0.90473 2.74837
Male and second quintile (female/least deprived) –0.15984 0.11780 –0.39074 0.07105
Male and third quintile (female/least deprived) –0.26252 0.11853 –0.49485 –0.03019
Male and fourth quintile (female/least deprived) –0.31174 0.12248 –0.55180 –0.07168
Male and fifth quintile (female/least deprived) –0.10714 0.13086 –0.36363 0.14935
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Good health (very good health)
Fair health (very good health)
Bad health (very good health)







25 – 34 years (16 – 24 years)
35 – 49 years (16 – 24 years)
50 – 64 years (16 – 24 years)
65 – 74 years (16 – 24 years)
75 – 84 years (16 – 24 years)
> 85 years (16 – 24 years)
Social rent (owner–occupier)
Private rent (owner–occupier)
Second quintile (least deprived LSOA)
Third quintile (least deprived LSOA)
Fourth quintile (least deprived LSOA)
Fifth quintile (least deprived LSOA)
25 – 34 years and male (16 – 24 years/female)
35 – 49 years and male (16 – 24 years/female)
50 – 64 years and male (16 – 24 years/female)
65 – 74 years and male (16 – 24 years/female)
75 – 84 years and male (16 – 24 years/female)
> 85 years and male (16 – 24 years/female)
25 – 34 years and LLTI (16 – 24 years/no LLTI)
35 – 49 years and LLTI (16 – 24 years/no LLTI)
50 – 64 years and LLTI (16 – 24 years/no LLTI)
65 – 74 years and LLTI (16 – 24 years/no LLTI)
75 – 84 years and LLTI (16 – 24 years/no LLTI)
> 85 years and LLTI (16 – 24 years/no LLTI)
Male and LLTI (female/no LLTI)
Male and social rent (female/owner–occupier)
Male and private rent (female/owner–occupier)
LLTI and second quintile (no LLTI/least deprived)
LLTI and third quintile (no LLTI/least deprived)
LLTI and fourth quintile (no LLTI/least deprived)
LLTI and fifth quintile (no LLTI/least deprived)
Male and good health (female/very good health)
Male and fair health (female/very good health)
Male and bad health (female/very good health)
Male and very bad health (female/very good health)
Male and mixed (female/white)
Male and black (female/white)
Male and Asian (female/white)
Male and other (female/white)
Male and second quintile (female/least deprived)
Male and third quintile (female/least deprived)
Male and fourth quintile (female/least deprived)
Male and fifth quintile (female/least deprived)
– 2 0 2 4
Parameter estimate and 95% CIs
FIGURE 34 Parameter plots: heart/circulatory disease as a self-reported LSI.
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FIGURE 35 Heart/circulatory disease as a self-reported LSI: individual estimates and their 95% CIs. (a) MSOAs;
(b) LAs; (c) CCGs; and (d) regions (GORs).
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Cardiovascular disease or diabetes as a self-reported
long-standing illness (Health Survey for England, 2006–11)
FIGURE 36 Cardiovascular disease or diabetes as a self-reported LSI: LSOA-level map. Contains Ordnance Survey
data © Crown copyright and database right 2012.
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Response variable definition, provenance and prediction
These estimates are based on respondents to the HSfE reporting that CVD, high blood pressure or diabetes
(see previous sections) is one of up to six LSIs, disabilities or infirmities; that is, one that ‘has troubled you
over a period of time, or that is likely to affect you over a period of time’. There is no necessity that the
respondent considers the condition to be a limiting illness.
The HSfE at this time includes multiple household respondents of all ages. The analytical data set is drawn
from the subset of respondents aged ≥ 16 years for whom data are available across all model response
and predictor variables, namely whether or not they responded to the LLTI question, whether or not they
provided responses to questions on age, sex, ethnicity, general health status, LLTI and tenure, and whether
or not information is available on the IMD quintile of their LSOA of residence (n= 57,363). To avoid a
potential household-level effect, a single randomly selected adult is drawn from each household, resulting
in an analytical data set of 29,905 adults aged ≥ 16 years.
















16–24 1346 19 1.4 16–24 1012 17 1.7
25–34 2613 66 2.5 25–34 1692 26 1.5
35–49 4275 281 6.2 35–49 3118 269 7.9
50–64 3258 713 18.0 50–64 2481 810 24.6
65–74 1561 715 31.4 65–74 1096 690 38.6
75–84 1036 741 41.7 75–84 610 479 44.0
≥ 85 408 257 38.6 ≥ 85 201 115 36.4




Model parameters (see below) are applied to microsimulated LSOA-level census data to produce estimates
of the number (and proportion) of people expected to report CVD, high blood pressure (hypertension) or
diabetes as a LSI in each age–sex cohort (and overall) in each of the 32,844 English LSOAs. As discussed in
the report, bootstrapping is used to derive 95% CIs for these estimates. The bootstrapped LSOA-level
prevalence rate estimates are aggregated into a number of higher geographies, namely for MSOAs, LAs,
CCGs and regions (GORs), and are then used to calculate 95% CIs for these higher-level estimates.
Proportionate attribution is used to restructure the estimates to align with 2001 MSOAs, as well as GP
practice populations as defined by the 2011 NHS ADS.
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Table 59 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured by
the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444 adults)
in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived quintile; and
6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule, variations in
prevalence rates reflect variations in the socioeconomic composition of populations in the different types of
LSOA rather than variations in deprivation per se.
TABLE 59 Cardiovascular disease or diabetes as a self-reported LSI: cohort-specific and overall prevalence rates by
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TABLE 60 Parameter estimates: CVD or diabetes as a self-reported LSI
Factor (reference group)
Model coefficients 95% CI
Estimate Standard error 2.5% CI 97.50%
(Intercept) –5.56429 0.28974 –6.13219 –4.99639
Age (16–24 years)
25–34 years 0.70170 0.31675 0.08087 1.32252
35–49 years 1.73795 0.28576 1.17786 2.29805
50–64 years 2.84251 0.28221 2.28938 3.39563
65–74 years 3.43491 0.28388 2.87850 3.99132
75–84 years 3.70361 0.28633 3.14241 4.26482
≥ 85 years 3.14721 0.30851 2.54253 3.75188
Sex (females)
Males 0.09979 0.35902 –0.60389 0.80347
Ethnicity (white)
Mixed 0.18667 0.28305 –0.36811 0.74144
Black 0.52386 0.15802 0.21415 0.83357
Asian 0.12699 0.13797 –0.14344 0.39741
Other –0.77717 0.54332 –1.84207 0.28773
General health status (very good)
Good health 0.95140 0.08388 0.78699 1.11581
Fair health 1.65270 0.09611 1.46433 1.84107
Bad health 2.13320 0.19440 1.75218 2.51422
Very bad health 2.03352 0.40776 1.23430 2.83273
LLTI (no LTTI)
LLTI 1.44728 0.38436 0.69393 2.20063
Tenure (owner–occupier)
Social rent 0.08154 0.06047 –0.03698 0.20005
Private rent or other tenure –0.15803 0.09804 –0.35020 0.03414
LSOA deprivation quintile (least deprived quintile)
Second quintile –0.05863 0.07225 –0.20024 0.08298
Third quintile 0.02610 0.07288 –0.11675 0.16894
Fourth quintile –0.00315 0.07713 –0.15433 0.14803
Fifth quintile (=most deprived quintile) –0.04769 0.08319 –0.21075 0.11537
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TABLE 60 Parameter estimates: CVD or diabetes as a self-reported LSI (continued )
Factor (reference group)
Model coefficients 95% CI
Estimate Standard error 2.5% CI 97.50%
Interaction effects
25–34 years and LLTI (16–24 years/no LLTI) –0.47437 0.41009 –1.27814 0.32940
35–49 years and LLTI (16–24 years/no LLTI) –0.86080 0.36049 –1.56735 –0.15424
50–64 years and LLTI (16–24 years/no LLTI) –0.97953 0.35397 –1.67331 –0.28576
65–74 years and LLTI (16–24 years/no LLTI) –0.82309 0.35590 –1.52065 –0.12553
75–84 years and LLTI (16–24 years/no LLTI) –0.81347 0.35822 –1.51559 –0.11136
≥ 85 years and LLTI (16–24 years/no LLTI) –0.25290 0.38079 –0.99924 0.49344
25–34 years and male (16–24 years/female) –0.77373 0.41570 –1.58850 0.04105
35–49 years and male (16–24 years/female) –0.10864 0.35441 –0.80329 0.58600
50–64 years and male (16–24 years/female) –0.00295 0.34918 –0.68734 0.68143
65–74 years and male (16–24 years/female) –0.01474 0.35150 –0.70368 0.67420
75–84 years and male (16–24 years/female) –0.22696 0.35438 –0.92155 0.46763
≥ 85 years and male (16–24 years/female) –0.52167 0.37742 –1.26142 0.21808
LLTI and second quintile (no LLTI/least deprived) 0.24953 0.11206 0.02989 0.46917
LLTI and third quintile (no LLTI/least deprived) 0.25093 0.11216 0.03110 0.47077
LLTI and fourth quintile (no LLTI/least deprived) 0.40024 0.11413 0.17654 0.62394
LLTI and fifth quintile (no LLTI/least deprived) 0.37492 0.11708 0.14543 0.60440
Male and good health (female/very good health) 0.27696 0.11950 0.04275 0.51118
Male and fair health (female/very good health) 0.36517 0.12863 0.11305 0.61728
Male and bad health (female/very good health) 0.25645 0.16316 –0.06334 0.57624
Male and very bad health (female/very good health) 0.16845 0.21859 –0.26000 0.59689
Good health and LLTI (very good health/no LLTI) –0.29240 0.15826 –0.60259 0.01779
Fair health and LLTI (very good health/no LLTI) –0.48816 0.15896 –0.79971 –0.17660
Bad health and LLTI (very good health/no LLTI) –0.68203 0.23073 –1.13426 –0.22980
Very bad health and LLTI (very good health/no LLTI) –0.50814 0.42823 –1.34747 0.33119
Male and LLTI (female/no LLTI) 0.17875 0.08369 0.01471 0.34278
Male and mixed (female/white) 0.13399 0.45430 –0.75643 1.02441
Male and black (female/white) –0.62927 0.26753 –1.15363 –0.10492
Male and Asian (female/white) 0.27528 0.19419 –0.10535 0.65590
Male and other (female/white) 0.53594 0.72477 –0.88461 1.95650
Male and social rent (female/owner–occupier) –0.21235 0.09092 –0.39056 –0.03415
Male and private rent (female/owner–occupier) 0.01826 0.14256 –0.26117 0.29768
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25 – 34 years (16 – 24 years)
35 – 49 years (16 – 24 years)
50 – 64 years (16 – 24 years)
65 – 74 years (16 – 24 years)
75 – 84 years (16 – 24 years)
> 85 years (16 – 24 years)
Social rent (owner–occupier)
Private rent (owner–occupier)
Second quintile (least deprived LSOA)
Third quintile (least deprived LSOA)
Fourth quintile (least deprived LSOA)
Fifth quintile (least deprived LSOA)
25 – 34 years and LLTI (16 – 24 years/no LLTI)
35 – 49 years and LLTI (16 – 24 years/no LLTI)
50 – 64 years and LLTI (16 – 24 years/no LLTI)
65 – 74 years and LLTI (16 – 24 years/no LLTI)
75 – 84 years and LLTI (16 – 24 years/no LLTI)
> 85 years and LLTI (16 – 24 years/no LLTI)
25 – 34 years and male (16 – 24 years/female)
35 – 49 years and male (16 – 24 years/female)
50 – 64 years and male (16 – 24 years/female)
65 – 74 years and male (16 – 24 years/female)
75 – 84 years and male (16 – 24 years/female)
> 85 years and male (16 – 24 years/female)
LLTI and second quintile (no LLTI/least deprived)
LLTI and third quintile (no LLTI/least deprived)
LLTI and fourth quintile (no LLTI/least deprived)
LLTI and fifth quintile (no LLTI/least deprived)
Male and good health (female/very good health)
Male and fair health (female/very good health)
Male and bad health (female/very good health)
Male and very bad health (female/very good health)
Good health and LLTI (very good health/no LLTI)
Fair health and LLTI (very good health/no LLTI)
Bad health and LLTI (very good health/no LLTI)
Very bad health and LLTI (very good health/no LLTI)
Male and LLTI (female/no LLTI)
Male and social rent (female/owner–occupier)
Male and private rent (female/owner–occupier)
Male and mixed (female/white)
Male and black (female/white)
Male and Asian (female/white)
Male and other (female/white)
– 2 0 2 4
Parameter estimate and 95% CIs
FIGURE 37 Parameter plots: CVD or diabetes as a self-reported LSI.
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FIGURE 38 Cardiovascular disease or diabetes as a self-reported LSI: individual estimates and their 95% CIs.
(a) MSOAs; (b) LAs; (c) CCGs; and (d) regions (GORs).
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Nurse-measured high blood pressure (Health Survey for
England, 2006 and 2009–11)
FIGURE 39 Nurse-measured high blood pressure: LSOA-level map. Contains Ordnance Survey data © Crown
copyright and database right 2012.
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Response variable definition, provenance and prediction
These estimates are based on nurse-administered blood pressure readings taken of a subsample of adult
respondents to the HSfE. If a valid Omeron reading above 140mmHg systolic or 90mmHg diastolic is
obtained, the respondent is flagged as having high blood pressure.
The HSfE at this time includes multiple household respondents of all ages. To facilitate comparison with
the four different markers of high blood pressure used in this study, the analytical data set is drawn from
the most data-restrictive subset of respondents aged ≥ 16 years, namely those for whom we have valid
data on blood pressure, doctor diagnoses of illnesses, prescribed drug use and reasons for that use, and
self-reported LSI; as well as for the usual set of predictor variables, namely age, sex, ethnicity, general
health status, LLTI and tenure and the IMD quintile of their LSOA of residence (n= 19,137). To avoid a
potential household-level effect, a single randomly selected adult is drawn from each household, resulting
in an analytical data set of 12,103 adults aged ≥ 16 years.















16–24 488 4 0.8 16–24 326 22 6.3
25–34 955 35 3.5 25–34 636 92 12.6
35–49 1897 206 9.8 35–49 1174 299 20.3
50–64 1417 489 25.7 50–64 946 488 34.0
65–74 461 331 41.8 65–74 385 249 39.3
75–84 318 262 45.2 75–84 204 153 42.9
≥ 85 91 89 49.4 ≥ 85 42 44 51.2




Model parameters (see below) are applied to microsimulated LSOA-level census data to produce estimates
of the number (and proportion) of people expected to have high blood pressure in each age–sex cohort
(and overall) in each of the 32,844 English LSOAs. As discussed in the report, bootstrapping is used to
derive 95% CIs for these estimates. The bootstrapped LSOA-level prevalence rate estimates are aggregated
into a number of higher geographies, namely for MSOAs, LAs, CCGs and GORs, and are then used to
calculate 95% CIs for these higher-level estimates. Proportionate attribution is used to restructure the
estimates to align with 2001 MSOAs, as well as GP practice populations as defined by the 2011 NHS ADS.
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Table 62 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured by
the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444 adults)
in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived quintile; and
6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule, variations in
prevalence rates reflect variations in the socioeconomic composition of populations in the different types of
LSOA rather than variations in deprivation per se.
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TABLE 63 Parameter estimates: nurse-measured high blood pressure
Factor (reference group)
Model coefficients 95% CI
Estimate Standard error 2.5% CI 97.50%
(Intercept) –5.11208 0.50637 –6.10457 –4.11960
Age (16–24 years)
25–34 years 1.50104 0.53088 0.46051 2.54156
35–49 years 2.59737 0.50794 1.60180 3.59294
50–64 years 3.73524 0.50570 2.74407 4.72642
65–74 years 4.45999 0.50831 3.46369 5.45628
75–84 years 4.57290 0.51033 3.57265 5.57315
≥ 85 years 4.73457 0.52525 3.70507 5.76407
Sex (females)
Males 2.11807 0.54848 1.04306 3.19309
Ethnicity (white)
Mixed –0.48477 0.30604 –1.08460 0.11506
Black 0.10545 0.17183 –0.23134 0.44225
Asian –0.40020 0.14739 –0.68909 –0.11130
Other –0.68594 0.48409 –1.63476 0.26288
General health status (very good)
Good health 0.31323 0.05727 0.20098 0.42548
Fair health 0.38343 0.07567 0.23511 0.53174
Bad health 0.38388 0.11534 0.15781 0.60995
Very bad health 0.05267 0.19245 –0.32454 0.42988
LLTI (no LTTI)
LLTI –0.15028 0.06175 –0.27132 –0.02924
Tenure (owner–occupier)
Social rent 0.01231 0.07141 –0.12766 0.15229
Private rent or other tenure –0.02181 0.08789 –0.19409 0.15046
LSOA deprivation quintile (least deprived quintile)
Second quintile 0.16318 0.06943 0.02710 0.29927
Third quintile 0.12825 0.07102 –0.01094 0.26745
Fourth quintile 0.18362 0.07473 0.03715 0.33008
Fifth quintile (=most deprived quintile) 0.23982 0.08332 0.07651 0.40312
Interaction effects
25–34 years and male (16–24 years/female) –0.71995 0.58567 –1.86787 0.42796
35–49 years and male (16–24 years/female) –1.26567 0.55719 –2.35775 –0.17358
50–64 years and male (16–24 years/female) –1.71331 0.55384 –2.79885 –0.62778
65–74 years and male (16–24 years/female) –2.22788 0.55923 –3.32397 –1.13179
75–84 years and male (16–24 years/female) –2.20247 0.56512 –3.31011 –1.09483
≥ 85 years and male (16–24 years/female) –2.04735 0.60839 –3.23980 –0.85490
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FIGURE 41 Nurse-measured high blood pressure: individual estimates and their 95% CIs. (a) MSOAs; (b) LAs;
(c) CCGs; and (d) region (GORs). BP, blood pressure.
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Nurse-measured high blood pressure or using blood pressure
medication (Health Survey for England, 2006 and 2009–11)
FIGURE 42 Nurse-measured high blood pressure or blood pressure drugs: LSOA-level map. Contains Ordnance
Survey data © Crown copyright and database right 2012.
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Response variable definition, provenance and prediction
These estimates are based on nurse-administered blood pressure readings and questions about use of
prescribed medicines taken of a subsample of adult respondents to the HSfE. If a valid Omeron reading
above 140mmHg systolic or 90mmHg diastolic is obtained then the respondent is flagged as having high
blood pressure. The respondent is flagged as taking medication for high blood pressure only if they are on
diuretics, beta-blockers, ACE inhibitors, calcium channel blockers or ‘other blood medication’ which is
specifically to control high blood pressure.
The HSfE at this time includes multiple household respondents of all ages. To facilitate comparison with
the four different markers of high blood pressure used in this study, the analytical data set is drawn from
the most data-restrictive subset of respondents aged ≥ 16 years, namely those for whom we have valid
data on blood pressure, doctor diagnoses of illnesses, prescribed drug use and reasons for that use, and
self-reported LSI; as well as for the usual set of predictor variables, namely age, sex, ethnicity, general
health status, LLTI and tenure and the IMD quintile of their LSOA of residence (n= 19,137). To avoid a
potential household-level effect, a single randomly selected adult is drawn from each household, resulting
in an analytical data set of 12,103 adults aged ≥ 16 years.
















16–24 488 4 0.8 16–24 326 22 6.3
25–34 951 39 3.9 25–34 632 96 13.2
35–49 1820 283 13.5 35–49 1123 350 23.8
50–64 1182 724 38.0 50–64 768 666 46.4
65–74 286 506 63.9 65–74 239 395 62.3
75–84 148 432 74.5 75–84 85 272 76.2
≥ 85 36 144 80.0 ≥ 85 23 63 73.3




Model parameters (see below) are applied to microsimulated LSOA-level census data to produce estimates
of the number (and proportion) of people expected to have high blood pressure and/or be taking
medication for high blood pressure in each age–sex cohort (and overall) in each of the 32,844 English
LSOAs. As discussed in the report, bootstrapping is used to derive 95% CIs for these estimates. The
bootstrapped LSOA-level prevalence rate estimates are aggregated into a number of higher geographies,
namely for MSOAs, LAs, CCGs and GORs, and are then used to calculate 95% CIs for these higher-level
estimates. Proportionate attribution is used to restructure the estimates to align with 2001 MSOAs, as well
as GP practice populations as defined by the 2011 NHS ADS.
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Table 65 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured by
the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444 adults)
in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived quintile; and
6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule, variations in
prevalence rates reflect variations in the socioeconomic composition of populations in the different types of
LSOA rather than variations in deprivation per se.
TABLE 65 Nurse-measured high blood pressure or blood pressure drugs: cohort-specific and overall prevalence
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TABLE 66 Parameter estimates: nurse-measured high blood pressure or blood pressure drugs
Factor (reference group)
Model coefficients 95% CI
Estimate Standard error 2.5% CI 97.50%
(Intercept) –5.33966 0.50643 –6.33227 –4.34705
Age (16–24 years)
25–34 years 1.59344 0.52833 0.55791 2.62898
35–49 years 2.93198 0.50682 1.93861 3.92534
50–64 years 4.26815 0.50533 3.27771 5.25860
65–74 years 5.31077 0.50876 4.31361 6.30794
75–84 years 5.71532 0.51247 4.71088 6.71976
≥ 85 years 6.02071 0.53736 4.96748 7.07394
Sex (females)
Males 2.14063 0.54878 1.06503 3.21623
Ethnicity (white)
Mixed –0.24575 0.26476 –0.76469 0.27319
Black 0.33107 0.16337 0.01085 0.65128
Asian –0.15877 0.13003 –0.41363 0.09609
Other –0.35014 0.40043 –1.13499 0.43470
General health status (very good)
Good health 0.57021 0.05553 0.46138 0.67904
Fair health 0.85827 0.07408 0.71307 1.00348
Bad health 1.01386 0.11437 0.78969 1.23802
Very bad health 0.75303 0.18102 0.39824 1.10782
LLTI (no LTTI)
LLTI –0.09072 0.06061 –0.20952 0.02807
Tenure (owner–occupier)
Social rent 0.05895 0.07063 –0.07948 0.19737
Private rent or other tenure –0.09328 0.08527 –0.26041 0.07385
LSOA deprivation quintile (least deprived quintile)
Second quintile 0.11757 0.06769 –0.01511 0.25024
Third quintile 0.09118 0.06893 –0.04392 0.22627
Fourth quintile 0.23073 0.07249 0.08866 0.37281
Fifth quintile (=most deprived quintile) 0.18176 0.08124 0.02253 0.34099
Interaction effects
25–34 years and male (16–24 years/female) –0.75694 0.58324 –1.90009 0.38621
35–49 years and male (16–24 years/female) –1.43376 0.55600 –2.52352 –0.34400
50–64 years and male (16–24 years/female) –1.79466 0.55349 –2.87950 –0.70981
65–74 years and male (16–24 years/female) –2.21634 0.56010 –3.31414 –1.11854
75–84 years and male (16–24 years/female) –1.99052 0.57115 –3.10998 –0.87107
≥ 85 years and male (16–24 years/female) –2.48169 0.63044 –3.71736 –1.24603
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FIGURE 44 Nurse-measured high blood pressure or blood pressure drugs: individual estimates and their 95% CIs.
(a) MSOAs; (b) LAs; (c) CCGs; and (d) regions (GORs).
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Clinical evidence of current treated or untreated high blood
pressure (Health Survey for England, 2006 and 2009–11)
FIGURE 45 Clinical evidence of treated/untreated high blood pressure: LSOA-level map. Contains Ordnance Survey
data © Crown copyright and database right 2012.
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Response variable definition, provenance and prediction
These estimates are based on HSfE nurse-administered blood pressure readings, questions about the use of
prescribed medicines, and questions about current doctor diagnosis of high blood pressure. If a valid
Omeron reading above 140mmHg systolic or 90mmHg diastolic is obtained, the respondent is flagged as
having high blood pressure. The respondent is flagged as taking medication for high blood pressure only if
they are on diuretics, beta-blockers, ACE inhibitors, calcium channel blockers or ‘other blood medication’
which is specifically to control high blood pressure.
The HSfE at this time includes multiple household respondents of all ages. To facilitate comparison with
the four different markers of high blood pressure used in this study, the analytical data set is drawn from
the most data-restrictive subset of respondents aged ≥ 16 years, namely those for whom we have valid
data on blood pressure, doctor diagnoses of illnesses, prescribed drug use and reasons for that use, and
self-reported LSI; as well as for the usual set of predictor variables, namely age, sex, ethnicity, general
health status, LLTI and tenure and the IMD quintile of their LSOA of residence (n= 19,137). To avoid a
potential household-level effect, a single randomly selected adult is drawn from each household, resulting
in an analytical data set of 12,103 adults aged ≥ 16 years.
















16–24 485 7 1.4 16–24 324 24 6.9
25–34 939 51 5.2 25–34 617 111 15.2
35–49 1785 318 15.1 35–49 1088 385 26.1
50–64 1130 776 40.7 50–64 705 729 50.8
65–74 270 522 65.9 65–74 211 423 66.7
75–84 117 463 79.8 75–84 80 277 77.6
≥ 85 28 152 84.4 ≥ 85 18 68 79.1




Model parameters (see below) are applied to microsimulated LSOA-level census data to produce estimates
of the number (and proportion) of people expected to have high blood pressure and/or be taking
medication for high blood pressure and/or who report that they are currently diagnosed with high blood
pressure in each age–sex cohort (and overall) in each of the 32,844 English LSOAs. As discussed in the
report, bootstrapping is used to derive 95% CIs for these estimates. The bootstrapped LSOA-level
prevalence rate estimates are aggregated into a number of higher geographies, namely for MSOAs, LAs,
CCGs and GORs, and are then used to calculate 95% CIs for these higher-level estimates. Proportionate
attribution is used to restructure the estimates to align with 2001 MSOAs, as well as GP practice
populations as defined by the 2011 NHS ADS.
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Table 68 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured
by the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444
adults) in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived
quintile; and 6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule,
variations in prevalence rates reflect variations in the socioeconomic composition of populations in the
different types of LSOA rather than variations in deprivation per se.
TABLE 68 Clinical evidence of treated/untreated high blood pressure: cohort-specific and overall prevalence rates
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TABLE 69 Parameter estimates: clinical evidence of treated/untreated high blood pressure
Factor (reference group)
Model coefficients 95% CI
Estimate Standard error 2.5% CI 97.50%
(Intercept) –4.81484 0.38630 –5.57199 –4.05768
Age (16–24 years)
25–34 years 1.30475 0.40740 0.50626 2.10325
35–49 years 2.47935 0.38642 1.72197 3.23673
50–64 years 3.77859 0.38487 3.02425 4.53293
65–74 years 4.78492 0.38968 4.02115 5.54868
75–84 years 5.37398 0.39649 4.59686 6.15111
≥ 85 years 5.67036 0.43534 4.81709 6.52363
Sex (females)
Males 1.69613 0.43631 0.84096 2.55131
Ethnicity (white)
Mixed –0.40990 0.26519 –0.92967 0.10987
Black 0.23751 0.16261 –0.08121 0.55623
Asian –0.20607 0.12745 –0.45588 0.04373
Other –0.39027 0.38834 –1.15142 0.37088
General health status (very good)
Good health 0.61759 0.05480 0.51017 0.72500
Fair health 0.97254 0.07387 0.82775 1.11733
Bad health 1.15673 0.11543 0.93048 1.38297
Very bad health 1.01538 0.18359 0.65555 1.37522
LLTI (no LTTI)
LLTI 0.04965 0.07516 –0.09766 0.19695
Tenure (owner–occupier)
Social rent 0.11767 0.07065 –0.02080 0.25615
Private rent or other tenure –0.11081 0.08350 –0.27448 0.05285
LSOA deprivation quintile (least deprived quintile)
Second quintile 0.05970 0.06738 –0.07236 0.19176
Third quintile 0.10009 0.06836 –0.03390 0.23407
Fourth quintile 0.21795 0.07198 0.07686 0.35904
Fifth quintile (=most deprived quintile) 0.11906 0.08067 –0.03906 0.27719
Interaction effects
25–34 years and male (16–24 years/female) –0.38531 0.47116 –1.30878 0.53816
35–49 years and male (16–24 years/female) –0.95171 0.44478 –1.82349 –0.07993
50–64 years and male (16–24 years/female) –1.23706 0.44254 –2.10444 –0.36967
65–74 years and male (16–24 years/female) –1.61142 0.45175 –2.49686 –0.72598
75–84 years and male (16–24 years/female) –1.68679 0.46804 –2.60414 –0.76944
≥ 85 years and male (16–24 years/female) –1.92701 0.55456 –3.01395 –0.84008
Male and LLTI (female/no LLTI) –0.15714 0.10192 –0.35690 0.04262
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FIGURE 47 Clinical evidence of treated/untreated high blood pressure: individual estimates and their 95% CIs.
(a) MSOAs; (b) LAs; (c) CCGs; and (d) regions (GORs).
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History of treated/untreated high blood pressure
(Health Survey for England, 2006 and 2009–11)
FIGURE 48 History of treated/untreated high blood pressure: LSOA-level map. Contains Ordnance Survey data ©
Crown copyright and database right 2012.
APPENDIX 26
NIHR Journals Library www.journalslibrary.nihr.ac.uk
338
Response variable definition, provenance and prediction
These estimates are based on HSfE nurse-administered blood pressure readings, questions about the use
of prescribed medicines, questions about ever having been diagnosed with high blood pressure, and
self-reported LSI. If a valid Omeron reading above 140mmHg systolic or 90mmHg diastolic is obtained,
the respondent is flagged as having high blood pressure. The respondent is flagged as taking medication
for high blood pressure only if they are on diuretics, beta-blockers, ACE inhibitors, calcium channel
blockers or ‘other blood medication’ which is specifically to control high blood pressure.
The HSfE at this time includes multiple household respondents of all ages. To facilitate comparison with
the four different markers of high blood pressure used in this study, the analytical data set is drawn from
the most data-restrictive subset of respondents aged ≥ 16 years, namely those for whom we have valid
data on blood pressure, doctor diagnoses of illnesses, prescribed drug use and reasons for that use, and
self-reported long-standing illness; as well as for the usual set of predictor variables, namely age, sex,
ethnicity, general health status, LLTI and tenure and the IMD quintile of their LSOA of residence
(n= 19,137). To avoid a potential household-level effect, a single randomly selected adult is drawn from
each household, resulting in an analytical data set of 12,103 adults aged ≥ 16 years.














16–24 472 20 4.1 16–24 317 31 8.9
25–34 886 104 10.5 25–34 588 140 19.2
35–49 1682 421 20.0 35–49 1028 445 30.2
50–64 1044 862 45.2 50–64 647 787 54.9
65–74 254 538 67.9 65–74 196 438 69.1
75–84 105 475 81.9 75–84 76 281 78.7
≥ 85 26 154 85.6 ≥ 85 17 69 80.2




Model parameters (see below) are applied to microsimulated LSOA-level census data to produce estimates
of the number (and proportion) of people expected to have high blood pressure and/or be taking
medication for high blood pressure and/or who have ever been diagnosed with high blood pressure and/or
who report high blood pressure as a LSI in each age–sex cohort (and overall) in each of the 32,844 English
LSOAs. As discussed in the report, bootstrapping is used to derive 95% CIs for these estimates. The
bootstrapped LSOA-level prevalence rate estimates are aggregated into a number of higher geographies,
namely for MSOAs, LAs, CCGs and GORs, and are then used to calculate 95% CIs for these higher-level
estimates. Proportionate attribution is used to restructure the estimates to align with 2001 MSOAs, as well
as GP practice populations as defined by the 2011 NHS ADS.
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Table 71 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured
by the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444
adults) in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived
quintile; and 6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule,
variations in prevalence rates reflect variations in the socioeconomic composition of populations in the
different types of LSOA rather than variations in deprivation per se.
TABLE 71 History of treated/untreated high blood pressure: cohort-specific and overall prevalence rates by IMD
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TABLE 72 Table of parameter estimates: history of treated/untreated high blood pressure
Factor (reference group)
Model coefficients 95% CI
Estimate Standard error 2.5% CI 97.50%
(Intercept) –3.74956 0.23697 –4.21402 –3.28511
Age (16–24 years)
25–34 years 1.00757 0.25171 0.51421 1.50093
35–49 years 1.74921 0.23634 1.28599 2.21243
50–64 years 2.88916 0.23513 2.42831 3.35002
65–74 years 3.80048 0.24332 3.32357 4.27738
75–84 years 4.43109 0.25536 3.93059 4.93159
≥ 85 years 4.68205 0.3149 4.06484 5.29926
Sex (females)
Males 0.88448 0.29709 0.30219 1.46678
Ethnicity (white)
Mixed –0.33233 0.23935 –0.80146 0.13681
Black 0.03827 0.15556 –0.26662 0.34316
Asian –0.27799 0.11938 –0.51198 –0.04400
Other –0.29365 0.34990 –0.97946 0.39216
General health status (very good)
Good health 0.62125 0.05211 0.51910 0.72339
Fair health 0.94170 0.07148 0.80160 1.08180
Bad health 1.16019 0.11438 0.93601 1.38438
Very bad health 1.15571 0.18565 0.79183 1.51958
LLTI (no LTTI)
LLTI 0.05996 0.05897 –0.05562 0.17553
Tenure (owner–occupier)
Social rent 0.08633 0.06831 –0.04755 0.22022
Private rent or other tenure –0.11064 0.07780 –0.26313 0.04185
LSOA deprivation quintile (least deprived quintile)
Second quintile 0.07032 0.06523 –0.05752 0.19816
Third quintile 0.10931 0.06611 –0.02027 0.23889
Fourth quintile 0.26470 0.06949 0.12851 0.40089
Fifth quintile (=most deprived quintile) 0.19392 0.07739 0.04224 0.34560
Interaction effects
25–34 years and male (16–24 years/female) –0.08904 0.32904 –0.73395 0.55587
35–49 years and male (16–24 years/female) –0.31453 0.30767 –0.91755 0.28850
50–64 years and male (16–24 years/female) –0.49373 0.30569 –1.09288 0.10542
65–74 years and male (16–24 years/female) –0.83284 0.31936 –1.45879 –0.20689
75–84 years and male (16–24 years/female) –1.00959 0.34271 –1.68130 –0.33787
≥ 85 years and male (16–24 years/female) –1.20249 0.45796 –2.10009 –0.30489
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FIGURE 50 History of treated/untreated high blood pressure: individual estimates and their 95% CIs. (a) MSOAs;
(b) LAs; (c) CCGs; and (d) regions (GORs).
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Coronary heart disease (angina or myocardial infarction)
symptoms (Health Survey for England, 2006 and 2011)
FIGURE 51 Coronary heart disease (angina or MI) symptoms: LSOA-level map. Contains Ordnance Survey data ©
Crown copyright and database right 2012.
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Response variable definition, provenance and prediction
These estimates are based on respondents to the HSfE reporting that they had (a) ever had chest pain in
sternum, sternum lower or anterior lower chest and in the left arm (angina symptoms) and/or (b) ever had
a severe pain across the front of their chest lasting half an hour or more (possible MI).
The HSfE at this time includes multiple household respondents of all ages. The analytical data set is drawn
from the subset of respondents aged ≥ 16 years for whom data are available across all model response
and predictor variables, namely whether or not they responded to questions on angina and MI symptoms,
whether or not they provided responses to questions on age, sex, ethnicity, general health status, LLTI and
tenure, and whether or not information is available on the IMD quintile of their LSOA of residence
(n= 20,965). To avoid a potential household-level effect, a single randomly selected adult is drawn from
each household, resulting in an analytical data set of 13,835 adults aged ≥ 16 years.















16–24 591 17 2.8 16–24 414 10 2.4
25–34 1153 58 4.8 25–34 775 40 4.9
35–49 2022 114 5.3 35–49 1496 115 7.1
50–64 1767 165 8.5 50–64 1324 196 12.9
65–74 635 88 12.2 65–74 498 80 13.8
75–84 514 67 11.5 75–84 294 70 19.2
≥ 85 185 23 11.1 ≥ 85 104 20 16.1




Model parameters (see below) are applied to microsimulated LSOA-level census data to produce estimates
of the number (and proportion) of people expected to report symptoms of CHD (angina or MI) in each
age–sex cohort (and overall) in each of the 32,844 English LSOAs. As discussed in the report,
bootstrapping is used to derive 95% CIs for these estimates. The bootstrapped LSOA-level prevalence rate
estimates are aggregated into a number of higher geographies, namely for MSOAs, LAs, CCGs and
regions (GORs), and are then used to calculate 95% CIs for these higher-level estimates. Proportionate
attribution is used to restructure the estimates to align with 2001 MSOAs, as well as GP practice
populations as defined by the 2011 NHS ADS.
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Table 74 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured
by the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444
adults) in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived
quintile; and 6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule,
variations in prevalence rates reflect variations in the socioeconomic composition of populations in the
different types of LSOA rather than variations in deprivation per se.
TABLE 74 Coronary heart disease (angina or MI) symptoms: cohort-specific and overall prevalence rates by IMD
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TABLE 75 Parameter estimates: CHD (angina or MI) symptoms
Factor (reference group)
Model coefficients 95% CI
Estimate Standard error 2.5% CI 97.50%
(Intercept) –4.45881 0.21999 –4.88998 –4.02763
Age (16–24 years)
25–34 years 0.37437 0.20549 –0.02840 0.77713
35–49 years 0.30978 0.19368 –0.06984 0.68939
50–64 years 0.64254 0.19134 0.26751 1.01756
65–74 years 0.82061 0.20263 0.42346 1.21775
75–84 years 0.81275 0.20682 0.40738 1.21812
≥ 85 years 0.50393 0.25547 0.00321 1.00464
Sex (females)
Males 0.44285 0.08457 0.27709 0.60860
Ethnicity (white)
Mixed 0.33828 0.33272 –0.31385 0.99042
Black 0.19133 0.21383 –0.22778 0.61044
Asian –0.47100 0.19814 –0.85935 –0.08265
Other 0.28069 0.42851 –0.55920 1.12058
General health status (very good)
Good health 0.75659 0.12022 0.52095 0.99223
Fair health 1.37962 0.13117 1.12252 1.63672
Bad health 1.95989 0.15305 1.65992 2.25987
Very bad health 2.14672 0.19346 1.76753 2.52591
LLTI (no LTTI)
LLTI 0.76818 0.08614 0.59934 0.93702
Tenure (owner–occupier)
Social rent 0.22624 0.11320 0.00437 0.44811
Private rent or other tenure 0.14334 0.16474 –0.17955 0.46623
LSOA deprivation quintile (least deprived quintile)
Second quintile 0.01708 0.11357 –0.20553 0.23968
Third quintile 0.02027 0.11307 –0.20135 0.24188
Fourth quintile 0.08282 0.11486 –0.14231 0.30794
Fifth quintile (=most deprived quintile) 0.05768 0.12009 –0.17771 0.29306
Interaction effects
Male and social rent (female/owner–occupier) –0.20631 0.15815 –0.51629 0.10367
Male and private rent (female/owner–occupier) –0.48203 0.24084 –0.95407 –0.00999
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FIGURE 53 Coronary heart disease (angina or MI) symptoms: individual estimates and their 95% CIs. (a) MSOAs;
(b) LAs; (c) CCGs; and (d) regions (GORs).
DOI: 10.3310/hsdr04140 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 14
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Asthana et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
349
Clinical evidence of current coronary heart disease: symptoms,
medication or recent doctor diagnosis (Health Survey for
England, 2006 and 2011)
FIGURE 54 Clinical evidence of current CHD: LSOA-level map. Contains Ordnance Survey data © Crown copyright
and database right 2012.
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Response variable definition, provenance and prediction
These estimates are based on respondents to the HSfE reporting that they had ever had symptoms of
angina or MI (as described above), or who were taking prescribed drugs for CHD (see below), or who had
recently (in the last 12 months) been diagnosed with angina or having had a heart attack. This is a
more restricted data set largely because questions on prescribed medicines were included in the
nurse-administered questionnaire, which was asked of only a subset of all respondents.
Respondents are deemed to be taking CHD drugs if they are taking any medicines classified into any of
the following BNF categories specifically for ‘a heart problem’: BNF 2.4 (beta-blockers), 2.5.5.1 (ACE
inhibitors), 2.6.1 (nitrates), 2.6.2 (calcium channel blockers), 2.6.3 (other antianginal drugs), 2.9
(antiplatelet drugs), 2.10.1 (drugs for management of stable angina and acute coronary symptoms) and
2.12 (lipid-regulating drugs, e.g. statins).487
The HSfE at this time includes multiple household respondents of all ages. The analytical data set is drawn
from the subset of respondents aged ≥ 16 years for whom data are available across all model response
and predictor variables, namely whether or not they responded to questions on angina and MI symptoms,
prescribed drug use and doctor diagnosis of angina/heart attack; whether or not they provided responses
to questions on age, sex, ethnicity, general health status, LLTI and tenure; and whether or not information
is available on the IMD quintile of their LSOA of residence (n= 14,896). To avoid a potential household-
level effect, a single randomly selected adult is drawn from each household, resulting in an analytical data
set of 9330 adults aged ≥ 16 years.















16–24 405 14 3.3 16–24 236 6 2.5
25–34 843 42 4.7 25–34 515 23 4.3
35–49 1523 95 5.9 35–49 1065 93 8.0
50–64 1380 163 10.6 50–64 925 207 18.3
65–74 442 98 18.1 65–74 314 101 24.3
75–84 269 96 26.3 75–84 172 96 35.8
≥ 85 95 34 26.4 ≥ 85 47 31 39.7




Model parameters (see below) are applied to microsimulated LSOA-level census data to produce estimates
of the number (and proportion) of people expected to report symptoms of CHD (angina or MI), who are
taking prescribed drugs for CHD, or who have been recently diagnosed with angina and/or a heart attack
in each age–sex cohort (and overall) in each of the 32,844 English LSOAs. As discussed in the report,
bootstrapping is used to derive 95% CIs for these estimates. The bootstrapped LSOA-level prevalence rate
estimates are aggregated into a number of higher geographies, namely for MSOAs, LAs, CCGs and
regions (GORs), and are then used to calculate 95% CIs for these higher-level estimates. Proportionate
attribution is used to restructure the estimates to align with 2001 MSOAs, as well as GP practice
populations as defined by the 2011 NHS ADS.
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Table 77 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured
by the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444
adults) in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived
quintile; and 6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule,
variations in prevalence rates reflect variations in the socioeconomic composition of populations in the
different types of LSOA rather than variations in deprivation per se.
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TABLE 78 Parameter estimates: clinical evidence of current CHD
Factor (reference group)
Model coefficients 95% CI
Estimate Standard error 2.5% CI 97.50%
(Intercept) –4.92453 0.32457 –5.56069 –4.28836
Age (16–24 years)
25–34 years 0.49150 0.33791 –0.17080 1.15379
35–49 years 0.69891 0.31422 0.08303 1.31478
50–64 years 1.49445 0.30768 0.89141 2.09749
65–74 years 1.97509 0.32038 1.34715 2.60304
75–84 years 2.49888 0.32677 1.85841 3.13936
≥ 85 years 2.58399 0.38169 1.83588 3.33209
Sex (females)
Males 0.69094 0.10226 0.4905 0.89137
Ethnicity (white)
Mixed –0.13975 0.54518 –1.20830 0.92879
Black 0.49575 0.29791 –0.08816 1.07965
Asian –0.21009 0.29542 –0.78911 0.36893
Other 0.91390 0.67018 –0.39966 2.22746
General health status (very good)
Good health 0.82726 0.12987 0.57272 1.08181
Fair health 1.58843 0.15226 1.28999 1.88686
Bad health 1.71657 0.41904 0.89524 2.53789
Very bad health –10.0834 178.3854 –359.719 339.552
LLTI (no LTTI)
LLTI 2.27225 0.54824 1.19769 3.34680
Tenure (owner–occupier)
Social rent 0.18207 0.09297 –0.00014 0.36429
Private rent or other tenure –0.07073 0.13569 –0.33669 0.19522
LSOA deprivation quintile (least deprived quintile)
Second quintile –0.04062 0.11234 –0.26081 0.17956
Third quintile 0.02405 0.11098 –0.19347 0.24157
Fourth quintile –0.01300 0.11582 –0.24001 0.21400
Fifth quintile (=most deprived quintile) 0.09913 0.12279 –0.14153 0.33980
continued
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TABLE 78 Parameter estimates: clinical evidence of current CHD (continued )
Factor (reference group)
Model coefficients 95% CI
Estimate Standard error 2.5% CI 97.50%
Interaction effects
25–34 years and LLTI (16–24 years/
no LLTI)
–0.49574 0.55564 –1.58479 0.59331
35–49 years and LLTI (16–24 years/
no LLTI)
–0.51362 0.51231 –1.51776 0.49051
50–64 years and LLTI (16–24 years/
no LLTI)
–1.01435 0.50152 –1.99733 –0.03138
65–74 years and LLTI (16–24 years/
no LLTI)
–1.13331 0.51517 –2.14304 –0.12359
75–84 years and LLTI (16–24 years/
no LLTI)
–1.36252 0.52027 –2.38225 –0.34279
≥ 85 years and LLTI (16–24 years/
no LLTI)
–1.53061 0.58069 –2.66877 –0.39246
Good health and LLTI (very good health/
no LLTI)
–0.44849 0.28408 –1.00529 0.10832
Fair health and LLTI (very good health/
no LLTI)
–0.83331 0.28652 –1.39488 –0.27173
Bad health and LLTI (very good health/
no LLTI)
–0.46839 0.48824 –1.42533 0.48856
Very bad health and LLTI (very good
health/no LLTI)
11.82463 178.3856 –337.811 361.4604
Male and LLTI (female/no LLTI) –0.33835 0.14025 –0.61325 –0.06346
Male and mixed (female/white) –0.20454 0.92524 –2.01800 1.60893
Male and black (female/white) –1.83615 0.79701 –3.39829 –0.27401
Male and Asian (female/white) –0.51906 0.46559 –1.43162 0.39350
Male and other (female/white) –0.35620 0.92655 –2.17223 1.45984
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FIGURE 56 Clinical evidence of current CHD: individual estimates and their 95% CIs. (a) MSOAs; (b) LAs; (c) CCGs;
and (d) regions (GORs).
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Any evidence of current coronary heart disease: symptoms,
medication, recent doctor diagnosis or as self-reported
long-standing illness (Health Survey for England, 2006
and 2011)
FIGURE 57 Any evidence of current CHD: LSOA-level map. Contains Ordnance Survey data © Crown copyright and
database right 2012.
DOI: 10.3310/hsdr04140 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 14
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Asthana et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
357
Response variable definition, provenance and prediction
These estimates are based on respondents to the HSfE reporting that they had ever had symptoms of
angina or MI (as described above), or who were taking prescribed drugs for CHD (see below), or who had
recently (last 12 months) been diagnosed with angina or having had a heart attack, or who self-reported
angina and/or heart attack as a LSI. This is a more restricted data set largely because questions on
prescribed medicines were included in the nurse-administered questionnaire, which was asked of only a
subset of all respondents.
Respondents are deemed to be taking CHD drugs if they are taking any medicines classified into any of
the following BNF categories specifically for ‘a heart problem’: BNF 2.4 (beta-blockers), 2.5.5.1 (ACE
inhibitors), 2.6.1 (nitrates), 2.6.2 (calcium channel blockers), 2.6.3 (other antianginal drugs), 2.9
(antiplatelet drugs), 2.10.1 (drugs for management of stable angina and acute coronary symptoms) and
2.12 (lipid-regulating drugs, e.g. statins).487
The HSfE at this time includes multiple household respondents of all ages. The analytical data set is drawn
from the subset of respondents aged ≥ 16 years for whom data are available across all model response
and predictor variables, namely whether or not they responded to questions on angina and MI symptoms,
prescribed drug use, doctor diagnosis of angina/heart attack, and self-reported LSIs; whether or not they
provided responses to questions on age, sex, ethnicity, general health status, LLTI and tenure; and whether
or not information is available on the IMD quintile of their LSOA of residence (n= 14,896). To avoid a
potential household-level effect, a single randomly selected adult is drawn from each household, resulting
in an analytical data set of 9330 adults aged > 16 years.















16–24 405 14 3.3 16–24 236 6 2.5
25–34 843 42 4.7 25–34 515 23 4.3
35–49 1522 96 5.9 35–49 1064 94 8.1
50–64 1380 163 10.6 50–64 924 208 18.4
65–74 441 99 18.3 65–74 312 103 24.8
75–84 267 98 26.8 75–84 166 102 38.1
≥ 85 94 35 27.1 ≥ 85 47 31 39.7




Model parameters (see below) are applied to microsimulated LSOA-level census data to produce estimates
of the number (and proportion) of people expected to report symptoms of CHD (angina or MI), to take
prescribed drugs for CHD, to have been recently diagnosed with angina and/or a heart attack, or to
self-report angina and/or heart attack as a LSI in each age–sex cohort (and overall) in each of the 32,844
English LSOAs. As discussed in the report, bootstrapping is used to derive 95% CIs for these estimates.
The bootstrapped LSOA-level prevalence rate estimates are aggregated into a number of higher
geographies, namely for MSOAs, LAs, CCGs and regions (GORs), and are then used to calculate 95% CIs
for these higher-level estimates. Proportionate attribution is used to restructure the estimates to align with
2001 MSOAs, as well as GP practice populations as defined by the 2011 NHS ADS.
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Table 80 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured
by the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444
adults) in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived
quintile; and 6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule,
variations in prevalence rates reflect variations in the socioeconomic composition of populations in the
different types of LSOA rather than variations in deprivation per se.
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TABLE 81 Parameter estimates: any evidence of current CHD
Factor (reference group)
Model coefficients 95% CI
Estimate Standard error 2.5% CI 97.50%
(Intercept) –4.95489 0.32479 –5.59149 –4.31829
Age (16–24 years)
25–34 years 0.49258 0.33796 –0.16983 1.15499
35–49 years 0.70030 0.31428 0.08432 1.31628
50–64 years 1.50281 0.30767 0.89978 2.10585
65–74 years 1.97679 0.32046 1.34869 2.60488
75–84 years 2.53821 0.32635 1.89855 3.17786
≥ 85 years 2.57509 0.38203 1.82632 3.32386
Sex (females)
Males 0.70463 0.10216 0.50440 0.90485
Ethnicity (white)
Mixed –0.14574 0.54538 –1.21468 0.92320
Black 0.48636 0.29875 –0.09919 1.07191
Asian –0.21590 0.29553 –0.79515 0.36335
Other 0.91147 0.67076 –0.40322 2.22616
General health status (very good)
Good health 0.83121 0.12987 0.57667 1.08575
Fair health 1.59510 0.15215 1.29688 1.89332
Bad health 1.87210 0.40674 1.07490 2.66930
Very bad health 10.08105 178.2591 –359.469 339.3068
LLTI (no LTTI)
LLTI 2.24961 0.54866 1.17423 3.32498
Tenure (owner–occupier)
Social rent 0.18471 0.09266 0.00309 0.36633
Private rent or other tenure –0.06563 0.13524 –0.33069 0.19944
LSOA deprivation quintile (least deprived quintile)
Second quintile –0.02055 0.11221 –0.24049 0.19939
Third quintile 0.04271 0.11090 –0.17466 0.26007
Fourth quintile 0.00416 0.11573 –0.22267 0.23099
Fifth quintile (=most deprived quintile) 0.12392 0.12263 –0.11643 0.36427
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TABLE 81 Parameter estimates: any evidence of current CHD (continued )
Factor (reference group)
Model coefficients 95% CI
Estimate Standard error 2.5% CI 97.50%
Interaction effects
25–34 years and LLTI (16–24 years/no LLTI) –0.49693 0.55578 –1.58625 0.59239
35–49 years and LLTI (16–24 years/no LLTI) –0.48858 0.51227 –1.49262 0.51546
50–64 years and LLTI (16–24 years/no LLTI) –1.02160 0.50161 –2.00477 –0.03844
65–74 years and LLTI (16–24 years/no LLTI) –1.09495 0.51514 –2.10462 –0.08528
75–84 years and LLTI (16–24 years/no LLTI) –1.31511 0.51984 –2.33400 –0.29621
≥ 85 years and LLTI (16–24 years/no LLTI) –1.47616 0.58059 –2.61411 –0.33821
Good health and LLTI (very good health/no LLTI) –0.42235 0.28405 –0.97908 0.13439
Fair health and LLTI (very good health/no LLTI) –0.81140 0.28660 –1.37314 –0.24966
Bad health and LLTI (very good health/no LLTI) –0.60710 0.47787 –1.54373 0.32953
Very bad health and LLTI (very good health/no LLTI) 11.85229 178.2593 –337.536 361.2406
Male and LLTI (female/no LLTI) –0.33196 0.13992 –0.60620 –0.05772
Male and mixed (female/white) –0.22058 0.92577 –2.03509 1.59393
Male and black (female/white) –1.84763 0.79787 –3.41146 –0.28380
Male and Asian (female/white) –0.53557 0.46594 –1.44880 0.37767
Male and other (female/white) –0.37833 0.92836 –2.19792 1.44125
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FIGURE 59 Any evidence of current CHD: individual estimates and their 95% CIs. (a) MSOAs; (b) LAs; (c) CCGs; and
(d) regions (GORs).
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Any history of coronary heart disease: symptoms, medication,
ever diagnosed or as self-reported long-standing illness
(Health Survey for England, 2006 and 2011)
FIGURE 60 Any history of CHD: LSOA-level map. Contains Ordnance Survey data © Crown copyright and database
right 2012.
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Response variable definition, provenance and prediction
These estimates are based on respondents to the HSfE reporting that they had ever had symptoms of
angina or MI (as described above), or who were taking prescribed drugs for CHD (see below), or who had
ever been diagnosed with angina or having had a heart attack, or who self-reported angina and/or heart
attack as a LSI. This is a restricted data set largely because questions on prescribed medicines were
included in the nurse-administered questionnaire, which was asked of only a subset of all respondents.
Respondents are deemed to be taking CHD drugs if they are taking any medicines classified into any of
the following BNF categories specifically for ‘a heart problem’: BNF 2.4 (beta-blockers), 2.5.5.1 (ACE
inhibitors), 2.6.1 (nitrates), 2.6.2 (calcium channel blockers), 2.6.3 (other antianginal drugs), 2.9
(antiplatelet drugs), 2.10.1 (drugs for management of stable angina and acute coronary symptoms) and
2.12 (lipid-regulating drugs, e.g. statins).487
The HSfE at this time includes multiple household respondents of all ages. The analytical data set is drawn
from the subset of respondents aged ≥ 16 years for whom data are available across all model response
and predictor variables, namely whether or not they responded to questions on angina and MI symptoms,
prescribed drug use, doctor diagnosis of angina/heart attack, and self-reported LSIs; whether or not they
provided responses to questions on age, sex, ethnicity, general health status, LLTI and tenure; and whether
or not information is available on the IMD quintile of their LSOA of residence (n= 14,902). To avoid a
potential household-level effect, a single randomly selected adult is drawn from each household, resulting
in an analytical data set of 9336 adults aged ≥ 16 years.















16–24 404 15 3.6 16–24 235 7 2.9
25–34 843 42 4.7 25–34 515 23 4.3
35–49 1521 97 6.0 35–49 1061 98 8.5
50–64 1374 169 11.0 50–64 914 220 19.4
65–74 434 106 19.6 65–74 307 109 26.2
75–84 254 113 30.8 75–84 160 108 40.3
≥ 85 87 42 32.6 ≥ 85 43 35 44.9




Model parameters (see below) are applied to microsimulated LSOA-level census data to produce estimates
of the number (and proportion) of people expected to report symptoms of CHD (angina or MI), to take
prescribed drugs for CHD, ever to have been diagnosed with angina and/or a heart attack or to self-report
angina and/or heart attack as a LSI in each age–sex cohort (and overall) in each of the 32,844 English
LSOAs. As discussed in the report, bootstrapping is used to derive 95% CIs for these estimates. The
bootstrapped LSOA-level prevalence rate estimates are aggregated into a number of higher geographies,
namely for MSOAs, LAs, CCGs and regions (GORs), and are then used to calculate 95% CIs for these
higher-level estimates. Proportionate attribution is used to restructure the estimates to align with 2001
MSOAs, as well as GP practice populations as defined by the 2011 NHS ADS.
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Table 83 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured
by the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444
adults) in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived
quintile; and 6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule,
variations in prevalence rates reflect variations in the socioeconomic composition of populations in the
different types of LSOA rather than variations in deprivation per se.
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TABLE 84 Parameter estimates: any history of CHD
Factor (reference group)
Model coefficients 95% CI
Estimate Standard error 2.5% CI 97.50%
(Intercept) –4.81247 0.30464 –5.40955 –4.21538
Age (16–24 years)
25–34 years 0.33176 0.31980 –0.29504 0.95856
35–49 years 0.55836 0.29445 –0.01876 1.13548
50–64 years 1.41872 0.28691 0.85638 1.98106
65–74 years 1.92250 0.29962 1.33524 2.50976
75–84 years 2.49131 0.30602 1.89151 3.09111
≥ 85 years 2.64601 0.36032 1.93978 3.35224
Sex (females)
Males 0.68817 0.09975 0.49266 0.88367
Ethnicity (white)
Mixed –0.18120 0.54516 –1.24971 0.88732
Black 0.44693 0.29986 –0.14079 1.03466
Asian –0.03476 0.27323 –0.57030 0.50078
Other 0.87699 0.67054 –0.43727 2.19125
General health status (very good)
Good health 0.84024 0.12664 0.59203 1.08845
Fair health 1.61050 0.14867 1.31910 1.90189
Bad health 1.78240 0.40847 0.98180 2.58300
Very bad health –10.1535 178.462 –359.939 339.6321
LLTI (no LTTI)
LLTI 2.05713 0.53598 1.00661 3.10766
Tenure (owner–occupier)
Social rent 0.17008 0.09165 –0.00955 0.34971
Private rent or other tenure –0.04505 0.13242 –0.30460 0.21450
LSOA deprivation quintile (least deprived quintile)
Second quintile 0.02449 0.10979 –0.19070 0.23967
Third quintile 0.05303 0.10913 –0.16086 0.26692
Fourth quintile 0.01869 0.11386 –0.20447 0.24186
Fifth quintile (=most deprived quintile) 0.12085 0.12110 –0.11651 0.35820
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TABLE 84 Parameter estimates: any history of CHD (continued )
Factor (reference group)
Model coefficients 95% CI
Estimate Standard error 2.5% CI 97.50%
Interaction effects
25–34 years and LLTI (16–24 years/no LLTI) –0.33521 0.54500 –1.40342 0.73299
35–49 years and LLTI (16–24 years/no LLTI) –0.31139 0.50018 –1.29175 0.66896
50–64 years and LLTI (16–24 years/no LLTI) –0.90205 0.48916 –1.86079 0.05669
65–74 years and LLTI (16–24 years/no LLTI) –0.97888 0.50231 –1.96341 0.00564
75–84 years and LLTI (16–24 years/no LLTI) –1.08844 0.50704 –2.08225 –0.09464
≥ 85 years and LLTI (16–24 years/no LLTI) –1.26860 0.56439 –2.37481 –0.16239
Good health and LLTI (very good health/no LLTI) –0.40604 0.27922 –0.95331 0.14123
Fair health and LLTI (very good health/no LLTI) –0.80597 0.28183 –1.35837 –0.25358
Bad health and LLTI (very good health/no LLTI) –0.44655 0.47763 –1.38271 0.48961
Very bad health and LLTI (very good health/no LLTI) 11.9581 178.4623 –337.828 361.7441
Male and mixed (female/white) –0.20582 0.92530 –2.01942 1.60777
Male and black (female/white) –1.85692 0.79963 –3.42420 –0.28965
Male and Asian (female/white) –0.75543 0.45228 –1.64189 0.13104
Male and other (female/white) –0.40665 0.93380 –2.23689 1.42359
Male and LLTI (female/no LLTI) –0.30108 0.13758 –0.57074 –0.03143
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FIGURE 62 Any history of CHD: individual estimates and their 95% CIs. (a) MSOAs; (b) LAs; (c) CCGs; and
(d) regions (GORs).
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Ever been diagnosed with coronary heart disease
(Health Survey for England, 2006 and 2011)
FIGURE 63 Ever diagnosed with CHD: LSOA-level map. Contains Ordnance Survey data © Crown copyright and
database right 2012.
DOI: 10.3310/hsdr04140 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 14
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Asthana et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
371
Response variable definition, provenance and prediction
These estimates are based on respondents to the HSfE reporting that they had ever been diagnosed with
angina or having had a heart attack.
The HSfE at this time includes multiple household respondents of all ages. The analytical data set is drawn
from the subset of respondents aged ≥ 16 years for whom data are available across all model response
and predictor variables, namely whether or not they responded to questions on doctor diagnosis of
angina/heart attack; whether or not they provided responses to questions on age, sex, ethnicity, general
health status, LLTI and tenure; and whether or not information is available on the IMD quintile of their
LSOA of residence (n= 20,952). To avoid a potential household-level effect, a single randomly selected
adult is drawn from each household, resulting in an analytical data set of 12,822 adults aged ≥ 16 years.















16–24 569 1 0.2 16–24 428 1 0.2
25–34 1213 5 0.4 25–34 811 2 0.2
35–49 2187 12 0.5 35–49 1517 22 1.4
50–64 1916 65 3.3 50–64 1361 129 8.7
65–74 669 72 9.7 65–74 456 102 18.3
75–84 474 100 17.4 75–84 275 96 25.9
≥ 85 167 49 22.7 ≥ 85 89 34 27.6




Model parameters (see below) are applied to microsimulated LSOA-level census data to produce estimates
of the number (and proportion) of people expected ever to have been diagnosed with angina and/or a
heart attack in each age–sex cohort (and overall) in each of the 32,844 English LSOAs. As discussed in the
report, bootstrapping is used to derive 95% CIs for these estimates. The bootstrapped LSOA-level
prevalence rate estimates are aggregated into a number of higher geographies, namely for MSOAs, LAs,
CCGs and regions (GORs), and are then used to calculate 95% CIs for these higher-level estimates.
Proportionate attribution is used to restructure the estimates to align with 2001 MSOAs, as well as GP
practice populations as defined by the 2011 NHS ADS.
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Table 86 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured
by the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444
adults) in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived
quintile; and 6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule,
variations in prevalence rates reflect variations in the socioeconomic composition of populations in the
different types of LSOA rather than variations in deprivation per se.
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TABLE 87 Parameter estimates: ever diagnosed with CHD
Factor (reference group)
Model coefficients 95% CI
Estimate Standard error 2.5% CI 97.50%
(Intercept) –7.64770 0.73784 –9.09387 –6.20153
Age (16–24 years)
25–34 years 0.49267 0.80416 –1.08348 2.06882
35–49 years 1.26850 0.73395 –0.17005 2.70705
50–64 years 2.92336 0.71751 1.51703 4.32969
65–74 years 3.83791 0.71935 2.42798 5.24783
75–84 years 4.26889 0.71974 2.85819 5.67958
≥ 85 years 4.45869 0.72742 3.03295 5.88442
Sex (females)
Males 0.71734 0.08910 0.54270 0.89199
Ethnicity (white)
Mixed –13.8491 602.4447 –1194.64 1166.943
Black –14.0686 334.0905 –668.886 640.7489
Asian 0.73582 0.29273 0.16208 1.30957
Other –13.9996 779.1782 –1541.19 1513.19
General health status (very good)
Good health 0.94033 0.18918 0.56954 1.31111
Fair health 1.61822 0.19548 1.23508 2.00137
Bad health 2.24823 0.21874 1.81949 2.67696
Very bad health 2.36815 0.25683 1.86476 2.87153
LLTI (no LTTI)
LLTI 0.54187 0.12488 0.29711 0.78664
Tenure (owner–occupier)
Social rent –0.07752 0.20538 –0.48006 0.32503
Private rent or other tenure –0.07752 0.20538 –0.48006 0.32503
LSOA deprivation quintile (least deprived quintile)
Second quintile –0.06638 0.14164 –0.34399 0.21123
Third quintile –0.08457 0.14324 –0.36531 0.19617
Fourth quintile 0.00441 0.14786 –0.28539 0.29421
Fifth quintile (=most deprived quintile) 0.08117 0.15542 –0.22345 0.38578
Interaction effects
LLTI and social rent (no LLTI/owner–occupier) 0.18634 0.23446 –0.27320 0.64588
LLTI and private rent (no LLTI/owner–occupier) –0.72387 0.36262 –1.43459 –0.01314
Mixed and LLTI (white/no LLTI) 13.87347 602.4453 –1166.92 1194.666
Black and LLTI (white/no LLTI) 13.10224 334.0911 –641.716 667.9209
Asian and LLTI (white/no LLTI) –0.93577 0.49708 –1.91006 0.03851
Other and LLTI (white/no LLTI) 13.68275 779.1787 –1513.51 1540.873
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FIGURE 65 Ever diagnosed with CHD: individual estimates and their 95% CIs. (a) MSOAs; (b) LAs; (c) CCGs; and
(d) regions (GORs).
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Ever been diagnosed with cardiovascular disease
(Health Survey for England, 2006a and 2011)
FIGURE 66 Ever diagnosed with CVD: LSOA-level map. Contains Ordnance Survey data © Crown copyright and
database right 2012.
DOI: 10.3310/hsdr04140 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 14
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Asthana et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
377
Response variable definition, provenance and prediction
These estimates are based on respondents to the HSfE reporting that they had ever been diagnosed with
CVD. Specifically, that the respondent had been ‘told by a doctor’ that they had angina, or had had a
heart attack, or had a heart murmur, or an abnormal heart rhythm, or another heart problem, or had had
a stroke.
The HSfE at this time includes multiple household respondents of all ages. The analytical data set is drawn
from the subset of respondents aged ≥ 16 years for whom data are available across all model response
and predictor variables, namely whether or not they responded to questions on doctor diagnosis of CVD
conditions; whether or not they provided responses to questions on age, sex, ethnicity, general health
status, LLTI and tenure; and whether or not information is available on the IMD quintile of their LSOA of
residence (n= 20,925). To avoid a potential household-level effect, a single randomly selected adult is
drawn from each household, resulting in an analytical data set of 12,803 adults aged ≥ 16 years.















16–24 540 29 5.1 16–24 413 16 3.7
25–34 1135 83 6.8 25–34 766 46 5.7
35–49 2015 179 8.2 35–49 1419 115 7.5
50–64 1681 298 15.1 50–64 1227 259 17.4
65–74 567 173 23.4 65–74 361 198 35.4
75–84 362 213 37.0 75–84 209 162 43.7
≥ 85 130 85 39.5 ≥ 85 65 57 46.7




Model parameters (see below) are applied to microsimulated LSOA-level census data to produce estimates
of the number (and proportion) of people expected ever to have been diagnosed with CVD (specifically
angina, heart attack, heart murmur, abnormal heart rhythm, another heart problem, stroke) in each
age–sex cohort (and overall) in each of the 32,844 English LSOAs. As discussed in the report,
bootstrapping is used to derive 95% CIs for these estimates. The bootstrapped LSOA-level prevalence rate
estimates are aggregated into a number of higher geographies, namely for MSOAs, LAs, CCGs and
regions (GORs), and are then used to calculate 95% CIs for these higher-level estimates. Proportionate
attribution is used to restructure the estimates to align with 2001 MSOAs, as well as GP practice
populations as defined by the 2011 NHS ADS.
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Table 89 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured
by the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444
adults) in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived
quintile; and 6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule,
variations in prevalence rates reflect variations in the socioeconomic composition of populations in the
different types of LSOA rather than variations in deprivation per se.
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TABLE 90 Parameter estimates: ever diagnosed with CVD
Factor (reference group)
Model coefficients 95% CI
Estimate Standard error 2.5% CI 97.50%
(Intercept) –3.56047 0.22354 –3.99861 –3.12234
Age (16–24 years)
25–34 years 0.33101 0.23137 –0.12247 0.78448
35–49 years 0.46484 0.21578 0.04191 0.88778
50–64 years 0.93751 0.21255 0.52091 1.35412
65–74 years 1.40494 0.22217 0.96947 1.84040
75–84 years 1.92357 0.22292 1.48665 2.36049
≥ 85 years 2.02663 0.25035 1.53594 2.51733
Sex (females)
Males –0.23803 0.35109 –0.92616 0.45010
Ethnicity (white)
Mixed 0.60826 0.34753 –0.07290 1.28942
Black –0.54887 0.27694 –1.09167 –0.00606
Asian –0.94766 0.26724 –1.47145 –0.42387
Other –0.78668 0.77192 –2.29964 0.72627
General health status (very good)
Good health 0.61274 0.10625 0.40448 0.82099
Fair health 0.86985 0.12114 0.63241 1.10730
Bad health 1.32434 0.15767 1.01530 1.63338
Very bad health 1.49338 0.22072 1.06077 1.92600
LLTI (no LTTI)
LLTI 0.54616 0.06824 0.41240 0.67992
Tenure (owner–occupier)
Social rent –0.10644 0.07692 –0.25720 0.04432
Private rent or other tenure 0.14435 0.09778 –0.04729 0.33600
LSOA deprivation quintile (least deprived quintile)
Second quintile –0.01650 0.08740 –0.18781 0.15481
Third quintile 0.03072 0.08763 –0.14102 0.20247
Fourth quintile 0.06026 0.09056 –0.11725 0.23777
Fifth quintile (=most deprived quintile) 0.07094 0.09717 –0.11950 0.26139
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TABLE 90 Parameter estimates: ever diagnosed with CVD (continued )
Factor (reference group)
Model coefficients 95% CI
Estimate Standard error 2.5% CI 97.50%
Interaction effects
25–34 years and male (16–24 years/female) 0.05380 0.38493 –0.70065 0.80825
35–49 years and male (16–24 years/female) 0.05233 0.35584 –0.64513 0.74978
50–64 years and male (16–24 years/female) 0.37142 0.34654 –0.30781 1.05064
65–74 years and male (16–24 years/female) 0.78792 0.35761 0.08701 1.48884
75–84 years and male (16–24 years/female) 0.54632 0.36304 –0.16523 1.25787
≥ 85 years and male (16–24 years/female) 0.39818 0.41198 –0.40930 1.20566
Male and good health (female/very good health) –0.14907 0.16379 –0.47010 0.17195
Male and fair health (female/very good health) 0.26809 0.17398 –0.07291 0.60908
Male and bad health (female/very good health) –0.02002 0.22005 –0.45133 0.41128
Male and very bad health (female/very good health) 0.44908 0.31416 –0.16667 1.06483
Male and mixed (female/white) –1.35256 0.73612 –2.79536 0.09024
Male and black (female/white) –0.33230 0.52289 –1.35717 0.69257
Male and Asian (female/white) 0.69674 0.34908 0.01254 1.38093
Male and other (female/white) 0.76635 0.95050 –1.09662 2.62933
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FIGURE 68 Ever diagnosed with CVD: individual estimates and their 95% CIs. (a) MSOAs; (b) LAs; (c) CCGs; and
(d) regions (GORs).
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Ever been diagnosed with high blood pressure (Health Survey
for England, 2006 and 2009–11)
FIGURE 69 Ever diagnosed with high blood pressure: LSOA-level map. Contains Ordnance Survey data © Crown
copyright and database right 2012.
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Response variable definition, provenance and prediction
These estimates are based on respondents to the HSfE reporting that they had ever been diagnosed with
high blood pressure (hypertension).
The HSfE at this time includes multiple household respondents of all ages. The analytical data set is drawn
from the subset of respondents aged ≥ 16 years for whom data are available across all model response
and predictor variables, namely whether or not they responded to the question on doctor diagnosis of
high blood pressure; whether or not they provided responses to questions on age, sex, ethnicity, general
health status, LLTI and tenure; and whether or not information is available on the IMD quintile of their
LSOA of residence (n= 33,872). To avoid a potential household-level effect, a single randomly selected
adult is drawn from each household, resulting in an analytical data set of 18,641 adults aged ≥ 16 years.















16–24 839 41 4.7 16–24 574 24 4.0
25–34 1653 117 6.6 25–34 997 116 10.4
35–49 2639 441 14.3 35–49 1862 377 16.8
50–64 1839 856 31.8 50–64 1350 791 36.9
65–74 561 567 50.3 65–74 485 473 49.4
75–84 399 548 57.9 75–84 249 320 56.2
≥ 85 157 194 55.3 ≥ 85 100 72 41.9




Model parameters (see below) are applied to microsimulated LSOA-level census data to produce estimates
of the number (and proportion) of people expected ever to have been diagnosed with high blood pressure
(hypertension) in each age–sex cohort (and overall) in each of the 32,844 English LSOAs. As discussed in
the report, bootstrapping is used to derive 95% CIs for these estimates. The bootstrapped LSOA-level
prevalence rate estimates are aggregated into a number of higher geographies, namely for MSOAs, LAs,
CCGs and regions (GORs), and are then used to calculate 95% CIs for these higher-level estimates.
Proportionate attribution is used to restructure the estimates to align with 2001 MSOAs, as well as GP
practice populations as defined by the 2011 NHS ADS.
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Table 92 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured
by the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444
adults) in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived
quintile; and 6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule,
variations in prevalence rates reflect variations in the socioeconomic composition of populations in the
different types of LSOA rather than variations in deprivation per se.
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TABLE 93 Parameter estimates: ever diagnosed with high blood pressure
Factor (reference group)
Model coefficients 95% CI
Estimate Standard error 2.5% CI 97.50%
(Intercept) –4.01592 0.19792 –4.40384 –3.628
Age (16–24 years)
25–34 years 0.65131 0.21242 0.23496 1.06765
35–49 years 1.53656 0.19441 1.15553 1.91760
50–64 years 2.42000 0.19286 2.04200 2.79800
65–74 years 3.18868 0.19965 2.79737 3.58000
75–84 years 3.48406 0.20652 3.07927 3.88884
≥ 85 years 3.44859 0.24348 2.97137 3.92581
Sex (females)
Males 0.06927 0.27976 –0.47906 0.61760
Ethnicity (white)
Mixed 0.41128 0.19242 0.03415 0.78842
Black –0.19321 0.13361 –0.45508 0.06866
Asian –0.16914 0.10204 –0.36913 0.03085
Other –0.42425 0.30548 –1.02300 0.17449
General health status (very good)
Good health 0.71588 0.05361 0.61080 0.82096
Fair health 1.27450 0.07347 1.13050 1.41850
Bad health 1.44787 0.21776 1.02106 1.87469
Very bad health 1.60065 0.57179 0.47994 2.72135
LLTI (no LTTI)
LLTI 1.65205 0.31502 1.03462 2.26949
Tenure (owner–occupier)
Social rent 0.09992 0.05334 –0.00463 0.20446
Private rent or other tenure –0.03512 0.06766 –0.16774 0.09749
LSOA deprivation quintile (least deprived quintile)
Second quintile –0.08134 0.07765 –0.23354 0.07086
Third quintile 0.07546 0.07788 –0.07719 0.22811
Fourth quintile 0.15328 0.07883 –0.00122 0.30778
Fifth quintile (=most deprived quintile) 0.07654 0.08424 –0.08858 0.24166
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TABLE 93 Parameter estimates: ever diagnosed with high blood pressure (continued )
Factor (reference group)
Model coefficients 95% CI
Estimate Standard error 2.5% CI 97.50%
Interaction effects
25–34 years and LLTI (16–24 years/no LLTI) –1.06141 0.33181 –1.71175 –0.41106
35–49 years and LLTI (16–24 years/no LLTI) –1.25514 0.29840 –1.84001 –0.67027
50–64 years and LLTI (16–24 years/no LLTI) –1.09377 0.29234 –1.66675 –0.52079
65–74 years and LLTI (16–24 years/no LLTI) –1.25582 0.29927 –1.84239 –0.66925
75–84 years and LLTI (16–24 years/no LLTI) –1.48607 0.30406 –2.08202 –0.89012
≥ 85 years and LLTI (16–24 years/no LLTI) –1.57558 0.33888 –2.23979 –0.91137
25–34 years and male (16–24 years/female) 0.60545 0.30187 0.01378 1.19711
35–49 years and male (16–24 years/female) 0.23200 0.27926 –0.31534 0.77935
50–64 years and male (16–24 years/female) 0.24697 0.27577 –0.29354 0.78749
65–74 years and male (16–24 years/female) 0.02876 0.28345 –0.52680 0.58432
75–84 years and male (16–24 years/female) 0.04788 0.29011 –0.52074 0.61649
≥ 85 years and male (16–24 years/female) –0.56382 0.33144 –1.21345 0.08581
Male and second quintile (female/least deprived) –0.02138 0.11597 –0.24867 0.20591
Male and third quintile (female/least deprived) –0.33915 0.11674 –0.56796 –0.11034
Male and fourth quintile (female/least deprived) –0.17873 0.11781 –0.40964 0.05219
Male and fifth quintile (female/least deprived) –0.04316 0.12058 –0.27950 0.19319
Good health and LLTI (very good health/no LLTI) –0.32453 0.16060 –0.63931 –0.00976
Fair health and LLTI (very good health/no LLTI) –0.50289 0.16353 –0.82341 –0.18237
Bad health and LLTI (very good health/no LLTI) –0.51113 0.26628 –1.03304 0.01078
Very bad health and LLTI (very good health/no LLTI) –0.56302 0.59880 –1.73667 0.61063
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FIGURE 71 Ever diagnosed with high blood pressure: individual estimates and their 95% CIs. (a) MSOAs; (b) LAs;
(c) CCGs; and (d) regions (GORs). BP, blood pressure.
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Ever been diagnosed with diabetes (Health Survey for England,
2006 and 2009–11)
FIGURE 72 Ever diagnosed with diabetes: LSOA-level map. Contains Ordnance Survey data © Crown copyright and
database right 2012.
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Response variable definition, provenance and prediction
These estimates are based on respondents to the HSfE reporting whether or not they had ever been
diagnosed with diabetes.
The HSfE at this time includes multiple household respondents of all ages. The analytical data set is drawn
from the subset of respondents aged ≥ 16 years for whom data are available across all model response
and predictor variables, namely: whether they responded to the question on doctor diagnosis diabetes;
whether they provided responses to questions on age, sex, ethnicity, general health status, LLTI and
tenure; and whether information is available on the IMD quintile of their LSOA of residence (n= 33,938).
To avoid a potential household-level effect, a single randomly selected adult is drawn from each
household, resulting in an analytical data set of 12,803 adults aged > 16 years.















16–24 876 4 0.5 16–24 599 5 0.8
25–34 1749 25 1.4 25–34 1104 13 1.2
35–49 3021 64 2.1 35–49 2175 69 3.1
50–64 2537 158 5.9 50–64 1959 185 8.6
65–74 1012 121 10.7 65–74 823 135 14.1
75–84 813 136 14.3 75–84 477 95 16.6
≥ 85 314 38 10.8 ≥ 85 149 28 15.8




Model parameters (see below) are applied to microsimulated LSOA-level census data to produce estimates
of the number (and proportion) of people expected ever to have been diagnosed with diabetes in each
age–sex cohort (and overall) in each of the 32,844 English LSOAs. As discussed in the report,
bootstrapping is used to derive 95% CIs for these estimates. The bootstrapped LSOA-level prevalence rate
estimates are aggregated into a number of higher geographies, namely for MSOAs, LAs, CCGs and
regions (GORs), and are then used to calculate 95% CIs for these higher-level estimates. Proportionate
attribution is used to restructure the estimates to align with 2001 MSOAs, as well as GP practice
populations as defined by the 2011 NHS ADS.
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Table 95 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured
by the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444
adults) in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived
quintile; and 6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule,
variations in prevalence rates reflect variations in the socioeconomic composition of populations in the
different types of LSOA rather than variations in deprivation per se.
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TABLE 96 Parameter estimates: ever diagnosed with diabetes
Factor (reference group)
Model coefficients 95% CI
Estimate Standard error 2.5% CI 97.50%
(Intercept) –6.72943 0.40065 –7.5147 –5.94415
Age (16–24 years)
25–34 years 0.79918 0.37558 0.06304 1.53532
35–49 years 1.36594 0.35022 0.67951 2.05237
50–64 years 2.27291 0.34557 1.59559 2.95022
65–74 years 2.79441 0.34813 2.11207 3.47676
75–84 years 2.87961 0.34994 2.19372 3.56549
≥ 85 years 2.64843 0.36834 1.92649 3.37038
Sex (females)
Males 0.62141 0.25880 0.11416 1.12866
Ethnicity (white)
Mixed –0.09266 0.60962 –1.28751 1.10220
Black –0.17116 0.40441 –0.96380 0.62148
Asian 1.19225 0.15974 0.87916 1.50534
Other –0.39234 1.04187 –2.43442 1.64973
General health status (very good)
Good health 0.93496 0.22605 0.49190 1.37802
Fair health 1.92701 0.22659 1.48289 2.37113
Bad health 2.45986 0.25109 1.96772 2.95199
Very bad health 2.64725 0.32004 2.01997 3.27453
LLTI (no LTTI)
LLTI 0.27487 0.08256 0.11305 0.43669
Tenure (owner–occupier)
Social rent –0.05812 0.53041 –1.09773 0.98149
Private rent or other tenure –0.30183 0.54936 –1.37857 0.77491
LSOA deprivation quintile (least deprived quintile)
Second quintile 0.04589 0.11080 –0.17127 0.26305
Third quintile 0.07768 0.11039 –0.13869 0.29405
Fourth quintile 0.11818 0.11210 –0.10154 0.33790
Fifth quintile (=most deprived quintile) 0.05295 0.11814 –0.17860 0.28450
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TABLE 96 Parameter estimates: ever diagnosed with diabetes (continued )
Factor (reference group)
Model coefficients 95% CI
Estimate Standard error 2.5% CI 97.50%
Interaction effects
Mixed and social rent (white/owner–occupier) –12.0283 207.1847 –418.110 394.0536
Black and social rent (white/owner–occupier) 0.72275 0.49589 –0.24919 1.69469
Asian and social rent (white/owner–occupier) –1.46816 0.50682 –2.46153 –0.47479
Other and social rent (white/owner–occupier) –11.6280 225.5789 –453.763 430.5065
Mixed and private rent (white/owner–occupier) 2.25433 0.81040 0.66593 3.84272
Black and private rent (white/owner–occupier) 0.80492 0.74606 –0.65736 2.26719
Asian and private rent (white/owner–occupier) –0.98010 0.57752 –2.11204 0.15185
Other and private rent (white/owner–occupier) 2.04220 1.26422 –0.43568 4.52007
Male and social rent (female/owner–occupier) –0.42674 0.15789 –0.73622 –0.11727
Male and private rent (female/owner–occupier) –0.13990 0.26818 –0.66553 0.38573
Male and good health (female/very good health) 0.10323 0.28515 –0.45566 0.66212
Male and fair health (female/very good health) –0.16437 0.28177 –0.71664 0.38790
Male and bad health (female/very good health) –0.45086 0.30932 –1.05713 0.15541
Male and very bad health (female/very good health) –0.63977 0.38064 –1.38583 0.10629
Good health and social rent (very good
health/owner–occupier)
0.97254 0.54280 –0.09134 2.03643
Fair health and social rent (very good health/owner–occupier) 0.41461 0.53856 –0.64098 1.47019
Bad health and social rent (very good health/owner–occupier) 0.31003 0.55189 –0.77167 1.39172
Very bad health and social rent (very good
health/owner–occupier)
0.45328 0.59201 –0.70705 1.61361
Good health and private rent (very good
health/owner–occupier)
–0.07428 0.57979 –1.21068 1.06211
Fair health and private rent (very good
health/owner–occupier)
0.72490 0.55793 –0.36864 1.81844
Bad health and private rent (very good
health/owner–occupier)
–0.04107 0.62283 –1.26182 1.17968
Very bad health and private rent (very good
health/owner–occupier)
0.11091 0.79381 –1.44496 1.66679
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FIGURE 74 Ever diagnosed with diabetes: individual estimates and their 95% CIs. (a) MSOAs; (b) LAs; (c) CCGs;
and (d) regions (GORs).
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Diagnosed and undiagnosed diabetes (Health Survey for
England, 2006 and 2009–11)
FIGURE 75 Diagnosed and undiagnosed diabetes: LSOA-level map. Contains Ordnance Survey data © Crown
copyright and database right 2012.
APPENDIX 26
NIHR Journals Library www.journalslibrary.nihr.ac.uk
398
Response variable definition, provenance and prediction
These estimates are based on respondents to the HSfE reporting whether they have ever been diagnosed
with diabetes and whether or not their nurse-administered blood sample returns a glycated haemoglobin
value of ≥ 6.5%. The latter should capture undiagnosed diabetes.
The HSfE at this time includes multiple household respondents of all ages. The analytical data set is drawn
from the subset of respondents aged ≥ 16 years for whom data are available for both doctor diagnoses
and the glycated haemoglobin blood test, as well as in response to questions on age, sex, ethnicity,
general health status, LLTI and tenure and whether information is available on the IMD quintile of their
LSOA of residence (n= 16,523). To avoid a potential household-level effect, a single randomly selected
adult is drawn from each household, resulting in an analytical data set of 11,061 adults aged ≥ 16 years.















16–24 343 2 0.6 16–24 273 5 1.8
25–34 787 6 0.8 25–34 660 12 1.8
35–49 1906 43 2.2 35–49 1438 39 2.6
50–64 1706 118 6.5 50–64 1283 147 10.3
65–74 646 79 10.9 65–74 494 95 16.1
75–84 378 67 15.1 75–84 254 58 18.6
≥ 85 129 16 11.0 ≥ 85 59 18 23.4




Model parameters (see below) are applied to microsimulated LSOA-level census data to produce estimates
of the number (and proportion) of people expected have diagnosed or undiagnosed diabetes in each
age–sex cohort (and overall) in each of the 32,844 English LSOAs. As discussed in the report,
bootstrapping is used to derive 95% CIs for these estimates. The bootstrapped LSOA-level prevalence rate
estimates are aggregated into a number of higher geographies, namely for MSOAs, LAs, CCGs and
regions (GORs), and are then used to calculate 95% CIs for these higher-level estimates. Proportionate
attribution is used to restructure the estimates to align with 2001 MSOAs, as well as GP practice
populations as defined by the 2011 NHS ADS.
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Table 98 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured
by the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444
adults) in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived
quintile; and 6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule,
variations in prevalence rates reflect variations in the socioeconomic composition of populations in the
different types of LSOA rather than variations in deprivation per se.
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TABLE 99 Parameter estimates: diagnosed and undiagnosed diabetes
Factor (reference group)
Model coefficients 95% CI
Estimate Standard error 2.5% CI 97.50%
(Intercept) –6.16878 0.42144 –6.99479 –5.34276
Age (16–24 years)
25–34 years 0.07655 0.45136 –0.80812 0.96122
35–49 years 0.74444 0.40062 –0.04078 1.52965
50–64 years 1.92090 0.39229 1.15202 2.68978
65–74 years 2.45388 0.39678 1.67620 3.23156
75–84 years 2.55626 0.40142 1.76947 3.34305
≥ 85 years 2.43772 0.43313 1.58879 3.28665
Sex (females)
Males 0.61605 0.09904 0.42193 0.81017
Ethnicity (white)
Mixed 0.86711 0.48180 –0.07722 1.81144
Black –0.60419 0.60196 –1.78403 0.57565
Asian 0.94024 0.24956 0.45110 1.42938
Other –11.4344 209.8598 –422.760 399.8908
General health status (very good)
Good health 0.89613 0.15749 0.58745 1.20480
Fair health 1.90906 0.17222 1.57151 2.24661
Bad health 1.52785 0.50193 0.54406 2.51164
Very bad health 1.89427 1.09476 –0.25147 4.04001
LLTI (no LTTI)
LLTI 0.11273 0.47701 –0.82222 1.04768
Tenure (owner–occupier)
Social rent 0.55847 0.14227 0.27963 0.83732
Private rent or other tenure –0.16193 0.25889 –0.66936 0.34550
LSOA deprivation quintile (least deprived quintile)
Second quintile 0.29119 0.13696 0.02276 0.55963
Third quintile 0.24200 0.13985 –0.03211 0.51611
Fourth quintile 0.35292 0.14060 0.07734 0.62850
Fifth quintile (=most deprived quintile) 0.35127 0.14973 0.05781 0.64474
continued
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TABLE 99 Parameter estimates: diagnosed and undiagnosed diabetes (continued )
Factor (reference group)
Model coefficients 95% CI
Estimate Standard error 2.5% CI 97.50%
Interaction effects
Male and social rent (female/owner–occupier) –0.57532 0.20061 –0.96851 –0.18213
Male and private rent (female/owner–occupier) 0.14822 0.33727 –0.51284 0.80928
Mixed and LLTI (white/no LLTI) 0.13357 0.83441 –1.50187 1.76901
Black and LLTI (white/no LLTI) 1.92048 0.75459 0.44147 3.39948
Asian and LLTI (white/no LLTI) 0.39243 0.38419 –0.36059 1.14545
Other and LLTI (white/no LLTI) 12.06304 209.8629 –399.268 423.3942
Good health and LLTI (very good health/no LLTI) 0.30628 0.49966 –0.67305 1.28561
Fair health and LLTI (very good health/no LLTI) –0.26503 0.49575 –1.23671 0.70664
Bad health and LLTI (very good health/no LLTI) 0.49725 0.68799 –0.85120 1.84571
Very bad health and LLTI (very good health/no LLTI) 0.18655 1.20929 –2.18366 2.55676
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FIGURE 77 Diagnosed and undiagnosed diabetes: individual estimates and their 95% CIs: (a) MSOAs; (b) LAs;
(c) CCGs; and (d) regions (GORs).
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Adults 25–74 years with ≥ 10% risk of coronary heart disease in
next 10 years (Health Survey for England, 2006 and 2009–11)
FIGURE 78 Adults 25–74 years with ≥ 10% risk of CHD in next 10 years: LSOA-level map. Contains Ordnance Survey
data © Crown copyright and database right 2012.
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Response variable definition, provenance and prediction
Estimates of the proportion of adults aged 25–74 years with a ≥ 10% risk of developing CHD in the next
10 years are based on HSfE data on respondents’ age, sex, cholesterol levels (total and high-density
lipoprotein), blood pressure, whether or not they have diagnosed or undiagnosed diabetes and whether or
not they smoke. Using the methodology described in Wilson et al.,502 each respondent’s risk of developing
CHD over the next 10 years is calculated. A generalised linear model for binomial data with a logistic link is
used to model whether or not individuals have/do not have a ≥ 10% risk of developing CHD over the next
10 years, using the usual set of sociodemographic predictor variables.
The methodology described by Wilson et al.502 was developed by analysing data from the Framingham
Heart Study on 2489 men and 2856 women aged 30–74 years at baseline (1971–74). These individuals
were followed for 12 years and the data were used to construct the Framingham Risk calculator, a
methodology for assessing the risk of developing CHD over the next 10 years.
There are shortcomings, not least the lack of ethnicity in the algorithm, and more recent risk calculators
have been developed, including QRISK® (ClinRisk Ltd, University of Nottingham/EMIS; www.qrisk.org/
index.php). Moreover, in 2010 NICE decided it could no longer recommend that the Framingham Risk
equation be used, as it tends to overestimate risk by approximately 5% in UK men.503 Nevertheless, as the
Framingham Risk calculator, unlike QRisk, uses data available in the HSfE, this provides an interesting and
potentially useful basis for assessing variations in the number and proportion of adults aged 25–74 years
with a ≥ 10% risk of developing CHD.
The HSfE at this time includes multiple household respondents of all ages. The analytical data set is drawn
from the subset of respondents aged ≥ 16 years for whom data are available across all variables used to
construct the individual risk score (namely their age and sex, nurse-administered blood tests of total and
high-density lipoprotein cholesterol, blood pressure and glycated haemoglobin, smoking status and
whether or not they have been diagnosed with diabetes – excluding in pregnancy), as well as the usual
range of predictor variables, namely age, sex, ethnicity, general health status, LLTI and tenure, along with
the IMD quintile of their LSOA of residence (n= 11,042). To avoid a household-level effect, a single
randomly selected adult is drawn from each household, resulting in an analytical data set of 8176 adults
aged ≥ 16 years.
















25–34 406 1 0.2 25–34 342 2 0.6
35–49 1760 86 4.7 35–49 1156 164 12.4
50–64 941 748 44.3 50–64 518 787 60.3
65–74 98 610 86.2 65–74 91 466 83.7
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Model parameters (see below) are applied to microsimulated LSOA-level census data to produce estimates
of the number (and proportion) of people expected to have a 10% or more risk of developing CHD over
the next 10 years in each age–sex cohort (and overall) in each of the 32,844 English LSOAs. As discussed
in the report, bootstrapping is used to derive 95% CIs for these estimates. The bootstrapped LSOA-level
prevalence rate estimates are aggregated into a number of higher geographies, namely for MSOAs, LAs,
CCGs and regions (GORs), and are then used to calculate 95% CIs for these higher-level estimates.
Proportionate attribution is used to restructure the estimates to align with 2001 MSOAs, as well as GP
practice populations as defined by the 2011 NHS ADS.
Table 101 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured
by the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444
adults) in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived
quintile; and 6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule,
variations in prevalence rates reflect variations in the socioeconomic composition of populations in the
different types of LSOA rather than variations in deprivation per se.
TABLE 101 Adults 25–74 years with ≥ 10% risk of CHD in next 10 years: cohort-specific and overall prevalence rates
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TABLE 102 Parameter estimates: adults 25–74 with ≥ 10% risk of CHD in next 10 years
Factor (reference group)
Model coefficients 95% CI
Estimate Standard error 2.5% CI 97.50%
(Intercept) –6.35822 1.00515 –8.32831 –4.38813
Age (25–34 years)
35–49 years 2.96567 1.00759 0.99080 4.94054
50–64 years 5.76793 1.00291 3.80222 7.73364
65–74 years 7.82133 1.00776 5.84612 9.79654
Sex (females)
Males 0.89443 1.23029 –1.51694 3.30580
Ethnicity (white)
Mixed –0.55011 0.38086 –1.29661 0.19638
Black –0.47142 0.28138 –1.02293 0.08009
Asian –0.42195 0.19297 –0.80017 –0.04372
Other –0.84356 0.57993 –1.98022 0.29311
General health status (very good)
Good health 0.18913 0.09856 –0.00404 0.38231
Fair health 0.46001 0.13318 0.19898 0.72104
Bad health 0.51319 0.21397 0.09381 0.93257
Very bad health 1.29992 0.41906 0.47857 2.12128
LLTI (no LTTI)
LLTI 0.12967 0.08435 –0.03565 0.29499
Tenure (owner–occupier)
Social rent 0.50207 0.10628 0.29375 0.71038
Private rent or other tenure 0.10449 0.12163 –0.13390 0.34288
LSOA deprivation quintile (least deprived quintile)
Second quintile 0.07956 0.08734 –0.09162 0.25074
Third quintile –0.04615 0.09102 –0.22456 0.13225
Fourth quintile 0.34197 0.09708 0.15168 0.53225
Fifth quintile (=most deprived quintile) 0.06950 0.11194 –0.14990 0.28889
Interaction effects
35–49 years and male (25–34 years/female) 0.21631 1.23509 –2.20446 2.63709
50–64 years and male (25–34 years/female) –0.22933 1.22966 –2.63946 2.18080
65–74 years and male (25–34 years/female) –1.05484 1.23759 –3.48052 1.37084
Male and good health (female/very good health) 0.07082 0.14147 –0.20647 0.34812
Male and fair health (female/very good health) –0.16320 0.17996 –0.51593 0.18953
Male and bad health (female/very good health) –0.06099 0.28369 –0.61703 0.49505
Male and very bad health (female/very good health) –1.73913 0.56315 –2.84289 –0.63536
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FIGURE 80 Adults 25–74 years with ≥ 10% risk of CHD in next 10 years: individual estimates and their 95% CIs.
(a) MSOAs; (b), LAs; (c) CCGs; and (d) regions (GORs).
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Adults aged 25–74 years expected to develop coronary heart
disease in the next 10 years (Health Survey for England,
2006 and 2009–11)
FIGURE 81 Adults aged 25–74 years expected to develop CHD in next 10 years: LSOA-level map. Contains Ordnance
Survey data © Crown copyright and database right 2012.
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Response variable definition, provenance and prediction
Estimates of the proportion of adults aged 25–74 years likely to develop CHD in the next 10 years are
based on HSfE data on respondents’ age, sex, cholesterol levels (total and high-density lipoprotein), blood
pressure, whether or not they have diagnosed or undiagnosed diabetes and whether or not they smoke.
Using the methodology described in Wilson et al.,502 each respondent’s risk of developing CHD over the
next 10 years is calculated. A generalised linear model (GLM) using the Gamma distribution and reciprocal
link is used to model individuals’ estimated risk (as calculated using the Framingham Risk Calculator – see
the previous section), using the usual set of sociodemographic predictor variables. (Note that the use of
the reciprocal link means that a negative coefficient indicates that, relative to the reference group, a factor
is associated with an increased risk of developing CHD in the next 10 years relative to the base.)
The HSfE at this time includes multiple household respondents of all ages. The analytical data set is drawn
from the subset of respondents aged ≥ 16 years for whom data are available across all variables used to
construct the individual risk score (namely their age and sex, nurse-administered blood tests of total and
high-density lipoprotein cholesterol, blood pressure and glycated haemoglobin, smoking status and
whether or not they have been diagnosed with diabetes – excluding in pregnancy), as well as the usual
range of predictor variables, namely age, sex, ethnicity, general health status, LLTI and tenure, along with
the IMD quintile of their LSOA of residence (n= 11,042). To avoid a household-level effect, a single
randomly selected adult is drawn from each household, resulting in an analytical data set of 8176 adults
aged ≥ 16 years.
The percentage of adults in each age–sex cohort, and overall, who are likely to develop CHD over the next
10 years are given in Table 103.
Model parameters (see below) are applied to microsimulated LSOA-level census data to produce estimates
of the number (and proportion) of people to develop CHD in the next 10 years in each age–sex cohort
(and overall) in each of the 32,844 English LSOAs. As discussed in the report, bootstrapping is used to
derive 95% CIs for these estimates. The bootstrapped LSOA-level prevalence rate estimates are aggregated
into a number of higher geographies, namely for MSOAs, LAs, CCGs, and regions (GORs), and are then
used to calculate 95% CIs for these higher-level estimates. Proportionate attribution is used to restructure
the estimates to align with 2001 MSOAs, as well as GP practice populations as defined by the 2011
NHS ADS.
Table 104 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured
by the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444
adults) in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived
quintile; and 6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule,
variations in prevalence rates reflect variations in the socioeconomic composition of populations in the
different types of LSOA rather than variations in deprivation per se.
TABLE 103 Percentage of adults aged 25–74 years likely to develop CHD over the next 10 years, by cohort
Age band (years) Females, % Males, % Overall, %
25–34 2.5 3.3 2.9
35–49 4.2 5.7 4.8
50–64 9.8 11.9 10.7
65–74 17.0 17.2 17.1
Total 8.0 9.6 8.7
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TABLE 105 Parameter estimates: adults aged 25–74 years expected to develop CHD in next 10 years
Factor (reference group)
Model coefficients 95% CI
Estimate Standard error 2.5% CI 97.50%
(Intercept) 42.43664 1.27651 39.93469 44.9386
Age (25–34 years)
35–49 years –16.3875 1.31137 –18.9578 –13.8172
50–64 years –30.5711 1.27462 –33.0694 –28.0728
65–74 years –35.1407 1.27426 –37.6383 –32.6432
Sex (females)
Males –10.62500 1.44116 –13.4497 –7.80034
Ethnicity (white)
Mixed 0.06519 0.79287 –1.48884 1.61923
Black 1.67579 0.66176 0.37875 2.97283
Asian 1.16825 0.46497 0.25692 2.07959
Other 2.11972 1.48992 –0.80053 5.03997
TABLE 104 Adults aged 25–74 years expected to develop CHD in next 10 years: cohort-specific and overall
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TABLE 105 Parameter estimates: adults aged 25–74 years expected to develop CHD in next 10 years (continued )
Factor (reference group)
Model coefficients 95% CI
Estimate Standard error 2.5% CI 97.50%
General health status (very good)
Good health –0.94419 0.23098 –1.39691 –0.49148
Fair health –1.90994 0.26855 –2.43631 –1.38357
Bad health –1.77176 0.41437 –2.58392 –0.95960
Very bad health –2.04808 0.64886 –3.31985 –0.77631
LLTI (no LTTI)
LLTI 0.08039 2.24780 –4.32529 4.48607
Tenure (owner–occupier)
Social rent –7.37434 1.91231 –11.1225 –3.62622
Private rent or other tenure –0.65215 1.65535 –3.89663 2.59233
LSOA deprivation quintile (least deprived)
Second quintile –0.42068 0.18695 –0.78711 –0.05425
Third quintile –0.20248 0.19473 –0.58416 0.17919
Fourth quintile –0.86152 0.20072 –1.25492 –0.46812
Fifth quintile (=most deprived quintile) –0.82423 0.22733 –1.26978 –0.37867
Interaction effects
35–49 years and male (16–24 years/female) 3.56172 1.48737 0.64647 6.47697
50–64 years and male (16–24 years/female) 8.39016 1.44303 5.56182 11.2185
65–74 years and male (16–24 years/female) 10.07211 1.44325 7.24333 12.90089
Male and good health (female/very good health) 0.18957 0.32000 –0.43763 0.81678
Male and fair health (female/very good health) 1.02045 0.36178 0.31136 1.72955
Male and bad health (female/very good health) 1.36557 0.54573 0.29594 2.43520
Male and very bad health (female/very good health) 2.73321 1.04701 0.68108 4.78534
35–49 years and LLTI (16–24 years/no LLTI) –1.58657 2.30138 –6.09727 2.92413
50–64 years and LLTI (16–24 years/no LLTI) –0.63821 2.25603 –5.06003 3.78361
65–74 years and LLTI (16–24 years/no LLTI) 0.22012 2.25483 –4.19935 4.63959
35–49 years and social rent (16–24 years/owner–occupier) 4.08132 1.98790 0.18504 7.97760
50–64 years and social rent (16–24 years/owner–occupier) 6.34544 1.92995 2.56273 10.12814
65–74 years and social rent (16–24 years/owner–occupier) 7.01028 1.92927 3.22890 10.79166
35–49 years and private rent (16–24 years/owner–occupier) 0.33550 1.78713 –3.16727 3.83827
50–64 years and private rent (16–24 years/owner–occupier) 0.08391 1.69901 –3.24615 3.41396
65–74 years and private rent (16–24 years/owner–occupier) 0.43177 1.70898 –2.91784 3.78138
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FIGURE 83 Adults aged 25–74 years expected to develop CHD in next 10 years: individual estimates and
their 95% CIs. (a) MSOAs; (b) LAs; (c) CCGs; and (d) regions (GORs).
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Three or more of the five National Institute for Health and Care
Excellence cardiovascular disease modifiable risk factors
(Health Survey for England, 2006 and 2009–11)
FIGURE 84 Three or more of the five NICE CVD modifiable risk factors: LSOA-level map. Contains Ordnance Survey
data © Crown copyright and database right 2012.
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Response variable definition, provenance and prediction
This response variable seeks to capture variations in the prevalence of modifiable factors known to increase
the risk of developing CVD, as detailed in NICE’s commissioning guide on services for the prevention of
cardiovascular disease.504
Referring to the nine modifiable risk factors identified by the Interheart study,505 the guide focuses on five
key factors for which reliable data in more generally available, namely:
l abnormal lipids (cholesterol > 5.0mmol/l)
l smoking or tobacco use
l obesity
l high blood pressure (hypertension)
l diabetes.
Health Survey for England data are used to establish whether or not respondents exhibit ≥ 3 of these
modifiable risk factors, and a binomial GLM with logistic link is fitted to the usual set of predictor variables.
The HSfE at this time includes multiple household respondents of all ages. The analytical data set is drawn
from the subset of respondents aged ≥ 16 years for whom data are available across all variables describing
individuals’ modifiable risk factors (namely nurse-administered blood tests for total cholesterol and glycated
haemoglobin, nurse-administered height, weight and blood pressure measurements, and questions on
smoking status and whether or not they have been diagnosed with diabetes – excluding in pregnancy),
as well as the usual range of predictor variables, namely age, sex, ethnicity, general health status, LLTI and
tenure, along with the IMD quintile of their LSOA of residence (n= 13,452). To avoid a household-level
effect, a single randomly selected adult is drawn from each household, resulting in an analytical data set of
9498 adults aged ≥ 16 years.
















16–24 299 10 3.2 16–24 226 7 3.0
25–34 673 37 5.2 25–34 504 42 7.7
35–49 1529 184 10.7 35–49 1054 184 14.9
50–64 1258 333 20.9 50–64 956 273 22.2
65–74 468 165 26.1 65–74 396 95 19.3
75–84 299 99 24.9 75–84 202 35 14.8
≥ 85 88 26 22.8 ≥ 85 47 9 16.1
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Model parameters (see below) are applied to microsimulated LSOA-level census data to produce estimates
of the number (and proportion) of people expected to exhibit at least three modifiable CVD risk factors in
each age–sex cohort (and overall) in each of the 32,844 English LSOAs. As discussed in the report,
bootstrapping is used to derive 95% CIs for these estimates. The bootstrapped LSOA-level prevalence rate
estimates are aggregated into a number of higher geographies, namely for MSOAs, LAs, CCGs and
regions (GORs), and are then used to calculate 95% CIs for these higher-level estimates. Proportionate
attribution is used to restructure the estimates to align with 2001 MSOAs, as well as GP practice
populations as defined by the 2011 NHS ADS.
Table 107 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured
by the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444
adults) in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived
quintile; and 6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule,
variations in prevalence rates reflect variations in the socioeconomic composition of populations in the
different types of LSOA rather than variations in deprivation per se.
TABLE 107 Three or more of the five NICE CVD modifiable risk factors: cohort-specific and overall prevalence rates
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TABLE 108 Parameter estimates: three or more of the five NICE CVD modifiable risk factors
Factor (reference group)
Model coefficients 95% CI
Estimate Standard error 2.5% CI 97.50%
(Intercept) –4.16945 0.33441 –4.8249 –3.51401
Age (16–24 years)
25–34 years 0.55485 0.36449 –0.15954 1.26924
35–49 years 1.37677 0.33304 0.72400 2.02953
50–64 years 2.12375 0.33041 1.47614 2.77137
65–74 years 2.34346 0.33763 1.68171 3.00521
75–84 years 2.17336 0.34596 1.49528 2.85144
≥ 85 years 1.99120 0.39661 1.21384 2.76857
Sex (females)
Males 0.01243 0.50217 –0.97184 0.99669
Ethnicity (white)
Mixed 0.02866 0.30972 –0.57839 0.63571
Black –0.37634 0.24879 –0.86397 0.11128
Asian –0.99713 0.23125 –1.45039 –0.54388
Other –0.79780 0.61246 –1.99822 0.40262
General health status (very good)
Good health 0.55171 0.07429 0.40610 0.69732
Fair health 0.72479 0.09666 0.53535 0.91424
Bad health 0.81735 0.14952 0.52430 1.11041
Very bad health 0.34447 0.28741 –0.21885 0.90780
LLTI (no LTTI)
LLTI 0.08647 0.09323 –0.09627 0.26920
Tenure (owner–occupier)
Social rent 0.35778 0.08693 0.18739 0.52817
Private rent or other tenure 0.17286 0.10512 –0.03318 0.37891
LSOA deprivation quintile (least deprived quintile)
Second quintile 0.24560 0.08991 0.06937 0.42183
Third quintile 0.19896 0.09230 0.01805 0.37987
Fourth quintile 0.33431 0.09465 0.14879 0.51983
Fifth quintile (=most deprived quintile) 0.40264 0.10428 0.19825 0.60703
Interaction effects
25–34 years and male (16–24 years/female) 0.49595 0.55397 –0.58983 1.58173
35–49 years and male (16–24 years/female) 0.41993 0.51462 –0.58872 1.42859
50–64 years and male (16–24 years/female) 0.13090 0.51135 –0.87135 1.13314
65–74 years and male (16–24 years/female) –0.26994 0.52426 –1.29749 0.75760
75–84 years and male (16–24 years/female) –0.49224 0.54967 –1.56960 0.58512
≥ 85 years and male (16–24 years/female) –0.29679 0.66358 –1.59741 1.00383
Male and LLTI (female/no LLTI) –0.29702 0.13369 –0.55905 –0.03499
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FIGURE 86 Three or more of the five NICE CVD modifiable risk factors: individual estimates and their 95% CIs.
(a) MSOAs; (b) LAs; (c) CCGs; and (d) regions (GORs).
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Appendix 27 Mental health prevalence estimates
Clinical Interview Schedule – Revised score of ≥ 12
(Adult Psychiatry Morbidity Survey, 2007)
FIGURE 87 Clinical Interview Schedule – Revised score of ≥ 12: LSOA-level map. Contains Ordnance Survey data ©
Crown copyright and database right 2012.
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Response variable definition, provenance and prediction
Derived from the CIS-R, a score of ≥ 12 is widely taken as being indicative of the presence of a common
mental disorder. Here we estimate the proportion of people in each age–sex cohort, and overall, for adults
aged ≥ 16 years, with a CIS-R score of ≥ 12. Although this marker of need is based on a well-established
instrument incorporated within the APMS, it is not independent of sociodemographic or geographic
variations in access to, or uptake of, care, as individuals may score < 12 precisely because they are being
treated for a mental health problem (see the alternative marker below which includes people currently
being treated).
The APMS data set (n= 7403) comprises adults aged ≥ 16 years (living in England) and surveyed only one
person per household; thus, the analytical data set contains all respondents for whom data is available
across all model response and predictor variables, namely CIS-R score, age band, sex, ethnicity, LLTI,
tenure and IMD quintile of LSOA of residence (n= 7326).
















16–24 225 68 23.2 16–24 233 33 12.4
25–34 476 138 22.5 25–34 347 60 14.7
35–49 866 250 22.4 35–49 744 127 14.6
50–64 822 191 18.9 50–64 694 103 12.9
65–74 487 75 13.3 65–74 428 33 7.2
75–84 386 49 11.3 75–84 268 18 6.3
≥ 85 122 11 8.3 ≥ 85 68 4 5.6




Model parameters are applied to microsimulated LSOA-level census data to produce estimates of the
number (and proportion) of people expected to return a CIS-R score of ≥ 12 in each age–sex cohort
(and overall) in each of the 32,844 English LSOAs. As discussed in the report, bootstrapping is used to
derive 95% CIs for the estimates. These LSOA-level prevalence rate estimates (and 95% CIs) are
aggregated into a number of higher geographies, namely MSOAs, LAs, CCGs and regions (GORs).
Proportionate attribution is used to restructure the prevalence rate estimates to align with 2001 MSOAs,
as well as GP practice populations as defined by the 2011 NHS ADS.
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Table 110 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured
by the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444
adults) in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived
quintile; and 6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule,
variations in prevalence rates reflect variations in the socioeconomic composition of populations in the
different types of LSOA rather than variations in deprivation per se.
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TABLE 111 Parameter estimates: CIS-R score of ≥ 12
Factor (reference group)
Model coefficients 95% CI
Estimate SE 2.5% CI 97.5%
(Intercept) –1.69971 0.21664 –2.12432 –1.2751
Age (16–24 years)
25–34 years –0.44013 0.22313 –0.87747 –0.00279
35–49 years –0.44214 0.19884 –0.83186 –0.05241
50–64 years –0.82381 0.20275 –1.22121 –0.42641
65–74 years –1.54817 0.22996 –1.99889 –1.09745
75–84 years –1.76752 0.2474 –2.25241 –1.28262
≥ 85 years –1.96847 0.36421 –2.68233 –1.25461
Sex (females)
Males –0.65139 0.09587 –0.83929 –0.46349
Ethnicity (white)
Mixed 0.18437 0.40067 –0.60094 0.96969
Black –0.43721 0.27113 –0.96864 0.09421
Asian –0.13946 0.26787 –0.66449 0.38556
Other 0.65314 0.44709 –0.22316 1.52943
LLTI (no LTTI)
LLTI 1.26179 0.19524 0.87912 1.64445
Tenure (owner–occupier)
Social rent 0.16883 0.28047 –0.38089 0.71855
Private rent or other tenure –0.20441 0.30836 –0.80879 0.39996
LSOA deprivation quintile (least deprived quintile)
Second LSOA deprivation quintile 0.06721 0.16205 –0.25041 0.38483
Third LSOA deprivation quintile 0.40613 0.15910 0.09429 0.71796
Fourth LSOA deprivation quintile 0.02185 0.16936 –0.31010 0.35380
Fifth LSOA deprivation quintile (=most deprived) 0.27737 0.16442 –0.04489 0.59963
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TABLE 111 Parameter estimates: CIS-R score of ≥ 12 (continued )
Factor (reference group)
Model coefficients 95% CI
Estimate SE 2.5% CI 97.5%
Interaction effects
Male and social rent 0.41371 0.17039 0.07974 0.74767
Male and private rent or other tenure –0.10108 0.22725 –0.54648 0.34433
Mixed and LLTI 0.53643 0.77155 –0.97582 2.04867
Black and LLTI 1.24709 0.40753 0.44834 2.04584
Asian and LLTI –0.09489 0.41381 –0.90596 0.71618
Other and LLTI –0.20076 0.79171 –1.75252 1.35100
LLTI and second deprivation quintile 0.45842 0.24981 –0.03120 0.94804
LLTI and third deprivation quintile 0.24101 0.24399 –0.23722 0.71924
LLTI and fourth deprivation quintile 0.74420 0.24951 0.25517 1.23323
LLTI and fifth deprivation quintile 0.53660 0.24008 0.06604 1.00716
25–34 years and social rent 0.83346 0.34185 0.16344 1.50348
35–49 years and social rent 0.56488 0.30980 –0.04232 1.17209
50–64 years and social rent 0.37222 0.31758 –0.25024 0.99469
65–74 years and social rent 0.18544 0.35905 –0.51830 0.88918
75–84 years and social rent –0.43845 0.40902 –1.24012 0.36322
≥ 85 years and social rent –1.10881 0.72522 –2.53024 0.31262
25–34 years and private rent or other tenure 0.77959 0.36797 0.05837 1.50082
35–49 years and private rent or other tenure 0.81082 0.35437 0.11626 1.50539
50–64 years and private rent or other tenure 0.45249 0.41387 –0.35869 1.26367
65–74 years and private rent or other tenure 0.17127 0.58864 –0.98247 1.32500
75–84 years and private rent or other tenure 0.09246 0.71221 –1.30347 1.48839
≥ 85 years and private rent or other tenure –11.76647 230.12616 –462.814 439.2808
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Individual CCGs (n = 211)
FIGURE 89 Clinical Interview Schedule – Revised score of ≥ 12: individual estimates and their 95% CIs. (a) MSOAs;
(b) LAs; (c) CCGs; and (d) regions (GORs). (continued )
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FIGURE 89 Clinical Interview Schedule – Revised score of ≥ 12: individual estimates and their 95% CIs. (a) MSOAs;
(b) LAs; (c) CCGs; and (d) regions (GORs).
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Clinical Interview Schedule – Revised score of ≥ 18
(Adult Psychiatry Morbidity Survey, 2007)
FIGURE 90 Clinical Interview Schedule – Revised score of ≥ 18: LSOA-level map. Contains Ordnance Survey data ©
Crown copyright and database right 2012.
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Response variable definition, provenance and prediction
Derived from CIS-R, a score of ≥ 18 is widely taken as being indicative of the presence of a common
mental disorder which requires treatment. Here we estimate the proportion of people in each age–sex
cohort, and overall, for adults aged ≥ 16 years, with a CIS-R score of ≥ 18. Although this marker of need
is based on a well-established instrument incorporated within the APMS, it is not independent of
sociodemographic or geographic variations in access to, or uptake of, care, as individuals may score
< 18 precisely because they are being treated for a mental health problem (see the alternative marker
below which includes people currently being treated).
The APMS data set (n= 7403) comprises adults aged ≥ 16 years (living in England) and surveyed only one
person per household; thus, the analytical data set contains all respondents for whom data are available
across all model response and predictor variables, namely CIS-R score, age band, sex, ethnicity, LLTI, tenure
and IMD quintile of LSOA of residence (n= 7326).
















16–24 252 41 14.0 16–24 249 17 6.4
25–34 548 66 10.7 25–34 375 32 7.9
35–49 980 136 12.2 35–49 805 66 7.6
50–64 912 101 10.0 50–64 739 58 7.3
65–74 534 28 5.0 65–74 453 8 1.7
75–84 417 18 4.1 75–84 279 7 2.4
≥ 85 129 4 3.0 ≥ 85 70 2 2.8




Model parameters are applied to microsimulated LSOA-level census data to produce estimates of the
number (and proportion) of people expected to return a CIS-R score of ≥ 18 in each age–sex cohort
(and overall) in each of the 32,844 English LSOAs. As discussed in the report, bootstrapping is used to
derive 95% CIs for the estimates. These LSOA-level prevalence rate estimates (and 95% CIs) are
aggregated into a number of higher geographies, namely MSOAs, LAs, CCGs, and regions (GORs).
Proportionate attribution is used to restructure the prevalence rate estimates to align with 2001 MSOAs,
as well as GP practice populations as defined by the 2011 NHS ADS.
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Table 113 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured by
the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444 adults)
in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived quintile; and
6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule, variations in
prevalence rates reflect variations in the socioeconomic composition of populations in the different types of
LSOA rather than variations in deprivation per se.
TABLE 113 Clinical Interview Schedule – Revised score of ≥ 18: cohort-specific and overall prevalence rates by IMD
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TABLE 114 Parameter estimates: CIS-R score of ≥ 18
Factor (reference group)
Model coefficients 95% CI
Estimate SE 2.5% CI 97.5%
(Intercept) –2.84741 0.29913 –3.43371 –2.26111
Age (16–24 years)
25–34 years –0.79571 0.3157 –1.41448 –0.17693
35–49 years –0.61097 0.26975 –1.13968 –0.08225
50–64 years –1.01588 0.27528 –1.55543 –0.47633
65–74 years –2.38890 0.35931 –3.09314 –1.68466
75–84 years –2.19187 0.35704 –2.89166 –1.49208
≥ 85 years –2.04559 0.49507 –3.01594 –1.07525
Sex (females)
Males –0.62213 0.14293 –0.90227 –0.34199
Ethnicity (white)
Mixed –0.60185 0.73575 –2.04392 0.84023
Black –0.79344 0.46472 –1.70428 0.11740
Asian –0.00007 0.34583 –0.67790 0.67776
Other –0.02310 0.75084 –1.49474 1.44854
LTI (no LTTI)
LLTI 1.86324 0.10955 1.64852 2.07795
Tenure (owner–occupier)
Social rent 0.78579 0.52779 –0.24868 1.82026
Private rent or other tenure –0.79959 0.68153 –2.13540 0.53621
LSOA deprivation quintile (least deprived quintile)
Second LSOA deprivation quintile 0.24104 0.22096 –0.19205 0.67412
Third LSOA deprivation quintile 0.46692 0.21956 0.03657 0.89727
Fourth LSOA deprivation quintile 0.60060 0.22188 0.16570 1.03549
Fifth LSOA deprivation quintile (=most deprived) 0.91083 0.22431 0.47117 1.35049
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TABLE 114 Parameter estimates: CIS-R score of ≥ 18 (continued )
Factor (reference group)
Model coefficients 95% CI
Estimate SE 2.5% CI 97.5%
Interaction effects
25–34 years and social rent 0.81569 0.43463 –0.03619 1.66756
35–49 years and social rent 0.58055 0.38270 –0.16954 1.33063
50–64 years and social rent 0.60057 0.38917 –0.16220 1.36333
65–74 years and social rent 0.69360 0.49418 –0.27500 1.66219
75–84 years and social rent –0.79932 0.62108 –2.01665 0.41800
≥ 85 years and social rent –14.0701 297.86920 –597.89400 569.75350
25–34 years and private rent or other tenure 1.14771 0.50517 0.15758 2.13784
35–49 years and private rent or other tenure 0.92090 0.47841 –0.01677 1.85858
50–64 years and private rent or other tenure 0.52906 0.55074 –0.55040 1.60852
65–74 years and private rent or other tenure 0.64356 0.88014 –1.08152 2.36865
75–84 years and private rent or other tenure 1.20243 0.79194 –0.34979 2.75464
≥ 85 years and private rent or other tenure –12.9688 619.56110 –1227.3100 1201.3710
Male and social rent 0.3899 0.21773 –0.03685 0.81665
Male and private rent or other tenure –0.23958 0.31263 –0.85233 0.37317
Social rent and second LSOA deprivation quintile –0.92318 0.54817 –1.99759 0.15123
Private rent or other tenure and second quintile 0.63745 0.65310 –0.64261 1.91752
Social rent and third LSOA deprivation quintile –0.24388 0.47012 –1.16532 0.67755
Private rent or other tenure and third quintile 1.26042 0.61021 0.06440 2.45643
Social rent and fourth LSOA deprivation quintile –0.39366 0.45321 –1.28196 0.49463
Private rent or other tenure and fourth quintile –0.10043 0.66037 –1.39475 1.19389
Social rent and fifth LSOA deprivation quintile –0.72511 0.43906 –1.58567 0.13544
Private rent or other tenure and fifth quintile 0.57724 0.61818 –0.63439 1.78887
Mixed and LLTI 2.2230 1.00266 0.25778 4.18822
Black and LLTI 1.07645 0.57732 –0.05510 2.20800
Asian and LLTI 0.03293 0.47853 –0.90499 0.97086
Other and LLTI –0.20244 1.11174 –2.38145 1.97657
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FIGURE 92 Clinical Interview Schedule – Revised score of ≥ 18: individual estimates and their 95% CIs. (a) MSOAs;
(b) LAs; (c) CCGs; and (d) regions (GORs).
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Clinical Interview Schedule – Revised score of ≥ 12 or any mental
health treatment (Adult Psychiatry Morbidity Survey, 2007)
FIGURE 93 Clinical Interview Schedule – Revised score of ≥ 12 or any mental health treatment: LSOA-level map.
Contains Ordnance Survey data © Crown copyright and database right 2012.
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Response variable definition, provenance and prediction
This marker of mental health needs is derived from the CIS-R and questions about whether the respondent
is currently receiving medication, counselling or therapy for a mental health problem. Here we estimate the
proportion of people in each age–sex cohort, and overall for adults aged ≥ 16 years, with a CIS-R score of
≥ 12 (which is indicative of the presence of a common mental disorder) or who are currently receiving
treatment for a mental health problem. This aims to capture individuals who would fall below the CIS-R
≥ 12 threshold because they are receiving treatment, and necessarily assumes that those who receive
treatment do indeed need treatment. This marker of need is vulnerable to any sociodemographic or
geographic variations in access to, or uptake of, care.
The APMS data set (n= 7403) comprises adults aged ≥ 16 years (living in England) and only surveyed one
person per household, thus the analytical data set contains all respondents for whom data is available
across all model response and predictor variables, namely CIS-R score, whether currently receiving
treatment for a mental health problem, along with information on age band, sex, ethnicity, LLTI, tenure
and IMD quintile of LSOA of residence (n= 7312).
TABLE 115 Clinical Interview Schedule – Revised score of ≥ 12 or any mental health treatment: survey counts and















16–24 218 75 25.6 16–24 231 35 13.2
25–34 455 158 25.8 25–34 335 72 17.7
35–49 807 308 27.6 35–49 717 154 17.7
50–64 758 255 25.2 50–64 673 124 15.6
65–74 451 110 19.6 65–74 411 50 10.8
75–84 355 74 17.2 75–84 254 29 10.2
≥ 85 106 25 19.1 ≥ 85 66 6 8.3




Model parameters are applied to microsimulated LSOA-level census data to produce estimates of the
number (and proportion) of people expected to return a CIS-R score of ≥ 12 and/or be receiving treatment
for a mental health problem in each age–sex cohort (and overall) in each of the 32,844 English LSOAs.
As discussed in the report, bootstrapping is used to derive 95% CIs for the estimates. These LSOA-level
prevalence rate estimates (and 95%CIs) are aggregated into a number of higher geographies, namely
MSOAs, LAs, CCGs and regions (GORs). Proportionate attribution is used to restructure the prevalence rate
estimates to align with 2001 MSOAs, as well as GP practice populations as defined by the 2011 NHS ADS.
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Table 116 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured
by the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444
adults) in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived
quintile; and 6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule,
variations in prevalence rates reflect variations in the socioeconomic composition of populations in the
different types of LSOA rather than variations in deprivation per se.
TABLE 116 Clinical Interview Schedule – Revised score of ≥ 12 or any mental health treatment: cohort-specific and











































































































































































































NIHR Journals Library www.journalslibrary.nihr.ac.uk
440
TABLE 117 Parameter estimates: CIS-R score of ≥ 12 or any mental health treatment
Factor (reference group)
Model coefficients 95% CI
Estimate SE 2.5% CI 97.5%
(Intercept) –1.68348 0.15765 –1.99248 –1.37448
Age (16–24 years)
25–34 years 0.12353 0.14025 –0.15136 0.39841
35–49 years 0.10458 0.13078 –0.15174 0.36091
50–64 years –0.29020 0.13680 –0.55833 –0.02206
65–74 years –0.94469 0.15458 –1.24767 –0.64171
75–84 years –1.31081 0.16946 –1.64296 –0.97867
≥ 85 years –1.46498 0.24024 –1.93585 –0.99411
Sex (females)
Males –0.69854 0.08529 –0.86571 –0.53138
Ethnicity (white)
Mixed 0.06194 0.38014 –0.68313 0.80701
Black –0.54233 0.25014 –1.03261 –0.05205
Asian –0.31027 0.25911 –0.81814 0.19759
Other 0.51270 0.42471 –0.31973 1.34514
LLTI (no LTTI)
LLTI 1.10383 0.16984 0.77094 1.43672
Tenure (owner–occupier)
Social rent 0.53020 0.09879 0.33657 0.72384
Private rent or other tenure 0.33443 0.12796 0.08363 0.58524
LSOA deprivation quintile (least deprived quintile)
Second LSOA deprivation quintile –0.11887 0.13896 –0.39123 0.15350
Third LSOA deprivation quintile 0.29091 0.13552 0.02530 0.55652
Fourth LSOA deprivation quintile –0.17998 0.14733 –0.46875 0.10879
Fifth LSOA deprivation quintile (=most deprived) 0.22540 0.14040 –0.04977 0.50058
Interaction effects
LLTI and second LSOA deprivation quintile 0.59927 0.22155 0.16502 1.03351
LLTI and third LSOA deprivation quintile 0.36408 0.21572 –0.05873 0.78690
LLTI and fourth LSOA deprivation quintile 0.99885 0.22267 0.56242 1.43529
LLTI and fifth LSOA deprivation quintile 0.46431 0.21205 0.04868 0.87993
Male and social rent 0.38207 0.15588 0.07654 0.68761
Male and private rent or other tenure –0.11796 0.20796 –0.52555 0.28964
Mixed and LLTI 0.29383 0.75672 –1.18933 1.77699
Black and LLTI 1.20991 0.39160 0.44237 1.97745
Asian and LLTI 0.09235 0.40263 –0.69681 0.88150
Other and LLTI –0.32211 0.77549 –1.84207 1.19784
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Individual CCGs (n = 211)
FIGURE 95 Clinical Interview Schedule – Revised score of ≥ 12 or any mental health treatment: individual estimates
and their 95% CIs. (a) MSOAs; (b) LAs; (c) CCGs; and (d) regions (GORs). MH, mental health. (continued )
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FIGURE 95 Clinical Interview Schedule – Revised score of ≥ 12 or any mental health treatment: individual estimates
and their 95% CIs. (a) MSOAs; (b) LAs; (c) CCGs; and (d) regions (GORs). MH, mental health.
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Clinical Interview Schedule – Revised score of ≥ 18 or any
mental health treatment (Adult Psychiatry Morbidity
Survey, 2007)
FIGURE 96 Clinical Interview Schedule – Revised score of ≥ 18 or any mental health treatment: LSOA-level map.
Contains Ordnance Survey data © Crown copyright and database right 2012.
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Response variable definition, provenance and prediction
This marker of mental health needs is derived from the CIS-R and questions about whether the respondent
is currently receiving medication, counselling or therapy for a mental health problem. Here we estimate the
proportion of people in each age–sex cohort, and overall for adults aged ≥ 16 years, with a CIS-R score of
≥ 18 (which is indicative of the presence of a common mental disorder which requires treatment) or who
are currently receiving treatment for a mental health problem. This aims to capture individuals who would
fall below the CIS-R ≥ 18 threshold because they are receiving treatment, and necessarily assumes that
those who receive treatment do indeed need treatment. This marker of need is vulnerable to any
sociodemographic or geographic variations in access to, or uptake of, care.
The APMS data set (n= 7403) comprises adults aged ≥ 16 years (living in England) and surveyed only one
person per household, thus the analytical data set contains all respondents for whom data are available
across all model response and predictor variables, namely CIS-R score and whether or not currently
receiving treatment for a mental health problem, along with information on age band, sex, ethnicity, LLTI,
tenure and IMD quintile of LSOA of residence (n= 7310).
TABLE 118 Clinical Interview Schedule – Revised score of ≥ 18 or any mental health treatment: survey counts and















16–24 242 51 17.4 16–24 246 20 7.5
25–34 514 99 16.2 25–34 360 47 11.5
35–49 891 224 20.1 35–49 767 104 11.9
50–64 824 188 18.6 50–64 714 83 10.4
65–74 487 74 13.2 65–74 430 30 6.5
75–84 381 48 11.2 75–84 263 20 7.1
≥ 85 111 20 15.3 ≥ 85 68 4 5.6




Model parameters are applied to microsimulated LSOA-level census data to produce estimates of the
number (and proportion) of people expected to return a CIS-R score of ≥ 18 and/or be receiving treatment
for a mental health problem in each age–sex cohort (and overall) in each of the 32,844 English LSOAs.
As discussed in the report, bootstrapping is used to derive 95% CIs for the estimates. These LSOA-level
prevalence rate estimates (and 95% CIs) are aggregated into a number of higher geographies, namely
MSOAs, LAs, CCGs and regions (GORs). Proportionate attribution is used to restructure the prevalence rate
estimates to align with 2001 MSOAs, as well as GP practice populations as defined by the 2011 NHS ADS.
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Table 119 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured
by the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444
adults) in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived
quintile; and 6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule,
variations in prevalence rates reflect variations in the socioeconomic composition of populations in the
different types of LSOA rather than variations in deprivation per se.
TABLE 119 Clinical Interview Schedule – Revised score of ≥ 18 or any mental health treatment: cohort-specific and
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TABLE 120 Parameter estimates: CIS-R score of ≥ 18 or any mental health treatment
Factor (reference group)
Model coefficients 95% CI
Estimate SE 2.5% CI 97.5%
(Intercept) –2.31263 0.20850 –2.72129 –1.90398
Age (16–24 years)
25–34 years 0.19518 0.19615 –0.18927 0.57963
35–49 years 0.14380 0.18540 –0.21958 0.50719
50–64 years –0.10894 0.20156 –0.50399 0.28611
65–74 years –0.51284 0.25723 –1.01701 –0.00867
75–84 years –1.41425 0.44525 –2.28693 –0.54156
≥ 85 years –0.12348 0.55127 –1.20396 0.95700
Sex (females)
Males –0.73218 0.10316 –0.93437 –0.52999
Ethnicity (white)
Mixed 0.10262 0.38631 –0.65454 0.85979
Black –0.39185 0.22539 –0.83362 0.04992
Asian –0.21892 0.22371 –0.65739 0.21954
Other –0.41120 0.50627 –1.40349 0.58109
LLTI (no LTTI)
LLTI 1.47531 0.37731 0.73578 2.21484
Tenure (owner–occupier)
Social rent 0.56185 0.10960 0.34704 0.77666
Private rent or other tenure 0.37678 0.14652 0.08960 0.66397
LSOA deprivation quintile (least deprived quintile)
Second LSOA deprivation quintile –0.25193 0.17587 –0.59664 0.09278
Third LSOA deprivation quintile 0.20440 0.16740 –0.12371 0.53251
Fourth LSOA deprivation quintile –0.16427 0.18041 –0.51788 0.18934
Fifth LSOA deprivation quintile (=most deprived) 0.19090 0.17055 –0.14339 0.52518
Interaction effects
LLTI and second LSOA deprivation quintile 0.61900 0.26352 0.10250 1.13549
LLTI and third LSOA deprivation quintile 0.48951 0.25077 –0.00199 0.98102
LLTI and fourth LSOA deprivation quintile 0.92920 0.25832 0.42290 1.43551
LLTI and fifth LSOA deprivation quintile 0.50110 0.24419 0.02248 0.97971
Male and social rent 0.37532 0.17608 0.03019 0.72044
Male and private rent or other tenure –0.21954 0.25150 –0.71248 0.27341
25–34 years and LLTI –0.48083 0.38120 –1.22797 0.26632
35–49 years and LLTI –0.02367 0.34952 –0.70874 0.66139
50–64 years and LLTI –0.32654 0.35459 –1.02154 0.36846
65–74 years and LLTI –0.77812 0.39941 –1.56096 0.00472
75–84 years and LLTI –0.08373 0.54302 –1.14805 0.98058
≥ 85 years and LLTI –1.51723 0.66443 –2.81952 –0.21494
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FIGURE 98 Clinical Interview Schedule – Revised score of ≥ 18 or any mental health treatment: individual estimates
and their 95% CIs. (a) MSOAs; (b) LAs; (c) CCGs; and (d) regions (GORs). (continued )
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FIGURE 98 Clinical Interview Schedule – Revised score of ≥ 18 or any mental health treatment: individual estimates
and their 95% CIs. (a) MSOAs; (b) LAs; (c) CCGs; and (d) regions (GORs).
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Generalised anxiety disorder symptoms in past week
(Adult Psychiatry Morbidity Survey, 2007)
FIGURE 99 Generalised anxiety disorder symptoms: LSOA-level map. Contains Ordnance Survey data © Crown
copyright and database right 2012.
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Response variable definition, provenance and prediction
On the basis of responses to the CIS-R, the APMS reports whether or not respondents had shown
symptoms of generalised anxiety disorder [International Classification of Diseases, Tenth Edition (ICD-10):
F41.1488] during the previous week. This is not entirely independent of sociodemographic or geographic
variations in access to, or uptake of, care, as individuals may be free of symptoms because they are
currently being treated for a generalised anxiety disorder. We cannot produce an alternative measure
capturing underlying levels of generalised anxiety disorder because information of treatment (medication
or otherwise) is not specific to this condition.
The APMS data set (n= 7403) comprises adults aged ≥ 16 years (living in England) and surveyed only one
person per household; thus, the analytical data set contains all respondents for whom data are available
across all model response and predictor variables, namely CIS-R question responses, age band, sex,
ethnicity, LLTI, tenure and IMD quintile of LSOA of residence (n= 7326).















16–24 274 19 6.5 16–24 261 5 1.9
25–34 586 28 4.6 25–34 386 21 5.2
35–49 1036 80 7.2 35–49 827 44 5.1
50–64 947 66 6.5 50–64 763 34 4.3
65–74 538 24 4.3 65–74 448 13 2.8
75–84 422 13 3.0 75–84 281 5 1.7
≥ 85 130 3 2.3 ≥ 85 71 1 1.4




Model parameters are applied to microsimulated LSOA-level census data to produce estimates of the
number (and proportion) of people expected to have shown symptoms of generalised anxiety disorder
(ICD-10: F41.1488) during the previous week in each age–sex cohort (and overall) in each of the 32,844
English LSOAs. As discussed in the report, bootstrapping is used to derive 95% CIs for the estimates.
These LSOA-level prevalence rate estimates (and 95% CIs) are aggregated into a number of higher
geographies; namely MSOAs, LAs, CCGs and regions (GORs). Proportionate attribution is used to
restructure the prevalence rate estimates to align with 2001 MSOAs, as well as GP practice populations as
defined by the 2011 NHS ADS.
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Table 123 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured by
the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444 adults)
in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived quintile; and
6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule, variations in
prevalence rates reflect variations in the socioeconomic composition of populations in the different types of
LSOA rather than variations in deprivation per se.








































































































































































































NIHR Journals Library www.journalslibrary.nihr.ac.uk
454
TABLE 123 Parameter estimates: generalised anxiety disorder symptoms
Factor (reference group)
Model coefficients 95% CI
Estimate SE 2.5% CI 97.5%
(Intercept) –3.89407 0.28512 –4.4529 –3.33523
Age (16–24 years)
25–34 years 0.02509 0.26284 –0.49007 0.54025
35–49 years 0.26883 0.23955 –0.20069 0.73835
50–64 years –0.05993 0.24951 –0.54898 0.42911
65–74 years –0.74005 0.28506 –1.29876 –0.18134
75–84 years –1.35781 0.33418 –2.01280 –0.70282
≥ 85 years –1.80545 0.55852 –2.90015 –0.71074
Sex (females)
Males –0.62822 0.19739 –1.0151 –0.24134
Ethnicity (white)
Mixed 0.86821 0.45406 –0.02174 1.75816
Black 0.45458 0.27028 –0.07516 0.98432
Asian 0.41929 0.27905 –0.12764 0.96622
Other 0.29891 0.62335 –0.92285 1.52067
LLTI (no LTTI)
LLTI 1.51032 0.14999 1.21634 1.80431
Tenure (owner–occupier)
Social rent 0.69269 0.13728 0.42362 0.96177
Private rent or other tenure 0.31761 0.18595 –0.04686 0.68208
LSOA deprivation quintile (least deprived quintile)
Second LSOA deprivation quintile 0.33703 0.20710 –0.06889 0.74295
Third LSOA deprivation quintile 0.48127 0.20280 0.08378 0.87875
Fourth LSOA deprivation quintile 0.19639 0.21119 –0.21754 0.61033
Fifth LSOA deprivation quintile (=most deprived) 0.24171 0.20830 –0.16656 0.64997
Interaction effects
Male and LLTI 0.46475 0.24650 –0.01840 0.94789
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Individual CCGs (n = 211)
FIGURE 101 Generalised anxiety disorder symptoms: individual estimates and their 95% CIs. (a) MSOAs; (b) LAs;
(c) CCGs; and (d) regions (GORs). GAD, generalised anxiety disorder. (continued )
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FIGURE 101 Generalised anxiety disorder symptoms: individual estimates and their 95% CIs. (a) MSOAs; (b) LAs;
(c) CCGs; and (d) regions (GORs). GAD, generalised anxiety disorder.
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Mixed anxiety/depressive disorder symptoms in past week
(Adult Psychiatry Morbidity Survey, 2007)
FIGURE 102 Mixed anxiety/depressive disorder symptoms: LSOA-level map. Contains Ordnance Survey data ©
Crown copyright and database right 2012.
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Response variable definition, provenance and prediction
On the basis of responses to the CIS-R, the APMS reports whether or not respondents had shown
symptoms of mixed anxiety/depressive disorder (F41.2) during the previous week. This is not entirely
independent of sociodemographic or geographic variations in access to, or uptake of, care, as individuals
may be free of symptoms because they are currently being treated for a mixed anxiety/depressive disorder.
We cannot produce an alternative measure capturing underlying levels of mixed anxiety/depressive disorder
because information of treatment (medication or otherwise) is not specific to this condition.
The APMS data set (n= 7403) comprises adults aged ≥ 16 years (living in England) and surveyed only one
person per household; thus, the analytical data set contains all respondents for whom data are available
across all model response and predictor variables, namely CIS-R question responses, age band, sex,
ethnicity, LLTI, tenure and IMD quintile of LSOA of residence (n= 7326).















16–24 258 35 11.9 16–24 246 20 7.5
25–34 531 83 13.5 25–34 376 31 7.6
35–49 991 125 11.2 35–49 805 66 7.6
50–64 908 105 10.4 50–64 744 53 6.6
65–74 519 43 7.7 65–74 443 18 3.9
75–84 405 30 6.9 75–84 275 11 3.8
≥ 85 128 5 3.8 ≥ 85 70 2 2.8




Model parameters are applied to microsimulated LSOA-level census data to produce estimates of the
number (and proportion) of people expected to have shown symptoms of mixed anxiety/depressive
disorder (F41.2) during the previous week in each age–sex cohort (and overall) in each of the 32,844
English LSOAs. As discussed in the report, bootstrapping is used to derive 95% CIs for the estimates.
These LSOA-level prevalence rate estimates (and 95% CIs) are aggregated into a number of higher
geographies; namely MSOAs, LAs, CCGs and regions (GORs). Proportionate attribution is used to
restructure the prevalence rate estimates to align with 2001 MSOAs, as well as GP practice populations as
defined by the 2011 NHS ADS.
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Table 125 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured by
the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444 adults)
in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived quintile; and
6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule, variations in
prevalence rates reflect variations in the socioeconomic composition of populations in the different types of
LSOA rather than variations in deprivation per se.
TABLE 125 Mixed anxiety/depressive disorder symptoms: cohort-specific and overall prevalence rates by IMD
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TABLE 126 Parameter estimates: mixed anxiety/depressive disorder symptoms
Factor (reference group)
Model coefficients 95% CI
Estimate SE 2.5% CI 97.5%
(Intercept) –2.46357 0.22673 –2.90796 –2.01918
Age (16–24 years)
25–34 years 0.30158 0.19982 –0.09008 0.69323
35–49 years –0.08291 0.19579 –0.46665 0.30083
50–64 years –0.40855 0.21729 –0.83443 0.01733
65–74 years –1.72903 0.39538 –2.50396 –0.95409
75–84 years –0.92594 0.38064 –1.67199 –0.17989
≥ 85 years –13.0749 200.8464 –406.734 380.5841
Sex (females)
Males –0.63127 0.12654 –0.87928 –0.38326
Ethnicity (white)
Mixed –0.78236 0.60033 –1.95901 0.39429
Black –0.08558 0.23361 –0.54346 0.37231
Asian –0.21076 0.26135 –0.72301 0.30150
Other 0.90961 0.39611 0.13323 1.68599
LLTI (no LTTI)
LLTI 0.59406 0.44123 –0.27076 1.45887
Tenure (owner–occupier)
Social rent 0.39707 0.10975 0.18197 0.61218
Private rent or other tenure 0.14257 0.13949 –0.13082 0.41597
LSOA deprivation quintile (least deprived quintile)
Second LSOA deprivation quintile –0.03640 0.19520 –0.41899 0.34618
Third LSOA deprivation quintile 0.40504 0.18717 0.03818 0.77189
Fourth LSOA deprivation quintile 0.02306 0.20057 –0.37006 0.41618
Fifth LSOA deprivation quintile (=most deprived) 0.29116 0.19336 –0.08783 0.67015
Interaction effects
25–34 years and LLTI –0.87494 0.43544 –1.72841 –0.02147
35–49 years and LLTI –0.10978 0.38917 –0.87255 0.65299
50–64 years and LLTI 0.03258 0.39591 –0.74341 0.80856
65–74 years and LLTI 0.98292 0.52478 –0.04566 2.01149
75–84 years and LLTI –0.34243 0.52579 –1.37298 0.68812
≥ 85 years and LLTI 11.29915 200.8471 –382.361 404.9594
Male and LLTI 0.30969 0.18258 –0.04816 0.66755
LLTI and second LSOA deprivation quintile 0.72095 0.31946 0.09481 1.34708
LLTI and third LSOA deprivation quintile 0.09488 0.31552 –0.52354 0.71330
LLTI and fourth LSOA deprivation quintile 0.54179 0.32101 –0.08740 1.17097
LLTI and fifth LSOA deprivation quintile 0.54286 0.30290 –0.05082 1.13654
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Individual CCGs (n = 211)
FIGURE 104 Mixed anxiety/depressive disorder symptoms: individual estimates and their 95% CIs. (a) MSOAs;
(b) LAs; (c) CCGs; and (d) regions (GORs). MADD, mixed anxiety/depressive disorder. (continued )
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FIGURE 104 Mixed anxiety/depressive disorder symptoms: individual estimates and their 95% CIs. (a) MSOAs;
(b) LAs; (c) CCGs; and (d) regions (GORs). MADD, mixed anxiety/depressive disorder.
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Depressive episode symptoms in past week (Adult Psychiatry
Morbidity Survey, 2007)
FIGURE 105 Depressive episode symptoms: LSOA-level map. Contains Ordnance Survey data © Crown copyright
and database right 2012.
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Response variable definition, provenance and prediction
On the basis of responses to the CIS-R, the APMS reports whether or not respondents had shown
symptoms of a depressive episode (F32) during the previous week. This is not entirely independent of
sociodemographic or geographic variations in access to, or uptake of, care, as individuals may be free of
symptoms because they are currently being treated for depression. We cannot produce an alternative
measure capturing underlying levels of depression because information of treatment (medication or
otherwise) is not specific to this condition.
The APMS data set (n= 7403) comprises adults ≥ 16 years (living in England) and surveyed only one
person per household; thus, the analytical data set contains all respondents for whom data are available
across all model response and predictor variables, namely CIS-R question responses, age band, sex,
ethnicity, LLTI, tenure and IMD quintile of LSOA of residence (n= 7326).















16–24 281 12 4.1 16–24 260 6 2.3
25–34 594 20 3.3 25–34 393 14 3.4
35–49 1048 68 6.1 35–49 842 29 3.3
50–64 976 37 3.7 50–64 769 28 3.5
65–74 546 16 2.8 65–74 457 4 0.9
75–84 425 10 2.3 75–84 283 3 1.0
≥ 85 131 2 1.5 ≥ 85 70 2 2.8




Model parameters are applied to microsimulated LSOA-level census data to produce estimates of the
number (and proportion) of people expected to have shown symptoms of a depressive episode (F32)
during the previous week in each age–sex cohort (and overall) in each of the 32,844 English LSOAs.
As discussed in the report, bootstrapping is used to derive 95% CIs for the estimates. These LSOA-level
prevalence rate estimates (and 95% CIs) are aggregated into a number of higher geographies; namely
MSOAs, LAs, CCGs and regions (GORs). Proportionate attribution is used to restructure the prevalence rate
estimates to align with 2001 MSOAs, as well as GP practice populations as defined by the 2011 NHS ADS.
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Table 128 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured by
the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444 adults)
in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived quintile; and
6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule, variations in
prevalence rates reflect variations in the socioeconomic composition of populations in the different types of
LSOA rather than variations in deprivation per se.
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TABLE 129 Parameter estimates: depressive episode symptoms
Factor (reference group)
Model coefficients 95% CI
Estimate SE 2.5% CI 97.5%
(Intercept) –3.98080 0.33425 –4.63592 –3.32567
Age (16–24 years)
25–34 years –0.15700 0.31105 –0.76666 0.45265
35–49 years 0.15994 0.27930 –0.38750 0.70737
50–64 years –0.45396 0.29431 –1.03081 0.12290
65–74 years –1.32688 0.35105 –2.01494 –0.63881
75–84 years –1.66296 0.38976 –2.42690 –0.89903
≥ 85 years –1.76210 0.57567 –2.89041 –0.63379
Sex (females)
Males –0.93063 0.31252 –1.54317 –0.31810
Ethnicity (white)
Mixed 1.15990 0.62362 –0.06240 2.38219
Black –14.3174 442.1516 –880.934 852.2997
Asian 0.34506 0.53114 –0.69597 1.38610
Other 0.53783 1.03589 –1.49251 2.56817
LLTI (no LTTI)
LLTI 1.87951 0.19223 1.50273 2.25628
Tenure (owner–occupier)
Social rent 0.50141 0.19307 0.12299 0.87982
Private rent or other tenure 0.24671 0.27844 –0.29905 0.79246
LSOA deprivation quintile (least deprived quintile)
Second LSOA deprivation quintile –0.34497 0.26678 –0.86785 0.17791
Third LSOA deprivation quintile –0.18197 0.25312 –0.67809 0.31415
Fourth LSOA deprivation quintile 0.41574 0.22935 –0.03379 0.86528
Fifth LSOA deprivation quintile (=most deprived) 0.27925 0.23336 –0.17813 0.73663
Interaction effects
Male and social rent 0.54560 0.30283 –0.04795 1.13915
Male and private rent –0.69823 0.56199 –1.79973 0.40326
Mixed and LLTI 0.74811 0.92559 –1.06605 2.56226
Black and LLTI 14.84164 442.1518 –851.776 881.4591
Asian and LLTI –0.86689 0.72015 –2.27839 0.54460
Other and LLTI –16.9906 2008.587 –3953.82 3919.84
Male and LLTI 0.58621 0.33840 –0.07706 1.24947
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Individual CCGs (n = 211)
FIGURE 107 Depressive episode symptoms: individual estimates and their 95% CIs. (a) MSOAs; (b) LAs; (c) CCGs;
and (d) regions (GORs). (continued )
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FIGURE 107 Depressive episode symptoms: individual estimates and their 95% CIs. (a) MSOAs; (b) LAs; (c) CCGs;
and (d) regions (GORs).
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Symptoms of generalised anxiety disorder, mixed
anxiety/depressive disorder or a depressive episode in
past week (Adult Psychiatry Morbidity Survey, 2007)
FIGURE 108 Symptoms of generalised anxiety disorder, mixed anxiety/depressive disorder or a depressive episode:
LSOA-level map. Contains Ordnance Survey data © Crown copyright and database right 2012.
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Response variable definition, provenance and prediction
On the basis of responses to the CIS-R, here we capture whether respondents to the APMS have shown
symptoms of generalised anxiety disorder (ICD-10: F41.1488), mixed anxiety/depressive disorder (F41.2) or a
depressive episode (F32) during the previous week. This is not entirely independent of sociodemographic
or geographic variations in access to, or uptake of, care, as individuals may be free of symptoms because
they are currently being treated for anxiety/depression. We cannot produce an alternative measure
capturing underlying levels of anxiety/depression because information of treatment (medication or
otherwise) is not specific to these conditions.
The APMS data set (n= 7403) comprises adults ≥ 16 years (living in England) and surveyed only one
person per household; thus, the analytical data set contains all respondents for whom data are available
across all model response and predictor variables, namely CIS-R question responses, age band, sex,
ethnicity, LLTI, tenure and IMD quintile of LSOA of residence (n= 7326).
TABLE 130 Symptoms of generalised anxiety disorder, mixed anxiety/depressive disorder or a depressive episode:















16–24 231 62 21.2 16–24 236 30 11.3
25–34 488 126 20.5 25–34 349 58 14.3
35–49 875 241 21.6 35–49 742 129 14.8
50–64 823 190 18.8 50–64 695 102 12.8
65–74 484 78 13.9 65–74 427 34 7.4
75–84 386 49 11.3 75–84 268 18 6.3
≥ 85 123 10 7.5 ≥ 85 68 4 5.6




Model parameters are applied to microsimulated LSOA-level census data to produce estimates of the
number (and proportion) of people expected to have shown symptoms of generalised anxiety disorder
(ICD-10: F41.1488), mixed anxiety/depressive disorder (F41.2) or a depressive episode (F32) during the
previous week in each age–sex cohort (and overall) in each of the 32,844 English LSOAs. As discussed in
the report, bootstrapping is used to derive 95% CIs for the estimates. These LSOA-level prevalence rate
estimates (and 95% CIs) are aggregated into a number of higher geographies; namely MSOAs, LAs, CCGs
and regions (GORs). Proportionate attribution is used to restructure the prevalence rate estimates to align
with 2001 MSOAs, as well as GP practice populations as defined by the 2011 NHS ADS.
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Table 131 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured by
the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444 adults)
in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived quintile; and
6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule, variations in
prevalence rates reflect variations in the socioeconomic composition of populations in the different types of
LSOA rather than variations in deprivation per se.
TABLE 131 Symptoms of generalised anxiety disorder, mixed anxiety/depressive disorder or a depressive episode:
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TABLE 132 Parameter estimates: symptoms of generalised anxiety disorder, mixed anxiety/depressive disorder or a
depressive episode
Factor (reference group)
Model coefficients 95% CI
Estimate SE 2.5% CI 97.5%
(Intercept) –1.94153 0.17425 –2.28307 –1.60000
Age (16–24 years)
25–34 years 0.04014 0.14955 –0.25298 0.33326
35–49 years 0.02324 0.13932 –0.24982 0.29630
50–64 years –0.39311 0.14652 –0.68029 –0.10592
65–74 years –1.09920 0.16871 –1.42988 –0.76852
75–84 years –1.54379 0.1891 –1.91443 –1.17316
≥ 85 years –2.07120 0.31296 –2.68459 –1.45781
Sex (females)
Males –0.76422 0.11815 –0.99579 –0.53264
Ethnicity (white)
Mixed 0.35669 0.33243 –0.29487 1.00826
Black 0.06141 0.18551 –0.30218 0.42501
Asian –0.09125 0.20635 –0.49569 0.31319
Other 0.77852 0.36457 0.06396 1.49309
LLTI (no LTTI)
LLTI 1.02786 0.1962 0.64331 1.41242
Tenure (owner–occupier)
Social rent 0.49385 0.10645 0.28520 0.70250
Private rent or other tenure 0.24494 0.13891 –0.02732 0.51720
LSOA deprivation quintile (least deprived quintile)
Second LSOA deprivation quintile –0.02011 0.15681 –0.32745 0.28724
Third LSOA deprivation quintile 0.28607 0.15462 –0.01697 0.58912
Fourth LSOA deprivation quintile –0.03346 0.16348 –0.35389 0.28696
Fifth LSOA deprivation quintile (=most deprived) 0.17192 0.15929 –0.14028 0.48413
Interaction effects
Male and LLTI 0.36556 0.14929 0.07294 0.65817
LLTI and second LSOA deprivation quintile 0.52515 0.24613 0.04274 1.00757
LLTI and third LSOA deprivation quintile 0.21691 0.24157 –0.25657 0.69039
LLTI and fourth LSOA deprivation quintile 0.67404 0.24517 0.19352 1.15457
LLTI and fifth LSOA deprivation quintile 0.58203 0.23381 0.12376 1.04029
Male and social rent 0.33888 0.17000 0.00568 0.67208
Male and private rent or other tenure –0.06480 0.22831 –0.51229 0.38269
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Individual CCGs (n = 211)
FIGURE 110 Symptoms of generalised anxiety disorder, mixed anxiety/depressive disorder or a depressive episode:
individual estimates and their 95% CIs. (a) MSOAs; (b) LAs; (c) CCGs; and (d) regions (GORs). GAD, generalised
anxiety disorder; MADD, mixed anxiety/depressive disorder. (continued )
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FIGURE 110 Symptoms of generalised anxiety disorder, mixed anxiety/depressive disorder or a depressive episode:
individual estimates and their 95% CIs. (a) MSOAs; (b) LAs; (c) CCGs; and (d) regions (GORs). GAD, generalised
anxiety disorder; MADD, mixed anxiety/depressive disorder.
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Symptoms of a neurotic disorder in past week
(Adult Psychiatry Morbidity Survey, 2007)
FIGURE 111 Symptoms of a neurotic disorder: LSOA-level map. Contains Ordnance Survey data © Crown copyright
and database right 2012.
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Response variable definition, provenance and prediction
On the basis of responses to the CIS-R, here we capture whether respondents to the APMS have shown
symptoms of generalised anxiety disorder (ICD-10: F41.1488), mixed anxiety/depressive disorder (F41.2), a
depressive episode (F32) during the previous week, or any other specified neurotic disorder (namely any
phobia, an obsessive compulsive disorder or a panic disorder). This constitutes a marker for any CMHD.
This is not entirely independent of sociodemographic or geographic variations in access to, or uptake of,
care, as individuals may be free of symptoms because they are currently being treated for a CMHD. It may
be possible to produce an alternative measure capturing underlying levels of CMHDs in that the vast
majority of treatment (medication or otherwise) will be for CMHDs rather than, for instance, psychotic
disorders such as schizophrenia. This marker is, however, based on symptoms only and does not include
reference to treatment for a mental health disorder.
The APMS data set (n= 7403) comprises adults aged ≥ 16 years (living in England) and surveyed only one
person per household; thus, the analytical data set contains all respondents for whom data is available
across all model response and predictor variables, namely CIS-R question responses, age band, sex,
ethnicity, LLTI, tenure and IMD quintile of LSOA of residence (n= 7326).















16–24 221 72 24.6 16–24 230 36 13.5
25–34 469 145 23.6 25–34 343 64 15.7
35–49 848 268 24.0 35–49 733 138 15.8
50–64 807 206 20.3 50–64 688 109 13.7
65–74 477 85 15.1 65–74 424 37 8.0
75–84 383 52 12.0 75–84 268 18 6.3
≥ 85 120 13 9.8 ≥ 85 67 5 6.9




Model parameters are applied to microsimulated LSOA-level census data to produce estimates of the
number (and proportion) of people expected to have shown symptoms of a CMHD during the previous
week in each age–sex cohort (and overall) in each of the 32,844 English LSOAs. As discussed in the report,
bootstrapping is used to derive 95% CIs for the estimates. These LSOA-level prevalence rate estimates (and
95% CIs) are aggregated into a number of higher geographies, namely MSOAs, LAs, CCGs and regions
(GORs). Proportionate attribution is used to restructure the prevalence rate estimates to align with 2001
MSOAs, as well as GP practice populations as defined by the 2011 NHS ADS.
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Table 134 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured by
the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444 adults)
in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived quintile; and
6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule, variations in
prevalence rates reflect variations in the socioeconomic composition of populations in the different types of
LSOA rather than variations in deprivation per se.
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TABLE 135 Parameter estimates: symptoms of a neurotic disorder
Factor (reference group)
Model coefficients 95% CI
Estimate SE 2.5% CI 97.5%
(Intercept) –1.45269 0.20596 –1.85637 –1.04901
Age (16–24 years)
25–34 years –0.48952 0.21306 –0.90713 –0.07192
35–49 years –0.47358 0.18982 –0.84564 –0.10153
50–64 years –0.86062 0.19375 –1.24037 –0.48088
65–74 years –1.56366 0.21936 –1.99360 –1.13371
75–84 years –1.87658 0.23894 –2.34490 –1.40825
≥ 85 years –2.03222 0.35047 –2.71914 –1.34531
Sex (females)
Males –0.76062 0.11551 –0.98703 –0.53421
Ethnicity (white)
Mixed 0.34638 0.32621 –0.29299 0.98575
Black 0.09660 0.17929 –0.25481 0.44800
Asian –0.19993 0.20544 –0.60259 0.20273
Other 0.63691 0.36758 –0.08355 1.35737
LLTI (no LTTI)
LLTI 1.21024 0.18935 0.83911 1.58137
Tenure (owner–occupier)
Social rent 0.03461 0.27482 –0.50405 0.57326
Private rent or other tenure –0.30152 0.29663 –0.88291 0.27987
LSOA deprivation quintile (least deprived quintile)
Second LSOA deprivation quintile –0.00278 0.15267 –0.30200 0.29645
Third LSOA deprivation quintile 0.31646 0.15053 0.02143 0.61150
Fourth LSOA deprivation quintile –0.03221 0.15931 –0.34447 0.28004
Fifth LSOA deprivation quintile (=most deprived) 0.13829 0.15643 –0.16831 0.44489
continued
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TABLE 135 Parameter estimates: symptoms of a neurotic disorder (continued )
Factor (reference group)
Model coefficients 95% CI
Estimate SE 2.5% CI 97.5%
Interaction effects
Male and social rent 0.42067 0.16835 0.09070 0.75063
Male and private rent or other tenure –0.05181 0.22044 –0.48386 0.38025
LLTI and second LSOA deprivation quintile 0.50121 0.23743 0.03584 0.96657
LLTI and second LSOA deprivation quintile 0.26182 0.23279 –0.19445 0.71809
LLTI and second LSOA deprivation quintile 0.66811 0.23749 0.20263 1.13359
LLTI and second LSOA deprivation quintile 0.62057 0.22874 0.17224 1.06890
25–34 years and social rent 0.92242 0.33507 0.26568 1.57916
35–49 years and social rent 0.66148 0.30404 0.06556 1.25741
50–64 years and social rent 0.41681 0.31226 –0.19522 1.02885
65–74 years and social rent 0.40076 0.34758 –0.28049 1.08202
75–84 years and social rent –0.34928 0.40428 –1.14167 0.44311
≥ 85 years and social rent –0.74275 0.65824 –2.03290 0.54739
25–34 years and private rent or other tenure 0.78694 0.35550 0.09016 1.48371
35–49 years and private rent or other tenure 0.88701 0.34167 0.21734 1.55668
50–64 years and private rent or other tenure 0.58867 0.39786 –0.19114 1.36848
65–74 years and private rent or other tenure 0.15348 0.57895 –0.98127 1.28823
75–84 years and private rent or other tenure 0.52744 0.64311 –0.73306 1.78795
≥ 85 years and private rent or other tenure 0.22714 1.13786 –2.00307 2.45735
Male and LLTI 0.20378 0.14535 –0.08110 0.48867
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25 – 34 years and social rent (16 – 24 years/owner–occupier)
35 – 49 years and social rent (16 – 24 years/owner–occupier)
50 – 64 years and social rent (16 – 24 years/owner–occupier)
65 – 74 years and social rent (16 – 24 years/owner–occupier)
75 – 84 years and social rent (16 – 24 years/owner–occupier)
> 85 years and social rent (16 – 24 years/owner–occupier)
25 – 34 years and private rent (16 – 24 years/owner–occupier)
35 – 49 years and private rent (16 – 24 years/owner–occupier)
50 – 64 years and private rent (16 – 24 years/owner–occupier)
65 – 74 years and private rent (16 – 24 years/owner–occupier)
75 – 84 years and private rent (16 – 24 years/owner–occupier)
> 85 years and private rent (16 – 24 years/owner–occupier)


















Second quintile (least deprived LSOA)
Third quintile (least deprived LSOA)
Fourth quintile (least deprived LSOA)
Fifth quintile (least deprived LSOA)
Male and social rent (female/owner–occupier)
Male and private rent (female/owner–occupier)
LLTI and second quintile (no LLTI/least deprived)
LLTI and third quintile (no LLTI/least deprived)
LLTI and fourth quintile (no LLTI/least deprived)
LLTI and fifth quintile (no LLTI/least deprived)
25 – 34 years (16 – 24 years)
35 – 49 years (16 – 24 years)
50 – 64 years (16 – 24 years)
65 – 74 years (16 – 24 years)
75 – 84 years (16 – 24 years)
> 85 years (16 – 24 years)
Parameter estimate and 95% CIs

























FIGURE 113 Symptoms of a neurotic disorder: individual estimates and their 95% CIs. (a) MSOAs; (b) LAs; (c) CCGs;
and (d) regions (GORs). (continued )
DOI: 10.3310/hsdr04140 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 14
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Asthana et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science


























































































FIGURE 113 Symptoms of a neurotic disorder: individual estimates and their 95% CIs. (a) MSOAs; (b) LAs; (c) CCGs;
and (d) regions (GORs).
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‘Possible’ psychiatric morbidity (12-item General Health
Questionnaire score of ≥ 4) (Health Survey for England, 2006
and 2008–10)
FIGURE 114 ‘Possible’ psychiatric morbidity (HSfE GHQ12 score of ≥ 4): LSOA-level map. Contains Ordnance Survey
data © Crown copyright and database right 2012.
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Response variable definition, provenance and prediction
Based on the GHQ12 incorporated within the HSfE in 2006 and 2008–10, here we capture whether
people score ≥ 4 using the standard 0–12 ‘caseness’ scoring approach. The GHQ12 is a screening device
for identifying minor psychiatric disorders in the general population. It assesses the respondent’s current
state and asks if that differs from their usual state. It is sensitive to short-term psychiatric disorders but not
long-standing attributes of the respondent. In the literature a score of ≥ 4 is usually taken as being
indicative of ‘possible psychiatric morbidity’. This marker of mental health needs is not independent of
sociodemographic or geographic variations in access to, or uptake of, care as individuals may score < 4
because they are currently being treated for a mental health issue. (See below for an alternative marker
below which includes people currently being treated with medication for anxiety/depression.)
The HSfE at this time includes multiple household respondents of all ages. The analytical data set is drawn
from a subset of respondents aged ≥ 16 years for whom data are available across all model response
and predictor variables, namely whether or not they completed the GHQ12 questionnaire, along with
information on age band, sex, ethnicity, general health status, LLTI, tenure and the IMD quintile of the
LSOA of residence (n= 38,935). A single randomly selected adult is then drawn from each household,
resulting in an analytical data set of 23,390 adults aged ≥ 16 years.
















16–24 860 168 16.3 16–24 634 78 11.0
25–34 1644 326 16.5 25–34 1082 171 13.6
35–49 2944 586 16.6 35–49 2130 359 14.4
50–64 2577 516 16.7 50–64 2108 377 15.2
65–74 1443 229 13.7 65–74 1235 142 10.3
75–84 1087 192 15.0 75–84 720 103 12.5
≥ 85 385 78 16.8 ≥ 85 172 44 20.4




Model parameters are applied to microsimulated LSOA-level census data to produce estimates of the
number (and proportion) of people with ‘possible psychiatric morbidity (i.e. who would score ≥ 4 on the
GHQ12) in each age–sex cohort (and overall) in each of the 32,844 English LSOAs. As discussed in the
report, bootstrapping is used to derive 95% CIs for the estimates. These LSOA-level prevalence rate
estimates (and 95% CIs) are aggregated into a number of higher geographies; namely MSOAs, LAs, CCGs
and regions (GORs). Proportionate attribution is used to restructure the prevalence rate estimates to align
with 2001 MSOAs, as well as GP practice populations as defined by the 2011 NHS ADS.
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Table 137 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured by
the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444 adults)
in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived quintile; and
6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule, variations in
prevalence rates reflect variations in the socioeconomic composition of populations in the different types of
LSOA rather than variations in deprivation per se.
TABLE 137 ‘Possible’ psychiatric morbidity (HSfE GHQ12 score of ≥ 4): cohort-specific and overall prevalence rates
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TABLE 138 Parameter estimates: ‘possible’ psychiatric morbidity (HSfE GHQ12 score of ≥ 4)
Factor (reference group)
Model coefficients 95% CI
Estimate SE 2.5% CI 97.50%
(Intercept) –2.48556 0.12767 –2.73579 –2.23534
Age (16–24 years)
25–34 years –0.11176 0.13737 –0.38101 0.15749
35–49 years –0.11463 0.12267 –0.35506 0.12581
50–64 years –0.41196 0.12389 –0.65479 –0.16914
65–74 years –0.9332 0.13628 –1.2003 –0.6661
75–84 years –0.83596 0.14175 –1.11378 –0.55814
≥ 85 years –0.46094 0.17559 –0.80509 –0.11679
Sex (females)
Males –0.2689 0.05297 –0.37272 –0.16509
Ethnicity (white)
Mixed 0.39098 0.18128 0.03566 0.74629
Black 0.05355 0.09759 –0.13772 0.24482
Asian –0.08612 0.13295 –0.3467 0.17447
Other –0.019 0.2893 –0.58603 0.54802
General health status (very good health)
Good health 0.50141 0.06017 0.38348 0.61934
Fair health 1.32364 0.06823 1.18991 1.45737
Bad health 2.31198 0.0883 2.13891 2.48505
Very bad health 2.9897 0.12999 2.73492 3.24448
LLTI (no LTTI)
LLTI 0.70989 0.05161 0.60873 0.81105
Tenure (owner–occupier)
Social rent 0.0981 0.18045 –0.2556 0.45179
Private rent or other tenure 0.16079 0.17637 –0.18489 0.50648
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TABLE 138 Parameter estimates: ‘possible’ psychiatric morbidity (HSfE GHQ12 score of ≥ 4) (continued )
Factor (reference group)
Model coefficients 95% CI
Estimate SE 2.5% CI 97.50%
LSOA deprivation quintile (least deprived quintile)
Second LSOA deprivation quintile –0.03605 0.06807 –0.16946 0.09737
Third LSOA deprivation quintile 0.03732 0.06698 –0.09396 0.16859
Fourth LSOA deprivation quintile 0.02369 0.06754 –0.10869 0.15607
Fifth LSOA deprivation quintile (=most deprived) 0.1786 0.06963 0.04213 0.31507
Interaction effects
25–34 years and social rent 0.28617 0.21877 –0.14262 0.71496
35–49 years and social rent 0.14432 0.20102 –0.24968 0.53832
50–64 years and social rent –0.05315 0.20389 –0.45277 0.34648
65–74 years and social rent –0.11082 0.22615 –0.55407 0.33243
75–84 years and social rent –0.37465 0.23569 –0.8366 0.0873
≥ 85 years and social rent –0.58592 0.29418 –1.16251 –0.00932
25–34 years and private rent or other tenure 0.27209 0.21027 –0.14004 0.68423
35–49 years and private rent or other tenure 0.19335 0.20442 –0.20731 0.59401
50–64 years and private rent or other tenure 0.23916 0.23128 –0.21414 0.69246
65–74 years and private rent or other tenure 0.36603 0.31734 –0.25595 0.98802
75–84 years and private rent or other tenure –0.84007 0.41381 –1.65114 –0.02899
≥ 85 years and private rent or other tenure –1.42118 0.79512 –2.97961 0.13725
Male and social rent 0.21163 0.1035 0.00877 0.4145
Male and private rent or other tenure 0.03568 0.12274 –0.20489 0.27626
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Good health (very good health)
Fair health (very good health)
Bad health (very good health)

















25 – 34 years (16 – 24 years)
35 – 49 years (16 – 24 years)
50 – 64 years (16 – 24 years)
65 – 74 years (16 – 24 years)
75 – 84 years (16 – 24 years)
> 85 years (16 – 24 years)
Social rent (owner–occupier)
Private rent (owner–occupier)
Second quintile (least deprived LSOA)
Third quintile (least deprived LSOA)
Fourth quintile (least deprived LSOA)
Fifth quintile (least deprived LSOA)
25 – 34 years and social rent (16 – 24 years/owner–occupier)
35 – 49 years and social rent (16 – 24 years/owner–occupier)
50 – 64 years and social rent (16 – 24 years/owner–occupier)
65 – 74 years and social rent (16 – 24 years/owner–occupier)
75 – 84 years and social rent (16 – 24 years/owner–occupier)
> 85 years and social rent (16 – 24 years/owner–occupier)
25 – 34 years and private rent (16 – 24 years/owner–occupier)
35 – 49 years and private rent (16 – 24 years/owner–occupier)
50 – 64 years and private rent (16 – 24 years/owner–occupier)
65 – 74 years and private rent (16 – 24 years/owner–occupier)
75 – 84 years and private rent (16 – 24 years/owner–occupier)
> 85 years and private rent (16 – 24 years/owner–occupier)
Male and social rent (female/owner–occupier)
Male and private rent (female/owner–occupier)



























FIGURE 116 ‘Possible’ psychiatric morbidity (HSfE GHQ12 score of ≥ 4): individual estimates and their 95% CIs.
(a) MSOAs; (b) LAs; (c) CCGs; and (d) regions (GORs). (continued )
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FIGURE 116 ‘Possible’ psychiatric morbidity (HSfE GHQ12 score of ≥ 4): individual estimates and their 95% CIs.
(a) MSOAs; (b) LAs; (c) CCGs; and (d) regions (GORs).
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‘Probable’ psychiatric morbidity (12-item General Health
Questionnaire score of ≥ 6) (Health Survey for England, 2006
and 2008–10)
FIGURE 117 ‘Probable’ psychiatric morbidity (HSfE GHQ12 of ≥ 6): LSOA-level map. Contains Ordnance Survey data
© Crown copyright and database right 2012.
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Response variable definition, provenance and prediction
Based on the GHQ12 incorporated within the HSfE in 2006 and 2008–10, here we capture whether
people score 6 or more using the standard 0–12 ‘caseness’ scoring approach. The GHQ12 is a screening
device for identifying minor psychiatric disorders in the general population. It assesses the respondent’s
current state and asks if that differs from their usual state. It is sensitive to short-term psychiatric disorders
but not long-standing attributes of the respondent. In the literature a score of ≥ 4 is usually taken as being
indicative of ‘possible psychiatric morbidity’, but occasionally a ≥ 6 threshold is used. For convenience
(and without clinical justification) we describe this as a marker of ‘probable psychiatric morbidity’ – to
distinguish this marker from those using the standard ≥ 4 threshold (‘possible psychiatric morbidity’) and
the higher ≥ 8 threshold (‘psychiatric morbidity’). This is not independent of sociodemographic or
geographic variations in access to, or uptake of, care as individuals may score below 6 because they are
currently being treated for a mental health issue. (See below for an alternative marker below which
includes people currently being treated with medication for anxiety/depression.)
The HSfE at this time includes multiple household respondents of all ages. The analytical data set is drawn
from a subset of respondents aged ≥ 16 years for whom data are available across all model response and
predictor variables, namely whether or not they completed the GHQ12 questionnaire, along with
information on age band, sex, ethnicity, general health status, LLTI, tenure and the IMD quintile of the
LSOA of residence (n= 38,935). A single randomly selected adult is then drawn from each household,
resulting in an analytical data set of 23,390 adults aged ≥ 16 years.
















16–24 930 98 9.5 16–24 678 34 4.8
25–34 1761 209 10.6 25–34 1157 96 7.7
35–49 3147 383 10.8 35–49 2242 247 9.9
50–64 2749 344 11.1 50–64 2224 261 10.5
65–74 1546 126 7.5 65–74 1284 93 6.8
75–84 1171 108 8.4 75–84 760 63 7.7
≥ 85 419 44 9.5 ≥ 85 192 24 11.1




Model parameters are applied to microsimulated LSOA-level census data to produce estimates of the
number (and proportion) of people with ‘probable’ psychiatric morbidity (i.e. who would score ≥ 6 on
the GHQ12) in each age–sex cohort (and overall) in each of the 32,844 English LSOAs. As discussed in the
report, bootstrapping is used to derive 95% CIs for the estimates. These LSOA-level prevalence rate
estimates (and 95% CIs) are aggregated into a number of higher geographies, namely MSOAs, LAs, CCGs
and regions (GORs). Proportionate attribution is used to restructure the prevalence rate estimates to align
with 2001 MSOAs, as well as GP practice populations as defined by the 2011 NHS ADS.
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Table 140 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured by
the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444 adults)
in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived quintile; and
6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule, variations in
prevalence rates reflect variations in the socioeconomic composition of populations in the different types of
LSOA rather than variations in deprivation per se.
TABLE 140 ‘Probable’ psychiatric morbidity (HSfE GHQ12 score of ≥ 6): cohort-specific and overall prevalence rates
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TABLE 141 Parameter estimates: ‘probable’ psychiatric morbidity (HSfE GHQ12 score of ≥ 6)
Factor (reference group)
Model coefficients 95% CI
Estimate SE 2.5% CI 97.50%
(Intercept) –3.49429 0.13239 –3.75377 –3.23481
Age (16–24 years)
25–34 years 0.17090 0.11390 –0.05234 0.39414
35–49 years 0.17401 0.10708 –0.03587 0.38390
50–64 years –0.19492 0.11144 –0.41335 0.02351
65–74 years –0.87139 0.12727 –1.12084 –0.62194
75–84 years –0.9296 0.13381 –1.19187 –0.66733
≥ 85 years –0.73051 0.17078 –1.06524 –0.39578
Sex (females)
Males –0.27103 0.07338 –0.41484 –0.12721
Ethnicity (white)
Mixed 0.53173 0.20740 0.12523 0.93823
Black 0.20294 0.11223 –0.01703 0.42291
Asian –0.16587 0.16641 –0.49204 0.16029
Other –0.30466 0.38290 –1.05514 0.44581
General health status (very good health)
Good health 0.63850 0.08183 0.47810 0.79889
Fair health 1.53768 0.08919 1.36287 1.71249
Bad health 2.53288 0.10643 2.32427 2.74149
Very bad health 3.04745 0.13903 2.77495 3.31994
LLTI (no LTTI)
LLTI 0.69784 0.08476 0.53171 0.86398
Tenure (owner–occupier)
Social rent 0.15674 0.10064 –0.04050 0.35399
Private rent or other tenure 0.40977 0.09508 0.22341 0.59614
LSOA deprivation quintile (least deprived quintile)
Second LSOA deprivation quintile 0.04229 0.08512 –0.12455 0.20914
Third LSOA deprivation quintile 0.07666 0.08364 –0.08727 0.24059
Fourth LSOA deprivation quintile 0.07879 0.08342 –0.08472 0.24230
Fifth LSOA deprivation quintile (=most deprived) 0.23214 0.08501 0.06552 0.39876
Interaction effects
LLTI and social rent 0.03595 0.12203 –0.20323 0.27513
LLTI and private rent or other tenure –0.38211 0.15294 –0.68186 –0.08235
Male and LLTI 0.18210 0.10155 –0.01694 0.38113
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Individual CCGs (n = 211)
FIGURE 119 ‘Probable’ psychiatric morbidity (HSfE GHQ12 score of ≥ 6): individual estimates and their 95% CIs.
(a) MSOAs; (b) LAs; (c) CCGs; and (d) regions (GORs). (continued )
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FIGURE 119 ‘Probable’ psychiatric morbidity (HSfE GHQ12 score of ≥ 6): individual estimates and their 95% CIs.
(a) MSOAs; (b) LAs; (c) CCGs; and (d) regions (GORs).
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Psychiatric morbidity (12-item General Health Questionnaire
score of ≥ 8) (Health Survey for England, 2006 and 2008–10)
FIGURE 120 Psychiatric morbidity (HSfE GHQ12 score of ≥ 8): LSOA-level map. Contains Ordnance Survey data ©
Crown copyright and database right 2012.
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Response variable definition, provenance and prediction
Based on the GHQ12 incorporated within the HSfE in 2006 and 2008–10, here we capture whether or not
people score ≥ 8 using the standard 0–12 ‘caseness’ scoring approach. The GHQ12 is a screening device
for identifying minor psychiatric disorders in the general population. It assesses the respondent’s current
state and asks if that differs from their usual state. It is sensitive to short-term psychiatric disorders but not
long-standing attributes of the respondent. In the literature, a score of ≥ 4 is usually taken as being
indicative of ‘possible psychiatric morbidity’, but occasionally ≥ 6 or ≥ 8 thresholds are used. For
convenience (and without clinical justification) we describe a score of ≥ 8 as being indicative of ‘psychiatric
morbidity’ – to distinguish it from the standard ≥ 4 threshold (‘possible psychiatric morbidity’) and the ≥ 6
threshold (‘probable psychiatric morbidity’). This is not independent of sociodemographic or geographic
variations in access to, or uptake of, care, as individuals may score < 8 because they are currently being
treated for a mental health issue. (See below for an alternative marker below which includes people
currently being treated with medication for anxiety/depression.)
The HSfE at this time includes multiple household respondents of all ages. The analytical data set is drawn
from a subset of respondents aged ≥ 16 years for whom data are available across all model response
and predictor variables, namely whether or not they completed the GHQ12 questionnaire, along with
information on age band, sex, ethnicity, general health status, LLTI, tenure and the IMD quintile of the
LSOA of residence (n= 38,935). A single randomly selected adult is then drawn from each household,
resulting in an analytical data set of 23,390 adults aged ≥ 16 years.















16–24 979 49 4.8 16–24 698 14 2.0
25–34 1865 105 5.3 25–34 1198 55 4.4
35–49 3278 252 7.1 35–49 2325 164 6.6
50–64 2875 218 7.0 50–64 2311 174 7.0
65–74 1602 70 4.2 65–74 1323 54 3.9
75–84 1212 67 5.2 75–84 780 43 5.2
≥ 85 444 19 4.1 ≥ 85 205 11 5.1




Model parameters are applied to microsimulated LSOA-level census data to produce estimates of the
number (and proportion) of people with psychiatric morbidity (i.e. who would score ≥ 8 on the GHQ12)
in each age–sex cohort (and overall) in each of the 32,844 English LSOAs. As discussed in the report,
bootstrapping is used to derive 95% CIs for the estimates. These LSOA-level prevalence rate estimates
(and 95% CIs) are aggregated into a number of higher geographies, namely MSOAs, LAs, CCGs and
regions (GORs). Proportionate attribution is used to restructure the prevalence rate estimates to align with
2001 MSOAs, as well as GP practice populations as defined by the 2011 NHS ADS.
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Table 143 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured by
the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444 adults)
in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived quintile; and
6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule, variations in
prevalence rates reflect variations in the socioeconomic composition of populations in the different types of
LSOA rather than variations in deprivation per se.
TABLE 143 Psychiatric morbidity (HSfE GHQ12 score of ≥ 8): cohort-specific and overall prevalence rates by IMD
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TABLE 144 Parameter estimates: psychiatric morbidity (HSfE GHQ12 score of ≥ 8)
Factor (reference group)
Model coefficients 95% CI
Estimate SE 2.5% CI 97.50%
(Intercept) –4.68258 0.18342 –5.04209 –4.32307
Age (16–24 years)
25–34 years 0.21527 0.15801 –0.09443 0.52496
35–49 years 0.45692 0.14593 0.17089 0.74295
50–64 years 0.02431 0.15113 –0.27190 0.32052
65–74 years –0.76521 0.17156 –1.10147 –0.42895
75–84 years –0.68071 0.17569 –1.02507 –0.33636
≥ 85 years –0.91962 0.24050 –1.39100 –0.44824
Sex (females)
Males –0.11694 0.06318 –0.24077 0.00688
Ethnicity (white)
Mixed 0.24025 0.28141 –0.31132 0.79182
Black 0.36136 0.13383 0.09906 0.62365
Asian –0.10964 0.20667 –0.51472 0.29545
Other –0.00655 0.44022 –0.86939 0.85629
General health status (very good health)
Good health 0.82891 0.11949 0.59471 1.06311
Fair health 1.77662 0.12557 1.53050 2.02274
Bad health 2.84287 0.14081 2.56688 3.11885
Very bad health 3.34685 0.16826 3.01706 3.67664
LLTI (no LTTI)
LLTI 0.77360 0.07991 0.61698 0.93022
Tenure (owner–occupier)
Social rent 0.22477 0.07876 0.07040 0.37913
Private rent or other tenure 0.37511 0.09576 0.18742 0.56280
LSOA deprivation quintile (least deprived quintile)
Second LSOA deprivation quintile 0.11868 0.11163 –0.10011 0.33746
Third LSOA deprivation quintile 0.19225 0.10839 –0.02020 0.40470
Fourth LSOA deprivation quintile 0.18515 0.10758 –0.02571 0.39601
Fifth LSOA deprivation quintile (=most deprived) 0.28001 0.10922 0.06594 0.49408
No interaction effects
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FIGURE 122 Psychiatric morbidity (HSfE GHQ12 score of ≥ 8): individual estimates and their 95% CIs. (a) MSOAs;
(b) LAs; (c) CCGs; and (d) regions (GORs).
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‘Possible’ psychiatric morbidity (12-item General Health
Questionnaire score of ≥ 4) or currently prescribed
depression/anxiety drugs (Health Survey for England, 2006 and 2008–10)
FIGURE 123 ‘Possible’ psychiatric morbidity (GHQ12 score of ≥ 4) or depression/anxiety drugs: LSOA-level map.
Contains Ordnance Survey data © Crown copyright and database right 2012.
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Response variable definition, provenance and prediction
Derived from the HSfE GHQ12 questionnaire score and questions about what medicines the respondent
is currently being prescribed, this marker captures respondents with a GHQ12 score of ≥ 4 using the
standard 0–12 ‘caseness’ scoring approach and/or who are currently being prescribed drugs for depression
and/or anxiety (BNF 4.1.1–4.1.3 or 4.3.1–4.3.4487). In the literature, a score of ≥ 4 is usually taken as being
indicative of ‘possible psychiatric morbidity’. We have no information regarding other forms of treatment
for mental health issues. This recognises the fact that individuals may return a GHQ12 score of < 4
because they are being receiving medication for anxiety/depression and thus aims to capture underlying
levels of ‘possible psychiatric morbidity’. This marker is affected by the fact that (a) other types of
medication, and other forms of treatment, are not captured, and (b) any sociodemographic and/or
geographic variations in access to, or uptake of, prescribing will affect rates of prescribing and thus
this statistic.
The HSfE at this time includes multiple household respondents of all ages. The analytical data set is drawn
from a subset of respondents aged ≥ 16 years for whom data are available across all model response and
predictor variables, namely whether or not they completed the GHQ12 questionnaire, whether or not they
completed question on medication currently being prescribed, along with information on age band, sex,
ethnicity, general health status, LLTI, tenure and the IMD quintile of the LSOA of residence (n= 28,766).
A single randomly selected adult is then drawn from each household, resulting in an analytical data set of
17,172 adults aged ≥ 16 years.
TABLE 145 ‘Possible’ psychiatric morbidity (HSfE GHQ12 score of ≥ 4) or depression/anxiety drugs: survey counts















16–24 577 143 19.9 16–24 442 45 9.2
25–34 1143 294 20.5 25–34 775 135 14.8
35–49 2137 631 22.8 35–49 1569 308 16.4
50–64 1925 623 24.5 50–64 1588 374 19.1
65–74 1017 307 23.2 65–74 908 153 14.4
75–84 712 225 24.0 75–84 558 114 17.0
≥ 85 219 82 27.2 ≥ 85 125 43 25.6




Model parameters are applied to microsimulated LSOA-level census data to produce estimates of the
number (and proportion) of people with treated or untreated ‘possible psychiatric morbidity (i.e. who
would score ≥ 4 on the GHQ12 or be currently prescribed drugs for depression and/or anxiety) in
each age–sex cohort (and overall) in each of the 32,844 English LSOAs. As discussed in the report,
bootstrapping is used to derive 95% CIs for the estimates. These LSOA-level prevalence rate estimates
(and 95% CIs) are aggregated into a number of higher geographies, namely MSOAs, LAs, CCGs and
regions (GORs). Proportionate attribution is used to restructure the prevalence rate estimates to align with
2001 MSOAs, as well as GP practice populations as defined by the 2011 NHS ADS.
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Table 146 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured by
the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444 adults)
in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived quintile; and
6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule, variations in
prevalence rates reflect variations in the socioeconomic composition of populations in the different types of
LSOA rather than variations in deprivation per se.
TABLE 146 ‘Possible’ psychiatric morbidity (HSfE GHQ12 score of ≥ 4) or depression/anxiety drugs: cohort-specific
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TABLE 147 Parameter estimates: ‘possible’ psychiatric morbidity (HSfE GHQ12 score of ≥ 4) or depression/
anxiety drugs
Factor (reference group)
Model coefficients 95% CI
Estimate SE 2.5% CI 97.50%
(Intercept) –2.32901 0.14924 –2.62152 –2.03649
Age (16–24 years)
25–34 years 0.04924 0.15971 –0.26379 0.36228
35–49 years 0.16438 0.14381 –0.11749 0.44626
50–64 years 0.03141 0.14562 –0.25401 0.31682
65–74 years –0.28554 0.16262 –0.60427 0.03319
75–84 years –0.00782 0.17474 –0.35030 0.33466
≥ 85 years 0.21762 0.25343 –0.27910 0.71433
Sex (females)
Males –0.47154 0.10822 –0.68365 –0.25943
Ethnicity (white)
Mixed –0.11832 0.36308 –0.82996 0.59331
Black –0.19977 0.16804 –0.52912 0.12959
Asian –0.19427 0.25430 –0.69271 0.30416
Other –0.72772 0.64304 –1.98808 0.53264
General health status (very good health)
Good health 0.68028 0.07233 0.53852 0.82204
Fair health 1.36094 0.08376 1.19678 1.52510
Bad health 2.35796 0.11790 2.12688 2.58904
Very bad health 2.64420 0.19926 2.25365 3.03476
LLTI (no LTTI)
LLTI 1.45229 0.22704 1.00730 1.89729
Tenure (owner–occupier)
Social rent 0.15835 0.21563 –0.26429 0.58099
Private rent or other tenure –0.08508 0.21658 –0.50957 0.33942
LSOA deprivation quintile (least deprived quintile)
Second LSOA deprivation quintile –0.09381 0.06676 –0.22466 0.03705
Third LSOA deprivation quintile –0.01193 0.06607 –0.14142 0.11756
Fourth LSOA deprivation quintile –0.08157 0.06824 –0.21531 0.05218
Fifth LSOA deprivation quintile (=most deprived) 0.02021 0.07179 –0.12049 0.16092
Interaction effects
25–34 years and social rent 0.20927 0.25620 –0.29288 0.71142
35–49 years and social rent 0.16585 0.23547 –0.29567 0.62737
50–64 years and social rent 0.03035 0.23741 –0.43498 0.49567
65–74 years and social rent –0.22324 0.25682 –0.72661 0.28014
75–84 years and social rent –0.56359 0.26348 –1.08000 –0.04718
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TABLE 147 Parameter estimates: ‘possible’ psychiatric morbidity (HSfE GHQ12 score of ≥ 4) or depression/
anxiety drugs (continued )
Factor (reference group)
Model coefficients 95% CI
Estimate SE 2.5% CI 97.50%
≥ 85 years and social rent –0.79115 0.33310 –1.44403 –0.13828
25–34 years and private rent or other tenure 0.53966 0.24958 0.05048 1.02884
35–49 years and private rent or other tenure 0.37052 0.24375 –0.10722 0.84826
50–64 years and private rent or other tenure 0.50474 0.26743 –0.01942 1.02891
65–74 years and private rent or other tenure 0.42258 0.34206 –0.24786 1.09301
75–84 years and private rent or other tenure –0.33595 0.38606 –1.09263 0.42074
≥ 85 years and private rent or other tenure –0.57861 0.65217 –1.85686 0.69964
25–34 years and LLTI –0.66694 0.26550 –1.18731 –0.14657
35–49 years and LLTI –0.61505 0.24347 –1.09225 –0.13785
50–64 years and LLTI –0.72764 0.24130 –1.20058 –0.25469
65–74 years and LLTI –0.71202 0.25528 –1.21236 –0.21168
75–84 years and LLTI –1.07710 0.26491 –1.59633 –0.55788
≥ 85 years and LLTI –0.87799 0.33306 –1.53080 –0.22519
Mixed and social rent –0.73038 0.58068 –1.86852 0.40776
Black and social rent –0.16382 0.29972 –0.75128 0.42364
Asian and social rent –0.50525 0.36274 –1.21623 0.20572
Other and social rent 0.91178 0.86800 –0.78951 2.61306
Mixed and private rent or other tenure 0.23844 0.53594 –0.81201 1.28888
Black and private rent or other tenure –0.47916 0.30583 –1.07858 0.12025
Asian and private rent or other tenure 0.95375 0.36011 0.24794 1.65956
Other and private rent or other tenure 1.88543 0.84468 0.22986 3.54100
Male and social rent 0.26229 0.11392 0.03901 0.48557
Male and private rent or other tenure –0.02100 0.13666 –0.28885 0.24685
Male and mixed 0.75805 0.46967 –0.16250 1.67860
Male and black 0.64727 0.22129 0.21355 1.08099
Male and Asian –0.27560 0.32960 –0.92161 0.37040
Male and other –0.62026 0.79087 –2.17036 0.92984
Male and good health –0.26949 0.12695 –0.51831 –0.02066
Male and fair health –0.00352 0.13236 –0.26294 0.25590
Male and bad health –0.20120 0.17105 –0.53647 0.13407
Male and very bad health 0.04755 0.28662 –0.51422 0.60933
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25 – 34 years and LLTI (16 – 24 years/no LLTI)
35 – 49 years and LLTI (16 – 24 years/no LLTI)
50 – 64 years and LLTI (16 – 24 years/no LLTI)
65 – 74 years and LLTI (16 – 24 years/no LLTI)
75 – 84 years and LLTI (16 – 24 years/no LLTI)
> 85 years and LLTI (16 – 24 years/no LLTI)
Mixed and social rent (white/owner–occupier)
Black and social rent (white/owner–occupier)
Asian and social rent (white/owner–occupier)
Other and social rent (white/owner–occupier)
Mixed and private rent (white/owner–occupier)
Black and private rent (white/owner–occupier)
Asian and private rent (white/owner–occupier)
Other and private rent (white/owner–occupier)
Male and mixed (female/white)
Male and black (female/white)
Male and Asian (female/white)
Male and other (female/white)
Male and good health (female/very good health)
Male and fair health (female/very good health)
Male and bad health (female/very good health)










Good health (very good health)
Fair health (very good health)
Bad health (very good health)







25 – 34 years (16 – 24 years)
35 – 49 years (16 – 24 years)
50 – 64 years (16 – 24 years)
65 – 74 years (16 – 24 years)
75 – 84 years (16 – 24 years)
> 85 years (16 – 24 years)
Social rent (owner–occupier)
Private rent (owner–occupier)
Second quintile (least deprived LSOA)
Third quintile (least deprived LSOA)
Fourth quintile (least deprived LSOA)
Fifth quintile (least deprived LSOA)
25 – 34 years and social rent (16 – 24 years/owner–occupier)
35 – 49 years and social rent (16 – 24 years/owner–occupier)
50 – 64 years and social rent (16 – 24 years/owner–occupier)
65 – 74 years and social rent (16 – 24 years/owner–occupier)
75 – 84 years and social rent (16 – 24 years/owner–occupier)
> 85 years and social rent (16 – 24 years/owner–occupier)
25 – 34 years and private rent (16 – 24 years/owner–occupier)
35 – 49 years and private rent (16 – 24 years/owner–occupier)
50 – 64 years and private rent (16 – 24 years/owner–occupier)
65 – 74 years and private rent (16 – 24 years/owner–occupier)
75 – 84 years and private rent (16 – 24 years/owner–occupier)
> 85 years and private rent (16 – 24 years/owner–occupier)
Male and social rent (female/owner–occupier)
Male and private rent (female/owner–occupier)
Parameter estimate and 95% CIs
FIGURE 124 Parameter plots: ‘possible’ psychiatric morbidity (HSfE GHQ12 score of ≥ 4) or depression/anxiety drugs.
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Individual CCGs (n = 211)
FIGURE 125 ‘Possible’ psychiatric morbidity (HSfE GHQ12 score of ≥ 4) or depression/anxiety drugs: individual
estimates and their 95% CIs. (a) MSOAs; (b) LAs; (c) CCGs; and (d) regions (GORs). (continued )
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FIGURE 125 ‘Possible’ psychiatric morbidity (HSfE GHQ12 score of ≥ 4) or depression/anxiety drugs: individual
estimates and their 95% CIs. (a) MSOAs; (b) LAs; (c) CCGs; and (d) regions (GORs).
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‘Probable’ psychiatric morbidity (12-item General Health
Questionnaire score of ≥ 6) or currently prescribed
depression/anxiety drugs (Health Survey for England, 2006
and 2008–10)
FIGURE 126 ‘Possible’ psychiatric morbidity (HSfE GHQ12 score of ≥ 6) or depression/anxiety drugs: LSOA-level map.
Contains Ordnance Survey data © Crown copyright and database right 2012.
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Response variable definition, provenance and prediction
Derived from the HSfE GHQ12 questionnaire score and questions about what medicines the respondent
is currently being prescribed, this marker captures respondents with a GHQ12 score of ≥ 6 using the
standard 0–12 ‘caseness’ scoring approach and/or who are currently being prescribed drugs for depression
and/or anxiety (BNF 4.1.1–4.1.3 or 4.3.1–4.3.4487). In the literature, a score of ≥ 4 is usually taken as being
indicative of ‘possible psychiatric morbidity’, but occasionally a ≥ 6 threshold is used. For convenience
(and without clinical justification) we describe this as a marker of ‘probable psychiatric morbidity’ – to
distinguish this marker from those using the standard ≥ 4 threshold (‘possible psychiatric morbidity’) and
the higher ≥ 8 threshold (‘psychiatric morbidity’). We have no information regarding other forms of
treatment for mental health issues. This marker recognises the fact that individuals may return a GHQ12
score of < 6 because they are being receiving medication for anxiety/depression and thus aims to capture
underlying levels of ‘probable psychiatric morbidity’. This marker is affected by (a) the fact that other types
of medication, and other forms of treatment, are not captured, and (b) any sociodemographic and/or
geographic variations in access to, or uptake of, prescribing.
The HSfE at this time includes multiple household respondents of all ages. The analytical data set is drawn
from a subset of respondents aged ≥ 16 years for whom data is available across all model response and
predictor variables, namely whether or not they completed the GHQ12 questionnaire, whether or not they
completed question on medication currently being prescribed, along with information on age band, sex,
ethnicity, general health status, LLTI, tenure and the IMD quintile of the LSOA of residence (n= 28,766).
A single randomly selected adult is then drawn from each household, resulting in an analytical data set of
17,172 adults aged ≥ 16 years.
TABLE 148 ‘Possible’ psychiatric morbidity (HSfE GHQ12 score of ≥ 6) or depression/anxiety drugs: survey counts















16–24 638 82 11.4 16–24 461 26 5.3
25–34 1224 213 14.8 25–34 822 88 9.7
35–49 2267 501 18.1 35–49 1660 217 11.6
50–64 2039 509 20.0 50–64 1670 292 14.9
65–74 1090 234 17.7 65–74 935 126 11.9
75–84 756 181 19.3 75–84 595 77 11.5
≥ 85 236 65 21.6 ≥ 85 140 28 16.7




Model parameters are applied to microsimulated LSOA-level census data to produce estimates of the
number (and proportion) of people with treated or untreated ‘probable psychiatric morbidity (i.e. who
would score ≥ 6 on the GHQ12 or be currently prescribed drugs for depression and/or anxiety) in
each age–sex cohort (and overall) in each of the 32,844 English LSOAs. As discussed in the report,
bootstrapping is used to derive 95% CIs for the estimates. These LSOA-level prevalence rate estimates
(and 95% CIs) are aggregated into a number of higher geographies, namely MSOAs, LAs, CCGs and
regions (GORs). Proportionate attribution is used to restructure the prevalence rate estimates to align with
2001 MSOAs, as well as GP practice populations as defined by the 2011 NHS ADS.
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Table 149 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured by
the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444 adults)
in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived quintile; and
6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule, variations in
prevalence rates reflect variations in the socioeconomic composition of populations in the different types of
LSOA rather than variations in deprivation per se.
TABLE 149 ‘Possible’ psychiatric morbidity (HSfE GHQ12 score of ≥ 6) or depression/anxiety drugs: cohort-specific
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TABLE 150 Parameter estimates: ‘possible’ psychiatric morbidity (HSfE GHQ12 score of ≥ 6) or depression/
anxiety drugs
Factor (reference group)
Model coefficients 95% CI
Estimate SE 2.5% CI 97.50%
(Intercept) –2.86204 0.17788 –3.21068 –2.51339
Age (16–24 years)
25–34 years 0.00094 0.19628 –0.38378 0.38566
35–49 years 0.29348 0.17498 –0.04948 0.63644
50–64 years 0.18754 0.17670 –0.15880 0.53387
65–74 years –0.04246 0.19359 –0.42189 0.33697
75–84 years 0.13642 0.20767 –0.27061 0.54345
≥ 85 years 0.47105 0.28579 –0.08909 1.03120
Sex (females)
Males –0.73582 0.07175 –0.87646 –0.59519
Ethnicity (white)
Mixed –0.14256 0.40955 –0.94527 0.66016
Black –0.29866 0.19293 –0.67679 0.07948
Asian –0.63512 0.32241 –1.26704 –0.00319
Other –0.31598 0.65049 –1.59094 0.95897
General health status (very good health)
Good health 0.69911 0.07229 0.55742 0.8408
Fair health 1.48802 0.08125 1.32876 1.64728
Bad health 2.39995 0.10217 2.19970 2.60020
Very bad health 2.65092 0.14959 2.35773 2.94411
LLTI (no LTTI)
LLTI 1.24982 0.25548 0.74908 1.75055
Tenure (owner–occupier)
Social rent –0.00890 0.26104 –0.52055 0.50274
Private rent or other tenure –0.45962 0.27826 –1.00502 0.08578
LSOA deprivation quintile (least deprived quintile)
Second LSOA deprivation quintile –0.04814 0.07478 –0.19470 0.09843
Third LSOA deprivation quintile 0.01863 0.07400 –0.12642 0.16367
Fourth LSOA deprivation quintile –0.08191 0.07649 –0.23182 0.06801
Fifth LSOA deprivation quintile (=most deprived) –0.00947 0.08021 –0.16669 0.14774
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TABLE 150 Parameter estimates: ‘possible’ psychiatric morbidity (HSfE GHQ12 score of ≥ 6) or depression/
anxiety drugs (continued )
Factor (reference group)
Model coefficients 95% CI
Estimate SE 2.5% CI 97.50%
Interaction effects
25–34 years and LLTI –0.44615 0.29456 –1.02348 0.13119
35–49 years and LLTI –0.45808 0.27083 –0.98890 0.07274
50–64 years and LLTI –0.54919 0.26908 –1.07659 –0.02180
65–74 years and LLTI –0.72293 0.28436 –1.28028 –0.16559
75–84 years and LLTI –1.06358 0.29561 –1.64297 –0.48419
≥ 85 years and LLTI –1.07771 0.36612 –1.79530 –0.36012
25–34 years and social rent 0.53575 0.30703 –0.06604 1.13754
35–49 years and social rent 0.42664 0.28148 –0.12507 0.97834
50–64 years and social rent 0.33200 0.28129 –0.21934 0.88333
65–74 years and social rent 0.07932 0.30143 –0.51147 0.67012
75–84 years and social rent –0.15384 0.30914 –0.75977 0.45208
≥ 85 years and social rent –0.42411 0.37953 –1.16800 0.31977
25–34 years and private rent or other tenure 1.10127 0.31784 0.47830 1.72424
35–49 years and private rent or other tenure 0.75179 0.30851 0.14710 1.35647
50–64 years and private rent or other tenure 0.79283 0.32917 0.14766 1.43800
65–74 years and private rent or other tenure 0.70331 0.40304 –0.08665 1.49327
75–84 years and private rent or other tenure 0.50429 0.42625 –0.33117 1.33975
≥ 85 years and private rent or other tenure –0.12219 0.73102 –1.55499 1.31062
Male and mixed 1.11218 0.50534 0.12171 2.10266
Male and black 0.75804 0.25173 0.26466 1.25142
Male and Asian –0.13211 0.41563 –0.94674 0.68252
Male and other –0.58103 1.23779 –3.00710 1.84504
Male and LLTI 0.22687 0.09893 0.03297 0.42078
Mixed and social rent –0.33906 0.60230 –1.51956 0.84145
Black and social rent 0.13731 0.32131 –0.49246 0.76707
Asian and social rent –0.47684 0.46055 –1.37951 0.42583
Other and social rent 0.21347 0.95791 –1.66404 2.09098
Mixed and private rent or other tenure –0.00332 0.60656 –1.19218 1.18553
Black and private rent or other tenure –0.70847 0.37687 –1.44713 0.03018
Asian and private rent or other tenure 1.05923 0.43807 0.20062 1.91785
Other and private rent or other tenure –0.99346 1.32161 –3.58381 1.59690
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Good health (very good health)
Fair health (very good health)
Bad health (very good health)







25 – 34 years (16 – 24 years)
35 – 49 years (16 – 24 years)
50 – 64 years (16 – 24 years)
65 – 74 years (16 – 24 years)
75 – 84 years (16 – 24 years)
> 85 years (16 – 24 years)
Social rent (owner – occupier)
Private rent (owner – occupier)
Second quintile (least deprived LSOA)
Third quintile (least deprived LSOA)
Fourth quintile (least deprived LSOA)
Fifth quintile (least deprived LSOA)
25 – 34 years and LLTI (16 – 24 years/no LLTI)
35 – 49 years and LLTI (16 – 24 years/no LLTI)
50 – 64 years and LLTI (16 – 24 years/no LLTI)
65 – 74 years and LLTI (16 – 24 years/no LLTI)
75 – 84 years and LLTI (16 – 24 years/no LLTI)
> 85 years and LLTI (16 – 24 years/no LLTI)
25 – 34 years and social rent (16 – 24 years/owner–occupier)
35 – 49 years and social rent (16 – 24 years/owner–occupier)
50 – 64 years and social rent (16 – 24 years/owner–occupier)
65 – 74 years and social rent (16 – 24 years/owner–occupier)
75 – 84 years and social rent (16 – 24 years/owner–occupier)
> 85 years and social rent (16 – 24 years/owner–occupier)
25 – 34 years and private rent (16 – 24 years/owner–occupier)
35 – 49 years and private rent (16 – 24 years/owner–occupier)
50 – 64 years and private rent (16 – 24 years/owner–occupier)
65 – 74 years and private rent (16 – 24 years/owner–occupier)
75 – 84 years and private rent (16 – 24 years/owner–occupier)
> 85 years and private rent (16 – 24 years/owner–occupier)
Male and mixed (female/white)
Mixed and social rent (white/owner–occupier)
Black and social rent (white/owner–occupier)
Asian and social rent (white/owner–occupier)
Other and social rent (white/owner–occupier)
Mixed and private rent (white/owner–occupier)
Black and private rent (white/owner–occupier)
Asian and private rent (white/owner–occupier)
Other and private rent (white/owner–occupier)
Male and black (female/white)
Male and Asian (female/white)
Male and other (female/white)
Male and LLTI (female/no LLTI)
Parameter estimate and 95% CIs
FIGURE 127 Parameter plots: ‘possible’ psychiatric morbidity (HSfE GHQ12 score of ≥ 6) or depression/anxiety drugs.
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Individual CCGs (n = 211)
FIGURE 128 ‘Possible’ psychiatric morbidity (HSfE GHQ12 score of ≥ 6) or depression/anxiety drugs: individual
estimates and their 95% CIs. (a) MSOAs; (b) LAs; (c) CCGs; and (d) regions (GORs). (continued )
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FIGURE 128 ‘Possible’ psychiatric morbidity (HSfE GHQ12 score of ≥ 6) or depression/anxiety drugs: individual
estimates and their 95% CIs. (a) MSOAs; (b) LAs; (c) CCGs; and (d) regions (GORs).
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Psychiatric morbidity (12-item General Health Questionnaire
score of ≥ 8) or currently prescribed depression/anxiety drugs
(Health Survey for England, 2006 and 2008–10)
FIGURE 129 Psychiatric morbidity (HSfE GHQ12 score of ≥ 8) or depression/anxiety drugs: LSOA-level map. Contains
Ordnance Survey data © Crown copyright and database right 2012.
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Response variable definition, provenance and prediction
Derived from the HSfE GHQ12 questionnaire score and questions about what medicines the respondent
is currently being prescribed, this marker captures respondents with a GHQ12 score of ≥ 8 using the
standard 0–12 ‘caseness’ scoring approach and/or who are currently being prescribed drugs for depression
and/or anxiety (BNF 4.1.1–4.1.3 or 4.3.1–4.3.4487). In the literature, a score of ≥ 4 is usually taken as
being indicative of ‘possible psychiatric morbidity’, but occasionally ≥ 6 or ≥ 8 thresholds are used. For
convenience (and without clinical justification) we describe this as a marker of ‘psychiatric morbidity’ – to
distinguish it from the standard ≥ 4 threshold (‘possible psychiatric morbidity’) and the ≥ 6 threshold
(‘probable psychiatric morbidity’). We have no information regarding other forms of treatment for mental
health issues. This marker recognises the fact that individuals may return a GHQ12 score of < 8 because
they are receiving medication for anxiety/depression and thus aims to capture underlying levels of
‘probable psychiatric morbidity’. This marker is affected by (a) the fact that other types of medication, and
other forms of treatment, are not captured, and (b) any sociodemographic and/or geographic variations in
access to, or uptake of, prescribing.
The HSfE at this time includes multiple household respondents of all ages. The analytical data set is drawn
from a subset of respondents aged ≥ 16 years for whom data are available across all model response and
predictor variables, namely whether or not they completed the GHQ12 questionnaire and whether or
not they completed question on medication currently being prescribed, along with information on age
band, sex, ethnicity, general health status, LLTI, tenure and the IMD quintile of the LSOA of residence
(n= 28,766). A single randomly selected adult is then drawn from each household, resulting in an
analytical data set of 17,172 adults aged ≥ 16 years.
















16–24 669 51 7.1 16–24 474 13 2.7
25–34 1271 166 11.6 25–34 849 61 6.7
35–49 2345 423 15.3 35–49 1708 169 9.0
50–64 2119 429 16.8 50–64 1731 231 11.8
65–74 1119 205 15.5 65–74 958 103 9.7
75–84 774 163 17.4 75–84 608 64 9.5
≥ 85 247 54 17.9 ≥ 85 147 21 12.5




Model parameters are applied to microsimulated LSOA-level census data to produce estimates of the
number (and proportion) of people with treated or untreated ‘psychiatric morbidity (i.e. who would score
≥ 8 on the GHQ12 or be currently prescribed drugs for depression and/or anxiety) in each age–sex cohort
(and overall) in each of the 32,844 English LSOAs. As discussed in the report, bootstrapping is used to
derive 95% CIs for the estimates. These LSOA-level prevalence rate estimates (and 95% CIs) are
aggregated into a number of higher geographies, namely MSOAs, LAs, CCGs and regions (GORs).
Proportionate attribution is used to restructure the prevalence rate estimates to align with 2001 MSOAs,
as well as GP practice populations as defined by the 2011 NHS ADS.
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Table 152 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured by
the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444 adults)
in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived quintile; and
6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule, variations in
prevalence rates reflect variations in the socioeconomic composition of populations in the different types of
LSOA rather than variations in deprivation per se.
TABLE 152 Psychiatric morbidity (HSfE GHQ12 score of ≥ 8) or depression/anxiety drugs: cohort-specific and overall
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TABLE 153 Parameter estimates: psychiatric morbidity (HSfE GHQ12 score of ≥ 8) or depression/anxiety drugs
Factor (reference group)
Model coefficients 95% CI
Estimate SE 2.5% CI 97.50%
(Intercept) –3.75825 0.24715 –4.24267 –3.27383
Age band (16–24 years)
25–34 years 0.52242 0.26545 0.00214 1.0427
35–49 years 0.89890 0.24401 0.42064 1.37716
50–64 years 0.74939 0.24577 0.26768 1.23111
65–74 years 0.67469 0.25854 0.16795 1.18144
75–84 years 0.89579 0.26927 0.36801 1.42356
≥ 85 years 1.26963 0.33889 0.60541 1.93384
Sex (females)
Males –0.84556 0.08237 –1.00701 –0.68411
Ethnicity (white)
Mixed –0.48883 0.36545 –1.20511 0.22744
Black –0.41011 0.19119 –0.78484 –0.03538
Asian –0.70688 0.24571 –1.18847 –0.22528
Other –0.36287 0.51384 –1.36998 0.64425
General health status (very good)
Good health 0.80239 0.08379 0.63816 0.96662
Fair health 1.55919 0.09245 1.37799 1.74039
Bad health 2.43467 0.11133 2.21646 2.65287
Very bad health 2.66917 0.15499 2.36539 2.97296
LLTI (no LLTI)
LLTI 1.47426 0.29551 0.89506 2.05347
Tenure (owner–occupier)
Social rent 0.34538 0.32371 –0.28909 0.97985
Private rent or other tenure –0.19559 0.35858 –0.89841 0.50724
LSOA deprivation quintile (least deprived quintile)
Second LSOA deprivation quintile –0.05647 0.08133 –0.21588 0.10294
Third LSOA deprivation quintile –0.00094 0.08048 –0.15868 0.1568
Fourth LSOA deprivation quintile –0.12888 0.08344 –0.29243 0.03467
Fifth LSOA deprivation quintile (=most deprived) –0.03808 0.08696 –0.20851 0.13236
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TABLE 153 Parameter estimates: psychiatric morbidity (HSfE GHQ12 score of ≥ 8) or depression/
anxiety drugs (continued )
Factor (reference group)
Model coefficients 95% CI
Estimate SE 2.5% CI 97.50%
Interaction effects
25–34 years and LLTI –0.58685 0.33512 –1.24370 0.06999
35–49 years and LLTI –0.67689 0.31041 –1.28530 –0.06848
50–64 years and LLTI –0.72838 0.30945 –1.33489 –0.12186
65–74 years and LLTI –1.03402 0.32371 –1.66849 –0.39955
75–84 years and LLTI –1.37504 0.33374 –2.02917 –0.72091
≥ 85 years and LLTI –1.49749 0.40696 –2.29515 –0.69984
25–34 years and social rent 0.20281 0.37171 –0.52573 0.93136
35–49 years and social rent 0.16526 0.34351 –0.50802 0.83853
50–64 years and social rent 0.01440 0.34258 –0.65706 0.68586
65–74 years and social rent –0.22258 0.36009 –0.92836 0.48319
75–84 years and social rent –0.49073 0.36753 –1.21109 0.22963
≥ 85 years and social rent –1.14008 0.45183 –2.02567 –0.25448
25–34 years and private rent or other tenure 0.72200 0.40094 –0.06384 1.50784
35–49 years and private rent or other tenure 0.42212 0.38883 –0.33998 1.18423
50–64 years and private rent or other tenure 0.63131 0.40416 –0.16085 1.42346
65–74 years and private rent or other tenure 0.37459 0.47398 –0.55442 1.30359
75–84 years and private rent or other tenure 0.32373 0.48834 –0.63341 1.28088
≥ 85 years and private rent or other tenure –0.17296 0.76420 –1.67078 1.32486
Male and LLTI 0.27662 0.10902 0.06294 0.49030
Male and mixed 1.21629 0.57584 0.08764 2.34495
Male and black 0.65021 0.27957 0.10225 1.19818
Male and Asian –0.33646 0.53650 –1.38800 0.71508
Male and other –0.23168 1.20640 –2.59622 2.13285
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25 – 34 years (16 – 24 years)
35 – 49 years (16 – 24 years)
50 – 64 years (16 – 24 years)
65 – 74 years (16 – 24 years)
75 – 84 years (16 – 24 years)
> 85 years (16 – 24 years)
Social rent (owner–occupier)
Private rent (owner–occupier)
Second quintile (least deprived LSOA)
Third quintile (least deprived LSOA)
Fourth quintile (least deprived LSOA)
Fifth quintile (least deprived LSOA)
25 – 34 years and LLTI (16 – 24 years/no LLTI)
35 – 49 years and LLTI (16 – 24 years/no LLTI)
50 – 64 years and LLTI (16 – 24 years/no LLTI)
65 – 74 years and LLTI (16 – 24 years/no LLTI)
75 – 84 years and LLTI (16 – 24 years/no LLTI)
> 85 years and LLTI (16 – 24 years/no LLTI)
25 – 34 years and social rent (16 – 24 years/owner–occupier)
35 – 49 years and social rent (16 – 24 years/owner–occupier)
50 – 64 years and social rent (16 – 24 years/owner–occupier)
65 – 74 years and social rent (16 – 24 years/owner–occupier)
75 – 84 years and social rent (16 – 24 years/owner–occupier)
> 85 years and social rent (16 – 24 years/owner–occupier)
25 – 34 years and private rent (16 – 24 years/owner–occupier)
35 – 49 years and private rent (16 – 24 years/owner–occupier)
50 – 64 years and private rent (16 – 24 years/owner–occupier)
65 – 74 years and private rent (16 – 24 years/owner–occupier)
75 – 84 years and private rent (16 – 24 years/owner–occupier)
> 85 years and private rent (16 – 24 years/owner–occupier)
Male and LLTI (female/no LLTI)
Male and mixed (female/white)
Male and black (female/white)
Male and Asian (female/white)
Male and other (female/white)
Parameter estimate and 95% CIs
FIGURE 130 Parameter plots: psychiatric morbidity (HSfE GHQ12 score of ≥ 8) or depression/anxiety drugs.
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FIGURE 131 Psychiatric morbidity (HSfE GHQ12 score of ≥ 8) or depression/anxiety drugs: individual estimates and
their 95% CIs. (a) MSOAs; (b) LAs; (c) CCGs; and (d) regions (GORs).
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‘Possible’ psychiatric morbidity (12-item General Health
Questionnaire score ≥ 4) (UK Household Longitudinal Survey,
wave 1, 2009–11)
FIGURE 132 ‘Possible’ psychiatric morbidity (UKHLS wave 1, GHQ12 score of ≥ 4): LSOA-level map. Contains
Ordnance Survey data © Crown copyright and database right 2012.
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Response variable definition, provenance and prediction
Based on the GHQ12 incorporated within the 2009–11 first wave of the UKHLS, here we capture whether
respondents score ≥ 4 using the standard 0–12 ‘caseness’ scoring approach. The GHQ12 is a screening
device for identifying minor psychiatric disorders in the general population. It assesses the respondent’s
current state and asks if that differs from their usual state. It is sensitive to short-term psychiatric disorders
but not long-standing attributes of the respondent. In the literature, a score of ≥ 4 is usually taken as
being indicative of ‘possible psychiatric morbidity’. This is not independent of sociodemographic or
geographic variations in access to, or uptake of, care as individuals may score < 4 because they are
currently being treated for a mental health issue. (See below for an alternative marker which includes
people currently being treated with medication for anxiety/depression.)
The first wave of the UKHLS data set (n= 50,994) runs from January 2009 to January 2011 and includes
multiple household respondents aged ≥ 16 years from across the UK. Here the analytical data set is
drawn from the subset of respondents living in England and for whom data are available across all model
response and predictor variables, namely that they completed the GHQ12 questionnaire, along with
information on age band, sex, ethnicity, LLTI, tenure and the IMD score of the LSOA of residence
(n= 32,903). A single randomly selected adult is then drawn from each household, resulting in an
analytical data set of 20,849 adults aged ≥ 16 years.
TABLE 154 ‘Possible’ psychiatric morbidity (UKHLS wave 1, GHQ12 score of ≥ 4): survey counts and rates for















16–24 626 208 24.9 16–24 469 89 15.9
25–34 1667 455 21.4 25–34 1103 247 18.3
35–49 3038 956 23.9 35–49 2098 492 19.0
50–64 2261 685 23.3 50–64 1921 382 16.6
65–74 1061 185 14.8 65–74 1083 129 10.6
75–84 613 118 16.1 75–84 536 99 15.6
≥ 85 152 45 22.8 ≥ 85 109 22 16.8




Model parameters are applied to microsimulated LSOA-level census data to produce estimates of the
number (and proportion) of people with ‘possible psychiatric morbidity (i.e. who would score ≥ 4 on
the GHQ12) in each age–sex cohort (and overall) in each of the 32,844 English LSOAs. As discussed in the
report, bootstrapping is used to derive 95% CIs for the estimates. These LSOA-level prevalence rate
estimates (and 95% CIs) are aggregated into a number of higher geographies, namely MSOAs, LAs, CCGs
and regions (GORs). Proportionate attribution is used to restructure the prevalence rate estimates to align
with 2001 MSOAs, as well as GP practice populations as defined by the 2011 NHS ADS.
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Table 155 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured
by the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444
adults) in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived
quintile; and 6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule,
variations in prevalence rates reflect variations in the socioeconomic composition of populations in the
different types of LSOA rather than variations in deprivation per se.
TABLE 155 ‘Possible’ psychiatric morbidity (UKHLS wave 1, GHQ12 score of ≥ 4): cohort-specific and overall
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TABLE 156 Parameter estimates: ‘possible’ psychiatric morbidity (UKHLS wave 1, GHQ12 score of ≥ 4)
Factor (reference group)
Model coefficients 95% CI
Estimate SE 2.5% CI 97.50%
(Intercept) –1.78638 0.08784 –1.95856 –1.61421
Age (16–24 years)
25–34 years 0.00019 0.08043 –0.15746 0.15784
35–49 years 0.07331 0.07693 –0.07748 0.22410
50–64 years –0.15686 0.08174 –0.31707 0.00335
65–74 years –0.81339 0.09785 –1.00517 –0.62161
75–84 years –0.71849 0.10806 –0.93029 –0.50670
≥ 85 years –0.48735 0.16123 –0.80336 –0.17135
Sex (females)
Males –0.39741 0.06783 –0.53035 –0.26447
Ethnicity (white)
Mixed 0.20351 0.12284 –0.03726 0.44428
Black 0.14654 0.06362 0.02185 0.27124
Asian –0.12776 0.07878 –0.28216 0.02664
Other 0.25149 0.12878 –0.00092 0.50389
LLTI (no LTTI)
LLTI 1.10975 0.06920 0.97413 1.24538
Tenure (owner–occupier)
Social rent 0.46941 0.04896 0.37344 0.56537
Private rent or other tenure 0.29205 0.05223 0.18969 0.39442
LSOA IMD deprivation score
IMD score 0.00357 0.00173 0.00019 0.00696
Interaction effects
Male (female) by LSOA IMD 0.00396 0.00224 –0.00043 0.00836
LLTI (no LLTI) by LSOA IMD score 0.00392 0.00225 –0.00048 0.00832
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Individual CCGs (n = 211)
FIGURE 134 ‘Possible’ psychiatric morbidity (UKHLS wave 1, GHQ12 score of ≥ 4): individual estimates and their
95% CIs. (a) MSOAs; (b) LAs; (c) CCGs; and (d) regions (GORs). (continued )
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FIGURE 134 ‘Possible’ psychiatric morbidity (UKHLS wave 1, GHQ12 score of ≥ 4): individual estimates and their
95% CIs. (a) MSOAs; (b) LAs; (c) CCGs; and (d) regions (GORs).
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‘Probable’ psychiatric morbidity (12-item General Health
Questionnaire score ≥ 6) (UK Household Longitudinal Survey,
wave 1, 2009–11)
FIGURE 135 ‘Possible’ psychiatric morbidity (UKHLS wave 1, GHQ12 score of ≥ 6): LSOA-level map. Contains
Ordnance Survey data © Crown copyright and database right 2012.
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Response variable definition, provenance and prediction
Based on the GHQ12 implemented as part of the 2009–11 first wave of the UKHLS, this captures whether
people score ≥ 6 using the standard 0–12 ‘caseness’ scoring approach. The GHQ12 is a screening device
for identifying minor psychiatric disorders in the general population. It assesses the respondent’s current
state and asks if that differs from their usual state. It is sensitive to short-term psychiatric disorders but not
long-standing attributes of the respondent. In the literature, a score of ≥ 4 is usually taken as being
indicative of ‘possible psychiatric morbidity’, but occasionally a ≥ 6 threshold is used. For convenience (and
without clinical justification) we describe this as a marker of ‘probable psychiatric morbidity’ – to
distinguish this marker from those using the standard ≥ 4 threshold (‘possible psychiatric morbidity’) and
the higher ≥ 8 threshold (‘psychiatric morbidity’). This is not independent of sociodemographic or
geographic variations in access to, or uptake of, care as individuals may score < 6 because they are
currently being treated for a mental health issue. (See below for an alternative marker below which
includes people currently being treated with medication for anxiety/depression.)
The first wave of the UKHLS data set (n= 50,994) runs from January 2009 to January 2011 and includes
multiple household respondents aged ≥ 16 years from across the UK. Here the analytical data set is
drawn from the subset of respondents living in England and for whom data is available across all model
response and predictor variables, namely that they completed the GHQ12 questionnaire, along with
information on age band, sex, ethnicity, LLTI, tenure and the IMD score of the LSOA of residence
(n= 32,903). A single randomly selected adult is then drawn from each household, resulting in an
analytical data set of 20,849 adults aged ≥ 16 years.
TABLE 157 ‘Possible’ psychiatric morbidity (UKHLS wave 1, GHQ12 score of ≥ 6): survey counts and rates for















16–24 712 122 14.6 16–24 507 51 9.1
25–34 1847 275 13.0 25–34 1203 147 10.9
35–49 3331 663 16.6 35–49 2263 327 12.6
50–64 2489 457 15.5 50–64 2042 261 11.3
65–74 1133 113 9.1 65–74 1133 79 6.5
75–84 671 60 8.2 75–84 574 61 9.6
≥ 85 168 29 14.7 ≥ 85 119 12 9.2




Model parameters are applied to microsimulated LSOA-level census data to produce estimates of the
number (and proportion) of people with ‘probable psychiatric morbidity (i.e. who would score ≥ 6 on
the GHQ12) in each age–sex cohort (and overall) in each of the 32,844 English LSOAs. As discussed in the
report, bootstrapping is used to derive 95% CIs for the estimates. These LSOA-level prevalence rate
estimates (and 95% CIs) are aggregated into a number of higher geographies, namely MSOAs, LAs, CCGs
and regions (GORs). Proportionate attribution is used to restructure the prevalence rate estimates to align
with 2001 MSOAs, as well as GP practice populations as defined by the 2011 NHS ADS.
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Table 158 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured
by the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444
adults) in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived
quintile; and 6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule,
variations in prevalence rates reflect variations in the socioeconomic composition of populations in the
different types of LSOA rather than variations in deprivation per se.
TABLE 158 ‘Possible’ psychiatric morbidity (UKHLS wave 1, GHQ12 score of ≥ 6): cohort-specific and overall
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TABLE 159 Parameter estimates: ‘possible’ psychiatric morbidity (UKHLS wave 1, GHQ12 score of ≥ 6)
Factor (reference group)
Model coefficients 95% CI
Estimate SE 2.5% CI 97.50%
(Intercept) –2.52055 0.10351 –2.72343 –2.31766
Age (16–24 years)
25–34 years 0.04674 0.09911 –0.14752 0.24100
35–49 years 0.25323 0.09350 0.06996 0.43650
50–64 years 0.00093 0.09895 –0.19301 0.19487
65–74 years –0.72443 0.11997 –0.95957 –0.48929
75–84 years –0.75722 0.13469 –1.02121 –0.49323
≥ 85 years –0.45101 0.19511 –0.83342 –0.06861
Sex (females)
Males –0.52028 0.09027 –0.69721 –0.34334
Ethnicity (white)
Mixed 0.51292 0.22535 0.07124 0.95460
Black 0.29177 0.09853 0.09865 0.48489
Asian –0.15536 0.18130 –0.51070 0.19998
Other 0.46520 0.23902 –0.00327 0.93367
LLTI (no LTTI)
LLTI 1.21390 0.05722 1.10175 1.32606
Tenure (owner–occupier)
Social rent 0.54350 0.06276 0.42049 0.66651
Private rent or other tenure 0.42325 0.07004 0.28596 0.56054
LSOA IMD deprivation score
IMD score 0.00410 0.00174 0.00068 0.00751
Interaction effects
Male by LSOA IMD 0.00726 0.00263 0.00211 0.01241
Mixed and social rent –0.40292 0.32153 –1.03312 0.22728
Black and social rent –0.48702 0.19078 –0.86095 –0.11310
Asian and social rent 0.01306 0.22098 –0.42005 0.44618
Other and social rent 0.02364 0.34254 –0.64774 0.69503
Mixed and private rent –0.41264 0.35262 –1.10378 0.27850
Black and private rent –0.44307 0.17987 –0.79561 –0.09052
Asian and private rent –0.29042 0.27702 –0.83338 0.25254
Other and private rent –0.67463 0.38023 –1.41989 0.07062
Male and LLTI 0.13733 0.09060 –0.04024 0.31491
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Individual CCGs (n = 211)
FIGURE 137 ‘Possible’ psychiatric morbidity (UKHLS wave 1, GHQ12 score of ≥ 6): individual estimates and their
95% CIs. (a) MSOAs; (b) LAs; (c) CCGs; and (d) regions (GORs). (continued )
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FIGURE 137 ‘Possible’ psychiatric morbidity (UKHLS wave 1, GHQ12 score of ≥ 6): individual estimates and their
95% CIs. (a) MSOAs; (b) LAs; (c) CCGs; and (d) regions (GORs).
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Psychiatric morbidity (12-item General Health Questionnaire
score ≥ 8) (UK Household Longitudinal Survey, wave 1, 2009–11)
FIGURE 138 ‘Possible’ psychiatric morbidity (UKHLS wave 1, GHQ12 score of ≥ 8): LSOA-level map. Contains
Ordnance Survey data © Crown copyright and database right 2012.
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Response variable definition, provenance and prediction
Based on the GHQ12 implemented as part of the 2009–11 first wave of the UKHLS, here we capture
whether or not people score ≥ 8 using the standard 0–12 ‘caseness’ scoring approach. The GHQ12 is a
screening device for identifying minor psychiatric disorders in the general population. It assesses the
respondent’s current state and asks if that differs from his or her usual state. It is sensitive to short-term
psychiatric disorders but not to long-standing attributes of the respondent. In the literature, a score of ≥ 4
is usually taken as being indicative of ‘possible psychiatric morbidity’, but occasionally ≥ 6 or ≥ 8 thresholds
are used. For convenience (and without clinical justification) we describe a score of ≥ 8 as being indicative
of ‘psychiatric morbidity’ – to distinguish it from the standard ≥ 4 threshold (‘possible psychiatric morbidity’)
and the ≥ 6 threshold (‘probable psychiatric morbidity’). This is not independent of sociodemographic or
geographic variations in access to, or uptake of, care, as individuals may score < 8 because they are currently
being treated for a mental health issue. (See below for an alternative marker below which includes people
currently being treated with medication for anxiety/depression.)
The first wave of the UKHLS data set (n= 50,994) runs from January 2009 to January 2011 and includes
multiple household respondents aged ≥ 16 from across the UK. Here the analytical data set is drawn from
the subset of respondents living in England and for whom data are available across all model response and
predictor variables, namely that they completed the GHQ12 questionnaire, along with information on age
band, sex, ethnicity, LLTI, tenure and the IMD score of the LSOA of residence (n= 32,903). A single
randomly selected adult is then drawn from each household, resulting in an analytical data set of 20,849
adults aged ≥ 16 years.
TABLE 160 ‘Possible’ psychiatric morbidity (UKHLS wave 1, GHQ12 score of ≥ 8): survey counts and rates for















16–24 766 68 8.2 16–24 536 22 3.9
25–34 1961 161 7.6 25–34 1267 83 6.1
35–49 3563 431 10.8 35–49 2366 224 8.6
50–64 2637 309 10.5 50–64 2120 183 7.9
65–74 1187 59 4.7 65–74 1165 47 3.9
75–84 707 24 3.3 75–84 598 37 5.8
≥ 85 181 16 8.1 ≥ 85 124 7 5.3




Model parameters are applied to microsimulated LSOA-level census data to produce estimates of the
number (and proportion) of people with ‘psychiatric morbidity (i.e. who would score ≥ 8 on the GHQ12)
in each age–sex cohort (and overall) in each of the 32,844 English LSOAs. As discussed in the report,
bootstrapping is used to derive 95% CIs for the estimates. These LSOA-level prevalence rate estimates
(and 95% CIs) are aggregated into a number of higher geographies; namely MSOAs, LAs, CCGs and
regions (GORs). Proportionate attribution is used to restructure the prevalence rate estimates to align with
2001 MSOAs, as well as GP practice populations as defined by the 2011 NHS ADS.
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Table 161 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured
by the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444
adults) in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived
quintile; and 6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule,
variations in prevalence rates reflect variations in the socioeconomic composition of populations in the
different types of LSOA rather than variations in deprivation per se.
TABLE 161 ‘Possible’ psychiatric morbidity (UKHLS wave 1, GHQ12 score of ≥ 8): cohort-specific and overall
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TABLE 162 ‘Parameter estimates: ‘possible’ psychiatric morbidity (UKHLS wave 1, GHQ12 score of ≥ 8)
Factor (reference group)
Model coefficients 95% CI
Estimate SE 2.5% CI 97.50%
(Intercept) –3.27198 0.13451 –3.53561 –3.00835
Age (16–24 years)
25–34 years 0.14697 0.13075 –0.10930 0.40324
35–49 years 0.44260 0.12241 0.20267 0.68253
50–64 years 0.18735 0.12808 –0.06369 0.43839
65–74 years –0.76187 0.15750 –1.07056 –0.45317
75–84 years –0.91148 0.18028 –1.26483 –0.55813
≥ 85 years –0.50382 0.25155 –0.99686 –0.01077
Sex (females)
Males –0.59383 0.11488 –0.81899 –0.36866
Ethnicity (white)
Mixed 0.34767 0.28430 –0.20955 0.90489
Black 0.29873 0.11896 0.06556 0.53189
Asian –0.27856 0.23700 –0.74309 0.18596
Other 0.45982 0.29100 –0.11054 1.03018
LLTI (no LTTI)
LLTI 1.30315 0.06908 1.16775 1.43854
Tenure (owner–occupier)
Social rent 0.52627 0.07492 0.37942 0.67313
Private rent or other tenure 0.38943 0.08588 0.22111 0.55775
LSOA IMD deprivation score
IMD score 0.00579 0.00210 0.00167 0.00991
Interaction effects
Male and LLTI 0.36439 0.11068 0.14746 0.58132
Male by LSOA IMD 0.00775 0.00317 0.00154 0.01397
Mixed and social rent –0.37794 0.40085 –1.16361 0.40772
Black and social rent –0.56026 0.23139 –1.01378 –0.10673
Asian and social rent –0.07937 0.28594 –0.63980 0.48107
Other and social rent –0.32572 0.41940 –1.14774 0.49631
Mixed and private rent –0.14362 0.43024 –0.98689 0.69964
Black and private rent –0.75558 0.24540 –1.23658 –0.27459
Asian and private rent –0.28624 0.36505 –1.00173 0.42926
Other and private rent –1.04429 0.52063 –2.06473 –0.02385
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(a)

















































































Individual CCGs (n = 211)
FIGURE 140 ‘Possible’ psychiatric morbidity (UKHLS wave 1, GHQ12 score of ≥ 8): individual estimates and their
95% CIs. (a) MSOAs; (b) LAs; (c) CCGs; and (d) regions (GORs). (continued )
DOI: 10.3310/hsdr04140 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 14
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Asthana et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science


















































FIGURE 140 ‘Possible’ psychiatric morbidity (UKHLS wave 1, GHQ12 score of ≥ 8): individual estimates and their
95% CIs. (a) MSOAs; (b) LAs; (c) CCGs; and (d) regions (GORs).
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‘Possible’ psychiatric morbidity (12-item General Health
Questionnaire score ≥ 4) or currently prescribed
depression/anxiety drugs (UK Household Longitudinal Survey,
wave 1, 2009–11)
FIGURE 141 ‘Possible’ psychiatric morbidity (UKHLS wave 1, GHQ12 score of ≥ 4) or depression/anxiety drugs:
LSOA-level map. Contains Ordnance Survey data © Crown copyright and database right 2012.
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Response variable definition, provenance and prediction
This marker of mental health needs is derived from the 2009–11 first wave of the UKHLS GHQ12
questionnaire score and questions about what medicines the respondent is currently being prescribed, this
marker captures respondents with a GHQ12 score of ≥ 4 using the standard 0–12 ‘caseness’ scoring
approach and/or who are currently being prescribed drugs for depression and/or anxiety (BNF 4.1.1–4.1.3
or 4.3.1–4.3.4487). In the literature, a score of ≥ 4 is usually taken as being indicative of ‘possible psychiatric
morbidity’. We have no information regarding other forms of treatment for mental health issues. This
recognises the fact that individuals may return a GHQ12 score of < 4 because they are being receiving
medication for anxiety/depression and thus aims to capture underlying levels of ‘possible psychiatric
morbidity’. This marker is affected by the fact that (a) other types of medication, and other forms of
treatment, are not captured, and (b) any sociodemographic and/or geographic variations in access to,
or uptake of, prescribing will affect rates of prescribing and thus this statistic.
The first wave of the UKHLS data set (n= 50,994) runs from January 2009 to January 2011 and includes
multiple household respondents aged ≥ 16 years from across the UK. Here the analytical data set is drawn
from the subset of respondents living in England and for whom data are available across all model
response and predictor variables, namely that they completed the GHQ12 questionnaire and we know
what medication they were currently being prescribed, along with information on age band, sex, ethnicity,
LLTI, tenure and the IMD score of the LSOA of residence (n= 12,113). A single randomly selected adult is
then drawn from each household, resulting in an analytical data set of 8340 adults aged ≥ 16 years.
TABLE 163 ‘Possible’ psychiatric morbidity (UKHLS wave 1, GHQ12 score of ≥ 4) or depression/anxiety drugs:















16–24 149 52 25.9 16–24 86 20 18.9
25–34 460 196 29.9 25–34 315 79 20.1
35–49 1075 503 31.9 35–49 689 226 24.7
50–64 941 480 33.8 50–64 845 226 21.1
65–74 488 138 22.0 65–74 512 85 14.2
75–84 263 79 23.1 75–84 241 62 20.5
≥ 85 45 23 33.8 ≥ 85 49 13 21.0




Model parameters are applied to microsimulated LSOA-level census data to produce estimates of the
number (and proportion) of people with treated or untreated ‘possible psychiatric morbidity (i.e. who
would score ≥ 4 on the GHQ12 or be currently prescribed drugs for depression and/or anxiety) in
each age–sex cohort (and overall) in each of the 32,844 English LSOAs. As discussed in the report,
bootstrapping is used to derive 95% CIs for the estimates. These LSOA-level prevalence rate estimates
(and 95% CIs) are aggregated into a number of higher geographies; namely MSOAs, LAs, CCGs and
regions (GORs). Proportionate attribution is used to restructure the prevalence rate estimates to align with
2001 MSOAs, as well as GP practice populations as defined by the 2011 NHS ADS.
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Table 164 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured
by the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444
adults) in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived
quintile; and 6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule,
variations in prevalence rates reflect variations in the socioeconomic composition of populations in the
different types of LSOA rather than variations in deprivation per se.
TABLE 164 ‘Possible’ psychiatric morbidity (UKHLS wave 1, GHQ12 ≥ 4) or depression/anxiety drugs: cohort-specific
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TABLE 165 Parameter estimates: ‘possible’ psychiatric morbidity (UKHLS wave 1, GHQ12 ≥ 4) or
depression/anxiety drugs
Factor (reference group)
Model coefficients 95% CI
Estimate SE 2.5% CI 97.50%
(Intercept) –1.55497 0.16150 –1.87151 –1.23843
Age (16–24 years)
25–34 years 0.31206 0.15903 0.00036 0.62376
35–49 years 0.41321 0.15136 0.11656 0.70987
50–64 years 0.22112 0.15387 –0.08046 0.52270
65–74 years –0.40205 0.16701 –0.72938 –0.07471
75–84 years –0.31810 0.17905 –0.66905 0.03284
≥ 85 years –0.08190 0.25491 –0.58153 0.41772
Sex (females)
Males –0.63823 0.09519 –0.82481 –0.45165
Ethnicity (white)
Mixed 0.20646 0.28344 –0.34909 0.76201
Black 0.10348 0.15929 –0.20873 0.41568
Asian –0.13101 0.20819 –0.53905 0.27704
Other 0.63174 0.26366 0.11497 1.14852
LLTI (no LTTI)
LLTI 1.00052 0.09634 0.81169 1.18935
Tenure (owner–occupier)
Social rent 0.53847 0.07476 0.39194 0.68499
Private rent or other tenure 0.27058 0.08578 0.10245 0.43871
LSOA IMD deprivation score
IMD score –0.00167 0.00269 –0.00695 0.00361
Interaction effects
LLTI (no LLTI) by LSOA IMD score 0.01094 0.00349 0.00409 0.01778
Male (female) by LSOA IMD 0.00817 0.00357 0.00118 0.01517
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(a)




















































































































Individual CCGs (n = 211)
FIGURE 143 ‘Possible’ psychiatric morbidity (UKHLS wave 1, GHQ12 score of ≥ 4) or depression/anxiety drugs:
individual estimates and their 95% CIs. (a) MSOAs; (b) LAs; (c) CCGs; and (d) regions (GORs). (continued )
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FIGURE 143 ‘Possible’ psychiatric morbidity (UKHLS wave 1, GHQ12 score of ≥ 4) or depression/anxiety drugs:
individual estimates and their 95% CIs. (a) MSOAs; (b) LAs; (c) CCGs; and (d) regions (GORs).
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‘Probable’ psychiatric morbidity (12-item General Health
Questionnaire score ≥ 6) or currently prescribed
depression/anxiety drugs (UK Household Longitudinal Survey,
wave 1, 2009–11)
FIGURE 144 ‘Possible’ psychiatric morbidity (UKHLS wave 1, GHQ12 ≥ 6) or depression/anxiety drugs:
LSOA-level map. Contains Ordnance Survey data © Crown copyright and database right 2012.
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Response variable definition, provenance and prediction
This marker of mental health needs is derived from the 2009–11 first wave of the UKHLS GHQ12
questionnaire score and questions therein about what medicines the respondent is currently being prescribed.
This marker captures respondents with a GHQ12 score of ≥ 6 using the standard 0–12 ‘caseness’ scoring
approach or who are currently being prescribed drugs for depression and/or anxiety (BNF 4.1.1–4.1.3 or
4.3.1–4.3.4487). In the literature, a score of ≥ 4 is usually taken as being indicative of ‘possible psychiatric
morbidity’, but occasionally a ≥ 6 threshold is used. For convenience (and without clinical justification) we
describe this as a marker of ‘probable psychiatric morbidity’ – to distinguish this marker from those using the
standard ≥ 4 threshold (‘possible psychiatric morbidity’) and the higher ≥ 8 threshold (‘psychiatric morbidity’).
We have no information regarding other forms of treatment for mental health issues. This marker recognises
the fact that individuals may return a GHQ12 score of < 6 because they are being receiving medication for
anxiety/depression and thus aims to capture underlying levels of ‘probable psychiatric morbidity’. This marker
is affected by the fact that (a) other types of medication, and other forms of treatment, are not captured, and
(b) any sociodemographic and/or geographic variations in access to, or uptake of, prescribing.
The first wave of the UKHLS data set (n= 50,994) runs from January 2009 to January 2011 and includes
multiple household respondents aged ≥ 16 years from across the UK. Here the analytical data set is drawn
from the subset of respondents living in England and for whom data are available across all model
response and predictor variables, namely that they completed the GHQ12 questionnaire and we know
what medication they were currently being prescribed, along with information on age band, sex, ethnicity,
LLTI, tenure and the IMD score of the LSOA of residence (n= 12,113). A single randomly selected adult is
then drawn from each household, resulting in an analytical data set of 8340 adults aged ≥ 16 years.
TABLE 166 ‘Possible’ psychiatric morbidity (UKHLS wave 1, GHQ12 ≥ 6) or depression/anxiety drugs: survey counts















16–24 161 40 19.9 16–24 94 12 11.3
25–34 515 141 21.5 25–34 346 48 12.2
35–49 1169 409 25.9 35–49 736 179 19.6
50–64 1035 386 27.2 50–64 889 182 17.0
65–74 517 109 17.4 65–74 527 70 11.7
75–84 284 58 17.0 75–84 260 43 14.2
≥ 85 47 21 30.9 ≥ 85 53 9 14.5




Model parameters are applied to microsimulated LSOA-level census data to produce estimates of the
number (and proportion) of people with treated or untreated ‘probable psychiatric morbidity (i.e. who
would score ≥ 6 on the GHQ12 or be currently prescribed drugs for depression and/or anxiety) in
each age–sex cohort (and overall) in each of the 32,844 English LSOAs. As discussed in the report,
bootstrapping is used to derive 95% CIs for the estimates. These LSOA-level prevalence rate estimates
(and 95% CIs) are aggregated into a number of higher geographies; namely MSOAs, LAs, CCGs and
regions (GORs). Proportionate attribution is used to restructure the prevalence rate estimates to align with
2001 MSOAs, as well as GP practice populations as defined by the 2011 NHS ADS.
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Table 167 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured
by the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444
adults) in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived
quintile; and 6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule,
variations in prevalence rates reflect variations in the socioeconomic composition of populations in the
different types of LSOA rather than variations in deprivation per se.
TABLE 167 ‘Possible’ psychiatric morbidity (UKHLS wave 1, GHQ12 score of ≥ 6) or depression/anxiety drugs:
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TABLE 168 Parameter estimates: ‘possible’ psychiatric morbidity (UKHLS wave 1, GHQ12 score of ≥ 6) or
depression/anxiety drugs
Factor (reference group)
Model coefficients 95% CI
Estimate SE 2.5% CI 97.50%
(Intercept) –2.02646 0.20426 –2.4268 –1.62611
Age (16–24 years)
25–34 years 0.25684 0.20563 –0.14620 0.65988
35–49 years 0.52770 0.19570 0.14412 0.91128
50–64 years 0.24382 0.20263 –0.15335 0.64098
65–74 years –0.09869 0.22677 –0.54316 0.34578
75–84 years –0.19998 0.27321 –0.73547 0.33551
≥ 85 years 0.78613 0.38871 0.02426 1.54800
Sex (females)
Males –0.77559 0.10669 –0.98470 –0.56648
Ethnicity (white)
Mixed –0.21495 0.37821 –0.95624 0.52634
Black –0.54234 0.27662 –1.08452 –0.00016
Asian –0.43700 0.29533 –1.01585 0.14185
Other 0.14660 0.38027 –0.59872 0.89192
LLTI (no LTTI)
LLTI 1.00689 0.38748 0.24743 1.76634
Tenure (owner–occupier)
Social rent 0.62302 0.07932 0.46756 0.77848
Private rent or other tenure 0.34836 0.09362 0.16486 0.53185
LSOA IMD deprivation score
IMD score –0.00134 0.00298 –0.00719 0.00450
Interaction effects
Male by LSOA IMD 0.01177 0.00387 0.00419 0.01935
LLTI by LSOA IMD score 0.00835 0.00373 0.00104 0.01566
Male and mixed 1.34394 0.63493 0.09947 2.58840
Male and black 0.63417 0.38021 –0.11103 1.37938
Male and Asian 0.36210 0.48889 –0.59612 1.32032
Male and other 0.88742 0.58044 –0.25024 2.02508
25–34 years and LLTI 0.04767 0.42217 –0.77979 0.87512
35–49 years and LLTI 0.18798 0.38534 –0.56728 0.94324
50–64 years and LLTI 0.27516 0.38463 –0.47872 1.02904
65–74 years and LLTI –0.15978 0.40707 –0.95764 0.63809
75–84 years and LLTI –0.08834 0.44188 –0.95443 0.77776
≥ 85 years and LLTI –0.95379 0.57293 –2.07674 0.16915
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Individual CCGs (n = 211)
FIGURE 146 Parameter estimates: ‘possible’ psychiatric morbidity (UKHLS wave 1, GHQ12 score of ≥ 6)
or depression/anxiety drugs: individual estimates and their 95% CIs. (a) MSOAs; (b) LAs; (c) CCGs; and
(d) regions (GORs). (continued )
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FIGURE 146 Parameter estimates: ‘possible’ psychiatric morbidity (UKHLS wave 1, GHQ12 score of ≥ 6)
or depression/anxiety drugs: individual estimates and their 95% CIs. (a) MSOAs; (b) LAs; (c) CCGs; and
(d) regions (GORs).
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Psychiatric morbidity (12-item General Health Questionnaire
score ≥ 8) or currently prescribed depression/anxiety drugs
(UK Household Longitudinal Survey, wave 1, 2009–11)
FIGURE 147 Parameter estimates: ‘possible’ psychiatric morbidity (UKHLS wave 1, GHQ12 score of ≥ 8)
or depression/anxiety drugs: LSOA-level map. Contains Ordnance Survey data © Crown copyright and database
right 2012.
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Response variable definition, provenance and prediction
This marker of mental health needs is derived from the 2009–11 first wave of the UKHLS GHQ12
questionnaire score and questions therein about what medicines the respondent is currently being
prescribed. This marker captures respondents with a GHQ12 score of ≥ 8 using the standard 0–12 ‘caseness’
scoring approach or who are currently being prescribed drugs for depression and/or anxiety (BNF 4.1.1–4.1.3
or 4.3.1–4.3.4487). In the literature, a score of ≥ 4 is usually taken as being indicative of ‘possible psychiatric
morbidity’, but occasionally ≥ 6 or ≥ 8 thresholds are used. For convenience (and without clinical
justification) we describe this as a marker of ‘psychiatric morbidity’ – to distinguish it from the standard
≥ 4 threshold (‘possible psychiatric morbidity’) and the ≥ 6 threshold (‘probable psychiatric morbidity’). We
have no information regarding other forms of treatment for mental health issues. This marker recognises the
fact that individuals may return a GHQ12 score of < 8 because they are being receiving medication for
anxiety/depression and thus aims to capture underlying levels of ‘probable psychiatric morbidity’. This marker
is affected by the fact that (a) other types of medication, and other forms of treatment, are not captured,
and (b) any sociodemographic and/or geographic variations in access to, or uptake of, prescribing.
The first wave of the UKHLS data set (n= 50,994) runs from January 2009 to January 2011 and includes
multiple household respondents aged ≥ 16 years from across the UK. Here the analytical data set is drawn
from the subset of respondents living in England and for whom data are available across all model
response and predictor variables, namely that they completed the GHQ12 questionnaire and we know
what medication they were currently being prescribed, along with information on age band, sex, ethnicity,
LLTI, tenure and the IMD score of the LSOA of residence (n= 12,113). A single randomly selected adult is
then drawn from each household, resulting in an analytical data set of 8340 adults aged ≥ 16 years.
TABLE 169 Parameter estimates: ‘possible’ psychiatric morbidity (UKHLS wave 1, GHQ12 of ≥ 8) or















16–24 172 29 14.4 16–24 99 7 6.6
25–34 537 119 18.1 25–34 362 32 8.1
35–49 1249 329 20.8 35–49 761 154 16.8
50–64 1088 333 23.4 50–64 913 158 14.8
65–74 535 91 14.5 65–74 540 57 9.5
75–84 297 45 13.2 75–84 270 33 10.9
≥ 85 50 18 26.5 ≥ 85 56 6 9.7




Model parameters are applied to microsimulated LSOA-level census data to produce estimates of the
number (and proportion) of people with treated or untreated ‘psychiatric morbidity (i.e. who would score
≥ 8 on the GHQ12 or be currently prescribed drugs for depression and/or anxiety) in each age–sex cohort
(and overall) in each of the 32,844 English LSOAs. As discussed in the report, bootstrapping is used to
derive 95% CIs for the estimates. These LSOA-level prevalence rate estimates (and 95% CIs) are
aggregated into a number of higher geographies, namely MSOAs, LAs, CCGs and regions (GORs).
Proportionate attribution is used to restructure the prevalence rate estimates to align with 2001 MSOAs,
as well as GP practice populations as defined by the 2011 NHS ADS.
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Table 170 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured
by the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444
adults) in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived
quintile; and 6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule,
variations in prevalence rates reflect variations in the socioeconomic composition of populations in the
different types of LSOA rather than variations in deprivation per se.
TABLE 170 Parameter estimates: ‘possible’ psychiatric morbidity (UKHLS wave 1, GHQ12 score of ≥ 8) or
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TABLE 171 Parameter estimates: ‘possible’ psychiatric morbidity (UKHLS wave 1, GHQ12 score of ≥ 8) or
depression/anxiety drugs
Factor (reference group)
Model coefficients 95% CI
Estimate SE 2.5% CI 97.50%
(Intercept) –2.32349 0.23244 –2.77906 –1.86791
Age (16–24 years)
25–34 years 0.43262 0.23621 –0.03036 0.89560
35–49 years 0.52730 0.22360 0.08904 0.96556
50–64 years 0.41619 0.22567 –0.02611 0.85850
65–74 years –0.20511 0.24663 –0.68851 0.27829
75–84 years –0.53640 0.27287 –1.07121 –0.00158
≥ 85 years 0.21607 0.36138 –0.49224 0.92438
Sex (females)
Males –1.48270 0.48362 –2.43060 –0.53480
Ethnicity (white)
Mixed –0.38407 0.52925 –1.42140 0.65326
Black –1.31403 0.43383 –2.16434 –0.46372
Asian –0.53058 0.38739 –1.28985 0.22870
Other –0.19511 0.51859 –1.21155 0.82133
LLTI (no LTTI)
LLTI 1.17185 0.11274 0.95088 1.39282
Tenure (owner–occupier)
Social rent 0.70507 0.12428 0.46148 0.94865
Private rent or other tenure 0.18902 0.13545 –0.07647 0.45450
LSOA IMD deprivation score
IMD score –0.00276 0.00343 –0.00949 0.00396
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TABLE 171 Parameter estimates: ‘possible’ psychiatric morbidity (UKHLS wave 1, GHQ12 score of ≥ 8) or
depression/anxiety drugs (continued )
Factor (reference group)
Model coefficients 95% CI
Estimate SE 2.5% CI 97.50%
Interaction effects
Male by LSOA IMD 0.01498 0.00414 0.00686 0.02309
LLTI by LSOA IMD score 0.00788 0.00434 –0.00061 0.01638
Male and mixed 1.47169 0.70144 0.09687 2.84650
Male and black 0.77491 0.48206 –0.16992 1.71975
Male and Asian 0.07344 0.57112 –1.04596 1.19283
Male and other 1.24587 0.68845 –0.10350 2.59523
Mixed and LLTI –0.09544 0.67417 –1.41682 1.22593
Black and LLTI 1.21832 0.47806 0.28132 2.15532
Asian and LLTI 0.20579 0.54851 –0.86929 1.28088
Other and LLTI –0.99885 0.82038 –2.60680 0.60910
25–34 years and male 0.12979 0.51222 –0.87416 1.13373
35–49 years and male 0.85024 0.47842 –0.08745 1.78794
50–64 years and male 0.61114 0.47886 –0.32743 1.54970
65–74 years and male 0.64353 0.50164 –0.33968 1.62674
75–84 years and male 1.03951 0.52902 0.00263 2.07638
≥ 85 years and male 0.10222 0.70582 –1.28119 1.48562
LLTI and social rent –0.06301 0.16695 –0.39023 0.26421
LLTI and private rent or other tenure 0.40662 0.20320 0.00835 0.80488
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FIGURE 149 Parameter estimates: ‘possible’ psychiatric morbidity (UKHLS wave 1, GHQ12 score of ≥ 8) or depression/
anxiety drugs: individual estimates and their 95% CIs. (a) MSOAs; (b) LAs; (c) CCGs; and (d) regions (GORs).
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‘Possible’ psychiatric morbidity (12-item General Health
Questionnaire score of ≥ 4) (UK Household Longitudinal Survey
wave 2, 2010–12)
FIGURE 150 ‘Possible’ psychiatric morbidity (UKHLS wave 2, GHQ12 score of ≥ 4): LSOA-level map. Contains
Ordnance Survey data © Crown copyright and database right 2012.
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Response variable definition, provenance and prediction
Based on the GHQ12 incorporated within the 2010–12 second wave of the UKHLS, here we capture
whether respondents score ≥ 4 more using the standard 0–12 ‘caseness’ scoring approach. The GHQ12
is a screening device for identifying minor psychiatric disorders in the general population. It assesses the
respondent’s current state and asks if that differs from their usual state. It is sensitive to short-term
psychiatric disorders but not long-standing attributes of the respondent. In the literature, a score of ≥ 4
is usually taken as being indicative of ‘possible psychiatric morbidity’. This is not independent of
sociodemographic or geographic variations in access to, or uptake of, care, as individuals may score ≤ 4
because they are currently being treated for a mental health issue. [See ‘Possible’ psychiatric morbidity
(12-item General Health Questionnaire score of ≥ 4) or currently prescribed depression/anxiety drugs
(UK Household Longitudinal Survey, 2010–12) for an alternative marker which includes people currently
being treated with medication for anxiety/depression.]
The second wave of the UKHLS data set (n= 31,242) runs from January 2010 to January 2012 and
includes multiple household respondents aged ≥ 16 years from across the UK. Here the analytical data set
is drawn from the subset of respondents living in England for whom data are available across all model
response and predictor variables, namely that they completed the GHQ12, along with information on age
band, sex, ethnicity, LLTI, tenure and the IMD score of the LSOA of residence (n= 16,121). A single
randomly selected adult is then drawn from each household, resulting in an analytical data set of 10,028
adults aged ≥ 16 years
TABLE 172 ‘Possible’ psychiatric morbidity (UKHLS wave 2, GHQ12 score of ≥ 4): survey counts and rates for















16–24 339 99 22.6 16–24 291 49 14.4
25–34 694 221 24.2 25–34 476 95 16.6
35–49 1280 372 22.5 35–49 934 208 18.2
50–64 1156 337 22.6 50–64 871 171 16.4
65–74 624 120 16.1 65–74 510 90 15.0
75–84 411 101 19.7 75–84 284 48 14.5
≥ 85 135 25 15.6 ≥ 85 62 25 28.7




Model parameters are applied to microsimulated LSOA-level census data to produce estimates of the
number (and proportion) of people with ‘possible’ psychiatric morbidity (i.e. who would score ≥ 4 on
the GHQ12) in each age–sex cohort (and overall) in each of the 32,844 English LSOAs. As discussed in the
report, bootstrapping is used to derive 95% CIs for the estimates. These LSOA-level prevalence rate
estimates (and 95% CIs) are aggregated into a number of higher geographies, namely MSOAs, LAs, CCGs
and regions (GORs). Proportionate attribution is used to restructure the prevalence rate estimates to align
with 2001 MSOAs, as well as GP practice populations as defined by the 2011 NHS ADS.
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Table 173 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured
by the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444 adults)
in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived quintile; and
6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule, variations in
prevalence rates reflect variations in the socioeconomic composition of populations in the different types of
LSOA rather than variations in deprivation per se.
TABLE 173 ‘Possible’ psychiatric morbidity (UKHLS wave 2, GHQ12 score of ≥ 4): cohort-specific and overall
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TABLE 174 ‘Parameter estimates: ‘possible’ psychiatric morbidity (UKHLS wave 2, GHQ12 score of ≥ 4)
Factor (reference group)
Model coefficients 95% CI
Estimate SE 2.5% CI 97.50%
(Intercept) –1.62204 0.12941 –1.87568 –1.36840
Age (16–24 years)
25–34 years 0.04183 0.14487 –0.24211 0.32578
35–49 years –0.09785 0.13809 –0.36850 0.17281
50–64 years –0.25096 0.14557 –0.53627 0.03435
65–74 years –0.87799 0.18807 –1.24660 –0.50938
75–84 years –0.58172 0.21879 –1.01054 –0.15290
≥ 85 years –1.60654 0.47877 –2.54493 –0.66815
Sex (females)
Males –0.53000 0.19379 –0.90983 –0.15017
Ethnicity (white)
Mixed –0.39650 0.29250 –0.96981 0.17681
Black 0.20093 0.14697 –0.08712 0.48899
Asian 0.20478 0.20089 –0.18896 0.59852
Other 0.31721 0.26167 –0.19566 0.83009
LLTI (no LTTI)
LLTI 0.35408 0.31407 –0.26149 0.96966
Tenure (owner–occupier)
Social rent 0.29678 0.07313 0.15344 0.44013
Private rent or other tenure 0.23901 0.07976 0.08268 0.39534
LSOA IMD deprivation score
IMD score 0.00755 0.00181 0.00399 0.01111
Interaction effects
Male and LLTI 0.24955 0.12302 0.00842 0.49068
25–34 years and male 0.03373 0.23808 –0.43291 0.50037
35–49 years and male 0.17236 0.21907 –0.25701 0.60173
50–64 years and male 0.02002 0.22618 –0.42329 0.46334
65–74 years and male 0.31722 0.25754 –0.18757 0.82201
75–84 years and male 0.00523 0.28521 –0.55378 0.56425
≥ 85 years and male 1.24325 0.40095 0.45740 2.02911
25–34 years and LLTI 0.52461 0.35818 –0.17742 1.22665
35–49 years and LLTI 0.75304 0.32928 0.10765 1.39843
50–64 years and LLTI 0.80665 0.32771 0.16434 1.44896
65–74 years and LLTI 0.93682 0.34947 0.25186 1.62177
75–84 years and LLTI 0.56214 0.37066 –0.16435 1.28863
≥ 85 years and LLTI 1.31875 0.55827 0.22453 2.41297
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FIGURE 152 ‘Possible’ psychiatric morbidity (UKHLS wave 2, GHQ12 score of ≥ 4): individual estimates and their
95% CIs. (a) MSOAs; (b) LAs; (c) CCGs; and (d) regions (GORs). (continued )
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FIGURE 152 ‘Possible’ psychiatric morbidity (UKHLS wave 2, GHQ12 score of ≥ 4): individual estimates and their
95% CIs. (a) MSOAs; (b) LAs; (c) CCGs; and (d) regions (GORs).
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‘Probable’ psychiatric morbidity (12-item General Health
Questionnaire score of ≥ 6) (UK Household Longitudinal Survey
wave 2, 2010–12)
FIGURE 153 ‘Probable’ psychiatric morbidity (UKHLS wave 2, GHQ12 score of ≥ 6): LSOA-level map. Contains
Ordnance Survey data © Crown copyright and database right 2012.
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Response variable definition, provenance and prediction
Based on the GHQ12 incorporated within the 2010–12 second wave of the UKHLS, here we capture
whether or not respondents score ≥ 6 using the standard 0–12 ‘caseness’ scoring approach. The GHQ12
is a screening device for identifying minor psychiatric disorders in the general population. It assesses the
respondent’s current state and asks if that differs from his or her usual state. It is sensitive to short-term
psychiatric disorders but not to long-standing attributes of the respondent. In the literature, a score of ≥ 4
is usually taken as being indicative of ‘possible psychiatric morbidity’, but occasionally a ≥ 6 threshold is
used. For convenience (and without clinical justification) we describe this as a marker of ‘probable
psychiatric morbidity’ to distinguish this marker from those using the standard ≥ 4 threshold (‘possible
psychiatric morbidity’) and the higher ≥ 8 threshold (‘psychiatric morbidity’). This is not independent of
sociodemographic or geographic variations in access to, or uptake of, care as individuals may score < 6
because they are currently being treated for a mental health issue. (See below for an alternative marker
which includes people currently being treated with medication for anxiety/depression.)
The second wave of the UKHLS data set (n= 31,242) runs from January 2010 to January 2012 and
includes multiple household respondents aged ≥ 16 years from across the UK. Here the analytical data set
is drawn from the subset of respondents living in England for whom data are available across all model
response and predictor variables, namely that they completed the GHQ12 questionnaire, along with
information on age band, sex, ethnicity, LLTI, tenure and the IMD score of the LSOA of residence
(n= 16,121). A single randomly selected adult is then drawn from each household, resulting in an
analytical data set of 10,028 adults aged ≥ 16 years.
















16–24 376 62 14.2 16–24 310 30 8.8
25–34 764 151 16.5 25–34 505 66 11.6
35–49 1392 260 15.7 35–49 1005 137 12.0
50–64 1264 229 15.3 50–64 928 114 10.9
65–74 664 80 10.8 65–74 536 64 10.7
75–84 449 63 12.3 75–84 292 40 12.0
≥ 85 150 10 6.3 ≥ 85 67 20 23.0




Model parameters are applied to microsimulated LSOA-level census data to produce estimates of the
number (and proportion) of people with ‘probable psychiatric morbidity (i.e. who would score ≥ 6 on
the GHQ12) in each age–sex cohort (and overall) in each of the 32,844 English LSOAs. As discussed in the
report, bootstrapping is used to derive 95% CIs for the estimates. These LSOA-level prevalence rate
estimates (and 95% CIs) are aggregated into a number of higher geographies; namely MSOAs, LAs, CCGs
and regions (GORs). Proportionate attribution is used to restructure the prevalence rate estimates to align
with 2001 MSOAs, as well as GP practice populations as defined by the 2011 NHS ADS.
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Table 176 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured
by the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444
adults) in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived
quintile; and 6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule,
variations in prevalence rates reflect variations in the socioeconomic composition of populations in the
different types of LSOA rather than variations in deprivation per se.
TABLE 176 ‘Probable’ psychiatric morbidity (UKHLS wave 2, GHQ12 score of ≥ 6): cohort-specific and overall
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TABLE 177 Parameter estimates: ‘probable’ psychiatric morbidity (UKHLS wave 2, GHQ12 ≥ 6)
Factor (reference group)
Model coefficients 95% CI
Estimate SE 2.5% CI 97.50%
(Intercept) –2.31048 0.15843 –2.62100 –1.99996
Age (16–24 years)
25–34 years 0.18348 0.16632 –0.14250 0.50946
35–49 years 0.14153 0.15829 –0.16872 0.45179
50–64 years –0.00373 0.16322 –0.32364 0.31618
65–74 years –0.50903 0.19071 –0.88281 –0.13524
75–84 years –0.51824 0.20409 –0.91826 –0.11823
≥ 85 years –1.39947 0.36317 –2.11130 –0.68765
Sex (females)
Males –0.56078 0.24119 –1.03351 –0.08805
Ethnicity (white)
Mixed –0.97899 0.43148 –1.82469 –0.13329
Black 0.32123 0.16478 –0.00174 0.64420
Asian 0.22809 0.22469 –0.21230 0.66848
Other 0.09465 0.31553 –0.52380 0.71310
LLTI (no LTTI)
LLTI 0.82270 0.12606 0.57562 1.06979
Tenure (owner–occupier)
Social rent 0.46206 0.11680 0.23314 0.69098
Private rent or other tenure 0.28671 0.11230 0.06661 0.50681
LSOA IMD deprivation score
IMD score 0.00650 0.00278 0.00106 0.01195
Interaction effects
Male and LLTI 0.50131 0.13906 0.22875 0.77387
25–34 years and male 0.07146 0.29006 –0.49705 0.63998
35–49 years and male 0.04286 0.26867 –0.48374 0.56946
50–64 years and male –0.08238 0.27601 –0.62336 0.45860
65–74 years and male 0.27769 0.30824 –0.32645 0.88184
75–84 years and male 0.20775 0.33678 –0.45233 0.86783
≥ 85 years and male 1.78644 0.49427 0.81768 2.75520
LLTI and social rent –0.28543 0.16449 –0.60784 0.03698
LLTI and private rent or other tenure 0.28191 0.18802 –0.08661 0.65042
LLTI by LSOA IMD score 0.00873 0.00416 0.00058 0.01688
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FIGURE 155 ‘Probable’ psychiatric morbidity (UKHLS wave 2, GHQ12 score of ≥ 6): individual estimates and their
95% CIs. (a) MSOAs; (b) LAs; (c) CCGs; and (d) regions (GORs). (continued )
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FIGURE 155 ‘Probable’ psychiatric morbidity (UKHLS wave 2, GHQ12 score of ≥ 6): individual estimates and their
95% CIs. (a) MSOAs; (b) LAs; (c) CCGs; and (d) regions (GORs).
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Psychiatric morbidity (12-item General Health Questionnaire
score of ≥ 8) (UK Household Longitudinal Survey, wave 2,
2010–12)
FIGURE 156 Psychiatric morbidity (UKHLS wave 2, GHQ12 score of ≥ 8): LSOA-level map. Contains Ordnance Survey
data © Crown copyright and database right 2012.
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Response variable definition, provenance and prediction
Based on the GHQ12 incorporated within the 2010–12 second wave of the UKHLS, here we capture
whether or not respondents score ≥ 8 using the standard 0–12 ‘caseness’ scoring approach. The GHQ12 is
a screening device for identifying minor psychiatric disorders in the general population. It assesses the
respondent’s current state and asks if that differs from his or her usual state. It is sensitive to short-term
psychiatric disorders but not to long-standing attributes of the respondent. In the literature, a score of ≥ 4
is usually taken as being indicative of ‘possible psychiatric morbidity’, but occasionally ≥ 6 or ≥ 8 thresholds
are used. For convenience (and without clinical justification) we describe this as a marker of ‘psychiatric
morbidity’ – to distinguish it from the standard ≥ 4 threshold (‘possible psychiatric morbidity’) and the ≥ 6
threshold (‘probable psychiatric morbidity’). This is not independent of sociodemographic or geographic
variations in access to, or uptake of, care, as individuals may score < 8 because they are currently being
treated for a mental health issue. (See below for an alternative marker which includes people currently
being treated with medication for anxiety/depression.)
The second wave of the UKHLS data set (n= 31,242) runs from January 2010 to January 2012 and
includes multiple household respondents aged ≥ 16 years from across the UK. Here the analytical data set
is drawn from the subset of respondents living in England for whom data are available across all model
response and predictor variables, namely that they completed the GHQ12, along with information on age
band, sex, ethnicity, LLTI, tenure and the IMD score of the LSOA of residence (n= 16,121). A single
randomly selected adult is then drawn from each household, resulting in an analytical data set of 10,028
adults aged ≥ 16 years.
















16–24 405 33 7.5 16–24 323 17 5.0
25–34 814 101 11.0 25–34 529 42 7.4
35–49 1491 161 9.7 35–49 1054 88 7.7
50–64 1346 147 9.8 50–64 961 81 7.8
65–74 694 50 6.7 65–74 554 46 7.7
75–84 472 40 7.8 75–84 304 28 8.4
≥ 85 156 4 2.5 ≥ 85 76 11 12.6




Model parameters are applied to microsimulated LSOA-level census data to produce estimates of the
number (and proportion) of people with ‘psychiatric morbidity (i.e. who would score ≥ 8 on the GHQ12)
in each age–sex cohort (and overall) in each of the 32,844 English LSOAs. As discussed in the report,
bootstrapping is used to derive 95% CIs for the estimates. These LSOA-level prevalence rate estimates
(and 95% CIs) are aggregated into a number of higher geographies; namely MSOAs, LAs, CCGs and
regions (GORs). Proportionate attribution is used to restructure the prevalence rate estimates to align with
2001 MSOAs, as well as GP practice populations as defined by the 2011 NHS ADS.
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Table 179 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured
by the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444
adults) in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived
quintile; and 6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule,
variations in prevalence rates reflect variations in the socioeconomic composition of populations in the
different types of LSOA rather than variations in deprivation per se.
TABLE 179 Psychiatric morbidity (UKHLS wave 2, GHQ12 score of ≥ 8): cohort-specific and overall prevalence rates
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TABLE 180 Parameter estimates: psychiatric morbidity (UKHLS wave 2, GHQ12 score of ≥ 8)
Factor (reference group)
Model coefficients 95% CI
Estimate SE 2.5% CI 97.50%
(Intercept) –3.10305 0.20093 –3.49687 –2.70923
Age (16–24 years)
25–34 years 0.41261 0.21262 –0.00413 0.82935
35–49 years 0.27287 0.20508 –0.12908 0.67483
50–64 years 0.15056 0.21018 –0.26140 0.56251
65–74 years –0.37018 0.24336 –0.84716 0.10680
75–84 years –0.37897 0.25786 –0.88438 0.12644
≥ 85 years –1.70579 0.54538 –2.77473 –0.63685
Sex (females)
Males –0.48237 0.31434 –1.09848 0.13374
Ethnicity (white)
Mixed –1.18182 0.59449 –2.34701 –0.01663
Black 0.05377 0.21289 –0.36350 0.47103
Asian 0.27567 0.26058 –0.23508 0.78641
Other 0.31980 0.35113 –0.36842 1.00802
LLTI (no LTTI)
LLTI 1.10403 0.11711 0.87449 1.33357
Tenure (owner–occupier)
Social rent 0.40696 0.13988 0.13280 0.68113
Private rent or other tenure 0.20870 0.14306 –0.07170 0.48910
LSOA IMD deprivation score
IMD score 0.01097 0.00245 0.00617 0.01577
Interaction effects
Male and LLTI 0.51237 0.16464 0.18967 0.83507
25–34 years and male –0.05868 0.36932 –0.78255 0.66518
35–49 years and male 0.00597 0.34526 –0.67073 0.68268
50–64 years and male –0.04618 0.35139 –0.73492 0.64255
65–74 years and male 0.32744 0.38781 –0.43266 1.08754
75–84 years and male 0.20997 0.41914 –0.61153 1.03148
≥ 85 years and male 1.84880 0.69031 0.49578 3.20181
LLTI and social rent –0.33009 0.18223 –0.68725 0.02708
LLTI and private rent or other tenure 0.41548 0.21592 –0.00772 0.83867
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FIGURE 158 Psychiatric morbidity (UKHLS wave 2, GHQ12 score of ≥ 8): individual estimates and their 95% CIs.
(a) MSOAs; (b) LAs; (c) CCGs; and (d) regions (GORs).
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‘Possible’ psychiatric morbidity (12-item General Health
Questionnaire score of ≥ 4) or currently prescribed
depression/anxiety drugs (UK Household Longitudinal
Survey, 2010–12)
FIGURE 159 Psychiatric morbidity (UKHLS wave 2, GHQ12 score of ≥ 4) or depression/anxiety drugs:
LSOA-level map. Contains Ordnance Survey data © Crown copyright and database right 2012.
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Response variable definition, provenance and prediction
This marker of mental health needs is derived from the 2010–12 second wave of the UKHLS GHQ12 score
and questions therein about what medicines the respondent is currently being prescribed. This marker
captures respondents with a GHQ12 score of ≥ 4 using the standard 0–12 ‘caseness’ scoring approach or
who are currently being prescribed drugs for depression and/or anxiety (BNF 4.1.1–4.1.3 or 4.3.1–4.3.4487).
In the literature, a score of ≥ 4 is usually taken as being indicative of ‘possible psychiatric morbidity’.
We have no information regarding other forms of treatment for mental health issues. This marker
recognises the fact that individuals may return a GHQ12 score of < 4 because they are being receiving
medication for anxiety/depression and thus aims to capture underlying levels of ‘possible psychiatric
morbidity’. This marker is affected by the fact that (a) other types of medication, and other forms of
treatment, are not captured, and (b) any sociodemographic and/or geographic variations in access to,
or uptake of, prescribing.
The second wave of the UKHLS data set (n= 31,242) runs from January 2010 to January 2012 and
includes multiple household respondents aged ≥ 16 years from across the UK. Here the analytical data set
is drawn from the subset of respondents living in England for whom data is available across all model
response and predictor variables, namely that they completed the GHQ12, data is available on currently
prescribed medication, along with information on age band, sex, ethnicity, LLTI, tenure and the IMD
score of the LSOA of residence (n= 7,172). A single randomly selected adult is then drawn from each
household, resulting in an analytical data set of 4682 adults aged ≥ 16 years.
TABLE 181 Psychiatric morbidity (UKHLS wave 2, GHQ12 ≥ 4) or depression/anxiety drugs: survey counts and rates















16–24 94 41 30.4 16–24 81 15 15.6
25–34 282 123 30.4 25–34 213 48 18.4
35–49 537 245 31.3 35–49 396 104 20.8
50–64 525 243 31.6 50–64 418 119 22.2
65–74 303 95 23.9 65–74 251 54 17.7
75–84 166 54 24.5 75–84 140 45 24.3
≥ 85 37 14 27.5 ≥ 85 25 14 35.9




Model parameters are applied to microsimulated LSOA-level census data to produce estimates of the
number (and proportion) of people with treated or untreated ‘possible psychiatric morbidity (i.e. who
would score ≥ 4 on the GHQ12 or be currently prescribed drugs for depression and/or anxiety) in
each age–sex cohort (and overall) in each of the 32,844 English LSOAs. As discussed in the report,
bootstrapping is used to derive 95% CIs for the estimates. These LSOA-level prevalence rate estimates
(and 95%CIs) are aggregated into a number of higher geographies; namely MSOAs, LAs, CCGs and
regions (GORs). Proportionate attribution is used to restructure the prevalence rate estimates to align with
2001 MSOAs, as well as GP practice populations as defined by the 2011 NHS ADS.
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Table 182 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured
by the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444
adults) in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived
quintile; and 6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule,
variations in prevalence rates reflect variations in the socioeconomic composition of populations in the
different types of LSOA rather than variations in deprivation per se.
TABLE 182 Psychiatric morbidity (UKHLS wave 2, GHQ12 ≥ 4) or depression/anxiety drugs: cohort-specific and
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TABLE 183 Parameter estimates: psychiatric morbidity (UKHLS wave 2, GHQ12 ≥ 4) or depression/anxiety drugs
Factor (reference group)
Model coefficients 95% CI
Estimate SE 2.5% CI 97.50%
(Intercept) –1.39974 0.17872 –1.75004 –1.04944
Age (16–24 years)
25–34 years 0.08149 0.18466 –0.28045 0.44343
35–49 years 0.09218 0.17534 –0.25149 0.43584
50–64 years –0.01860 0.17741 –0.36632 0.32912
65–74 years –0.47408 0.19280 –0.85197 –0.09619
75–84 years –0.48659 0.20849 –0.89522 –0.07795
≥ 85 years –0.20392 0.29267 –0.77756 0.36971
Sex (females)
Males –0.62948 0.09453 –0.81476 –0.44421
Ethnicity (white)
Mixed 0.01401 0.39694 –0.76399 0.79201
Black –0.06709 0.21538 –0.48924 0.35506
Asian 0.01289 0.27464 –0.52540 0.55119
Other 0.84902 0.36409 0.13540 1.56264
LLTI (no LTTI)
LLTI 1.08426 0.11066 0.86737 1.30116
Tenure (owner–occupier)
Social rent 0.42582 0.12874 0.17348 0.67816
Private rent or other tenure 0.03353 0.13528 –0.23162 0.29868
LSOA IMD deprivation score
IMD score 0.00788 0.00253 0.00292 0.01284
Interaction effects
Male and LLTI 0.40873 0.15318 0.10850 0.70897
LLTI and social rent 0.07156 0.18255 –0.28625 0.42936
LLTI and private rent or other tenure 0.52148 0.24559 0.04012 1.00283
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Individual CCGs (n = 211)
FIGURE 161 Psychiatric morbidity (UKHLS wave 2, GHQ12 score of ≥ 4) or depression/anxiety drugs: individual
estimates and their 95% CIs. (a) MSOAs; (b) LAs; (c) CCGs; and (d) regions (GORs). (continued )
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FIGURE 161 Psychiatric morbidity (UKHLS wave 2, GHQ12 score of ≥ 4) or depression/anxiety drugs: individual
estimates and their 95% CIs. (a) MSOAs; (b) LAs; (c) CCGs; and (d) regions (GORs).
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‘Probable’ psychiatric morbidity (12-item General Health
Questionnaire score ≥ 6) or currently prescribed
depression/anxiety drugs (UK Household Longitudinal Survey,
wave 2, 2010–12)
FIGURE 162 Psychiatric morbidity (UKHLS wave 2, GHQ12 ≥ 6) or depression/anxiety drugs: LSOA-level map.
Contains Ordnance Survey data © Crown copyright and database right 2012.
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Response variable definition, provenance and prediction
This marker of mental health needs is derived from the 2010–12 second wave of the UKHLS GHQ12
questionnaire score and questions therein about what medicines the respondent is currently being
prescribed. This marker captures respondents with a GHQ12 score of ≥ 6 using the standard 0–12 ‘caseness’
scoring approach or who are currently being prescribed drugs for depression and/or anxiety (BNF 4.1.1–4.1.3
or 4.3.1–4.3.4487). In the literature, a score of ≥ 4 is usually taken as being indicative of ‘possible psychiatric
morbidity’, but occasionally a ≥ 6 threshold is used. For convenience (and without clinical justification) we
describe this as a marker of ‘probable psychiatric morbidity’ – to distinguish this marker from those using the
standard ≥ 4 threshold (‘possible psychiatric morbidity’) and the higher ≥ 8 threshold (‘psychiatric morbidity’).
We have no information regarding other forms of treatment for mental health issues. This marker recognises
the fact that individuals may return a GHQ12 score of < 6 because they are being receiving medication for
anxiety/depression and thus aims to capture underlying levels of ‘probable psychiatric morbidity’. This marker
is affected by the fact that (a) other types of medication, and other forms of treatment, are not captured,
and (b) any sociodemographic and/or geographic variations in access to, or uptake of, prescribing.
The second wave of the UKHLS data set (n= 31,242) runs from January 2010 to January 2012 and
includes multiple household respondents aged ≥ 16 years from across the UK. Here the analytical data set
is drawn from the subset of respondents living in England for whom data are available across all model
response and predictor variables, namely that they completed the GHQ12 questionnaire, data are available
on currently prescribed medication, along with information on age band, sex, ethnicity, LLTI, tenure and
the IMD score of the LSOA of residence (n= 7172). A single randomly selected adult is then drawn from
each household, resulting in an analytical data set of 4682 adults aged ≥ 16 years.
TABLE 184 Psychiatric morbidity (UKHLS wave 2, GHQ12 ≥ 6) or depression/anxiety drugs: survey counts and rates















16–24 102 33 24.4 16–24 88 8 8.3
25–34 314 91 22.5 25–34 221 40 15.3
35–49 591 191 24.4 35–49 414 86 17.2
50–64 572 196 25.5 50–64 440 97 18.1
65–74 321 77 19.3 65–74 255 50 16.4
75–84 180 40 18.2 75–84 148 37 20.0
≥ 85 40 11 21.6 ≥ 85 25 14 35.9




Model parameters are applied to microsimulated LSOA-level census data to produce estimates of the
number (and proportion) of people with treated or untreated ‘probable psychiatric morbidity (i.e. who
would score ≥ 6 on the GHQ12 or be currently prescribed drugs for depression and/or anxiety) in
each age–sex cohort (and overall) in each of the 32,844 English LSOAs. As discussed in the report,
bootstrapping is used to derive 95% CIs for the estimates. These LSOA-level prevalence rate estimates
(and 95% CIs) are aggregated into a number of higher geographies; namely MSOAs, LAs, CCGs and
regions (GORs). Proportionate attribution is used to restructure the prevalence rate estimates to align with
2001 MSOAs, as well as GP practice populations as defined by the 2011 NHS ADS.
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Table 185 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured
by the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444
adults) in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived
quintile; and 6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule,
variations in prevalence rates reflect variations in the socioeconomic composition of populations in the
different types of LSOA rather than variations in deprivation per se.
TABLE 185 Psychiatric morbidity (UKHLS wave 2, GHQ12 ≥ 6) or depression/anxiety drugs: cohort-specific and
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TABLE 186 Parameter estimates: psychiatric morbidity (UKHLS wave 2, GHQ12 ≥ 6) or depression/anxiety drugs
Factor (reference group)
Model coefficients 95% CI
Estimate SE 2.5% CI 97.50%
(Intercept) –1.68620 0.22691 –2.13094 –1.24145
Age (16–24 years)
25–34 years –0.15004 0.25038 –0.64078 0.34070
35–49 years –0.04669 0.23762 –0.51242 0.41905
50–64 years –0.15123 0.24327 –0.62803 0.32558
65–74 years –0.48139 0.27698 –1.02426 0.06149
75–84 years –0.44614 0.32867 –1.09033 0.19804
≥ 85 years 0.14258 0.47508 –0.78857 1.07374
Sex (females)
Males –1.44101 0.44045 –2.30429 –0.57773
Ethnicity (white)
Mixed –0.17268 0.44911 –1.05294 0.70757
Black –0.54372 0.26536 –1.06383 –0.02361
Asian –0.11097 0.29761 –0.69429 0.47236
Other 0.54586 0.39108 –0.22066 1.31238
LLTI (no LTTI)
LLTI 1.04535 0.51441 0.03710 2.05359
Tenure (owner–occupier)
Social rent 0.53099 0.10433 0.32651 0.73547
Private rent or other tenure 0.32404 0.12062 0.08761 0.56046
LSOA IMD deprivation score
IMD score 0.00866 0.00269 0.00338 0.01394
Interaction effects
Male and LLTI 0.49223 0.17211 0.15490 0.82957
25–34 years and male 0.90736 0.49157 –0.05611 1.87083
35–49 years and male 0.86677 0.46568 –0.04595 1.77950
50–64 years and male 0.75529 0.46664 –0.15932 1.66990
65–74 years and male 0.91647 0.49107 –0.04603 1.87897
75–84 years and male 1.26521 0.51619 0.25348 2.27693
≥ 85 years and male 2.00439 0.65491 0.72077 3.28801
25–34 years and LLTI 0.29583 0.57918 –0.83935 1.43102
35–49 years and LLTI 0.18311 0.53490 –0.86529 1.23151
50–64 years and LLTI 0.22086 0.53075 –0.81940 1.26113
65–74 years and LLTI 0.03021 0.55133 –1.05040 1.11082
75–84 years and LLTI –0.46440 0.57935 –1.59992 0.67112
≥ 85 years and LLTI –1.34386 0.70379 –2.72329 0.03557
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FIGURE 164 Psychiatric morbidity (UKHLS wave 2, GHQ12 score of ≥ 6) or depression/anxiety drugs: individual
estimates and their 95% CIs. (a) MSOAs; (b) LAs; (c) CCGs; and (d) regions (GORs). (continued )
APPENDIX 27



























































FIGURE 164 Psychiatric morbidity (UKHLS wave 2, GHQ12 score of ≥ 6) or depression/anxiety drugs: individual
estimates and their 95% CIs. (a) MSOAs; (b) LAs; (c) CCGs; and (d) regions (GORs).
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Psychiatric morbidity (12-item General Health Questionnaire
score of ≥ 8) or currently prescribed depression/anxiety drugs
(UK Household Longitudinal Survey, wave 2, 2010–12)
FIGURE 165 Psychiatric morbidity (UKHLS GHQ12 score of ≥ 8) or depression/anxiety drugs: LSOA-level map.
Contains Ordnance Survey data © Crown copyright and database right 2012.
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Response variable definition, provenance and prediction
This marker of mental health needs is derived from the 2010–12 second wave of the UKHLS GHQ12 score
and questions therein about what medicines the respondent is currently being prescribed. This marker
captures respondents with a GHQ12 score of ≥ 8 using the standard 0–12 ‘caseness’ scoring approach or
who are currently being prescribed drugs for depression and/or anxiety (BNF 4.1.1–4.1.3 or 4.3.1–4.3.4487).
In the literature, a score of ≥ 4 is usually taken as being indicative of ‘possible psychiatric morbidity’, but
occasionally ≥ 6 or ≥ 8 thresholds are used. For convenience (and without clinical justification) we describe
this as a marker of ‘psychiatric morbidity’ – to distinguish it from the standard ≥ 4 threshold (‘possible
psychiatric morbidity’) and the ≥ 6 threshold (‘probable psychiatric morbidity’). We have no information
regarding other forms of treatment for mental health issues. This marker recognises the fact that
individuals may return a GHQ12 score of < 8 because they are being receiving medication for anxiety/
depression and thus aims to capture underlying levels of ‘probable psychiatric morbidity’. This marker is
affected by the fact that (a) other types of medication, and other forms of treatment, are not captured,
and (b) any sociodemographic and/or geographic variations in access to, or uptake of, prescribing.
The second wave of the UKHLS data set (n= 31,242) runs from January 2010 to January 2012 and
includes multiple household respondents aged ≥ 16 years from across the UK. Here the analytical data set
is drawn from the subset of respondents living in England for whom data are available across all model
response and predictor variables, namely that they completed the GHQ12, data are available on currently
prescribed medication, along with information on age band, sex, ethnicity, LLTI, tenure and the IMD score
of the LSOA of residence (n= 7172). A single randomly selected adult is then drawn from each household,
resulting in an analytical data set of 4682 adults aged ≥ 16 years.
TABLE 187 Psychiatric morbidity (UKHLS GHQ12 score of ≥ 8) or depression/anxiety drugs: survey counts and rates















16–24 110 25 18.5 16–24 91 5 5.2
25–34 332 73 18.0 25–34 233 28 10.7
35–49 629 153 19.6 35–49 430 70 14.0
50–64 611 157 20.4 50–64 453 84 15.6
65–74 335 63 15.8 65–74 262 43 14.1
75–84 189 31 14.1 75–84 154 31 16.8
≥ 85 41 10 19.6 ≥ 85 31 8 20.5




Model parameters are applied to microsimulated LSOA-level census data to produce estimates of the
number (and proportion) of people with treated or untreated ‘psychiatric morbidity (i.e. who would score
≥ 8 on the GHQ12 or be currently prescribed drugs for depression and/or anxiety) in each age–sex cohort
(and overall) in each of the 32,844 English LSOAs. As discussed in the report, bootstrapping is used to
derive 95% CIs for the estimates. These LSOA-level prevalence rate estimates (and 95% CIs) are
aggregated into a number of higher geographies; namely MSOAs, LAs, CCGs and regions (GORs).
Proportionate attribution is used to restructure the prevalence rate estimates to align with 2001 MSOAs, as
well as GP practice populations as defined by the 2011 NHS ADS.
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Table 188 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured
by the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444
adults) in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived
quintile; and 6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule,
variations in prevalence rates reflect variations in the socioeconomic composition of populations in the
different types of LSOA rather than variations in deprivation per se.
TABLE 188 Psychiatric morbidity (UKHLS GHQ12 score of ≥ 8) or depression/anxiety drugs: cohort-specific and
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TABLE 189 Parameter estimates: psychiatric morbidity (UKHLS GHQ12 score of ≥ 8) or currently prescribed
depression/anxiety drugs
Factor (reference group)
Model coefficients 95% CI
Estimate SE 2.5% CI 97.50%
(Intercept) –2.11468 0.24507 –2.59502 –1.63434
Age (16–24 years)
25–34 years 0.07316 0.25799 –0.43250 0.57882
35–49 years 0.16775 0.24659 –0.31557 0.65107
50–64 years 0.10954 0.25248 –0.38532 0.60439
65–74 years –0.15840 0.28465 –0.71632 0.39952
75–84 years –0.01828 0.33399 –0.67290 0.63633
≥ 85 years 1.07861 0.42293 0.24967 1.90755
Sex (females)
Males –0.65915 0.12056 –0.89544 –0.42286
Ethnicity (white)
Mixed –0.08027 0.47947 –1.02004 0.85950
Black –0.91361 0.33322 –1.56673 –0.26050
Asian –0.12705 0.33138 –0.77656 0.52246
Other 0.57534 0.41784 –0.24362 1.39431
LLTI (no LTTI)
LLTI 0.78214 0.54080 –0.27782 1.84211
Tenure (owner–occupier)
Social rent 0.39576 0.15677 0.08849 0.70302
Private rent or other tenure 0.11049 0.17083 –0.22434 0.44532
LSOA IMD deprivation score
IMD score 0.00586 0.00293 0.00011 0.0116
Interaction effects
Male and LLTI 0.73400 0.17724 0.38662 1.08138
25–34 years and LLTI 0.57259 0.59649 –0.59652 1.74171
35–49 years and LLTI 0.38225 0.55188 –0.69943 1.46394
50–64 years and LLTI 0.21091 0.54868 –0.86450 1.28631
65–74 years and LLTI 0.10867 0.57301 –1.01442 1.23177
75–84 years and LLTI –0.35462 0.60674 –1.54383 0.83459
≥ 85 years and LLTI –1.93496 0.75789 –3.42043 –0.44949
LLTI and social rent 0.32577 0.20701 –0.07997 0.73150
LLTI and private rent or other tenure 0.58345 0.27385 0.04670 1.12020
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FIGURE 167 Psychiatric morbidity (UKHLS wave 2 GHQ12 score of ≥ 8) or depression/anxiety drugs: individual
estimates and their 95% CIs. (a) MSOAs; (b) LAs; (c) CCGs; and (d) regions (GORs). (continued )
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FIGURE 167 Psychiatric morbidity (UKHLS wave 2 GHQ12 score of ≥ 8) or depression/anxiety drugs: individual
estimates and their 95% CIs. (a) MSOAs; (b) LAs; (c) CCGs; and (d) regions (GORs).
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Diagnosed with clinical depression (UK Household Longitudinal
Survey, wave 1, 2009–10)
FIGURE 168 Diagnosed with clinical depression: LSOA-level map. Contains Ordnance Survey data © Crown
copyright and database right 2012.
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Response variable definition, provenance and prediction
Based on the question ‘Has a doctor or other health professional ever told you that you have . . . clinical
depression’, here we estimate of the proportion of people in each age–sex cohort, and overall for adults
aged ≥ 16 years, who have ever had doctor diagnosed clinical depression. As this explicitly refers to a
doctor diagnosis, this marker is vulnerable to any sociodemographic or geographic variations in access to,
or uptake of, care. (A smaller, but more recent, data set provides the basis for an alternative measure of
the prevalence of adults who have ‘ever been diagnosed with clinical depression’ – see below).
The first wave of the UKHLS data set (n= 50,994) runs from January 2009 to January 2011 and includes
multiple household respondents aged ≥ 16 from across the UK. The analytical data set is drawn from a
subset of respondents living in England for whom data is available across all model response and predictor
variables, namely whether or not told by a doctor they have clinical depression, along with information on
age band, sex, ethnicity, LLTI, tenure and the IMD score of the LSOA of residence (n= 39,754). A single
randomly selected adult is then drawn from each household, resulting in an analytical data set of 24,889
adults aged ≥ 16 years.















16–24 1373 88 6.0 16–24 1095 27 2.4
25–34 2507 185 6.9 25–34 1673 70 4.0
35–49 3768 476 11.2 35–49 2843 187 6.2
50–64 2838 357 11.2 50–64 2201 201 8.4
65–74 1462 85 5.5 65–74 1196 62 4.9
75–84 938 33 3.4 75–84 716 19 2.6
≥ 85 304 10 3.2 ≥ 85 174 1 0.6




Model parameters are applied to microsimulated LSOA-level census data to produce estimates of the
number (and proportion) of people expected to ever have had doctor-diagnosed clinical depression in
each age–sex cohort (and overall) in each of the 32,844 English LSOAs. As discussed in the report,
bootstrapping is used to derive 95% CIs for the estimates. These LSOA-level prevalence rate estimates
(and 95% CIs) are aggregated into a number of higher geographies, namely MSOAs, LAs, CCGs and
regions (GORs). Proportionate attribution is used to restructure the prevalence rate estimates to align with
2001 MSOAs, as well as GP practice populations as defined by the 2011 NHS ADS.
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Table 191 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured
by the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444
adults) in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived
quintile; and 6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule,
variations in prevalence rates reflect variations in the socioeconomic composition of populations in the
different types of LSOA rather than variations in deprivation per se.
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TABLE 192 Parameter estimates: diagnosed with clinical depression
Factor (reference group)
Model coefficients 95% CI
Estimate SE 2.5% CI 97.50%
(Intercept) –3.27051 0.22045 –3.70259 –2.83844
Age (16–24 years)
25–34 years 0.14429 0.25224 –0.35010 0.63869
35–49 years 0.53848 0.22599 0.09554 0.98142
50–64 years 0.62174 0.22917 0.17256 1.07092
65–74 years 0.11690 0.26511 –0.40271 0.63652
75–84 years –0.69504 0.37895 –1.43778 0.04771
≥ 85 years –1.83787 1.08818 –3.97070 0.29495
Sex (females)
Males –1.11855 0.24067 –1.59027 –0.64682
Ethnicity (white)
Mixed –0.43799 0.27041 –0.96799 0.09201
Black –1.01326 0.16916 –1.34481 –0.68171
Asian –1.64876 0.23891 –2.11703 –1.18050
Other –1.56966 0.45377 –2.45904 –0.68027
LLTI (no LTTI)
LLTI 1.33919 0.23349 0.88155 1.79683
Tenure (owner–occupier)
Social rent 1.02122 0.25201 0.52727 1.51517
Private rent or other tenure 0.35313 0.26971 –0.17550 0.88176
LSOA deprivation score
IMD score –0.00227 0.00258 –0.00733 0.00279
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TABLE 192 Parameter estimates: diagnosed with clinical depression (continued )
Factor (reference group)
Model coefficients 95% CI
Estimate SE 2.5% CI 97.50%
Interaction effects
25–34 years and LLTI 0.00648 0.25599 –0.49525 0.50822
35–49 years and LLTI –0.03076 0.23103 –0.48357 0.42205
50–64 years and LLTI –0.42518 0.23562 –0.88701 0.03664
65–74 years and LLTI –0.81919 0.28124 –1.37043 –0.26796
75–84 years and LLTI –0.85097 0.39051 –1.61637 –0.08558
≥ 85 years and LLTI 0.06041 1.07803 –2.05253 2.17335
Male and LLTI 0.48401 0.11580 0.25705 0.71097
Mixed and LLTI 0.49348 0.35573 –0.20374 1.19071
Black and LLTI 0.50986 0.21994 0.07877 0.94095
Asian and LLTI 0.48037 0.30365 –0.11479 1.07552
Other and LLTI 0.91174 0.53938 –0.14543 1.96892
LLTI by LSOA IMD score 0.01040 0.00326 0.00402 0.01678
25–34 years and social rent –0.03381 0.30079 –0.62336 0.55573
35–49 years and social rent –0.01540 0.26980 –0.54420 0.51340
50–64 years and social rent –0.47440 0.27367 –1.01079 0.06199
65–74 years and social rent –0.80588 0.32183 –1.43665 –0.17510
75–84 years and social rent –0.27175 0.38930 –1.03478 0.49128
≥ 85 years and social rent –0.11621 0.70722 –1.50237 1.26995
25–34 years and private rent or other tenure 0.18649 0.31919 –0.43912 0.81211
35–49 years and private rent or other tenure 0.31695 0.29545 –0.26212 0.89603
50–64 years and private rent or other tenure 0.13599 0.31079 –0.47316 0.74515
65–74 years and private rent or other tenure –0.94607 0.58533 –2.09332 0.20118
75–84 years and private rent or other tenure –0.19357 0.79074 –1.74342 1.35627
≥ 85 years and private rent or other tenure 0.43774 1.17569 –1.86662 2.74209
25–34 years and male 0.31776 0.28134 –0.23366 0.86918
35–49 years and male 0.16300 0.25534 –0.33747 0.66347
50–64 years and male 0.48776 0.25577 –0.01355 0.98907
65–74 years and male 0.74655 0.29378 0.17074 1.32236
75–84 years and male 0.54506 0.37937 –0.19851 1.28863
≥ 85 years and male –0.85680 1.08710 –2.98751 1.27391
DOI: 10.3310/hsdr04140 HEALTH SERVICES AND DELIVERY RESEARCH 2016 VOL. 4 NO. 14
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Asthana et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
617
LSOA deprivation score (IMD)
–0.010 –0.005 0.000 0.005 0.010














25 – 34 years (16 – 24 years)
35 – 49 years (16 – 24 years)
50 – 64 years (16 – 24 years)
65 – 74 years (16 – 24 years)
75 – 84 years (16 – 24 years)




25 – 34 years and LLTI (16 – 24 years/no LLTI)
35 – 49 years and LLTI (16 – 24 years/no LLTI)
50 – 64 years and LLTI (16 – 24 years/no LLTI)
65 – 74 years and LLTI (16 – 24 years/no LLTI)
75 – 84 years and LLTI (16 – 24 years/no LLTI)
> 85 years and LLTI (16 – 24 years/no LLTI)
Male and LLTI (female/no LLTI)
Mixed and LLTI (white/no LLTI)
Black and LLTI (white/no LLTI)
Asian and LLTI (white/no LLTI)
Other and LLTI (white/no LLTI)
25 – 34 years and social rent (16 – 24 years/owner–occupier)
35 – 49 years and social rent (16 – 24 years/owner–occupier)
50 – 64 years and social rent (16 – 24 years/owner–occupier)
65 – 74 years and social rent (16 – 24 years/owner–occupier)
75 – 84 years and social rent (16 – 24 years/owner–occupier)
> 85 years and social rent (16 – 24 years/owner–occupier)
25 – 34 years and private rent (16 – 24 years/owner–occupier)
35 – 49 years and private rent (16 – 24 years/owner–occupier)
50 – 64 years and private rent (16 – 24 years/owner–occupier)
65 – 74 years and private rent (16 – 24 years/owner–occupier)
75 – 84 years and private rent (16 – 24 years/owner–occupier)
> 85 years and private rent (16 – 24 years/owner–occupier)
25 – 34 years and male (16 – 24 years/female)
35 – 49 years and male (16 – 24 years/female)
50 – 64 years and male (16 – 24 years/female)
65 – 74 years and male (16 – 24 years/female)
75 – 84 years and male (16 – 24 years/female)
> 85 years and male (16 – 24 years/female)
–4 –2 0 2
Parameter estimate and 95% CIs
FIGURE 169 Parameter plots: diagnosed with clinical depression.





































FIGURE 170 Diagnosed with clinical depression: individual estimates and their 95% CIs. (a) MSOAs; (b) LAs;
(c) CCGs; and (d) regions (GORs). (continued )
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FIGURE 170 Diagnosed with clinical depression: individual estimates and their 95% CIs. (a) MSOAs; (b) LAs;
(c) CCGs; and (d) regions (GORs).
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Current diagnosed clinical depression (UK Household
Longitudinal Survey wave 1, 2009–11)
FIGURE 171 Current diagnosed clinical depression: LSOA-level map. Contains Ordnance Survey data © Crown
copyright and database right 2012.
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Response variable definition, provenance and prediction
Based on the question ‘Do you still have . . . clinical depression’, which is asked of respondents who
answer yes to the question ‘Has a doctor or other health professional ever told you that you have . . .
Clinical depression’, here we estimate of the proportion of people in each age–sex cohort, and overall for
adults aged ≥ 16 years, who currently suffer from doctor-diagnosed clinical depression. As this explicitly
refers to a doctor diagnosis, this marker is vulnerable to any sociodemographic or geographic variations in
access to, or uptake of, care.
The first wave of the UKHLS data set (n= 50,994) runs from January 2009 to January 2011 and includes
multiple household respondents aged ≥ 16 years from across the UK. The analytical data set is drawn from
a subset of respondents living in England for whom data are available across all model response and
predictor variables, namely whether or not they still have doctor-diagnosed clinical depression, along with
information on age band, sex, ethnicity, LLTI, tenure and the IMD score of the LSOA of residence
(n= 39,754). A single randomly selected adult is then drawn from each household, resulting in an
analytical data set of 24,889 adults aged ≥ 16 years.








condition Has condition %
Does not have
condition Has condition %
16–24 1403 58 4.0 16–24 1100 22 2.0
25–34 2574 118 4.4 25–34 1693 50 2.9
35–49 3916 328 7.7 35–49 2888 142 4.7
50–64 2950 245 7.7 50–64 2254 148 6.2
65–74 1491 56 3.6 65–74 1216 42 3.3
75–84 943 28 2.9 75–84 720 15 2.0
≥ 85 307 7 2.2 ≥ 85 175 0 0.0
Females 13,584 840 5.8 Males 10,046 419 4.0
Adults 23,630 1259 5.1
Model parameters are applied to microsimulated LSOA-level census data to produce estimates of the
number (and proportion) of people expected to currently suffer doctor-diagnosed clinical depression in
each age–sex cohort (and overall) in each of the 32,844 English LSOAs. As discussed in the report,
bootstrapping is used to derive 95% CIs for the estimates. These LSOA-level prevalence rate estimates (and
95% CIs) are aggregated into a number of higher geographies, namely MSOAs, LAs, CCGs and regions
(GORs). Proportionate attribution is used to restructure the prevalence rate estimates to align with 2001
MSOAs, as well as GP practice populations as defined by the 2011 NHS ADS.
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Table 194 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured
by the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444
adults) in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived
quintile; and 6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule,
variations in prevalence rates reflect variations in the socioeconomic composition of populations in the
different types of LSOA rather than variations in deprivation per se.
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TABLE 195 Parameter estimates: current diagnosed clinical depression
Factor (reference group)
Model coefficients 95% CI
Estimate SE 2.5% CI 97.50%
(Intercept) –4.14813 0.19200 –4.52445 –3.77181
Age (16–24 years)
25–34 years 0.04213 0.19315 –0.33645 0.42071
35–49 years 0.52827 0.17604 0.18323 0.87330
50–64 years 0.47360 0.19216 0.09696 0.85024
65–74 years 0.03992 0.25408 –0.45808 0.53792
75–84 years –0.51029 0.38975 –1.27420 0.25362
≥ 85 years –1.31535 1.01575 –3.30623 0.67553
Sex (females)
Males –0.75317 0.11797 –0.98440 –0.52195
Ethnicity (white)
Mixed –0.12747 0.19711 –0.51380 0.25886
Black –0.54765 0.11947 –0.78180 –0.31349
Asian –1.26095 0.16566 –1.58564 –0.93626
Other –0.78907 0.25991 –1.29849 –0.27965
LLTI (no LTTI)
LLTI 1.52111 0.26927 0.99335 2.04888
Tenure (owner–occupier)
Social rent 1.22029 0.14189 0.94219 1.49838
Private rent or other tenure 0.52233 0.16543 0.19809 0.84658
LSOA deprivation score
IMD score 0.00375 0.00403 –0.00414 0.01165
Interaction effects
Male and LLTI 0.50620 0.14211 0.22767 0.78474
25–34 years and LLTI 0.35113 0.29116 –0.21954 0.92179
35–49 years and LLTI 0.19088 0.26218 –0.32298 0.70475
50–64 years and LLTI –0.11726 0.27212 –0.65061 0.41609
65–74 years and LLTI –0.69747 0.33561 –1.35526 –0.03969
75–84 years and LLTI –0.67117 0.46375 –1.58013 0.23779
≥ 85 years and LLTI –0.68891 1.11189 –2.86821 1.49039
LLTI by LSOA IMD score 0.01047 0.00385 0.00292 0.01802
Social rent by LSOA IMD score –0.00725 0.00429 –0.01567 0.00117
Private rent or other tenure by LSOA IMD score 0.00476 0.00542 –0.00587 0.01539
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FIGURE 173 Current diagnosed clinical depression: individual estimates and their 95% CIs. (a) MSOAs; (b) LAs;
(c) CCGs; and (d) regions (GORs).
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Ever been diagnosed with clinical depression (UK Household
Longitudinal Survey, waves 1 and 2)
FIGURE 174 Ever been diagnosed with clinical depression: LSOA-level map. Contains Ordnance Survey data ©
Crown copyright and database right 2012.
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Response variable definition, provenance and prediction
This concerns respondents who appear in both waves of the UKHLS and is based on the second wave
question ‘Have you been diagnosed with clinical depression since your last interview’, and the first wave
question ‘Has a doctor or other health professional ever told you that you have . . . clinical depression ‘.
Taken together, this describes whether or not people in wave 2 (who were also in wave 1) have ever been
diagnosed with clinical depression. As such, it represents a more recent estimate of the prevalence of
doctor-diagnosed clinical depression, although the size of the sample (n= 8434) is somewhat smaller than
that based on wave 1 respondents (n= 24,899). As this explicitly refers to a doctor diagnosis, this marker is
vulnerable to any sociodemographic or geographic variations in access to, or uptake of, care.
The first wave of the UKHLS data set (n= 50,994) runs from January 2009 to January 2011 and includes
multiple household respondents aged ≥ 16 years from across the UK. The second wave (n= 31,242)
runs from January 2010 to January 2012 and similarly comprises multiple household respondents aged
≥ 16 years from across the UK. Here the analytical data set is drawn from the subset of second wave
respondents living in England who were also interviewed during the first wave and for whom data is
available across all model response and predictor variables, namely that they reported (in the first wave
questionnaire) whether they had ever been doctor-diagnosed with clinical depression, that they reported
(in the second wave questionnaire) whether or not they had been diagnosed with clinical depression since
their last interview, along with information on age band, sex, ethnicity, LLTI, tenure and the IMD score of
the LSOA of residence (n= 12,756). A single randomly selected adult is then drawn from each household,
resulting in an analytical data set of 8434 adults aged ≥ 16 years.















16–24 305 27 8.1 16–24 240 9 3.6
25–34 731 70 8.7 25–34 440 22 4.8
35–49 1310 167 11.3 35–49 838 63 7.0
50–64 1126 152 11.9 50–64 821 74 8.3
65–74 591 48 7.5 65–74 488 27 5.2
75–84 396 17 4.1 75–84 259 12 4.4
≥ 85 114 4 3.4 ≥ 85 82 1 1.2




Model parameters are applied to microsimulated LSOA-level census data to produce estimates of the
number (and proportion) of people expected ever to have been diagnosed with clinical depression in
each age–sex cohort (and overall) in each of the 32,844 English LSOAs. As discussed in the report,
bootstrapping is used to derive 95% CIs for the estimates. These LSOA-level prevalence rate estimates
(and 95% CIs) are aggregated into a number of higher geographies, namely MSOAs, LAs, CCGs and
regions (GORs). Proportionate attribution is used to restructure the prevalence rate estimates to align with
2001 MSOAs, as well as GP practice populations as defined by the 2011 NHS ADS.
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Table 197 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured
by the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444
adults) in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived
quintile; and 6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule,
variations in prevalence rates reflect variations in the socioeconomic composition of populations in the
different types of LSOA rather than variations in deprivation per se.
TABLE 197 Ever been diagnosed with clinical depression: cohort-specific and overall prevalence rates by IMD
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TABLE 198 Parameter estimates: ever been diagnosed with clinical depression
Factor (reference group)
Model coefficients 95% CI
Estimate SE 2.5% CI 97.50%
(Intercept) –3.20525 0.22865 –3.65341 –2.75709
Age (16–24 years)
25–34 years 0.31673 0.24556 –0.16458 0.79803
35–49 years 0.47023 0.23336 0.01285 0.92762
50–64 years 0.54806 0.23936 0.07891 1.01721
65–74 years 0.21118 0.28107 –0.33973 0.76208
75–84 years –0.31178 0.40104 –1.09781 0.47425
≥ 85 years –1.35252 1.02813 –3.36766 0.66262
Sex (females)
Males –0.64438 0.12622 –0.89176 –0.39700
Ethnicity (white)
Mixed 0.05616 0.38218 –0.69292 0.80524
Black –0.45637 0.26057 –0.96709 0.05436
Asian –1.02405 0.37418 –1.75745 –0.29065
Other –0.45364 0.44084 –1.31769 0.41041
LLTI (no LTTI)
LLTI 1.91352 0.40822 1.11341 2.71363
Tenure (owner–occupier)
Social rent 0.69449 0.10721 0.48436 0.90463
Private rent or other tenure 0.40230 0.12501 0.15729 0.64731
LSOA deprivation score
IMD score 0.00354 0.00278 –0.00191 0.00899
Interaction effects
25–34 years and LLTI –0.78413 0.48006 –1.72504 0.15678
35–49 years and LLTI –0.42622 0.43106 –1.27111 0.41867
50–64 years and LLTI –0.84258 0.43040 –1.68616 0.00100
65–74 years and LLTI –1.30853 0.47215 –2.23395 –0.38311
75–84 years and LLTI –1.42002 0.57611 –2.54920 –0.29084
≥ 85 years and LLTI –0.90099 1.19819 –3.24944 1.44745
Male and LLTI 0.31797 0.17921 –0.03328 0.66922
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Individual CCGs (n = 211)
FIGURE 176 Ever been diagnosed with clinical depression: individual estimates and their 95% CIs. (a) MSOAs;
(b) LAs; (c) CCGs; and (d) regions (GORs). (continued )
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FIGURE 176 Ever been diagnosed with clinical depression: individual estimates and their 95% CIs. (a) MSOAs;
(b) LAs; (c) CCGs; and (d) regions (GORs).
APPENDIX 27
NIHR Journals Library www.journalslibrary.nihr.ac.uk
632
Incidence of diagnosis of clinical depression (UK Household
Longitudinal Survey, waves 1 and 2)
FIGURE 177 Incidence of diagnosis of clinical depression: LSOA-level map. Contains Ordnance Survey data © Crown
copyright and database right 2012.
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Response variable definition, provenance and prediction
Based on the question, ‘Have you been diagnosed with clinical depression since your last interview’, this
provides an approximate estimate of the incidence of diagnosis of clinical depression. (People who were
diagnosed with clinical depression prior to their first wave interview will answer ‘no’ to this question, so
this cannot be used as a marker of the prevalence of clinical depression.) This is problematic as a measure
of incidence, as the time interval (in months) between interviews varies, as illustrated below.




























Interval between interviews (months)
FIGURE 178 Interval (in months) between UKHLS respondents’ wave 1 and 2 interviews (n= 11,448).
Nevertheless, with a mean interval of 12.2 months this should yield a reasonable estimate of the annual
incidence of diagnosis of clinical depression during the period 2009–11. As this explicitly refers to a doctor
diagnosis, this measure of incidence will reflect any sociodemographic or geographic variations in access
to, or uptake of, care.
The first wave of the UKHLS data set (n= 50,994) runs from January 2009 to January 2011 and includes
multiple household respondents aged ≥ 16 years from across the UK. The second wave (n= 31,242)
runs from January 2010 to January 2012 and similarly comprises multiple household respondents aged
≥ 16 years from across the UK. Here the analytical data set is drawn from the subset of second wave
respondents living in England who were also interviewed during the first wave and for whom data are
available across all model response and predictor variables, namely that they reported (in the second wave
questionnaire) whether or not they had been diagnosed with clinical depression since their last interview,
along with information on age band, sex, ethnicity, LLTI, tenure and the IMD score of the LSOA of
residence (n= 17,614). A single randomly selected adult is then drawn from each household, resulting in
an analytical data set of 11,448 adults aged ≥ 16 years. (Note that in this instance we do not require a
valid response to the first wave question about ever having been diagnosed with clinical depression.)
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16–24 449 17 3.6 16–24 338 5 1.5
25–34 1032 28 2.6 25–34 693 8 1.1
35–49 1894 52 2.7 35–49 1268 22 1.7
50–64 1662 38 2.2 50–64 1161 17 1.4
65–74 844 11 1.3 65–74 651 6 0.9
75–84 573 5 0.9 75–84 366 4 1.1
≥ 85 187 3 1.6 ≥ 85 113 1 0.9




Model parameters are applied to microsimulated LSOA-level census data to produce estimates of the
number (and proportion) of people expected to be diagnosed with clinical depression during a 12-month
period in each age–sex cohort (and overall) in each of the 32,844 English LSOAs. As discussed in the
report, bootstrapping is used to derive 95% CIs for the estimates. These LSOA-level prevalence rate
estimates (and 95% CIs) are aggregated into a number of higher geographies, namely MSOAs, LAs, CCGs
and regions (GORs). Proportionate attribution is used to restructure the prevalence rate estimates to align
with 2001 MSOAs, as well as GP practice populations as defined by the 2011 NHS ADS.
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Table 200 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured
by the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444
adults) in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived
quintile; and 6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule,
variations in prevalence rates reflect variations in the socioeconomic composition of populations in the
different types of LSOA rather than variations in deprivation per se.
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TABLE 201 Parameter estimates: incidence of diagnosis of clinical depression
Factor (reference group)
Model coefficients 95% CI
Estimate Standard error 2.5% CI 97.50%
(Intercept) –3.31248 0.43025 –4.15577 –2.46919
Age (16–24 years)
25–34 years –0.95707 0.51064 –1.95793 0.04378
35–49 years –1.30457 0.45263 –2.19172 –0.41742
50–64 years –1.58920 0.47168 –2.51368 –0.66471
65–74 years –1.58624 0.58216 –2.72727 –0.44521
75–84 years 0.06859 0.77132 –1.44319 1.58037
≥ 85 years –2.71679 1.05476 –4.78412 –0.64946
Sex (females)
Males –0.04736 0.26441 –0.56560 0.47089
Ethnicity (white)
Mixed –0.31139 0.72894 –1.74011 1.11733
Black –0.87083 0.59020 –2.02762 0.28597
Asian 0.38725 0.38460 –0.36657 1.14108
Other –0.26081 0.73735 –1.70602 1.18439
LLTI (no LTTI)
LLTI 1.07034 0.21233 0.65418 1.4865
Tenure (owner–occupier)
Social rent 0.86057 0.35043 0.17372 1.54742
Private rent or other tenure –0.67455 0.41468 –1.48733 0.13823
LSOA deprivation score
IMD score –0.01962 0.01727 –0.05347 0.01423
Interaction effects
25–34 years by LSOA IMD 0.02603 0.01901 –0.01124 0.06329
35–49 years by LSOA IMD 0.03981 0.01707 0.00636 0.07326
50–64 years by LSOA IMD 0.03760 0.01763 0.00304 0.07215
65–74 years by LSOA IMD 0.01024 0.02357 –0.03596 0.05644
75–84 years by LSOA IMD –0.17262 0.07376 –0.31718 –0.02805
≥ 85 years by LSOA IMD 0.04914 0.03488 –0.01923 0.11750
Social rent by LSOA IMD score –0.00987 0.00994 –0.02936 0.00962
Private rent or other tenure by LSOA IMD score 0.02522 0.01191 0.00188 0.04855
LLTI and social rent 0.33369 0.32954 –0.31220 0.97959
LLTI and private rent or other tenure 0.93068 0.40569 0.13552 1.72583
Male by LSOA IMD –0.01837 0.00922 –0.03644 –0.00030
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FIGURE 180 Incidence of diagnosis of clinical depression: individual estimates and their 95% CIs. (a) MSOAs;
(b) LAs; (c) CCGs; and (d) regions (GORs).
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Incidence of diagnosis of current clinical depression
(UK Household Longitudinal Survey, waves 1 and 2)
FIGURE 181 Incidence of diagnosis of current clinical depression: LSOA-level map. Contains Ordnance Survey data
© Crown copyright and database right 2012.
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Response variable definition, provenance and prediction
Based on the question asked of respondents to the second wave of the UKHLS, ‘Have you been diagnosed
since your last interview and still have clinical depression’, this provides an approximate estimate of the
incidence of the diagnosis of clinical depression of people who, at the time of their interview, still have
clinical depression. As noted above, people diagnosed with clinical depression prior to their first wave
interview will answer ‘no’ to this question so this measure cannot be used as a marker of the prevalence of
clinical depression. Moreover, as also noted above, the time interval between individuals’ interviews varies,
albeit around a mean of 12.2 months. This can perhaps be seen as providing the basis for estimating the
incidence of ‘unresolved’ doctor-diagnosed clinical depression – which is probably too specific to be of
particular use, as a proxy for health-care needs. As this explicitly refers to a doctor diagnosis, this measure
of incidence will reflect any sociodemographic or geographic variations in access to, or uptake of, care.
The first wave of the UKHLS data set (n= 50,994) runs from January 2009 to January 2011 and includes
multiple household respondents aged ≥ 16 years from across the UK. The second wave (n= 31,242)
runs from January 2010 to January 2012 and similarly comprises multiple household respondents aged
≥ 16 years from across the UK. Here the analytical data set is drawn from the subset of second wave
respondents living in England who were also interviewed during the first wave and for whom data are
available across all model response and predictor variables, namely that they reported (in the second wave
questionnaire) whether or not they still had clinical depression which had been diagnosed since their last
interview, along with information on age band, sex, ethnicity, LLTI, tenure and the IMD score of the LSOA
of residence (n= 17,614). A single randomly selected adult is then drawn from each household, resulting
in an analytical data set of 11,448 adults aged ≥ 16. (Note that in this instance we do not require a valid
response to the first wave question about ever having been diagnosed with clinical depression.)
















16–24 456 10 2.1 16–24 338 5 1.5
25–34 1044 16 1.5 25–34 694 7 1.0
35–49 1903 43 2.2 35–49 1274 16 1.2
50–64 1668 32 1.9 50–64 1164 14 1.2
65–74 845 10 1.2 65–74 651 6 0.9
75–84 574 4 0.7 75–84 368 2 0.5
≥ 85 189 1 0.5 ≥ 85 114 0 0.0




Model parameters are applied to microsimulated LSOA-level census data to produce estimates of the
number (and proportion) of people expected to be diagnosed with clinical depression during a 12-month
period in each age–sex cohort (and overall) in each of the 32,844 English LSOAs. As discussed in the
report, bootstrapping is used to derive 95% CIs for the estimates. These LSOA-level prevalence rate
estimates (and 95% CIs) are aggregated into a number of higher geographies, namely MSOAs, LAs, CCGs
and regions (GORs). Proportionate attribution is used to restructure the prevalence rate estimates to align
with 2001 MSOAs, as well as GP practice populations as defined by the 2011 NHS ADS.
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Table 203 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured
by the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444
adults) in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived
quintile; and 6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule,
variations in prevalence rates reflect variations in the socioeconomic composition of populations in the
different types of LSOA rather than variations in deprivation per se.
TABLE 203 Incidence of diagnosis of current clinical depression: cohort-specific and overall prevalence rates by
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TABLE 204 Parameter estimates: incidence of diagnosis of current clinical depression
Factor (reference group)
Model coefficients 95% CI
Estimate SE 2.5% CI 97.50%
(Intercept) –4.11967 0.52972 –5.15792 –3.08142
Age (16–24 years)
25–34 years –0.88175 0.63640 –2.12910 0.36560
35–49 years –0.91742 0.54616 –1.98788 0.15305
50–64 years –1.13284 0.56338 –2.23706 –0.02862
65–74 years –0.83686 0.65812 –2.12678 0.45306
75–84 years 0.08223 0.92754 –1.73575 1.90021
≥ 85 years –3.61552 2.03743 –7.60888 0.37784
Sex (females)
Males –0.05319 0.30397 –0.64897 0.54260
Ethnicity (white)
Mixed –0.00459 0.73326 –1.44178 1.43261
Black –0.96635 0.72068 –2.37889 0.44618
Asian 0.63062 0.39018 –0.13414 1.39537
Other –0.01624 0.74296 –1.47245 1.43996
LLTI (no LTTI)
LLTI 1.13743 0.24735 0.65263 1.62222
Tenure (owner–occupier)
Social rent 0.87918 0.40847 0.07858 1.67977
Private rent or other tenure –0.48197 0.48164 –1.42598 0.46203
LSOA deprivation score
IMD score –0.00650 0.01904 –0.04382 0.03082
Interaction effects
25–34 years by LSOA IMD 0.01777 0.02139 –0.02415 0.05969
35–49 years by LSOA IMD 0.02792 0.01853 –0.00840 0.06425
50–64 years by LSOA IMD 0.02564 0.01909 –0.01178 0.06306
65–74 years by LSOA IMD –0.00856 0.02526 –0.05807 0.04094
75–84 years by LSOA IMD –0.15062 0.07907 –0.30560 0.00436
≥ 85 years by LSOA IMD 0.04136 0.06135 –0.07889 0.16161
LLTI and social rent 0.32212 0.37705 –0.41691 1.06114
LLTI and private rent or other tenure 1.16359 0.45993 0.26212 2.06506
Social rent by LSOA IMD score –0.00761 0.01119 –0.02954 0.01433
Private rent or other tenure by LSOA IMD score 0.02005 0.01322 –0.00585 0.04596
Male by LSOA IMD –0.01512 0.00990 –0.03452 0.00427
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FIGURE 183 Incidence of diagnosis of current clinical depression: individual estimates and their 95% CIs. (a) MSOAs;
(b) LAs; (c) CCGs; and (d) regions (GORs).
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Self-reported moderate/extreme anxiety/depression
(Health Survey for England, 2006, 2008 and 2010–11)
FIGURE 184 Self-reported moderate/extreme anxiety/depression: LSOA-level map. Contains Ordnance Survey data
© Crown copyright and database right 2012.
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Response variable definition, provenance and prediction
Based on one of the questions in the EuroQol EQ-5D general health instrument, which was included
in the HSfE in 2006, 2008 and 2010–11, respondents were asked to select one of the following options:
(a) I am not anxious or depressed; (b) I am moderately anxious or depressed; or (c) I am extremely anxious
or depressed. Here we capture those who have responded ‘yes’ to either (b) or (c). This is not entirely
independent of sociodemographic or geographic variations in access to, or uptake of, care, as individuals
may be able to state that they are not anxious or depressed because they are currently being treated (see
the alternative marker below which describes the prevalence of moderate or extreme anxiety/depression
which includes people currently being treated).
The HSfE at this time includes multiple household respondents of all ages. The analytical data set is drawn
from a subset of respondents aged ≥ 16 years for whom data are available across all model response and
predictor variables, namely whether or not they responded to this EuroQol EQ-5D question, along with
information on age band, sex, ethnicity, general health status, LLTI, tenure and the IMD quintile of the
LSOA of residence (n= 42,287). A single randomly selected adult is then drawn from each household,
resulting in an analytical data set of 23,822 adults aged ≥ 16 years.
















16–24 899 216 19.4 16–24 644 108 14.4
25–34 1670 454 21.4 25–34 1130 245 17.8
35–49 2873 842 22.7 35–49 2126 516 19.5
50–64 2471 907 26.9 50–64 2006 577 22.3
65–74 1370 449 24.7 65–74 1181 221 15.8
75–84 1009 348 25.6 75–84 698 157 18.4
≥ 85 336 145 30.1 ≥ 85 160 64 28.6




Model parameters are applied to microsimulated LSOA-level census data to produce estimates of the
number (and proportion) of people expected to report moderate or extreme anxiety and/or depression
in each age–sex cohort (and overall) in each of the 32,844 English LSOAs. As discussed in the report,
bootstrapping is used to derive 95% CIs for the estimates. These LSOA-level prevalence rate estimates (and
95% CIs) are aggregated into a number of higher geographies, namely MSOAs, LAs, CCGs and regions
(GORs). Proportionate attribution is used to restructure the prevalence rate estimates to align with 2001
MSOAs, as well as GP practice populations as defined by the 2011 NHS ADS.
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Table 206 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured
by the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444
adults) in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived
quintile; and 6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule,
variations in prevalence rates reflect variations in the socioeconomic composition of populations in the
different types of LSOA rather than variations in deprivation per se.
TABLE 206 Self-reported moderate/extreme anxiety/depression: cohort-specific and overall prevalence rates by
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TABLE 207 Parameter estimates: self-reported moderate/extreme anxiety/depression
Factor (reference group)
Model coefficients 95% CI
Estimate SE 2.5% CI 97.50%
(Intercept) –2.35267 0.12570 –2.59903 –2.10630
Age (16–24 years)
25–34 years –0.07016 0.13640 –0.33750 0.19719
35–49 years 0.04530 0.12323 –0.19624 0.28683
50–64 years 0.05842 0.12301 –0.18268 0.29952
65–74 years –0.10321 0.13134 –0.36064 0.15422
75–84 years –0.18033 0.13866 –0.45211 0.09145
≥ 85 years 0.10935 0.17036 –0.22455 0.44324
Sex (females)
Males –0.16364 0.15150 –0.46059 0.13330
Ethnicity (white)
Mixed 0.14685 0.19518 –0.23570 0.52941
Black –0.11681 0.09934 –0.31153 0.07790
Asian –0.32077 0.13632 –0.58796 –0.05357
Other 0.19295 0.27256 –0.34126 0.72717
General health status (very good health)
Good health 0.80504 0.06095 0.68558 0.92449
Fair health 1.48262 0.07000 1.34542 1.61983
Bad health 2.11738 0.09684 1.92757 2.30719
Very bad health 2.61408 0.15356 2.31309 2.91506
LLTI (no LTTI)
LLTI 0.50794 0.04362 0.42245 0.59343
Tenure (owner–occupier)
Social rent 0.12904 0.15792 –0.18048 0.43855
Private rent or other tenure 0.14439 0.15223 –0.15397 0.44276
LSOA deprivation quintile (least deprived quintile)
Second LSOA deprivation quintile –0.03083 0.05527 –0.13915 0.07749
Third LSOA deprivation quintile 0.07159 0.05445 –0.03513 0.17831
Fourth LSOA deprivation quintile 0.02644 0.05587 –0.08307 0.13595
Fifth LSOA deprivation quintile (=most deprived) 0.07720 0.05854 –0.03753 0.19194
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TABLE 207 Parameter estimates: self-reported moderate/extreme anxiety/depression (continued )
Factor (reference group)
Model coefficients 95% CI
Estimate SE 2.5% CI 97.50%
Interaction effects
25–34 years and social rent 0.44347 0.19416 0.06292 0.82403
35–49 years and social rent 0.41431 0.17771 0.06599 0.76262
50–64 years and social rent 0.28633 0.17830 –0.06315 0.63580
65–74 years and social rent –0.22477 0.19558 –0.60810 0.15856
75–84 years and social rent –0.27405 0.20052 –0.66707 0.11897
≥ 85 years and social rent –0.47514 0.25036 –0.96585 0.01557
25–34 years and private rent or other tenure 0.33057 0.18466 –0.03135 0.69250
35–49 years and private rent or other tenure 0.31291 0.17955 –0.03902 0.66484
50–64 years and private rent or other tenure 0.24802 0.19877 –0.14157 0.63762
65–74 years and private rent or other tenure 0.05444 0.26081 –0.45674 0.56562
75–84 years and private rent or other tenure –0.62048 0.32221 –1.25201 0.01105
≥ 85 years and private rent or other tenure –0.94228 0.52153 –1.96448 0.07993
25–34 years and male 0.12056 0.16428 –0.20142 0.44254
35–49 years and male 0.00340 0.15086 –0.29228 0.29908
50–64 years and male –0.10746 0.15172 –0.40483 0.18991
65–74 years and male –0.47117 0.16866 –0.80175 –0.14059
75–84 years and male –0.33054 0.18082 –0.68495 0.02387
≥ 85 and male 0.05275 0.23644 –0.41067 0.51616
Mixed and LLTI –0.59751 0.37502 –1.33255 0.13754
Black and LLTI 0.54932 0.18473 0.18725 0.91139
Asian and LLTI 0.15753 0.25551 –0.34327 0.65834
Other and LLTI –0.08964 0.57721 –1.22097 1.04169
Male and good health –0.18440 0.10060 –0.38158 0.01278
Male and fair health 0.04090 0.10869 –0.17213 0.25394
Male and bad health 0.19159 0.14549 –0.09357 0.47675
Male and very bad health 0.01818 0.23288 –0.43826 0.47463
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Fair health (very good health)
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25 – 34 years (16 – 24 years)
35 – 49 years (16 – 24 years)
50 – 64 years (16 – 24 years)
65 – 74 years (16 – 24 years)
75 – 84 years (16 – 24 years)
> 85 years (16 – 24 years)
Social rent (owner–occupier)
Private rent (owner–occupier)
Second quintile (least deprived LSOA)
Third quintile (least deprived LSOA)
Fourth quintile (least deprived LSOA)
Fifth quintile (least deprived LSOA)
25 – 34 years and social rent (16 – 24 years/owner–occupier)
35 – 49 years and social rent (16 – 24 years/owner–occupier)
50 – 64 years and social rent (16 – 24 years/owner–occupier)
65 – 74 years and social rent (16 – 24 years/owner–occupier)
75 – 84 years and social rent (16 – 24 years/owner–occupier)
> 85 years and social rent (16 – 24 years/owner–occupier)
25 – 34 years and private rent (16 – 24 years/owner–occupier)
35 – 49 years and private rent (16 – 24 years/owner–occupier)
50 – 64 years and private rent (16 – 24 years/owner–occupier)
65 – 74 years and private rent (16 – 24 years/owner–occupier)
75 – 84 years and private rent (16 – 24 years/owner–occupier)
> 85 years and private rent (16 – 24 years/owner–occupier)
25 – 34 years and male (16 – 24 years/female)
35 – 49 years and male (16 – 24 years/female)
50 – 64 years and male (16 – 24 years/female)
65 – 74 years and male (16 – 24 years/female)
75 – 84 years and male (16 – 24 years/female)
> 85 years and male (16 – 24 years/female)
Mixed and LLTI (white/no LLTI)
Black and LLTI (white/no LLTI)
Asian and LLTI (white/no LLTI)
Other and LLTI (white/no LLTI)
Male and good health (female/very good health)
Male and fair health (female/very good health)
Male and bad health (female/very good health)
Male and very bad health (female/very good health)
–2 –1 0 1 2 3
Parameter estimate and 95% CIs
FIGURE 185 Parameter plots: self-reported moderate/extreme anxiety/depression.
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Individual CCGs (n = 211)
FIGURE 186 Self-reported moderate/extreme anxiety/depression: individual estimates and their 95% CIs.
(a) MSOAs; (b) LAs; (c) CCGs; and (d) regions (GORs). (continued )
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FIGURE 186 Self-reported moderate/extreme anxiety/depression: individual estimates and their 95% CIs.
(a) MSOAs; (b) LAs; (c) CCGs; and (d) regions (GORs).
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Self-reported extreme anxiety/depression (Health Survey for
England, 2006, 2008 and 2010–11)
FIGURE 187 Self-reported extreme anxiety/depression: LSOA-level map. Contains Ordnance Survey data © Crown
copyright and database right 2012.
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Response variable definition, provenance and prediction
Based on one of the questions in the EuroQol EQ-5D General Health instrument, which was included in
the HSfE in 2006, 2008 and 2010–11, respondents were asked to select one of the following options:
(a) I am not anxious or depressed; (b) I am moderately anxious or depressed; or (c) I am extremely anxious
or depressed. Here we capture those who have responded ‘yes’ to (c). This is not entirely independent of
sociodemographic or geographic variations in access to, or uptake of, care, as individuals may be able to
state that they are not anxious or depressed because they are currently being treated (see the alternative
marker below which describes the prevalence of extreme anxiety/depression which includes people
currently being treated).
The HSfE at this time includes multiple household respondents of all ages. The analytical data set is drawn
from a subset of respondents aged ≥ 16 years for whom data are available across all model response and
predictor variables, namely whether or not they responded to this EuroQol EQ-5D question, along with
information on age band, sex, ethnicity, general health status, LLTI, tenure and the IMD quintile of the
LSOA of residence (n= 42,287). A single randomly selected adult is then drawn from each household,
resulting in an analytical data set of 23,822 adults aged ≥ 16 years.















16–24 1095 20 1.8 16–24 741 11 1.5
25–34 2073 51 2.4 25–34 1348 27 2.0
35–49 3623 92 2.5 35–49 2578 64 2.4
50–64 3259 119 3.5 50–64 2514 69 2.7
65–74 1786 33 1.8 65–74 1386 16 1.1
75–84 1336 21 1.5 75–84 840 15 1.8
≥ 85 473 8 1.7 ≥ 85 220 4 1.8




Model parameters are applied to microsimulated LSOA-level census data to produce estimates of the
number (and proportion) of people expected to report extreme anxiety and/or depression in each age–sex
cohort (and overall) in each of the 32,844 English LSOAs. As discussed in the report, bootstrapping is used
to derive 95% CIs for the estimates. These LSOA-level prevalence rate estimates (and 95% CIs) are
aggregated into a number of higher geographies, namely MSOAs, LAs, CCGs and regions (GORs).
Proportionate attribution is used to restructure the prevalence rate estimates to align with 2001 MSOAs,
as well as GP practice populations as defined by the 2011 NHS ADS.
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Table 209 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured
by the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444
adults) in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived
quintile; and 6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule,
variations in prevalence rates reflect variations in the socioeconomic composition of populations in the
different types of LSOA rather than variations in deprivation per se.
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TABLE 210 Parameter estimates: self-reported extreme anxiety/depression
Factor (reference group)
Model coefficients 95% CI
Estimate SE 2.5% CI 97.50%
(Intercept) –7.07318 0.48360 –8.02103 –6.12533
Age (16–24 years)
25–34 years 0.49172 0.38612 –0.26507 1.24852
35–49 years 0.50278 0.36251 –0.20774 1.21329
50–64 years 0.41881 0.37274 –0.31175 1.14937
65–74 years –0.95315 0.55693 –2.04474 0.13843
75–84 years –0.62873 0.56042 –1.72715 0.46968
≥ 85 years 0.15193 0.61310 –1.04975 1.35361
Sex (females)
Males –0.56682 0.30913 –1.17271 0.03907
Ethnicity (white)
Mixed –0.40724 0.45431 –1.2977 0.48321
Black –0.04028 0.22491 –0.4811 0.40055
Asian –0.64900 0.37357 –1.3812 0.08320
Other –0.04941 0.63893 –1.30171 1.20289
General health status (very good health)
Good health 1.26407 0.37143 0.53606 1.99208
Fair health 2.98812 0.36540 2.27194 3.70430
Bad health 4.54642 0.42986 3.70391 5.38894
Very bad health 4.61144 0.71974 3.20075 6.02214
LLTI (no LTTI)
LLTI 3.26350 0.67990 1.93089 4.5961
Tenure (owner–occupier)
Social rent 0.68126 0.11197 0.46180 0.90072
Private rent or other tenure 0.67180 0.14307 0.39138 0.95221
LSOA deprivation quintile (least deprived quintile)
Second LSOA deprivation quintile –0.24950 0.23774 –0.71548 0.21648
Third LSOA deprivation quintile 0.24804 0.21028 –0.16412 0.66019
Fourth LSOA deprivation quintile –0.06075 0.21534 –0.48282 0.36131
Fifth LSOA deprivation quintile (=most deprived) 0.02917 0.20788 –0.37828 0.43662
continued
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TABLE 210 Parameter estimates: self-reported extreme anxiety/depression (continued )
Factor (reference group)
Model coefficients 95% CI
Estimate SE 2.5% CI 97.50%
Interaction effects
Good health and LLTI –0.66070 0.60767 –1.85173 0.53033
Fair health and LLTI –1.45711 0.58771 –2.60904 –0.30519
Bad health and LLTI –2.00885 0.62929 –3.24225 –0.77545
Very bad health and LLTI –1.35961 0.85944 –3.04411 0.32490
25–34 years and LLTI –0.65846 0.48258 –1.60432 0.28740
35–49 years and LLTI –0.90168 0.44975 –1.78320 –0.02017
50–64 years and LLTI –1.17807 0.45448 –2.06884 –0.28729
65–74 years and LLTI –0.63567 0.62789 –1.86633 0.59500
75–84 years and LLTI –1.20204 0.63862 –2.45374 0.04966
≥ 85 years and LLTI –2.30358 0.75312 –3.77970 –0.82747
Male and second LSOA deprivation quintile 0.80773 0.39643 0.03074 1.58473
Male and third LSOA deprivation quintile –0.03841 0.38459 –0.79222 0.71539
Male and fourth LSOA deprivation quintile 0.50386 0.36813 –0.21767 1.22540
Male and fifth LSOA deprivation quintile 0.59010 0.34888 –0.09370 1.27390
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FIGURE 189 Self-reported extreme anxiety/depression: individual estimates and their 95% CIs. (a) MSOAs; (b) LAs;
(c) CCGs; and (d) regions (GORs).
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Self-reported moderate/extreme anxiety/depression or
currently prescribed anxiety/depression drugs
(Health Survey for England, 2006, 2008, 2010–11)
FIGURE 190 Self-reported moderate/extreme anxiety/depression or anxiety/depression drugs: LSOA-level map.
Contains Ordnance Survey data © Crown copyright and database right 2012.
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Response variable definition, provenance and prediction
Based on the recorded use of prescribed medication in addition to the EuroQol EQ-5D General Health
instrument that was included in the HSfE in 2006, 2008 and 2010–11, respondents were asked to select
one of the following options: (a) I am not anxious or depressed; (b) I am moderately anxious or depressed;
or (c) I am extremely anxious or depressed. Here we capture those who have responded ‘yes’ to either (b) or
(c) or who are currently prescribed drugs for depression and/or anxiety (BNF 4.1.1–4.1.3 or 4.3.1–4.3.4487).
This aims to capture individuals would have answered that they were moderately or extremely anxious or
depressed because they are receiving medication. There is no evidence available on whether they are
receiving any other type of treatment. This marker of need is vulnerable to any sociodemographic or
geographic variations in access to, or uptake of, care.
The HSfE at this time includes multiple household respondents of all ages. The analytical data set is drawn
from a subset of respondents aged ≥ 16 years for whom data are available across all model response and
predictor variables, namely: whether they responded to this EuroQol EQ-5D question, whether or not data
are available on current prescriptions, along with information on age band, sex, ethnicity, general health
status, LLTI, tenure and the IMD quintile of the LSOA of residence (n= 31,018). A single randomly selected
adult is then drawn from each household, resulting in an analytical data set of 18,301 adults aged
≥ 16 years.
TABLE 211 Self-reported moderate/extreme anxiety/depression or anxiety/depression drugs: survey counts and















16–24 607 140 18.7 16–24 437 67 13.3
25–34 1210 343 22.1 25–34 805 179 18.2
35–49 2084 805 27.9 35–49 1604 436 21.4
50–64 1901 811 29.9 50–64 1589 517 24.5
65–74 979 411 29.6 65–74 928 223 19.4
75–84 686 336 32.9 75–84 535 141 20.9
≥ 85 213 129 37.7 ≥ 85 131 54 29.2




Model parameters are applied to microsimulated LSOA-level census data to produce estimates of the
number (and proportion) of people expected to report moderate or extreme anxiety and/or depression or
who are currently being prescribed drugs for depression and/or anxiety (BNF 4.1.1–4.1.3 or 4.3.1–4.3.4487)
in each age–sex cohort (and overall) in each of the 32,844 English LSOAs. As discussed in the report,
bootstrapping is used to derive 95% CIs for the estimates. These LSOA-level prevalence rate estimates
(and 95% CIs) are aggregated into a number of higher geographies, namely MSOAs, LAs, CCGs and
regions (GORs). Proportionate attribution is used to restructure the prevalence rate estimates to align with
2001 MSOAs, as well as GP practice populations as defined by the 2011 NHS ADS.
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Table 212 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured
by the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444
adults) in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived
quintile; and 6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule,
variations in prevalence rates reflect variations in the socioeconomic composition of populations in the
different types of LSOA rather than variations in deprivation per se.
TABLE 212 Self-reported moderate/extreme anxiety/depression or anxiety/depression drugs: cohort-specific and
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TABLE 213 Parameter estimates: self-reported moderate/extreme anxiety/depression or anxiety/depression
drugs
Factor (reference group)
Model coefficients 95% CI
Estimate SE 2.5% CI 97.50%
(Intercept) –2.2187 0.14783 –2.50845 –1.92896
Age (16–24 years)
25–34 years –0.16173 0.16732 –0.48968 0.16622
35–49 years 0.29593 0.14949 0.00294 0.58892
50–64 years 0.20435 0.15015 –0.08993 0.49864
65–74 years 0.18434 0.16190 –0.13299 0.50166
75–84 years 0.32530 0.17369 –0.01514 0.66573
≥ 85 years 0.52227 0.23848 0.05486 0.98969
Sex (females)
Males –0.26273 0.16792 –0.59185 0.06640
Ethnicity (white)
Mixed 0.10428 0.19504 –0.27800 0.48656
Black 0.03031 0.09692 –0.15966 0.22027
Asian –0.49119 0.13920 –0.76402 –0.21836
Other 0.26472 0.27572 –0.27569 0.80513
General health status (very good health)
Good health 0.68153 0.05212 0.57937 0.78368
Fair health 1.45591 0.06149 1.33540 1.57643
Bad health 2.23415 0.08856 2.06057 2.40773
Very bad health 2.62240 0.14328 2.34156 2.90323
LLTI (no LTTI)
LLTI 0.69588 0.22223 0.26030 1.13146
Tenure (owner–occupier)
Social rent 0.08962 0.19648 –0.29548 0.47471
Private rent or other tenure –0.10132 0.19097 –0.47563 0.27299
LSOA deprivation quintile (least deprived quintile)
Second LSOA deprivation quintile –0.07842 0.05912 –0.19430 0.03746
Third LSOA deprivation quintile 0.02672 0.05856 –0.08805 0.14149
Fourth LSOA deprivation quintile –0.05066 0.06095 –0.17012 0.06880
Fifth LSOA deprivation quintile (=most deprived) 0.02282 0.06396 –0.10254 0.14819
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TABLE 213 Parameter estimates: self-reported moderate/extreme anxiety/depression or anxiety/depression
drugs (continued )
Factor (reference group)
Model coefficients 95% CI
Estimate SE 2.5% CI 97.50%
Interaction effects
25–34 years and social rent 0.59139 0.23859 0.12375 1.05904
35–49 years and social rent 0.40558 0.21792 –0.02155 0.83270
50–64 years and social rent 0.45105 0.21764 0.02448 0.87762
65–74 years and social rent –0.01084 0.23397 –0.46943 0.44775
75–84 years and social rent –0.23482 0.23894 –0.70314 0.23350
≥ 85 years and social rent –0.50259 0.29545 –1.08166 0.07649
25–34 years and private rent or other tenure 0.68246 0.22695 0.23764 1.12728
35–49 years and private rent or other tenure 0.51534 0.21888 0.08633 0.94435
50–64 years and private rent or other tenure 0.49046 0.23808 0.02383 0.95710
65–74 years and private rent or other tenure 0.34153 0.29711 –0.24081 0.92387
75–84 years and private rent or other tenure –0.10458 0.34220 –0.77529 0.56613
≥ 85 years and private rent or other tenure –1.00777 0.57829 –2.14122 0.12569
25–34 years and LLTI 0.12768 0.25737 –0.37676 0.63212
35–49 years and LLTI 0.02218 0.23629 –0.44095 0.48530
50–64 years and LLTI –0.12794 0.23381 –0.58622 0.33033
65–74 years and LLTI –0.30658 0.24339 –0.78364 0.17047
75–84 years and LLTI –0.46120 0.25112 –0.95340 0.03100
≥ 85 years and LLTI –0.29870 0.30186 –0.89035 0.29296
25–34 years and male 0.08055 0.20164 –0.31466 0.47577
35–49 years and male –0.15319 0.18368 –0.51320 0.20682
50–64 years and male –0.18814 0.18336 –0.54754 0.17125
65–74 years and male –0.41150 0.19644 –0.79653 –0.02647
75–84 and male –0.38921 0.20797 –0.79683 0.01840
≥ 85 years and male –0.16273 0.27007 –0.69207 0.36660
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Individual CCGs (n = 211)
FIGURE 192 Self-reported moderate/extreme anxiety/depression or anxiety/depression drugs: individual estimates
and their 95% CIs. (a) MSOAs; (b) LAs; (c) CCGs; and (d) regions (GORs). (continued )
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FIGURE 192 Self-reported moderate/extreme anxiety/depression or anxiety/depression drugs: individual estimates
and their 95% CIs. (a) MSOAs; (b) LAs; (c) CCGs; and (d) regions (GORs).
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Self-reported extreme anxiety/depression or currently
prescribed anxiety/depression drugs (Health Survey for
England, 2006, 2008 and 2010–11)
FIGURE 193 Self-reported extreme anxiety/depression or anxiety/depression drugs: LSOA-level map. Contains
Ordnance Survey data © Crown copyright and database right 2012.
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Response variable definition, provenance and prediction
Based on the recorded use of prescribed medication in addition to the EuroQol EQ-5D General Health
instrument that was included in the HSfE in 2006, 2008 and 2010–11, respondents were asked to select
one of the following options: (a) I am not anxious or depressed; (b) I am moderately anxious or depressed;
or (c) I am extremely anxious or depressed. Here we capture those who have responded ‘yes’ to (c) or who
are currently prescribed drugs for depression and/or anxiety (BNF 4.1.1–4.1.3 or 4.3.1–4.3.4487). This aims
to capture individuals would have answered that they were extremely anxious or depressed because they
are receiving medication. The problem, of course, is that here we will pick up individuals who would have
been prescribed medication for moderate anxiety/depression, and thus this marker will overestimate levels
of underlying ‘extreme’ anxiety/depression. There is no evidence available on whether or not they are
receiving any other type of treatment. This marker of need is vulnerable to any sociodemographic or
geographic variations in access to, or uptake of, care.
The HSfE at this time includes multiple household respondents of all ages. The analytical data set is drawn
from a subset of respondents aged ≥ 16 years for whom data are available across all model response and
predictor variables, namely whether or not they responded to this EuroQol EQ-5D question, whether or not
data are available on current prescriptions, along with information on age band, sex, ethnicity, general
health status, LLTI, tenure and the IMD quintile of the LSOA of residence (n= 31,018). A single randomly
selected adult is then drawn from each household, resulting in an analytical data set of 18,301 adults aged
≥ 16 years.
TABLE 214 Self-reported extreme anxiety/depression or anxiety/depression drugs: survey counts and rates for















16–24 722 25 3.3 16–24 499 5 1.0
25–34 1434 119 7.7 25–34 942 42 4.3
35–49 2544 345 11.9 35–49 1921 119 5.8
50–64 2350 362 13.3 50–64 1923 183 8.7
65–74 1204 186 13.4 65–74 1059 92 8.0
75–84 868 154 15.1 75–84 628 48 7.1
≥ 85 288 54 15.8 ≥ 85 164 21 11.4




Model parameters are applied to microsimulated LSOA-level census data to produce estimates of the
number (and proportion) of people expected to report extreme anxiety and/or depression or who are
currently being prescribed drugs for depression and/or anxiety (BNF 4.1.1–4.1.3 or 4.3.1–4.3.4487) in
each age–sex cohort (and overall) in each of the 32,844 English LSOAs. As discussed in the report,
bootstrapping is used to derive 95% CIs for the estimates. These LSOA-level prevalence rate estimates
(and 95% CIs) are aggregated into a number of higher geographies, namely MSOAs, LAs, CCGs and
regions (GORs). Proportionate attribution is used to restructure the prevalence rate estimates to align with
2001 MSOAs, as well as GP practice populations as defined by the 2011 NHS ADS.
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Table 215 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured
by the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444
adults) in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived
quintile; and 6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule,
variations in prevalence rates reflect variations in the socioeconomic composition of populations in the
different types of LSOA rather than variations in deprivation per se.
TABLE 215 Self-reported extreme anxiety/depression or anxiety/depression drugs: cohort-specific and overall
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TABLE 216 Parameter estimates: self-reported extreme anxiety/depression or anxiety/depression drugs
Factor (reference group)
Model coefficients 95% CI
Estimate Standard error 2.5% CI 97.50%
(Intercept) –4.38152 0.3483 –5.06418 –3.69886
Age (16–24 years)
25–34 years 0.58146 0.37304 –0.14970 1.31263
35–49 years 1.17971 0.34553 0.50247 1.85696
50–64 years 1.11331 0.34603 0.43509 1.79153
65–74 years 1.27780 0.35440 0.58318 1.97243
75–84 years 1.58266 0.36123 0.87465 2.29066
≥ 85 years 1.89093 0.41161 1.08418 2.69769
Sex (females)
Males –1.03266 0.10445 –1.23739 –0.82794
Ethnicity (white)
Mixed –0.53974 0.37780 –1.28023 0.20074
Black –0.76690 0.23181 –1.22125 –0.31256
Asian –0.79977 0.28152 –1.35155 –0.24799
Other –1.50919 1.04268 –3.55285 0.53447
General health status (very good)
Good health 0.74735 0.10667 0.53828 0.95643
Fair health 1.54514 0.12499 1.30016 1.79013
Bad health 2.81559 0.23646 2.35213 3.27906
Very bad health 2.99189 0.58551 1.84429 4.13949
LLTI (no LTTI)
LLTI 1.17926 0.46327 0.27126 2.08726
Tenure (owner–occupier)
Social rent 0.34248 0.44355 –0.52689 1.21184
Private rent or other tenure –0.19424 0.50045 –1.17511 0.78663
LSOA deprivation quintile (least deprived quintile)
Second quintile –0.16484 0.08802 –0.33735 0.00768
Third quintile –0.09180 0.08662 –0.26157 0.07797
Fourth quintile –0.18701 0.09006 –0.36353 –0.01049
Fifth quintile (=most deprived quintile) –0.12155 0.09256 –0.30297 0.05987
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TABLE 216 Parameter estimates: self-reported extreme anxiety/depression or anxiety/depression drugs (continued )
Factor (reference group)
Model coefficients 95% CI
Estimate Standard error 2.5% CI 97.50%
Interaction effects
25–34 years and LLTI (16–24 years/no LLTI) 0.10368 0.43812 –0.75504 0.96240
35–49 years and LLTI (16–24 years/no LLTI) –0.24095 0.41402 –1.05243 0.57053
50–64 years and LLTI (16–24 years/no LLTI) –0.32910 0.41334 –1.13924 0.48104
65–74 years and LLTI (16–24 years/no LLTI) –0.68726 0.42386 –1.51803 0.14350
75–84 years and LLTI (16–24 years/no LLTI) –1.17761 0.43139 –2.02313 –0.33208
≥ 85 years and LLTI (16–24 years/no LLTI) –1.25070 0.48478 –2.20086 –0.30054
25–34 years and social rent (16–24 years/owner–occupier) 0.39106 0.49096 –0.57122 1.35333
35–49 years and social rent (16–24 years/owner–occupier) 0.17378 0.45968 –0.72719 1.07475
50–64 years and social rent (16–24 years/owner–occupier) –0.00972 0.45811 –0.90761 0.88817
65–74 years and social rent (16–24 years/owner–occupier) –0.31994 0.47161 –1.24430 0.60443
75–84 years and social rent (16–24 years/owner–occupier) –0.56243 0.47781 –1.49894 0.37408
≥ 85 years and social rent (16–24 years/owner–occupier) –0.97606 0.53275 –2.02025 0.06813
25–34 years and private rent (16–24 years/owner–occupier) 0.74691 0.54402 –0.31938 1.81320
35–49 years and private rent (16–24 years/owner–occupier) 0.69327 0.52295 –0.33171 1.71824
50–64 years and private rent (16–24 years/owner–occupier) 0.77457 0.53215 –0.26846 1.81759
65–74 years and private rent (16–24 years/owner–occupier) 0.23286 0.58882 –0.92122 1.38694
75–84 years and private rent (16–24 years/owner–occupier) –0.03171 0.63747 –1.28116 1.21774
≥ 85 years and private rent (16–24 years/owner–occupier) –0.32670 0.82406 –1.94186 1.28845
Male and LLTI (female/no LLTI) 0.32475 0.12409 0.08152 0.56797
Good health and LLTI (very good health/no LLTI) 0.10680 0.26249 –0.40767 0.62127
Fair health and LLTI (very good health/no LLTI) –0.08419 0.26411 –0.60184 0.43346
Bad health and LLTI (very good health/no LLTI) –0.71388 0.33408 –1.36868 –0.05908
Very bad health and LLTI (very good health/no LLTI) –0.33156 0.63924 –1.58448 0.92135
Male and social rent (female/owner–occupier) 0.28414 0.13860 0.01250 0.55579
Male and private rent (female/owner–occupier) 0.09122 0.18933 –0.27986 0.46230
Male and mixed (female/white) 0.51708 0.73034 –0.91438 1.94854
Male and black (female/white) 0.46737 0.35697 –0.23230 1.16704
Male and Asian (female/white) –1.56020 1.05067 –3.61952 0.49913
Male and other (female/white) 2.24701 1.21302 –0.13051 4.62454
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25 – 34 years (16 – 24 years)
35 – 49 years (16 – 24 years)
50 – 64 years (16 – 24 years)
65 – 74 years (16 – 24 years)
75 – 84 years (16 – 24 years)
> 85 years (16 – 24 years)
Social rent (owner–occupier)
Private rent (owner–occupier)
Second quintile (least deprived LSOA)
Third quintile (least deprived LSOA)
Fourth quintile (least deprived LSOA)
Fifth quintile (least deprived LSOA)
25 – 34 years and LLTI (16 – 24 years/no LLTI)
35 – 49 years and LLTI (16 – 24 years/no LLTI)
50 – 64 years and LLTI (16 – 24 years/no LLTI)
65 – 74 years and LLTI (16 – 24 years/no LLTI)
75 – 84 years and LLTI (16 – 24 years/no LLTI)
> 85 years and LLTI (16 – 24 years/no LLTI)
25 – 34 years and social rent (16 – 24 years/owner–occupier)
35 – 49 years and social rent (16 – 24 years/owner–occupier)
50 – 64 years and social rent (16 – 24 years/owner–occupier)
65 – 74 years and social rent (16 – 24 years/owner–occupier)
75 – 84 years and social rent (16 – 24 years/owner–occupier)
> 85 years and social rent (16 – 24 years/owner–occupier)
25 – 34 years and private rent (16 – 24 years/owner–occupier)
35 – 49 years and private rent (16 – 24 years/owner–occupier)
50 – 64 years and private rent (16 – 24 years/owner–occupier)
65 – 74 years and private rent (16 – 24 years/owner–occupier)
75 – 84 years and private rent (16 – 24 years/owner–occupier)
> 85 years and private rent (16 – 24 years/owner–occupier)
Male and LLTI (female/no LLTI)
Good health and LLTI (very good health/no LLTI)
Fair health and LLTI (very good health/no LLTI)
Bad health and LLTI (very good health/no LLTI)
Very bad health and LLTI (very good health/no LLTI)
Male and social rent (female/owner–occupier)
Male and private rent (female/owner–occupier)
Male and mixed (female/white)
Male and black (female/white)
Male and Asian (female/white)
Male and other (female/white)
–2.5 0.0 2.5 5.0
Parameter estimate and 95% CIs
FIGURE 194 Parameter plots: self-reported extreme anxiety/depression or anxiety/depression drugs.
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FIGURE 195 Self-reported extreme anxiety/depression or anxiety/depression drugs: individual estimates and their
95% CIs. (a) MSOAs; (b) LAs; (c) CCGs; and (d) regions (GORs).
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Self-reported ‘ever had a mental health issue’
(Adult Psychiatric Morbidity Survey, 2007)
FIGURE 196 Self-reported ‘ever had a mental health issue’: LSOA-level map. Contains Ordnance Survey data ©
Crown copyright and database right 2012.
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Response variable definition, provenance and prediction
Respondents to the APMS were asked whether or not they had any of a series of conditions since the age
of 16 years, including ‘anxiety, depression or other mental health issue’. Unlike the three APMS variables
above, addressing mental health issues experienced during the previous 12 months, this does not specify
that they should say yes ‘even if you have not experienced any symptoms because you use medication or
an aid’. This is, however, unlikely to be an issue as, unlike the previous APMS questions, this question is
not given a time frame. This, of course, is not so much a marker of ‘need for mental health-care services’
as a measure of the proportion of people who have been affected by mental health issues at some point
in their adult life – although one might expect this to be strongly correlated with need for care services.
Although this does not specify that the ‘mental health issue’ needs to have been specifically doctor
diagnosed, this measure will still be influenced by access to, and use of, health-care services; this is in part
because individuals are presumably more likely to report a mental health issue if they have been diagnosed
with such, and in part because somatisation means that many mental health conditions initially present as
physical symptoms, and individuals will recognise that they have a ‘mental health issue’ only once it has
been identified as such by a GP or other health professional.
The APMS data set (n= 7403) comprises adults aged ≥ 16 years (living in England) and surveyed only one
person per household; thus, the analytical data set contains all respondents for whom data are available
across all model response and predictor variables, namely CIS-R score, age band, sex, ethnicity, LLTI, tenure
and IMD quintile of LSOA of residence (n= 7323).















16–24 236 57 19.5 16–24 243 23 8.6
25–34 432 182 29.6 25–34 335 72 17.7
35–49 740 376 33.7 35–49 683 188 21.6
50–64 681 332 32.8 50–64 655 142 17.8
65–74 422 139 24.8 65–74 403 57 12.4
75–84 368 67 15.4 75–84 255 30 10.5
≥ 85 112 21 15.8 ≥ 85 63 9 12.5




Model parameters are applied to microsimulated LSOA-level census data to produce estimates of the
number (and proportion) of people who have ever had a mental health issue in each age–sex cohort
(and overall) in each of the 32,844 English LSOAs. As discussed in the report, bootstrapping is used to
derive 95% CIs for the estimates. These LSOA-level prevalence rate estimates (and 95% CIs) are aggregated
into a number of higher geographies, namely MSOAs, LAs, CCGs and regions (GORs). Proportionate
attribution is used to restructure the prevalence rate estimates to align with 2001 MSOAs, as well as GP
practice populations as defined by the 2011 NHS ADS.
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Table 218 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured
by the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444
adults) in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived
quintile; and 6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule,
variations in prevalence rates reflect variations in the socioeconomic composition of populations in the
different types of LSOA rather than variations in deprivation per se.
TABLE 218 Self-reported ‘ever had a mental health issue’: cohort-specific and overall prevalence rates by IMD
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TABLE 219 Parameter estimates: self-reported ‘ever had a mental health issue’
Factor (reference group)
Model coefficients 95% CI
Estimate SE 2.5% CI 97.50%
(Intercept) –1.86456 0.16303 –2.18410 –1.54502
Age (16–24 years)
25–34 years 0.69887 0.16601 0.37349 1.02425
35–49 years 0.81609 0.15700 0.50837 1.12381
50–64 years 0.63722 0.16385 0.31607 0.95836
65–74 years 0.13799 0.19455 –0.24332 0.51931
75–84 years –0.35353 0.26269 –0.86842 0.16135
≥ 85 years –0.17576 0.49551 –1.14696 0.79545
Sex (females)
Males –0.76074 0.07577 –0.90926 –0.61222
Ethnicity (white)
Mixed 0.39582 0.29784 –0.18794 0.97957
Black –0.86151 0.20301 –1.25941 –0.46361
Asian –0.70151 0.21056 –1.11420 –0.28881
Other –1.13537 0.49610 –2.10773 –0.16301
LLTI (no LTTI)
LLTI 1.58179 0.31519 0.96401 2.19957
Tenure (owner–occupier)
Social rent 0.21547 0.09676 0.02583 0.40511
Private rent or other tenure 0.33644 0.12101 0.09926 0.57363
LSOA deprivation quintile (least deprived quintile)
Second quintile 0.10396 0.09246 –0.07725 0.28517
Third quintile 0.07976 0.09532 –0.10706 0.26659
Fourth quintile –0.05889 0.09842 –0.25179 0.13401
Fifth quintile (=most deprived quintile) –0.02319 0.10107 –0.22129 0.17490
Interaction effects
25–34 years and LLTI (16–24 years/no LLTI) –0.20380 0.36496 –0.91912 0.51152
35–49 years and LLTI (16–24 years/no LLTI) –0.11992 0.33627 –0.77901 0.53917
50–64 years and LLTI (16–24 years/no LLTI) –0.52149 0.33429 –1.17670 0.13373
65–74 years and LLTI (16–24 years/no LLTI) –0.65828 0.35651 –1.35704 0.04049
75–84 years and LLTI (16–24 years/no LLTI) –0.85698 0.40452 –1.64984 –0.06412
≥ 85 years and LLTI (16–24 years/no LLTI) –1.13189 0.61043 –2.32834 0.06456
Male and social rent (female/owner–occupier) 0.35195 0.15326 0.05155 0.65235
Male and private rent (female/owner–occupier) –0.15301 0.19703 –0.53920 0.23318
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Individual CCGs (n = 211)
FIGURE 198 Self-reported ‘ever had a mental health issue’: individual estimates and their 95% CIs. (a) MSOAs;
(b) LAs; (c) CCGs; and (d) regions (GORs). MH, mental health. (continued )
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FIGURE 198 Self-reported ‘ever had a mental health issue’: individual estimates and their 95% CIs. (a) MSOAs;
(b) LAs; (c) CCGs; and (d) regions (GORs). MH, mental health.
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Self-reported ‘mental health issue’ in last 12 months
(Adult Psychiatric Morbidity Survey, 2007)
FIGURE 199 Self-reported ‘mental health issue’ in last 12 months: LSOA-level map. Contains Ordnance Survey data
© Crown copyright and database right 2012.
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Response variable definition, provenance and prediction
Respondents to the APMS who have said that they have had any ‘anxiety, depression or other mental
health issue’ since the age of 16 years were then asked whether or not they had had the condition in the
past 12 months, and directed to say yes ‘even if you have not experienced any symptoms because you
use medication or an aid’ [our emphasis]. This addresses the issue discussed at length in the previous
section, and thus this measure is likely to be a much more reliable marker of ‘need for health care’ than
simply the presence of a self-reported long-standing mental health problem. Note, however, that this
question does not specify how long the condition has been present, and so it is not entirely comparable
(see below for a more direct comparator). Although possibly less affected by sociodemographic and/or
geographic variations in access to, or uptake of, mental health care than most measures, this will
nevertheless be influenced by access to, and use of, primary services, as somatisation means that many
mental health conditions initially present as physical symptoms, and individuals will recognise that they
have a ‘mental health issue’ only once it has been identified as such by a GP or another
health professional.
The APMS data set (n= 7403) comprises adults ≥ 16 years (living in England) and surveyed only one
person per household, and thus the analytical data set contains all respondents for whom data are
available across all model response and predictor variables, namely CIS-R score, age band, sex, ethnicity,
LLTI, tenure and IMD quintile of LSOA of residence (n= 7323).
















16–24 254 39 13.3 16–24 251 15 5.6
25–34 517 97 15.8 25–34 370 37 9.1
35–49 900 216 19.4 35–49 769 102 11.7
50–64 836 177 17.5 50–64 733 64 8.0
65–74 485 76 13.5 65–74 438 22 4.8
75–84 398 37 8.5 75–84 270 15 5.3
≥ 85 125 8 6.0 ≥ 85 65 7 9.7




Model parameters are applied to microsimulated LSOA-level census data to produce estimates of the
number (and proportion) of people expected to have had a mental health issue in the last 12 months in
each age–sex cohort (and overall) in each of the 32,844 English LSOAs. As discussed in the report,
bootstrapping is used to derive 95% CIs for the estimates. These LSOA-level prevalence rate estimates
(and 95% CIs) are aggregated into a number of higher geographies, namely MSOAs, LAs, CCGs and
regions (GORs). Proportionate attribution is used to restructure the prevalence rate estimates to align with
2001 MSOAs, as well as GP practice populations as defined by the 2011 NHS ADS.
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Table 221 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured
by the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444
adults) in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived
quintile; and 6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule,
variations in prevalence rates reflect variations in the socioeconomic composition of populations in the
different types of LSOA rather than variations in deprivation per se.
TABLE 221 Self-reported ‘mental health issue’ in last 12 months: cohort-specific and overall prevalence rates by
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TABLE 222 Parameter estimates: self-reported ‘mental health issue’ in last 12 months
Factor (reference group)
Model coefficients 95% CI
Estimate SE 2.5% CI 97.50%
(Intercept) –2.38568 0.18871 –2.75556 –2.01579
Age (16–24 years)
25–34 years 0.23602 0.18104 –0.11881 0.59085
35–49 years 0.41002 0.16815 0.08045 0.73959
50–64 years –0.08679 0.17477 –0.42933 0.25575
65–74 years –0.69976 0.19489 –1.08175 –0.31777
75–84 years –1.29323 0.21978 –1.72400 –0.86246
≥ 85 years –1.49555 0.31857 –2.11994 –0.87115
Sex (females)
Males –0.86436 0.10492 –1.06999 –0.65872
Ethnicity (white)
Mixed 0.79588 0.38042 0.05025 1.54151
Black –0.78471 0.36836 –1.50671 –0.06272
Asian –1.27150 0.51498 –2.28086 –0.26215
Other 0.04608 0.61879 –1.16674 1.25891
LLTI (no LTTI)
LLTI 1.44479 0.10197 1.24493 1.64465
Tenure (owner–occupier)
Social rent 0.03959 0.16677 –0.28729 0.36647
Private rent or other tenure –0.09467 0.19333 –0.47360 0.28426
LSOA deprivation quintile (least deprived quintile)
Second quintile –0.01192 0.12922 –0.26520 0.24136
Third quintile 0.32596 0.12485 0.08126 0.57067
Fourth quintile 0.14178 0.12930 –0.11165 0.39521
Fifth quintile (=most deprived quintile) 0.24202 0.13005 –0.01288 0.49692
Interaction effects
Male and social rent (female/owner–occupier) 0.54132 0.18738 0.17405 0.90859
Male and private rent (female/owner–occupier) –0.01901 0.26552 –0.53942 0.50141
LLTI and social rent (no LLTI/owner–occupier) 0.32311 0.18870 –0.04675 0.69296
LLTI and private rent (no LLTI/owner–occupier) 0.61669 0.25114 0.12446 1.10893
Mixed and LLTI (white/no LLTI) –0.16195 0.76671 –1.66471 1.34081
Black and LLTI (white/no LLTI) 0.75725 0.48955 –0.20226 1.71675
Asian and LLTI (white/no LLTI) 0.54326 0.62646 –0.68460 1.77112
Other and LLTI (white/no LLTI) –12.8935 165.4733 –337.221 311.4342
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FIGURE 201 Self-reported ‘mental health issue’ in last 12 months: individual estimates and their 95% CIs.
(a) MSOAs; (b) LAs; (c) CCGs; and (d) regions (GORs). MH, mental health. (continued )
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FIGURE 201 Self-reported ‘mental health issue’ in last 12 months: individual estimates and their 95% CIs.
(a) MSOAs; (b) LAs; (c) CCGs; and (d) regions (GORs). MH, mental health.
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Self-reported ‘mental health issue’ in last 12 months first
experienced at least 1 year previously (Adult Psychiatry
Morbidity Survey, 2007)
FIGURE 202 Self-reported ‘mental health issue’ in last 12 months first experienced > 1 year ago: LSOA-level map.
Contains Ordnance Survey data © Crown copyright and database right 2012.
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Response variable definition, provenance and prediction
Respondents to the APMS who state that they have had any ‘anxiety, depression or other mental health
issue’ over the last 12 months are asked whether they first suffered from it over 1 year ago. Once again,
it is explicitly stated that they should say yes ‘even if you have not experienced any symptoms because you
use medication or an aid’. This gets closer to representing a ‘long-standing’ condition (although the
wording means that a respondent could respond yes if they had a condition that lasted only, say, 4
months from 14 months to 10 months previously). Such notwithstanding, this appears a better measure of
a long-standing mental health problem than the HSfE version, which does not explicitly draw attention to
conditions controlled by drugs or other treatments. The difference between this measure (with an overall
adult prevalence rate of 10.8%) and the HSfE self-reported long-standing mental health problem
prevalence rate (of 4.4%) is possibly indicative of the impact of treatment on whether or not individuals
are likely to view their condition as having ‘troubled’ them.
Although possibly less affected by sociodemographic and/or geographic variations in access to, or uptake
of, mental health care than most measures, this will nevertheless be influenced by access to, and use of,
primary services, as somatisation means that many mental health conditions initially present as physical
symptoms, and individuals will only recognise that they have a ‘mental health issue’ once it has been
identified as such by a GP or another health professional.
The APMS data set (n= 7403) comprises adults ≥ 16 (living in England) and surveyed only one person per
household, and thus the analytical data set contains all respondents for whom data are available across all
model response and predictor variables, namely CIS-R score, age band, sex, ethnicity, LLTI, tenure and IMD
quintile of LSOA of residence (n= 7323).
TABLE 223 Self-reported ‘mental health issue’ in last 12 months first experienced > 1 year ago: survey counts and















16–24 261 32 10.9 16–24 254 12 4.5
25–34 533 81 13.2 25–34 377 30 7.4
35–49 934 182 16.3 35–49 777 94 10.8
50–64 855 158 15.6 50–64 738 59 7.4
65–74 495 66 11.8 65–74 439 21 4.6
75–84 403 32 7.4 75–84 273 12 4.2
≥ 85 128 5 3.8 ≥ 85 66 6 8.3




Model parameters are applied to microsimulated LSOA-level census data to produce estimates of the
number (and proportion) of people expected to have had a mental health issue in the last 12 months which
was first experienced over a year ago in each age–sex cohort (and overall) in each of the 32,844 English
LSOAs. As discussed in the report, bootstrapping is used to derive 95% CIs for the estimates. These
LSOA-level prevalence rate estimates (and 95% CIs) are aggregated into a number of higher geographies,
namely MSOAs, LAs, CCGs and regions (GORs). Proportionate attribution is used to restructure the
prevalence rate estimates to align with 2001 MSOAs, as well as GP practice populations as defined by the
2011 NHS ADS.
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Table 224 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured
by the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444
adults) in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived
quintile; and 6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule,
variations in prevalence rates reflect variations in the socioeconomic composition of populations in the
different types of LSOA rather than variations in deprivation per se.
TABLE 224 Self-reported ‘mental health issue’ in last 12 months first experienced > 1 year ago: cohort-specific and
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TABLE 225 Parameter estimates: self-reported ‘mental health issue’ in last 12 months first experienced > 1 year ago
Factor (reference group)
Model coefficients 95% CI
Estimate SE 2.5% CI 97.50%
(Intercept) –2.59699 0.23278 –3.05324 –2.14073
Age (16–24 years)
25–34 years 0.17544 0.23531 –0.28576 0.63664
35–49 years 0.29708 0.21984 –0.13380 0.72797
50–64 years –0.05439 0.22575 –0.49686 0.38809
65–74 years –0.66610 0.24793 –1.15205 –0.18015
75–84 years –1.43499 0.28043 –1.98463 –0.88535
≥ 85 years –2.37380 0.50399 –3.36162 –1.38598
Sex (females)
Males –1.08677 0.38109 –1.83371 –0.33983
Ethnicity (white)
Mixed 0.62252 0.36925 –0.10121 1.34624
Black –0.38898 0.24988 –0.87874 0.10078
Asian –0.82749 0.29855 –1.41266 –0.24232
Other –1.91437 1.03052 –3.93418 0.10544
LLTI (no LTTI)
LLTI 1.54562 0.10689 1.33611 1.75513
Tenure (owner–occupier)
Social rent –0.07567 0.1869 –0.44199 0.29065
Private rent or other tenure –0.09106 0.2128 –0.50816 0.32603
LSOA deprivation quintile (least deprived quintile)
Second quintile –0.01877 0.13969 –0.29256 0.25503
Third quintile 0.35788 0.13371 0.09581 0.61994
Fourth quintile 0.16900 0.13862 –0.10271 0.44070
Fifth quintile (=most deprived quintile) 0.26538 0.13903 –0.00712 0.53788
Interaction effects
LLTI and social rent (no LLTI/owner–occupier) 0.45305 0.20597 0.04934 0.85675
LLTI and private rent (no LLTI/owner–occupier) 0.65368 0.26659 0.13116 1.17620
Male and social rent (female/owner–occupier) 0.56772 0.19858 0.17850 0.95693
Male and private rent (female/owner–occupier) –0.02797 0.28986 –0.59610 0.54017
25–34 years and male (16–24 years/female) 0.16070 0.43479 –0.69149 1.01290
35–49 years and male (16–24 years/female) 0.46049 0.39553 –0.31475 1.23572
50–64 years and male (16–24 years/female) 0.10807 0.40556 –0.68682 0.90296
65–74 years and male (16–24 years/female) 0.01093 0.45489 –0.88065 0.90251
75–84 years and male (16–24 years/female) 0.43998 0.51072 –0.56103 1.44100
≥ 85 years and male (16–24 years female) 2.07077 0.73329 0.63353 3.50801
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FIGURE 204 Self-reported ‘mental health issue’ in last 12 months first experienced > 1 year ago: individual
estimates and their 95% CIs. (a) MSOAs; (b) LAs; (c) CCGs; and (d) regions (GORs). MH, mental health. (continued )
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FIGURE 204 Self-reported ‘mental health issue’ in last 12 months first experienced > 1 year ago: individual
estimates and their 95% CIs. (a) MSOAs; (b) LAs; (c) CCGs; and (d) regions (GORs). MH, mental health.
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Self-reported ‘mental health issue’ in last 12 months first
experienced at least 5 years previously (Adult Psychiatry
Morbidity Survey, 2007)
FIGURE 205 Self-reported ‘mental health issue’ in last 12 months first experienced > 5 years ago: LSOA-level map.
Contains Ordnance Survey data © Crown copyright and database right 2012.
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Response variable definition, provenance and prediction
Respondents to the APMS who stated that they have had any ‘anxiety, depression or other mental health
issue’ over the last 12 months were asked whether they first suffered from it over 5 years ago. Once again,
it is explicitly stated that they should say yes ‘even if you have not experienced any symptoms because you
use medication or an aid’. This undoubtedly represents a ‘long-standing’ condition. Indeed, it might be
interpreted as providing the basis for a measure of long-term, ongoing and unresolved mental health
problems. Once again, although possibly less affected by sociodemographic and/or geographic variations in
access to, or uptake of, mental health care than most measures, this will nevertheless be influenced by
access to, and use of, primary services, as somatisation means many mental health conditions initially
present as physical symptoms, and individuals will recognise that they have a ‘mental health issue’ only
once it has been identified as such by a GP or another health professional.
The APMS data set (n= 7403) comprises adults ≥ 16 years (living in England) and surveyed only one
person per household, and thus the analytical data set contains all respondents for whom data are
available across all model response and predictor variables, namely CIS-R score, age band, sex, ethnicity,
LLTI, tenure and IMD quintile of LSOA of residence (n= 7323).
TABLE 226 Self-reported ‘mental health issue’ in last 12 months first experienced > 5 years ago: survey counts and















16–24 282 11 3.8 16–24 263 3 1.1
25–34 563 51 8.3 25–34 387 20 4.9
35–49 981 135 12.1 35–49 804 67 7.7
50–64 888 125 12.3 50–64 758 39 4.9
65–74 510 51 9.1 65–74 442 18 3.9
75–84 414 21 4.8 75–84 279 6 2.1
≥ 85 131 2 1.5 ≥ 85 68 4 5.6




Model parameters are applied to microsimulated LSOA-level census data to produce estimates of the
number (and proportion) of people expected to have a long-term, ongoing and unresolved mental health
issue in each age–sex cohort (and overall) in each of the 32,844 English LSOAs. As discussed in the report,
bootstrapping is used to derive 95% CIs for the estimates. These LSOA-level prevalence rate estimates
(and 95% CIs) are aggregated into a number of higher geographies, namely MSOAs, LAs, CCGs, and
regions (GORs). Proportionate attribution is used to restructure the prevalence rate estimates to align with
2001 MSOAs, as well as GP practice populations as defined by the 2011 NHS ADS.
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Table 227 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured
by the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444
adults) in the third least deprived quintile; 6568 LSOAs (9,650,576 adults) in the fourth least deprived
quintile; and 6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule,
variations in prevalence rates reflect variations in the socioeconomic composition of populations in the
different types of LSOA rather than variations in deprivation per se.
TABLE 227 Self-reported ‘mental health issue’ in last 12 months first experienced > 5 years ago: cohort-specific and
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TABLE 228 Parameter estimates: self-reported ‘mental health issue’ in last 12 months first experienced
> 5 years ago
Factor (reference group)
Model coefficients 95% CI
Estimate SE 2.5% CI 97.50%
(Intercept) –3.92446 0.31244 –4.53684 –3.31209
Age (16–24 years)
25–34 years 0.96319 0.30647 0.36250 1.56388
35–49 years 1.31954 0.29113 0.74893 1.89016
50–64 years 0.89480 0.29564 0.31535 1.47425
65–74 years 0.33609 0.31171 –0.27485 0.94704
75–84 years –0.58354 0.34780 –1.26522 0.09815
≥ 85 years –1.06311 0.50606 –2.05499 –0.07122
Sex (females)
Males –0.87628 0.13412 –1.13916 –0.61340
Ethnicity (white)
Mixed 0.55396 0.45978 –0.34721 1.45512
Black –0.41378 0.30214 –1.00598 0.17842
Asian –1.03550 0.38095 –1.78217 –0.28884
Other –13.2644 214.23420 –433.163 406.63450
LLTI (no LTTI)
LLTI 1.57871 0.12409 1.33550 1.82193
Tenure (owner–occupier)
Social rent –0.12239 0.23336 –0.57977 0.33499
Private rent or other tenure –0.11457 0.27212 –0.64793 0.41879
LSOA deprivation quintile (least deprived quintile)
Second quintile –0.05368 0.16417 –0.37545 0.26810
Third quintile 0.32647 0.15567 0.02136 0.63158
Fourth quintile 0.13382 0.16187 –0.18346 0.45109
Fifth quintile (=most deprived quintile) 0.26904 0.16137 –0.04726 0.58533
Interaction effects
Male and social rent 0.63092 0.22852 0.18302 1.07882
Male and private rent or other tenure –0.05390 0.34161 –0.72347 0.61566
LLTI and social rent 0.47104 0.25159 –0.02208 0.96417
LLTI and private rent or other tenure 0.71913 0.32289 0.08627 1.35198
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Individual LAs (n = 326)







































FIGURE 207 Self-reported ‘mental health issue’ in last 12 months first experienced > 5 years ago: individual
estimates and their 95% CIs. (a) MSOAs; (b) LAs; (c) CCGs; and (d) regions (GORs). (continued )
APPENDIX 27


























































FIGURE 207 Self-reported ‘mental health issue’ in last 12 months first experienced > 5 years ago: individual
estimates and their 95% CIs. (a) MSOAs; (b) LAs; (c) CCGs; and (d) regions (GORs).
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Self-reported long-standing mental health problem
(Health Survey for England, 2006–11)
FIGURE 208 Self-reported long-standing mental health problem: LSOA-level map. Contains Ordnance Survey data
© Crown copyright and database right 2012.
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Response variable definition, provenance and prediction
Based on an open-ended question asked annually of all HSfE respondents: ‘Do you have any long-standing
illness, disability or infirmity? By long-standing I mean anything that has troubled you over a period of
time, or that is likely to affect you over a period of time?’ Responses are then categorised under a number
of standard headings, including ‘04 Mental illness/anxiety/depression/nerves (nes)’.
Interestingly, and perhaps counterintuitively, there is surprisingly little overlap between those currently
being prescribed medication for a mental health problem (BNF 4.1.x–4.6.x and 4.10.x–4.11.x487) and those
self-reporting a long-standing mental health problem. Thus, as shown in Table 229, although 2.5% of all
adult (≥ 16 years) respondents in the 2006–11 HSfE were self-reporting a mental health problem and
being prescribed mental health medication, 1.4% of adults self-reported a mental health problem without
being prescribed mental health medication (although we have no evidence on other treatments, such as
IAPT or other psychological therapies), and fully 6.8% were being prescribed mental health medication
while not admitting to a long-standing mental health problem. In other words, 73% of people being
prescribed mental health medication did not see themselves as having a mental health problem.
A very similar pattern is observed if one restricts the range of drugs to hypnotics and anxiolytics
(BNF 4.1.1–4.1.3487) and antidepressants (BNF 4.3.1–4.3.4487), as shown in Table 230.























No 36,792 2360 39,152 90.2% 5.8% 96.0%
Yes 686 930 1616 1.7% 2.3% 4.0%
Total 37,478 3290 40,768 91.9% 8.1% 100.0%























No 36,373 2779 39,152 89.2% 6.8% 96.0%
Yes 586 1030 1616 1.4% 2.5% 4.0%
Total 36,959 3809 40,768 90.7% 9.3% 100.0%
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It is difficult to satisfactorily account for this dislocation between self-reported long-standing mental health
problems and use of prescription drugs. Presumably some individuals on medication do not consider their
mental health problems to be long-standing, but one must suspect that a majority of respondents on
medication simply feel that their mental health problem is being sufficiently well contained that it has not
‘troubled’ them over a period of time, and is not likely to in the future. To that extent the presence of a
self-reported mental health problem cannot be taken as a marker of health care. What we have here
seems to be a marker of a recognised but unresolved mental health problem. Once again, this statistic is
likely to be affected by sociodemographic and/or geographic variations in access to, or uptake of,
prescribing – particularly if it is indeed the treatment people receive which means that respondents are
able to ‘dismiss’ the fact that they may have a longstanding mental health problem.
The HSfE at this time includes multiple household respondents of all ages. The analytical data set is drawn
from a subset of respondents aged ≥ 16 years for whom data are available across all model response and
predictor variables, namely whether or not they responded to this EQ-5D question, along with information
on age band, sex, ethnicity, general health status, LLTI, tenure and the IMD quintile of the LSOA of
residence (n= 57,363). A single randomly selected adult is then drawn from each household, resulting in
an analytical data set of 30,228 adults aged ≥ 16 years.
















16–24 727 38 5.0 16–24 444 12 2.6
25–34 2382 144 5.7 25–34 1638 69 4.0
35–49 4666 278 5.6 35–49 3461 184 5.0
50–64 3823 242 6.0 50–64 3653 177 4.6
65–74 2030 53 2.5 65–74 2123 43 2.0
75–84 1673 39 2.3 75–84 1293 22 1.7
≥ 85 649 15 2.3 ≥ 85 344 6 1.7




Model parameters are applied to microsimulated LSOA-level census data to produce estimates of the
number (and proportion) of people expected to report a long-standing mental health problem in each
age–sex cohort (and overall) in each of the 32,844 English LSOAs. As discussed in the report,
bootstrapping is used to derive 95% CIs for the estimates. These LSOA-level prevalence rate estimates
(and 95% CIs) are aggregated into a number of higher geographies, namely MSOAs, LAs, CCGs and
regions (GORs). Proportionate attribution is used to restructure the prevalence rate estimates to align with
2001 MSOAs, as well as GP practice populations as defined by the 2011 NHS ADS.
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Table 232 summarises how expected prevalence rates vary by age, sex and local deprivation (as measured
by the 2010 IMD). There are 6569 LSOAs (with 9,226,227 adults) classified as being in the least deprived
quintile; 6568 LSOAs (9,525,344 adults) in the second least deprived quintile; 6568 LSOAs (9,658,444
adults) in the third least deprived quintile; 6,568 LSOAs (9,650,576 adults) in the fourth least deprived
quintile; and 6568 LSOAs (9,535,167 adults) in the most deprived quintile. Note that, as a general rule,
variations in prevalence rates reflect variations in the socioeconomic composition of populations in the
different types of LSOA rather than variations in deprivation per se.
TABLE 232 Self-reported long-standing mental health problem: cohort-specific and overall prevalence rates by IMD
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TABLE 233 Parameter estimates: self-reported long-standing mental health problem
Factor (reference group)
Model coefficients 95% CI
Estimate SE 2.5% CI 97.50%
(Intercept) –6.79508 0.79181 –8.34702 –5.24314
Age (16–24 years)
25–34 years 1.65553 0.79558 0.09620 3.21487
35–49 years 1.87656 0.78253 0.34280 3.41032
50–64 years 1.77963 0.78466 0.24169 3.31757
65–74 years 1.27734 0.80621 –0.30284 2.85751
75–84 years 1.31947 0.81630 –0.28048 2.91942
≥ 85 years –11.70700 183.49721 –371.36154 347.94754
Sex (females)
Males –0.71655 0.13897 –0.98894 –0.44416
Ethnicity (white)
Mixed –0.17813 0.28754 –0.74170 0.38545
Black –0.58186 0.17214 –0.91924 –0.24447
Asian –1.44568 0.30316 –2.03987 –0.85148
Other –0.62763 0.45913 –1.52753 0.27228
General health status (very good health)
Good health 0.94617 0.17035 0.61229 1.28005
Fair health 1.88629 0.18403 1.52559 2.24700
Bad health 2.59859 0.32908 1.95358 3.24359
Very bad health 3.13191 0.56661 2.02134 4.24247
LLTI (no LTTI)
LLTI 3.55988 0.42736 2.72226 4.39749
Tenure (owner–occupier)
Social rent 1.80924 0.77058 0.29890 3.31957
Private rent or other tenure 1.46351 0.77232 –0.05024 2.97725
LSOA deprivation quintile (least deprived quintile)
Second quintile –0.04968 0.11419 –0.27349 0.17412
Third quintile 0.05808 0.10885 –0.15527 0.27143
Fourth quintile 0.17668 0.10630 –0.03166 0.38503
Fifth quintile (=most deprived quintile) 0.08311 0.10900 –0.13053 0.29675
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TABLE 233 Parameter estimates: self-reported long-standing mental health problem (continued )
Factor (reference group)
Model coefficients 95% CI
Estimate SE 2.5% CI 97.50%
Interaction effects
25–34 years and LLTI –0.40779 0.39564 –1.18326 0.36767
35–49 years and LLTI –1.16162 0.37346 –1.89361 –0.42963
50–64 years and LLTI –1.45454 0.37954 –2.19845 –0.71064
65–74 years and LLTI –1.89815 0.43336 –2.74755 –1.04876
75–84 years and LLTI –2.56334 0.45679 –3.45865 –1.66802
≥ 85 years and LLTI 10.938320 183.49599 –348.71382 370.590460
Male and social rent 0.77654 0.13954 0.50305 1.05004
Male and private rent or other tenure 0.24249 0.18815 –0.12628 0.61125
25–34 years and social rent –1.34892 0.79313 –2.90345 0.20561
35–49 years and social rent –1.09327 0.77826 –2.61866 0.43212
50–64 years and social rent –1.57804 0.77909 –3.10506 –0.05102
65–74 years and social rent –2.30459 0.81071 –3.89358 –0.71560
75–84 years and social rent –1.76754 0.81942 –3.37361 –0.16147
≥ 85 years and social rent –2.60182 0.9347 –4.43384 –0.76981
25–34 years and private rent or other tenure –1.16539 0.79734 –2.72817 0.39739
35–49 years and private rent or other tenure –1.11734 0.78904 –2.66386 0.42918
50–64 years and private rent or other tenure –0.92503 0.79384 –2.48096 0.63091
65–74 years and private rent or other tenure –1.07728 0.87441 –2.79113 0.63656
75–84 years and private rent or other tenure –1.01182 0.94135 –2.85686 0.83321
≥ 85 years and private rent or other tenure –0.75172 1.10436 –2.91626 1.41281
Good health and LLTI –0.61271 0.27205 –1.14593 –0.07948
Fair health and LLTI –0.87063 0.27319 –1.40609 –0.33517
Bad health and LLTI –1.33602 0.38832 –2.09713 –0.57491
Very bad health and LLTI –1.67931 0.60965 –2.87422 –0.48439
Male and LLTI 0.27043 0.14713 –0.01795 0.55880
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25 – 34 years (16 – 24 years)
35 – 49 years (16 – 24 years)
50 – 64 years (16 – 24 years)
65 – 74 years (16 – 24 years)
75 – 84 years (16 – 24 years)
> 85 years (16 – 24 years)
Good health (very good health)
Fair health (very good health)
Bad health (very good health)




Second quintile (least deprived LSOA)
Third quintile (least deprived LSOA)
Fourth quintile (least deprived LSOA)
Fifth quintile (least deprived LSOA)
25 – 34 years and LLTI (16 – 24 years/no LLTI)
35 – 49 years and LLTI (16 – 24 years/no LLTI)
50 – 64 years and LLTI (16 – 24 years/no LLTI)
65 – 74 years and LLTI (16 – 24 years/no LLTI)
75 – 84 years and LLTI (16 – 24 years/no LLTI)
> 85 years and LLTI (16 – 24 years/no LLTI)
Male and social rent (female/owner–occupier)
Male and private rent (female/owner–occupier)
25 – 34 years and social rent (16 – 24 years/owner–occupier)
35 – 49 years and social rent (16 – 24 years/owner–occupier)
50 – 64 years and social rent (16 – 24 years/owner–occupier)
65 – 74 years and social rent (16 – 24 years/owner–occupier)
75 – 84 years and social rent (16 – 24 years/owner–occupier)
> 85 years and social rent (16 – 24 years/owner–occupier)
25 – 34 years and private rent (16 – 24 years/owner–occupier)
35 – 49 years and private rent (16 – 24 years/owner–occupier)
50 – 64 years and private rent (16 – 24 years/owner–occupier)
65 – 74 years and private rent (16 – 24 years/owner–occupier)
75 – 84 years and private rent (16 – 24 years/owner–occupier)
> 85 years and private rent (16 – 24 years/owner–occupier)
Good health and LLTI (very good health/no LLTI)
Fair health and LLTI (very good health/no LLTI)
Bad health and LLTI (very good health/no LLTI)
Very bad health and LLTI (very good health/no LLTI)
Male and LLTI (female/no LLTI)
–5.0 –2.5 0 2.5
Parameter estimate and 95% CIs
FIGURE 209 Parameter plots: self-reported long-standing mental health problem.
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FIGURE 210 Self-reported long-standing mental health problem: individual estimates and their 95% CIs. (a) MSOAs;
(b) LAs; (c) CCGs; and (d) regions (GORs). LS, long-standing; MH, mental health. (continued )
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FIGURE 210 Self-reported long-standing mental health problem: individual estimates and their 95% CIs. (a) MSOAs;
(b) LAs; (c) CCGs; and (d) regions (GORs). LS, long-standing; MH, mental health.
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